AGE|AGE_SPECIFIC_CI_LOWER|AGE_SPECIFIC_CI_UPPER|AGE_SPECIFIC_RATE|COUNT|EVENT_TYPE|POPULATION|SITE|YEAR
1-4|2.5|3.0|2.7|420|Mortality|15285559|All Cancer Sites Combined|2001
1-4|21.0|22.5|21.7|3287|Incidence|15123657|All Cancer Sites Combined|2001
1-4|0.5|0.8|0.7|100|Mortality|15285559|Brain and Other Nervous System|2001
1-4|3.7|4.4|4.0|610|Incidence|15123657|Brain and Other Nervous System|2001
1-4|~|~|~|~|Mortality|7468536|Cervix|2001
1-4|~|~|~|~|Incidence|7389458|Cervix|2001
1-4|~|~|~|~|Mortality|15285559|Colon and Rectum|2001
1-4|~|~|~|~|Incidence|15123657|Colon and Rectum|2001
1-4|~|~|~|~|Mortality|7468536|Corpus and Uterus, NOS|2001
1-4|~|~|~|~|Incidence|7389458|Corpus and Uterus, NOS|2001
1-4|~|~|~|~|Mortality|15285559|Esophagus|2001
1-4|~|~|~|~|Incidence|15123657|Esophagus|2001
1-4|~|~|~|~|Mortality|7468536|Female Breast|2001
1-4|~|~|~|~|Incidence|7389458|Female Breast|2001
1-4|~|~|~|~|Incidence|7389458|Female Breast, <i>in situ</i>|2001
1-4|~|~|~|~|Mortality|15285559|Hodgkin Lymphoma|2001
1-4|0.1|0.2|0.1|20|Incidence|15123657|Hodgkin Lymphoma|2001
1-4|.|.|.|.|Mortality|15285559|Kaposi Sarcoma|2001
1-4|~|~|~|~|Incidence|15123657|Kaposi Sarcoma|2001
1-4|0.1|0.2|0.1|22|Mortality|15285559|Kidney and Renal Pelvis|2001
1-4|1.9|2.3|2.1|318|Incidence|15123657|Kidney and Renal Pelvis|2001
1-4|~|~|~|~|Mortality|15285559|Larynx|2001
1-4|~|~|~|~|Incidence|15123657|Larynx|2001
1-4|0.9|1.2|1.0|155|Mortality|15285559|Leukemias|2001
1-4|8.5|9.5|9.0|1357|Incidence|15123657|Leukemias|2001
1-4|0.1|0.2|0.1|18|Mortality|15285559|Liver and Intrahepatic Bile Duct|2001
1-4|0.3|0.5|0.4|63|Incidence|15123657|Liver and Intrahepatic Bile Duct|2001
1-4|~|~|~|~|Mortality|15285559|Lung and Bronchus|2001
1-4|~|~|~|~|Incidence|15123657|Lung and Bronchus|2001
1-4|~|~|~|~|Mortality|7468536|Male and Female Breast|2001
1-4|~|~|~|~|Incidence|7389458|Male and Female Breast|2001
1-4|~|~|~|~|Incidence|7389458|Male and Female Breast, <i>in situ</i>|2001
1-4|~|~|~|~|Mortality|15285559|Melanomas of the Skin|2001
1-4|~|~|~|~|Incidence|15123657|Melanomas of the Skin|2001
1-4|~|~|~|~|Mortality|15285559|Mesothelioma|2001
1-4|~|~|~|~|Incidence|15123657|Mesothelioma|2001
1-4|~|~|~|~|Mortality|15285559|Myeloma|2001
1-4|~|~|~|~|Incidence|15123657|Myeloma|2001
1-4|~|~|~|~|Mortality|15285559|Non-Hodgkin Lymphoma|2001
1-4|0.5|0.7|0.6|90|Incidence|15123657|Non-Hodgkin Lymphoma|2001
1-4|~|~|~|~|Mortality|15285559|Oral Cavity and Pharynx|2001
1-4|0.1|0.2|0.1|17|Incidence|15123657|Oral Cavity and Pharynx|2001
1-4|~|~|~|~|Mortality|7468536|Ovary|2001
1-4|~|~|~|~|Incidence|7389458|Ovary|2001
1-4|~|~|~|~|Mortality|15285559|Pancreas|2001
1-4|~|~|~|~|Incidence|15123657|Pancreas|2001
1-4|~|~|~|~|Mortality|7817023|Prostate|2001
1-4|~|~|~|~|Incidence|7734199|Prostate|2001
1-4|~|~|~|~|Mortality|15285559|Stomach|2001
1-4|~|~|~|~|Incidence|15123657|Stomach|2001
1-4|~|~|~|~|Mortality|7817023|Testis|2001
1-4|0.3|0.6|0.4|32|Incidence|7734199|Testis|2001
1-4|~|~|~|~|Mortality|15285559|Thyroid|2001
1-4|~|~|~|~|Incidence|15123657|Thyroid|2001
1-4|~|~|~|~|Mortality|15285559|Urinary Bladder|2001
1-4|~|~|~|~|Incidence|15123657|Urinary Bladder|2001
10-14|2.2|2.7|2.5|515|Mortality|20978678|All Cancer Sites Combined|2001
10-14|12.8|13.8|13.3|2756|Incidence|20758808|All Cancer Sites Combined|2001
10-14|0.5|0.7|0.6|130|Mortality|20978678|Brain and Other Nervous System|2001
10-14|2.5|3.0|2.7|569|Incidence|20758808|Brain and Other Nervous System|2001
10-14|~|~|~|~|Mortality|10231469|Cervix|2001
10-14|~|~|~|~|Incidence|10123827|Cervix|2001
10-14|~|~|~|~|Mortality|20978678|Colon and Rectum|2001
10-14|~|~|~|~|Incidence|20758808|Colon and Rectum|2001
10-14|~|~|~|~|Mortality|10231469|Corpus and Uterus, NOS|2001
10-14|~|~|~|~|Incidence|10123827|Corpus and Uterus, NOS|2001
10-14|~|~|~|~|Mortality|20978678|Esophagus|2001
10-14|~|~|~|~|Incidence|20758808|Esophagus|2001
10-14|~|~|~|~|Mortality|10231469|Female Breast|2001
10-14|~|~|~|~|Incidence|10123827|Female Breast|2001
10-14|~|~|~|~|Incidence|10123827|Female Breast, <i>in situ</i>|2001
10-14|~|~|~|~|Mortality|20978678|Hodgkin Lymphoma|2001
10-14|1.1|1.4|1.2|252|Incidence|20758808|Hodgkin Lymphoma|2001
10-14|.|.|.|.|Mortality|20978678|Kaposi Sarcoma|2001
10-14|~|~|~|~|Incidence|20758808|Kaposi Sarcoma|2001
10-14|~|~|~|~|Mortality|20978678|Kidney and Renal Pelvis|2001
10-14|0.1|0.2|0.1|31|Incidence|20758808|Kidney and Renal Pelvis|2001
10-14|~|~|~|~|Mortality|20978678|Larynx|2001
10-14|~|~|~|~|Incidence|20758808|Larynx|2001
10-14|0.7|0.9|0.8|170|Mortality|20978678|Leukemias|2001
10-14|2.7|3.2|3.0|618|Incidence|20758808|Leukemias|2001
10-14|~|~|~|~|Mortality|20978678|Liver and Intrahepatic Bile Duct|2001
10-14|0.1|0.1|0.1|19|Incidence|20758808|Liver and Intrahepatic Bile Duct|2001
10-14|~|~|~|~|Mortality|20978678|Lung and Bronchus|2001
10-14|~|~|~|~|Incidence|20758808|Lung and Bronchus|2001
10-14|~|~|~|~|Mortality|10231469|Male and Female Breast|2001
10-14|~|~|~|~|Incidence|10123827|Male and Female Breast|2001
10-14|~|~|~|~|Incidence|10123827|Male and Female Breast, <i>in situ</i>|2001
10-14|~|~|~|~|Mortality|20978678|Melanomas of the Skin|2001
10-14|0.3|0.5|0.4|78|Incidence|20758808|Melanomas of the Skin|2001
10-14|~|~|~|~|Mortality|20978678|Mesothelioma|2001
10-14|~|~|~|~|Incidence|20758808|Mesothelioma|2001
10-14|~|~|~|~|Mortality|20978678|Myeloma|2001
10-14|~|~|~|~|Incidence|20758808|Myeloma|2001
10-14|0.1|0.2|0.1|27|Mortality|20978678|Non-Hodgkin Lymphoma|2001
10-14|1.1|1.4|1.3|263|Incidence|20758808|Non-Hodgkin Lymphoma|2001
10-14|~|~|~|~|Mortality|20978678|Oral Cavity and Pharynx|2001
10-14|0.2|0.4|0.3|60|Incidence|20758808|Oral Cavity and Pharynx|2001
10-14|~|~|~|~|Mortality|10231469|Ovary|2001
10-14|0.4|0.8|0.6|59|Incidence|10123827|Ovary|2001
10-14|~|~|~|~|Mortality|20978678|Pancreas|2001
10-14|~|~|~|~|Incidence|20758808|Pancreas|2001
10-14|~|~|~|~|Mortality|10747209|Prostate|2001
10-14|~|~|~|~|Incidence|10634981|Prostate|2001
10-14|~|~|~|~|Mortality|20978678|Stomach|2001
10-14|~|~|~|~|Incidence|20758808|Stomach|2001
10-14|~|~|~|~|Mortality|10747209|Testis|2001
10-14|0.1|0.3|0.2|17|Incidence|10634981|Testis|2001
10-14|~|~|~|~|Mortality|20978678|Thyroid|2001
10-14|0.5|0.7|0.6|117|Incidence|20758808|Thyroid|2001
10-14|~|~|~|~|Mortality|20978678|Urinary Bladder|2001
10-14|~|~|~|~|Incidence|20758808|Urinary Bladder|2001
15-19|3.3|3.8|3.6|732|Mortality|20456284|All Cancer Sites Combined|2001
15-19|20.7|22.0|21.3|4310|Incidence|20227701|All Cancer Sites Combined|2001
15-19|0.4|0.6|0.5|104|Mortality|20456284|Brain and Other Nervous System|2001
15-19|2.0|2.4|2.2|436|Incidence|20227701|Brain and Other Nervous System|2001
15-19|~|~|~|~|Mortality|9908897|Cervix|2001
15-19|0.1|0.3|0.2|21|Incidence|9797025|Cervix|2001
15-19|~|~|~|~|Mortality|20456284|Colon and Rectum|2001
15-19|0.2|0.4|0.3|56|Incidence|20227701|Colon and Rectum|2001
15-19|~|~|~|~|Mortality|9908897|Corpus and Uterus, NOS|2001
15-19|~|~|~|~|Incidence|9797025|Corpus and Uterus, NOS|2001
15-19|~|~|~|~|Mortality|20456284|Esophagus|2001
15-19|~|~|~|~|Incidence|20227701|Esophagus|2001
15-19|~|~|~|~|Mortality|9908897|Female Breast|2001
15-19|0.1|0.3|0.2|22|Incidence|9797025|Female Breast|2001
15-19|~|~|~|~|Incidence|9797025|Female Breast, <i>in situ</i>|2001
15-19|0.1|0.2|0.1|25|Mortality|20456284|Hodgkin Lymphoma|2001
15-19|3.0|3.5|3.2|650|Incidence|20227701|Hodgkin Lymphoma|2001
15-19|.|.|.|.|Mortality|20456284|Kaposi Sarcoma|2001
15-19|~|~|~|~|Incidence|20227701|Kaposi Sarcoma|2001
15-19|~|~|~|~|Mortality|20456284|Kidney and Renal Pelvis|2001
15-19|0.1|0.2|0.2|33|Incidence|20227701|Kidney and Renal Pelvis|2001
15-19|~|~|~|~|Mortality|20456284|Larynx|2001
15-19|~|~|~|~|Incidence|20227701|Larynx|2001
15-19|1.0|1.3|1.1|225|Mortality|20456284|Leukemias|2001
15-19|2.6|3.1|2.9|577|Incidence|20227701|Leukemias|2001
15-19|~|~|~|~|Mortality|20456284|Liver and Intrahepatic Bile Duct|2001
15-19|0.1|0.2|0.1|28|Incidence|20227701|Liver and Intrahepatic Bile Duct|2001
15-19|~|~|~|~|Mortality|20456284|Lung and Bronchus|2001
15-19|0.1|0.2|0.2|33|Incidence|20227701|Lung and Bronchus|2001
15-19|~|~|~|~|Mortality|9908897|Male and Female Breast|2001
15-19|0.1|0.3|0.2|22|Incidence|9797025|Male and Female Breast|2001
15-19|~|~|~|~|Incidence|9797025|Male and Female Breast, <i>in situ</i>|2001
15-19|~|~|~|~|Mortality|20456284|Melanomas of the Skin|2001
15-19|1.5|1.8|1.6|333|Incidence|20227701|Melanomas of the Skin|2001
15-19|~|~|~|~|Mortality|20456284|Mesothelioma|2001
15-19|~|~|~|~|Incidence|20227701|Mesothelioma|2001
15-19|~|~|~|~|Mortality|20456284|Myeloma|2001
15-19|~|~|~|~|Incidence|20227701|Myeloma|2001
15-19|0.2|0.4|0.3|61|Mortality|20456284|Non-Hodgkin Lymphoma|2001
15-19|1.6|2.0|1.8|357|Incidence|20227701|Non-Hodgkin Lymphoma|2001
15-19|~|~|~|~|Mortality|20456284|Oral Cavity and Pharynx|2001
15-19|0.3|0.4|0.4|72|Incidence|20227701|Oral Cavity and Pharynx|2001
15-19|~|~|~|~|Mortality|9908897|Ovary|2001
15-19|0.9|1.4|1.1|112|Incidence|9797025|Ovary|2001
15-19|~|~|~|~|Mortality|20456284|Pancreas|2001
15-19|~|~|~|~|Incidence|20227701|Pancreas|2001
15-19|~|~|~|~|Mortality|10547387|Prostate|2001
15-19|~|~|~|~|Incidence|10430676|Prostate|2001
15-19|~|~|~|~|Mortality|20456284|Stomach|2001
15-19|~|~|~|~|Incidence|20227701|Stomach|2001
15-19|~|~|~|~|Mortality|10547387|Testis|2001
15-19|3.0|3.7|3.3|345|Incidence|10430676|Testis|2001
15-19|~|~|~|~|Mortality|20456284|Thyroid|2001
15-19|1.5|1.8|1.6|328|Incidence|20227701|Thyroid|2001
15-19|~|~|~|~|Mortality|20456284|Urinary Bladder|2001
15-19|0.1|0.2|0.1|25|Incidence|20227701|Urinary Bladder|2001
5-9|2.2|2.7|2.4|493|Mortality|20173362|All Cancer Sites Combined|2001
5-9|11.1|12.0|11.6|2306|Incidence|19962452|All Cancer Sites Combined|2001
5-9|0.7|1.0|0.8|170|Mortality|20173362|Brain and Other Nervous System|2001
5-9|3.1|3.6|3.4|673|Incidence|19962452|Brain and Other Nervous System|2001
5-9|~|~|~|~|Mortality|9844298|Cervix|2001
5-9|~|~|~|~|Incidence|9740654|Cervix|2001
5-9|~|~|~|~|Mortality|20173362|Colon and Rectum|2001
5-9|~|~|~|~|Incidence|19962452|Colon and Rectum|2001
5-9|~|~|~|~|Mortality|9844298|Corpus and Uterus, NOS|2001
5-9|~|~|~|~|Incidence|9740654|Corpus and Uterus, NOS|2001
5-9|~|~|~|~|Mortality|20173362|Esophagus|2001
5-9|~|~|~|~|Incidence|19962452|Esophagus|2001
5-9|~|~|~|~|Mortality|9844298|Female Breast|2001
5-9|~|~|~|~|Incidence|9740654|Female Breast|2001
5-9|~|~|~|~|Incidence|9740654|Female Breast, <i>in situ</i>|2001
5-9|~|~|~|~|Mortality|20173362|Hodgkin Lymphoma|2001
5-9|0.3|0.5|0.4|85|Incidence|19962452|Hodgkin Lymphoma|2001
5-9|.|.|.|.|Mortality|20173362|Kaposi Sarcoma|2001
5-9|~|~|~|~|Incidence|19962452|Kaposi Sarcoma|2001
5-9|0.1|0.2|0.1|30|Mortality|20173362|Kidney and Renal Pelvis|2001
5-9|0.4|0.6|0.5|102|Incidence|19962452|Kidney and Renal Pelvis|2001
5-9|~|~|~|~|Mortality|20173362|Larynx|2001
5-9|~|~|~|~|Incidence|19962452|Larynx|2001
5-9|0.6|0.9|0.8|153|Mortality|20173362|Leukemias|2001
5-9|3.5|4.0|3.8|751|Incidence|19962452|Leukemias|2001
5-9|~|~|~|~|Mortality|20173362|Liver and Intrahepatic Bile Duct|2001
5-9|0.1|0.2|0.1|20|Incidence|19962452|Liver and Intrahepatic Bile Duct|2001
5-9|~|~|~|~|Mortality|20173362|Lung and Bronchus|2001
5-9|~|~|~|~|Incidence|19962452|Lung and Bronchus|2001
5-9|~|~|~|~|Mortality|9844298|Male and Female Breast|2001
5-9|~|~|~|~|Incidence|9740654|Male and Female Breast|2001
5-9|~|~|~|~|Incidence|9740654|Male and Female Breast, <i>in situ</i>|2001
5-9|~|~|~|~|Mortality|20173362|Melanomas of the Skin|2001
5-9|0.1|0.2|0.1|24|Incidence|19962452|Melanomas of the Skin|2001
5-9|~|~|~|~|Mortality|20173362|Mesothelioma|2001
5-9|~|~|~|~|Incidence|19962452|Mesothelioma|2001
5-9|~|~|~|~|Mortality|20173362|Myeloma|2001
5-9|~|~|~|~|Incidence|19962452|Myeloma|2001
5-9|~|~|~|~|Mortality|20173362|Non-Hodgkin Lymphoma|2001
5-9|0.8|1.1|0.9|187|Incidence|19962452|Non-Hodgkin Lymphoma|2001
5-9|~|~|~|~|Mortality|20173362|Oral Cavity and Pharynx|2001
5-9|0.1|0.2|0.1|20|Incidence|19962452|Oral Cavity and Pharynx|2001
5-9|~|~|~|~|Mortality|9844298|Ovary|2001
5-9|0.1|0.3|0.2|20|Incidence|9740654|Ovary|2001
5-9|~|~|~|~|Mortality|20173362|Pancreas|2001
5-9|~|~|~|~|Incidence|19962452|Pancreas|2001
5-9|~|~|~|~|Mortality|10329064|Prostate|2001
5-9|~|~|~|~|Incidence|10221798|Prostate|2001
5-9|~|~|~|~|Mortality|20173362|Stomach|2001
5-9|~|~|~|~|Incidence|19962452|Stomach|2001
5-9|~|~|~|~|Mortality|10329064|Testis|2001
5-9|~|~|~|~|Incidence|10221798|Testis|2001
5-9|~|~|~|~|Mortality|20173362|Thyroid|2001
5-9|0.1|0.2|0.1|21|Incidence|19962452|Thyroid|2001
5-9|~|~|~|~|Mortality|20173362|Urinary Bladder|2001
5-9|~|~|~|~|Incidence|19962452|Urinary Bladder|2001
<1|1.3|2.1|1.6|66|Mortality|4012658|All Cancer Sites Combined|2001
<1|23.2|26.3|24.7|982|Incidence|3970113|All Cancer Sites Combined|2001
<1|0.2|0.6|0.4|16|Mortality|4012658|Brain and Other Nervous System|2001
<1|3.2|4.4|3.7|148|Incidence|3970113|Brain and Other Nervous System|2001
<1|~|~|~|~|Mortality|1962905|Cervix|2001
<1|~|~|~|~|Incidence|1942094|Cervix|2001
<1|~|~|~|~|Mortality|4012658|Colon and Rectum|2001
<1|~|~|~|~|Incidence|3970113|Colon and Rectum|2001
<1|~|~|~|~|Mortality|1962905|Corpus and Uterus, NOS|2001
<1|~|~|~|~|Incidence|1942094|Corpus and Uterus, NOS|2001
<1|~|~|~|~|Mortality|4012658|Esophagus|2001
<1|~|~|~|~|Incidence|3970113|Esophagus|2001
<1|~|~|~|~|Mortality|1962905|Female Breast|2001
<1|~|~|~|~|Incidence|1942094|Female Breast|2001
<1|~|~|~|~|Incidence|1942094|Female Breast, <i>in situ</i>|2001
<1|~|~|~|~|Mortality|4012658|Hodgkin Lymphoma|2001
<1|~|~|~|~|Incidence|3970113|Hodgkin Lymphoma|2001
<1|.|.|.|.|Mortality|4012658|Kaposi Sarcoma|2001
<1|~|~|~|~|Incidence|3970113|Kaposi Sarcoma|2001
<1|~|~|~|~|Mortality|4012658|Kidney and Renal Pelvis|2001
<1|1.5|2.4|1.9|75|Incidence|3970113|Kidney and Renal Pelvis|2001
<1|~|~|~|~|Mortality|4012658|Larynx|2001
<1|~|~|~|~|Incidence|3970113|Larynx|2001
<1|0.4|0.9|0.6|25|Mortality|4012658|Leukemias|2001
<1|3.5|4.7|4.1|161|Incidence|3970113|Leukemias|2001
<1|~|~|~|~|Mortality|4012658|Liver and Intrahepatic Bile Duct|2001
<1|0.8|1.4|1.1|42|Incidence|3970113|Liver and Intrahepatic Bile Duct|2001
<1|~|~|~|~|Mortality|4012658|Lung and Bronchus|2001
<1|~|~|~|~|Incidence|3970113|Lung and Bronchus|2001
<1|~|~|~|~|Mortality|1962905|Male and Female Breast|2001
<1|~|~|~|~|Incidence|1942094|Male and Female Breast|2001
<1|~|~|~|~|Incidence|1942094|Male and Female Breast, <i>in situ</i>|2001
<1|~|~|~|~|Mortality|4012658|Melanomas of the Skin|2001
<1|~|~|~|~|Incidence|3970113|Melanomas of the Skin|2001
<1|~|~|~|~|Mortality|4012658|Mesothelioma|2001
<1|~|~|~|~|Incidence|3970113|Mesothelioma|2001
<1|~|~|~|~|Mortality|4012658|Myeloma|2001
<1|~|~|~|~|Incidence|3970113|Myeloma|2001
<1|~|~|~|~|Mortality|4012658|Non-Hodgkin Lymphoma|2001
<1|~|~|~|~|Incidence|3970113|Non-Hodgkin Lymphoma|2001
<1|~|~|~|~|Mortality|4012658|Oral Cavity and Pharynx|2001
<1|~|~|~|~|Incidence|3970113|Oral Cavity and Pharynx|2001
<1|~|~|~|~|Mortality|1962905|Ovary|2001
<1|~|~|~|~|Incidence|1942094|Ovary|2001
<1|~|~|~|~|Mortality|4012658|Pancreas|2001
<1|~|~|~|~|Incidence|3970113|Pancreas|2001
<1|~|~|~|~|Mortality|2049753|Prostate|2001
<1|~|~|~|~|Incidence|2028019|Prostate|2001
<1|~|~|~|~|Mortality|4012658|Stomach|2001
<1|~|~|~|~|Incidence|3970113|Stomach|2001
<1|~|~|~|~|Mortality|2049753|Testis|2001
<1|0.6|1.6|1.0|21|Incidence|2028019|Testis|2001
<1|~|~|~|~|Mortality|4012658|Thyroid|2001
<1|~|~|~|~|Incidence|3970113|Thyroid|2001
<1|~|~|~|~|Mortality|4012658|Urinary Bladder|2001
<1|~|~|~|~|Incidence|3970113|Urinary Bladder|2001
1-4|2.3|2.9|2.6|402|Mortality|15477731|All Cancer Sites Combined|2002
1-4|20.6|22.1|21.4|3273|Incidence|15313864|All Cancer Sites Combined|2002
1-4|0.6|0.9|0.7|114|Mortality|15477731|Brain and Other Nervous System|2002
1-4|4.2|4.8|4.5|686|Incidence|15313864|Brain and Other Nervous System|2002
1-4|~|~|~|~|Mortality|7564711|Cervix|2002
1-4|~|~|~|~|Incidence|7484518|Cervix|2002
1-4|~|~|~|~|Mortality|15477731|Colon and Rectum|2002
1-4|~|~|~|~|Incidence|15313864|Colon and Rectum|2002
1-4|~|~|~|~|Mortality|7564711|Corpus and Uterus, NOS|2002
1-4|~|~|~|~|Incidence|7484518|Corpus and Uterus, NOS|2002
1-4|~|~|~|~|Mortality|15477731|Esophagus|2002
1-4|~|~|~|~|Incidence|15313864|Esophagus|2002
1-4|~|~|~|~|Mortality|7564711|Female Breast|2002
1-4|~|~|~|~|Incidence|7484518|Female Breast|2002
1-4|~|~|~|~|Incidence|7484518|Female Breast, <i>in situ</i>|2002
1-4|~|~|~|~|Mortality|15477731|Hodgkin Lymphoma|2002
1-4|~|~|~|~|Incidence|15313864|Hodgkin Lymphoma|2002
1-4|.|.|.|.|Mortality|15477731|Kaposi Sarcoma|2002
1-4|~|~|~|~|Incidence|15313864|Kaposi Sarcoma|2002
1-4|~|~|~|~|Mortality|15477731|Kidney and Renal Pelvis|2002
1-4|1.8|2.3|2.0|312|Incidence|15313864|Kidney and Renal Pelvis|2002
1-4|~|~|~|~|Mortality|15477731|Larynx|2002
1-4|~|~|~|~|Incidence|15313864|Larynx|2002
1-4|0.5|0.8|0.7|104|Mortality|15477731|Leukemias|2002
1-4|8.2|9.1|8.6|1319|Incidence|15313864|Leukemias|2002
1-4|0.1|0.3|0.2|28|Mortality|15477731|Liver and Intrahepatic Bile Duct|2002
1-4|0.3|0.6|0.4|67|Incidence|15313864|Liver and Intrahepatic Bile Duct|2002
1-4|~|~|~|~|Mortality|15477731|Lung and Bronchus|2002
1-4|~|~|~|~|Incidence|15313864|Lung and Bronchus|2002
1-4|~|~|~|~|Mortality|7564711|Male and Female Breast|2002
1-4|~|~|~|~|Incidence|7484518|Male and Female Breast|2002
1-4|~|~|~|~|Incidence|7484518|Male and Female Breast, <i>in situ</i>|2002
1-4|~|~|~|~|Mortality|15477731|Melanomas of the Skin|2002
1-4|0.1|0.2|0.1|16|Incidence|15313864|Melanomas of the Skin|2002
1-4|~|~|~|~|Mortality|15477731|Mesothelioma|2002
1-4|~|~|~|~|Incidence|15313864|Mesothelioma|2002
1-4|~|~|~|~|Mortality|15477731|Myeloma|2002
1-4|~|~|~|~|Incidence|15313864|Myeloma|2002
1-4|~|~|~|~|Mortality|15477731|Non-Hodgkin Lymphoma|2002
1-4|0.6|0.9|0.7|109|Incidence|15313864|Non-Hodgkin Lymphoma|2002
1-4|~|~|~|~|Mortality|15477731|Oral Cavity and Pharynx|2002
1-4|~|~|~|~|Incidence|15313864|Oral Cavity and Pharynx|2002
1-4|~|~|~|~|Mortality|7564711|Ovary|2002
1-4|~|~|~|~|Incidence|7484518|Ovary|2002
1-4|~|~|~|~|Mortality|15477731|Pancreas|2002
1-4|~|~|~|~|Incidence|15313864|Pancreas|2002
1-4|~|~|~|~|Mortality|7913020|Prostate|2002
1-4|~|~|~|~|Incidence|7829346|Prostate|2002
1-4|~|~|~|~|Mortality|15477731|Stomach|2002
1-4|~|~|~|~|Incidence|15313864|Stomach|2002
1-4|~|~|~|~|Mortality|7913020|Testis|2002
1-4|0.2|0.5|0.3|27|Incidence|7829346|Testis|2002
1-4|~|~|~|~|Mortality|15477731|Thyroid|2002
1-4|~|~|~|~|Incidence|15313864|Thyroid|2002
1-4|~|~|~|~|Mortality|15477731|Urinary Bladder|2002
1-4|~|~|~|~|Incidence|15313864|Urinary Bladder|2002
10-14|2.3|2.7|2.5|535|Mortality|21261421|All Cancer Sites Combined|2002
10-14|12.2|13.2|12.7|2676|Incidence|21040663|All Cancer Sites Combined|2002
10-14|0.5|0.8|0.6|135|Mortality|21261421|Brain and Other Nervous System|2002
10-14|2.4|2.9|2.7|560|Incidence|21040663|Brain and Other Nervous System|2002
10-14|~|~|~|~|Mortality|10371422|Cervix|2002
10-14|~|~|~|~|Incidence|10263170|Cervix|2002
10-14|~|~|~|~|Mortality|21261421|Colon and Rectum|2002
10-14|0.1|0.1|0.1|19|Incidence|21040663|Colon and Rectum|2002
10-14|~|~|~|~|Mortality|10371422|Corpus and Uterus, NOS|2002
10-14|~|~|~|~|Incidence|10263170|Corpus and Uterus, NOS|2002
10-14|~|~|~|~|Mortality|21261421|Esophagus|2002
10-14|~|~|~|~|Incidence|21040663|Esophagus|2002
10-14|~|~|~|~|Mortality|10371422|Female Breast|2002
10-14|~|~|~|~|Incidence|10263170|Female Breast|2002
10-14|~|~|~|~|Incidence|10263170|Female Breast, <i>in situ</i>|2002
10-14|~|~|~|~|Mortality|21261421|Hodgkin Lymphoma|2002
10-14|1.1|1.4|1.2|259|Incidence|21040663|Hodgkin Lymphoma|2002
10-14|.|.|.|.|Mortality|21261421|Kaposi Sarcoma|2002
10-14|~|~|~|~|Incidence|21040663|Kaposi Sarcoma|2002
10-14|~|~|~|~|Mortality|21261421|Kidney and Renal Pelvis|2002
10-14|0.1|0.2|0.1|26|Incidence|21040663|Kidney and Renal Pelvis|2002
10-14|~|~|~|~|Mortality|21261421|Larynx|2002
10-14|~|~|~|~|Incidence|21040663|Larynx|2002
10-14|0.7|0.9|0.8|168|Mortality|21261421|Leukemias|2002
10-14|2.6|3.0|2.8|583|Incidence|21040663|Leukemias|2002
10-14|~|~|~|~|Mortality|21261421|Liver and Intrahepatic Bile Duct|2002
10-14|0.0|0.1|0.1|17|Incidence|21040663|Liver and Intrahepatic Bile Duct|2002
10-14|~|~|~|~|Mortality|21261421|Lung and Bronchus|2002
10-14|~|~|~|~|Incidence|21040663|Lung and Bronchus|2002
10-14|~|~|~|~|Mortality|10371422|Male and Female Breast|2002
10-14|~|~|~|~|Incidence|10263170|Male and Female Breast|2002
10-14|~|~|~|~|Incidence|10263170|Male and Female Breast, <i>in situ</i>|2002
10-14|~|~|~|~|Mortality|21261421|Melanomas of the Skin|2002
10-14|0.3|0.5|0.4|78|Incidence|21040663|Melanomas of the Skin|2002
10-14|~|~|~|~|Mortality|21261421|Mesothelioma|2002
10-14|~|~|~|~|Incidence|21040663|Mesothelioma|2002
10-14|~|~|~|~|Mortality|21261421|Myeloma|2002
10-14|~|~|~|~|Incidence|21040663|Myeloma|2002
10-14|0.1|0.3|0.2|42|Mortality|21261421|Non-Hodgkin Lymphoma|2002
10-14|1.0|1.3|1.1|237|Incidence|21040663|Non-Hodgkin Lymphoma|2002
10-14|~|~|~|~|Mortality|21261421|Oral Cavity and Pharynx|2002
10-14|0.2|0.3|0.3|54|Incidence|21040663|Oral Cavity and Pharynx|2002
10-14|~|~|~|~|Mortality|10371422|Ovary|2002
10-14|0.4|0.7|0.6|57|Incidence|10263170|Ovary|2002
10-14|~|~|~|~|Mortality|21261421|Pancreas|2002
10-14|~|~|~|~|Incidence|21040663|Pancreas|2002
10-14|~|~|~|~|Mortality|10889999|Prostate|2002
10-14|~|~|~|~|Incidence|10777493|Prostate|2002
10-14|~|~|~|~|Mortality|21261421|Stomach|2002
10-14|~|~|~|~|Incidence|21040663|Stomach|2002
10-14|~|~|~|~|Mortality|10889999|Testis|2002
10-14|0.1|0.3|0.2|24|Incidence|10777493|Testis|2002
10-14|~|~|~|~|Mortality|21261421|Thyroid|2002
10-14|0.4|0.6|0.5|97|Incidence|21040663|Thyroid|2002
10-14|~|~|~|~|Mortality|21261421|Urinary Bladder|2002
10-14|~|~|~|~|Incidence|21040663|Urinary Bladder|2002
15-19|3.3|3.8|3.5|723|Mortality|20610370|All Cancer Sites Combined|2002
15-19|21.1|22.4|21.7|4430|Incidence|20386049|All Cancer Sites Combined|2002
15-19|0.4|0.6|0.5|108|Mortality|20610370|Brain and Other Nervous System|2002
15-19|2.0|2.4|2.2|452|Incidence|20386049|Brain and Other Nervous System|2002
15-19|~|~|~|~|Mortality|9981879|Cervix|2002
15-19|0.1|0.3|0.2|23|Incidence|9872299|Cervix|2002
15-19|~|~|~|~|Mortality|20610370|Colon and Rectum|2002
15-19|0.2|0.3|0.2|47|Incidence|20386049|Colon and Rectum|2002
15-19|~|~|~|~|Mortality|9981879|Corpus and Uterus, NOS|2002
15-19|~|~|~|~|Incidence|9872299|Corpus and Uterus, NOS|2002
15-19|~|~|~|~|Mortality|20610370|Esophagus|2002
15-19|~|~|~|~|Incidence|20386049|Esophagus|2002
15-19|~|~|~|~|Mortality|9981879|Female Breast|2002
15-19|0.1|0.3|0.2|19|Incidence|9872299|Female Breast|2002
15-19|~|~|~|~|Incidence|9872299|Female Breast, <i>in situ</i>|2002
15-19|0.1|0.2|0.1|27|Mortality|20610370|Hodgkin Lymphoma|2002
15-19|3.0|3.5|3.3|669|Incidence|20386049|Hodgkin Lymphoma|2002
15-19|.|.|.|.|Mortality|20610370|Kaposi Sarcoma|2002
15-19|~|~|~|~|Incidence|20386049|Kaposi Sarcoma|2002
15-19|~|~|~|~|Mortality|20610370|Kidney and Renal Pelvis|2002
15-19|0.1|0.2|0.1|28|Incidence|20386049|Kidney and Renal Pelvis|2002
15-19|~|~|~|~|Mortality|20610370|Larynx|2002
15-19|~|~|~|~|Incidence|20386049|Larynx|2002
15-19|1.0|1.3|1.1|237|Mortality|20610370|Leukemias|2002
15-19|2.6|3.1|2.8|575|Incidence|20386049|Leukemias|2002
15-19|~|~|~|~|Mortality|20610370|Liver and Intrahepatic Bile Duct|2002
15-19|0.1|0.2|0.1|25|Incidence|20386049|Liver and Intrahepatic Bile Duct|2002
15-19|~|~|~|~|Mortality|20610370|Lung and Bronchus|2002
15-19|0.1|0.2|0.2|32|Incidence|20386049|Lung and Bronchus|2002
15-19|~|~|~|~|Mortality|9981879|Male and Female Breast|2002
15-19|0.1|0.3|0.2|19|Incidence|9872299|Male and Female Breast|2002
15-19|~|~|~|~|Incidence|9872299|Male and Female Breast, <i>in situ</i>|2002
15-19|~|~|~|~|Mortality|20610370|Melanomas of the Skin|2002
15-19|1.6|2.0|1.8|373|Incidence|20386049|Melanomas of the Skin|2002
15-19|~|~|~|~|Mortality|20610370|Mesothelioma|2002
15-19|~|~|~|~|Incidence|20386049|Mesothelioma|2002
15-19|~|~|~|~|Mortality|20610370|Myeloma|2002
15-19|~|~|~|~|Incidence|20386049|Myeloma|2002
15-19|0.2|0.3|0.2|44|Mortality|20610370|Non-Hodgkin Lymphoma|2002
15-19|1.6|2.0|1.8|370|Incidence|20386049|Non-Hodgkin Lymphoma|2002
15-19|~|~|~|~|Mortality|20610370|Oral Cavity and Pharynx|2002
15-19|0.3|0.5|0.4|86|Incidence|20386049|Oral Cavity and Pharynx|2002
15-19|~|~|~|~|Mortality|9981879|Ovary|2002
15-19|1.2|1.6|1.4|137|Incidence|9872299|Ovary|2002
15-19|~|~|~|~|Mortality|20610370|Pancreas|2002
15-19|~|~|~|~|Incidence|20386049|Pancreas|2002
15-19|~|~|~|~|Mortality|10628491|Prostate|2002
15-19|~|~|~|~|Incidence|10513750|Prostate|2002
15-19|~|~|~|~|Mortality|20610370|Stomach|2002
15-19|~|~|~|~|Incidence|20386049|Stomach|2002
15-19|~|~|~|~|Mortality|10628491|Testis|2002
15-19|3.1|3.8|3.5|364|Incidence|10513750|Testis|2002
15-19|~|~|~|~|Mortality|20610370|Thyroid|2002
15-19|1.5|1.9|1.7|351|Incidence|20386049|Thyroid|2002
15-19|~|~|~|~|Mortality|20610370|Urinary Bladder|2002
15-19|0.1|0.1|0.1|19|Incidence|20386049|Urinary Bladder|2002
5-9|2.5|2.9|2.7|537|Mortality|19872417|All Cancer Sites Combined|2002
5-9|11.7|12.6|12.1|2387|Incidence|19665950|All Cancer Sites Combined|2002
5-9|0.9|1.2|1.0|202|Mortality|19872417|Brain and Other Nervous System|2002
5-9|3.4|3.9|3.6|717|Incidence|19665950|Brain and Other Nervous System|2002
5-9|~|~|~|~|Mortality|9699735|Cervix|2002
5-9|~|~|~|~|Incidence|9598433|Cervix|2002
5-9|~|~|~|~|Mortality|19872417|Colon and Rectum|2002
5-9|~|~|~|~|Incidence|19665950|Colon and Rectum|2002
5-9|~|~|~|~|Mortality|9699735|Corpus and Uterus, NOS|2002
5-9|~|~|~|~|Incidence|9598433|Corpus and Uterus, NOS|2002
5-9|~|~|~|~|Mortality|19872417|Esophagus|2002
5-9|~|~|~|~|Incidence|19665950|Esophagus|2002
5-9|~|~|~|~|Mortality|9699735|Female Breast|2002
5-9|~|~|~|~|Incidence|9598433|Female Breast|2002
5-9|~|~|~|~|Incidence|9598433|Female Breast, <i>in situ</i>|2002
5-9|~|~|~|~|Mortality|19872417|Hodgkin Lymphoma|2002
5-9|0.3|0.4|0.4|69|Incidence|19665950|Hodgkin Lymphoma|2002
5-9|.|.|.|.|Mortality|19872417|Kaposi Sarcoma|2002
5-9|~|~|~|~|Incidence|19665950|Kaposi Sarcoma|2002
5-9|0.1|0.2|0.1|23|Mortality|19872417|Kidney and Renal Pelvis|2002
5-9|0.4|0.6|0.5|96|Incidence|19665950|Kidney and Renal Pelvis|2002
5-9|~|~|~|~|Mortality|19872417|Larynx|2002
5-9|~|~|~|~|Incidence|19665950|Larynx|2002
5-9|0.6|0.9|0.7|148|Mortality|19872417|Leukemias|2002
5-9|3.6|4.2|3.9|763|Incidence|19665950|Leukemias|2002
5-9|~|~|~|~|Mortality|19872417|Liver and Intrahepatic Bile Duct|2002
5-9|0.1|0.1|0.1|18|Incidence|19665950|Liver and Intrahepatic Bile Duct|2002
5-9|~|~|~|~|Mortality|19872417|Lung and Bronchus|2002
5-9|~|~|~|~|Incidence|19665950|Lung and Bronchus|2002
5-9|~|~|~|~|Mortality|9699735|Male and Female Breast|2002
5-9|~|~|~|~|Incidence|9598433|Male and Female Breast|2002
5-9|~|~|~|~|Incidence|9598433|Male and Female Breast, <i>in situ</i>|2002
5-9|~|~|~|~|Mortality|19872417|Melanomas of the Skin|2002
5-9|0.1|0.2|0.2|33|Incidence|19665950|Melanomas of the Skin|2002
5-9|~|~|~|~|Mortality|19872417|Mesothelioma|2002
5-9|~|~|~|~|Incidence|19665950|Mesothelioma|2002
5-9|~|~|~|~|Mortality|19872417|Myeloma|2002
5-9|~|~|~|~|Incidence|19665950|Myeloma|2002
5-9|~|~|~|~|Mortality|19872417|Non-Hodgkin Lymphoma|2002
5-9|0.8|1.1|0.9|184|Incidence|19665950|Non-Hodgkin Lymphoma|2002
5-9|~|~|~|~|Mortality|19872417|Oral Cavity and Pharynx|2002
5-9|0.1|0.1|0.1|17|Incidence|19665950|Oral Cavity and Pharynx|2002
5-9|~|~|~|~|Mortality|9699735|Ovary|2002
5-9|0.2|0.4|0.3|26|Incidence|9598433|Ovary|2002
5-9|~|~|~|~|Mortality|19872417|Pancreas|2002
5-9|~|~|~|~|Incidence|19665950|Pancreas|2002
5-9|~|~|~|~|Mortality|10172682|Prostate|2002
5-9|~|~|~|~|Incidence|10067517|Prostate|2002
5-9|~|~|~|~|Mortality|19872417|Stomach|2002
5-9|~|~|~|~|Incidence|19665950|Stomach|2002
5-9|~|~|~|~|Mortality|10172682|Testis|2002
5-9|~|~|~|~|Incidence|10067517|Testis|2002
5-9|~|~|~|~|Mortality|19872417|Thyroid|2002
5-9|0.1|0.2|0.1|21|Incidence|19665950|Thyroid|2002
5-9|~|~|~|~|Mortality|19872417|Urinary Bladder|2002
5-9|~|~|~|~|Incidence|19665950|Urinary Bladder|2002
<1|1.5|2.4|1.9|74|Mortality|3951461|All Cancer Sites Combined|2002
<1|23.1|26.3|24.6|964|Incidence|3910837|All Cancer Sites Combined|2002
<1|~|~|~|~|Mortality|3951461|Brain and Other Nervous System|2002
<1|3.3|4.5|3.9|151|Incidence|3910837|Brain and Other Nervous System|2002
<1|~|~|~|~|Mortality|1932939|Cervix|2002
<1|~|~|~|~|Incidence|1913004|Cervix|2002
<1|~|~|~|~|Mortality|3951461|Colon and Rectum|2002
<1|~|~|~|~|Incidence|3910837|Colon and Rectum|2002
<1|~|~|~|~|Mortality|1932939|Corpus and Uterus, NOS|2002
<1|~|~|~|~|Incidence|1913004|Corpus and Uterus, NOS|2002
<1|~|~|~|~|Mortality|3951461|Esophagus|2002
<1|~|~|~|~|Incidence|3910837|Esophagus|2002
<1|~|~|~|~|Mortality|1932939|Female Breast|2002
<1|~|~|~|~|Incidence|1913004|Female Breast|2002
<1|~|~|~|~|Incidence|1913004|Female Breast, <i>in situ</i>|2002
<1|~|~|~|~|Mortality|3951461|Hodgkin Lymphoma|2002
<1|~|~|~|~|Incidence|3910837|Hodgkin Lymphoma|2002
<1|.|.|.|.|Mortality|3951461|Kaposi Sarcoma|2002
<1|~|~|~|~|Incidence|3910837|Kaposi Sarcoma|2002
<1|~|~|~|~|Mortality|3951461|Kidney and Renal Pelvis|2002
<1|1.5|2.4|1.9|75|Incidence|3910837|Kidney and Renal Pelvis|2002
<1|~|~|~|~|Mortality|3951461|Larynx|2002
<1|~|~|~|~|Incidence|3910837|Larynx|2002
<1|0.3|0.8|0.5|21|Mortality|3951461|Leukemias|2002
<1|3.6|5.0|4.3|167|Incidence|3910837|Leukemias|2002
<1|~|~|~|~|Mortality|3951461|Liver and Intrahepatic Bile Duct|2002
<1|0.6|1.2|0.8|33|Incidence|3910837|Liver and Intrahepatic Bile Duct|2002
<1|~|~|~|~|Mortality|3951461|Lung and Bronchus|2002
<1|~|~|~|~|Incidence|3910837|Lung and Bronchus|2002
<1|~|~|~|~|Mortality|1932939|Male and Female Breast|2002
<1|~|~|~|~|Incidence|1913004|Male and Female Breast|2002
<1|~|~|~|~|Incidence|1913004|Male and Female Breast, <i>in situ</i>|2002
<1|~|~|~|~|Mortality|3951461|Melanomas of the Skin|2002
<1|~|~|~|~|Incidence|3910837|Melanomas of the Skin|2002
<1|~|~|~|~|Mortality|3951461|Mesothelioma|2002
<1|~|~|~|~|Incidence|3910837|Mesothelioma|2002
<1|~|~|~|~|Mortality|3951461|Myeloma|2002
<1|~|~|~|~|Incidence|3910837|Myeloma|2002
<1|~|~|~|~|Mortality|3951461|Non-Hodgkin Lymphoma|2002
<1|~|~|~|~|Incidence|3910837|Non-Hodgkin Lymphoma|2002
<1|~|~|~|~|Mortality|3951461|Oral Cavity and Pharynx|2002
<1|~|~|~|~|Incidence|3910837|Oral Cavity and Pharynx|2002
<1|~|~|~|~|Mortality|1932939|Ovary|2002
<1|~|~|~|~|Incidence|1913004|Ovary|2002
<1|~|~|~|~|Mortality|3951461|Pancreas|2002
<1|~|~|~|~|Incidence|3910837|Pancreas|2002
<1|~|~|~|~|Mortality|2018522|Prostate|2002
<1|~|~|~|~|Incidence|1997833|Prostate|2002
<1|~|~|~|~|Mortality|3951461|Stomach|2002
<1|~|~|~|~|Incidence|3910837|Stomach|2002
<1|~|~|~|~|Mortality|2018522|Testis|2002
<1|0.7|1.7|1.1|22|Incidence|1997833|Testis|2002
<1|~|~|~|~|Mortality|3951461|Thyroid|2002
<1|~|~|~|~|Incidence|3910837|Thyroid|2002
<1|~|~|~|~|Mortality|3951461|Urinary Bladder|2002
<1|~|~|~|~|Incidence|3910837|Urinary Bladder|2002
1-4|2.3|2.8|2.5|392|Mortality|15616575|All Cancer Sites Combined|2003
1-4|20.1|21.5|20.8|3249|Incidence|15616575|All Cancer Sites Combined|2003
1-4|0.5|0.8|0.7|104|Mortality|15616575|Brain and Other Nervous System|2003
1-4|3.9|4.5|4.2|654|Incidence|15616575|Brain and Other Nervous System|2003
1-4|~|~|~|~|Mortality|7636693|Cervix|2003
1-4|~|~|~|~|Incidence|7636693|Cervix|2003
1-4|~|~|~|~|Mortality|15616575|Colon and Rectum|2003
1-4|~|~|~|~|Incidence|15616575|Colon and Rectum|2003
1-4|~|~|~|~|Mortality|7636693|Corpus and Uterus, NOS|2003
1-4|~|~|~|~|Incidence|7636693|Corpus and Uterus, NOS|2003
1-4|~|~|~|~|Mortality|15616575|Esophagus|2003
1-4|~|~|~|~|Incidence|15616575|Esophagus|2003
1-4|~|~|~|~|Mortality|7636693|Female Breast|2003
1-4|~|~|~|~|Incidence|7636693|Female Breast|2003
1-4|~|~|~|~|Incidence|7636693|Female Breast, <i>in situ</i>|2003
1-4|~|~|~|~|Mortality|15616575|Hodgkin Lymphoma|2003
1-4|0.1|0.2|0.1|19|Incidence|15616575|Hodgkin Lymphoma|2003
1-4|.|.|.|.|Mortality|15616575|Kaposi Sarcoma|2003
1-4|~|~|~|~|Incidence|15616575|Kaposi Sarcoma|2003
1-4|~|~|~|~|Mortality|15616575|Kidney and Renal Pelvis|2003
1-4|1.8|2.3|2.0|315|Incidence|15616575|Kidney and Renal Pelvis|2003
1-4|~|~|~|~|Mortality|15616575|Larynx|2003
1-4|~|~|~|~|Incidence|15616575|Larynx|2003
1-4|0.7|1.0|0.9|133|Mortality|15616575|Leukemias|2003
1-4|7.7|8.6|8.1|1267|Incidence|15616575|Leukemias|2003
1-4|0.1|0.2|0.1|23|Mortality|15616575|Liver and Intrahepatic Bile Duct|2003
1-4|0.4|0.6|0.5|73|Incidence|15616575|Liver and Intrahepatic Bile Duct|2003
1-4|~|~|~|~|Mortality|15616575|Lung and Bronchus|2003
1-4|~|~|~|~|Incidence|15616575|Lung and Bronchus|2003
1-4|~|~|~|~|Mortality|7636693|Male and Female Breast|2003
1-4|~|~|~|~|Incidence|7636693|Male and Female Breast|2003
1-4|~|~|~|~|Incidence|7636693|Male and Female Breast, <i>in situ</i>|2003
1-4|~|~|~|~|Mortality|15616575|Melanomas of the Skin|2003
1-4|~|~|~|~|Incidence|15616575|Melanomas of the Skin|2003
1-4|~|~|~|~|Mortality|15616575|Mesothelioma|2003
1-4|~|~|~|~|Incidence|15616575|Mesothelioma|2003
1-4|~|~|~|~|Mortality|15616575|Myeloma|2003
1-4|~|~|~|~|Incidence|15616575|Myeloma|2003
1-4|~|~|~|~|Mortality|15616575|Non-Hodgkin Lymphoma|2003
1-4|0.6|0.9|0.7|115|Incidence|15616575|Non-Hodgkin Lymphoma|2003
1-4|~|~|~|~|Mortality|15616575|Oral Cavity and Pharynx|2003
1-4|~|~|~|~|Incidence|15616575|Oral Cavity and Pharynx|2003
1-4|~|~|~|~|Mortality|7636693|Ovary|2003
1-4|~|~|~|~|Incidence|7636693|Ovary|2003
1-4|~|~|~|~|Mortality|15616575|Pancreas|2003
1-4|~|~|~|~|Incidence|15616575|Pancreas|2003
1-4|~|~|~|~|Mortality|7979882|Prostate|2003
1-4|~|~|~|~|Incidence|7979882|Prostate|2003
1-4|~|~|~|~|Mortality|15616575|Stomach|2003
1-4|~|~|~|~|Incidence|15616575|Stomach|2003
1-4|~|~|~|~|Mortality|7979882|Testis|2003
1-4|0.2|0.4|0.3|24|Incidence|7979882|Testis|2003
1-4|~|~|~|~|Mortality|15616575|Thyroid|2003
1-4|~|~|~|~|Incidence|15616575|Thyroid|2003
1-4|~|~|~|~|Mortality|15616575|Urinary Bladder|2003
1-4|~|~|~|~|Incidence|15616575|Urinary Bladder|2003
10-14|2.4|2.8|2.6|560|Mortality|21415353|All Cancer Sites Combined|2003
10-14|12.3|13.3|12.8|2744|Incidence|21415353|All Cancer Sites Combined|2003
10-14|0.6|0.9|0.8|161|Mortality|21415353|Brain and Other Nervous System|2003
10-14|2.5|3.0|2.7|583|Incidence|21415353|Brain and Other Nervous System|2003
10-14|~|~|~|~|Mortality|10444875|Cervix|2003
10-14|~|~|~|~|Incidence|10444875|Cervix|2003
10-14|~|~|~|~|Mortality|21415353|Colon and Rectum|2003
10-14|0.0|0.1|0.1|18|Incidence|21415353|Colon and Rectum|2003
10-14|~|~|~|~|Mortality|10444875|Corpus and Uterus, NOS|2003
10-14|~|~|~|~|Incidence|10444875|Corpus and Uterus, NOS|2003
10-14|~|~|~|~|Mortality|21415353|Esophagus|2003
10-14|~|~|~|~|Incidence|21415353|Esophagus|2003
10-14|~|~|~|~|Mortality|10444875|Female Breast|2003
10-14|~|~|~|~|Incidence|10444875|Female Breast|2003
10-14|~|~|~|~|Incidence|10444875|Female Breast, <i>in situ</i>|2003
10-14|~|~|~|~|Mortality|21415353|Hodgkin Lymphoma|2003
10-14|1.0|1.3|1.2|255|Incidence|21415353|Hodgkin Lymphoma|2003
10-14|.|.|.|.|Mortality|21415353|Kaposi Sarcoma|2003
10-14|~|~|~|~|Incidence|21415353|Kaposi Sarcoma|2003
10-14|~|~|~|~|Mortality|21415353|Kidney and Renal Pelvis|2003
10-14|0.1|0.2|0.2|34|Incidence|21415353|Kidney and Renal Pelvis|2003
10-14|~|~|~|~|Mortality|21415353|Larynx|2003
10-14|~|~|~|~|Incidence|21415353|Larynx|2003
10-14|0.7|1.0|0.9|186|Mortality|21415353|Leukemias|2003
10-14|2.4|2.8|2.6|549|Incidence|21415353|Leukemias|2003
10-14|~|~|~|~|Mortality|21415353|Liver and Intrahepatic Bile Duct|2003
10-14|0.1|0.2|0.1|29|Incidence|21415353|Liver and Intrahepatic Bile Duct|2003
10-14|~|~|~|~|Mortality|21415353|Lung and Bronchus|2003
10-14|~|~|~|~|Incidence|21415353|Lung and Bronchus|2003
10-14|~|~|~|~|Mortality|10444875|Male and Female Breast|2003
10-14|~|~|~|~|Incidence|10444875|Male and Female Breast|2003
10-14|~|~|~|~|Incidence|10444875|Male and Female Breast, <i>in situ</i>|2003
10-14|~|~|~|~|Mortality|21415353|Melanomas of the Skin|2003
10-14|0.3|0.5|0.4|79|Incidence|21415353|Melanomas of the Skin|2003
10-14|~|~|~|~|Mortality|21415353|Mesothelioma|2003
10-14|~|~|~|~|Incidence|21415353|Mesothelioma|2003
10-14|~|~|~|~|Mortality|21415353|Myeloma|2003
10-14|~|~|~|~|Incidence|21415353|Myeloma|2003
10-14|0.1|0.2|0.1|28|Mortality|21415353|Non-Hodgkin Lymphoma|2003
10-14|0.9|1.2|1.0|221|Incidence|21415353|Non-Hodgkin Lymphoma|2003
10-14|~|~|~|~|Mortality|21415353|Oral Cavity and Pharynx|2003
10-14|0.2|0.4|0.3|58|Incidence|21415353|Oral Cavity and Pharynx|2003
10-14|~|~|~|~|Mortality|10444875|Ovary|2003
10-14|0.6|0.9|0.7|76|Incidence|10444875|Ovary|2003
10-14|~|~|~|~|Mortality|21415353|Pancreas|2003
10-14|~|~|~|~|Incidence|21415353|Pancreas|2003
10-14|~|~|~|~|Mortality|10970478|Prostate|2003
10-14|~|~|~|~|Incidence|10970478|Prostate|2003
10-14|~|~|~|~|Mortality|21415353|Stomach|2003
10-14|~|~|~|~|Incidence|21415353|Stomach|2003
10-14|~|~|~|~|Mortality|10970478|Testis|2003
10-14|0.2|0.3|0.2|26|Incidence|10970478|Testis|2003
10-14|~|~|~|~|Mortality|21415353|Thyroid|2003
10-14|0.4|0.6|0.5|113|Incidence|21415353|Thyroid|2003
10-14|~|~|~|~|Mortality|21415353|Urinary Bladder|2003
10-14|~|~|~|~|Incidence|21415353|Urinary Bladder|2003
15-19|3.1|3.6|3.3|690|Mortality|20797166|All Cancer Sites Combined|2003
15-19|20.8|22.0|21.4|4450|Incidence|20797166|All Cancer Sites Combined|2003
15-19|0.5|0.7|0.6|119|Mortality|20797166|Brain and Other Nervous System|2003
15-19|2.0|2.5|2.2|466|Incidence|20797166|Brain and Other Nervous System|2003
15-19|~|~|~|~|Mortality|10086567|Cervix|2003
15-19|0.1|0.3|0.2|19|Incidence|10086567|Cervix|2003
15-19|~|~|~|~|Mortality|20797166|Colon and Rectum|2003
15-19|0.2|0.3|0.3|55|Incidence|20797166|Colon and Rectum|2003
15-19|~|~|~|~|Mortality|10086567|Corpus and Uterus, NOS|2003
15-19|~|~|~|~|Incidence|10086567|Corpus and Uterus, NOS|2003
15-19|~|~|~|~|Mortality|20797166|Esophagus|2003
15-19|~|~|~|~|Incidence|20797166|Esophagus|2003
15-19|~|~|~|~|Mortality|10086567|Female Breast|2003
15-19|0.1|0.3|0.2|18|Incidence|10086567|Female Breast|2003
15-19|~|~|~|~|Incidence|10086567|Female Breast, <i>in situ</i>|2003
15-19|0.0|0.1|0.1|16|Mortality|20797166|Hodgkin Lymphoma|2003
15-19|3.0|3.4|3.2|664|Incidence|20797166|Hodgkin Lymphoma|2003
15-19|.|.|.|.|Mortality|20797166|Kaposi Sarcoma|2003
15-19|~|~|~|~|Incidence|20797166|Kaposi Sarcoma|2003
15-19|~|~|~|~|Mortality|20797166|Kidney and Renal Pelvis|2003
15-19|0.1|0.2|0.1|31|Incidence|20797166|Kidney and Renal Pelvis|2003
15-19|~|~|~|~|Mortality|20797166|Larynx|2003
15-19|~|~|~|~|Incidence|20797166|Larynx|2003
15-19|0.8|1.0|0.9|183|Mortality|20797166|Leukemias|2003
15-19|2.5|3.0|2.7|568|Incidence|20797166|Leukemias|2003
15-19|~|~|~|~|Mortality|20797166|Liver and Intrahepatic Bile Duct|2003
15-19|0.1|0.2|0.1|24|Incidence|20797166|Liver and Intrahepatic Bile Duct|2003
15-19|~|~|~|~|Mortality|20797166|Lung and Bronchus|2003
15-19|0.1|0.2|0.1|27|Incidence|20797166|Lung and Bronchus|2003
15-19|~|~|~|~|Mortality|10086567|Male and Female Breast|2003
15-19|0.1|0.3|0.2|18|Incidence|10086567|Male and Female Breast|2003
15-19|~|~|~|~|Incidence|10086567|Male and Female Breast, <i>in situ</i>|2003
15-19|~|~|~|~|Mortality|20797166|Melanomas of the Skin|2003
15-19|1.6|1.9|1.8|365|Incidence|20797166|Melanomas of the Skin|2003
15-19|~|~|~|~|Mortality|20797166|Mesothelioma|2003
15-19|~|~|~|~|Incidence|20797166|Mesothelioma|2003
15-19|~|~|~|~|Mortality|20797166|Myeloma|2003
15-19|~|~|~|~|Incidence|20797166|Myeloma|2003
15-19|0.2|0.3|0.3|53|Mortality|20797166|Non-Hodgkin Lymphoma|2003
15-19|1.4|1.8|1.6|334|Incidence|20797166|Non-Hodgkin Lymphoma|2003
15-19|~|~|~|~|Mortality|20797166|Oral Cavity and Pharynx|2003
15-19|0.4|0.6|0.5|108|Incidence|20797166|Oral Cavity and Pharynx|2003
15-19|~|~|~|~|Mortality|10086567|Ovary|2003
15-19|1.0|1.5|1.3|127|Incidence|10086567|Ovary|2003
15-19|~|~|~|~|Mortality|20797166|Pancreas|2003
15-19|~|~|~|~|Incidence|20797166|Pancreas|2003
15-19|~|~|~|~|Mortality|10710599|Prostate|2003
15-19|~|~|~|~|Incidence|10710599|Prostate|2003
15-19|~|~|~|~|Mortality|20797166|Stomach|2003
15-19|~|~|~|~|Incidence|20797166|Stomach|2003
15-19|~|~|~|~|Mortality|10710599|Testis|2003
15-19|3.0|3.7|3.3|353|Incidence|10710599|Testis|2003
15-19|~|~|~|~|Mortality|20797166|Thyroid|2003
15-19|1.6|2.0|1.8|378|Incidence|20797166|Thyroid|2003
15-19|~|~|~|~|Mortality|20797166|Urinary Bladder|2003
15-19|0.1|0.2|0.1|22|Incidence|20797166|Urinary Bladder|2003
5-9|2.4|2.9|2.6|516|Mortality|19620851|All Cancer Sites Combined|2003
5-9|11.0|12.0|11.5|2254|Incidence|19620851|All Cancer Sites Combined|2003
5-9|0.8|1.0|0.9|175|Mortality|19620851|Brain and Other Nervous System|2003
5-9|3.0|3.5|3.3|642|Incidence|19620851|Brain and Other Nervous System|2003
5-9|~|~|~|~|Mortality|9581247|Cervix|2003
5-9|~|~|~|~|Incidence|9581247|Cervix|2003
5-9|~|~|~|~|Mortality|19620851|Colon and Rectum|2003
5-9|~|~|~|~|Incidence|19620851|Colon and Rectum|2003
5-9|~|~|~|~|Mortality|9581247|Corpus and Uterus, NOS|2003
5-9|~|~|~|~|Incidence|9581247|Corpus and Uterus, NOS|2003
5-9|~|~|~|~|Mortality|19620851|Esophagus|2003
5-9|~|~|~|~|Incidence|19620851|Esophagus|2003
5-9|~|~|~|~|Mortality|9581247|Female Breast|2003
5-9|~|~|~|~|Incidence|9581247|Female Breast|2003
5-9|~|~|~|~|Incidence|9581247|Female Breast, <i>in situ</i>|2003
5-9|~|~|~|~|Mortality|19620851|Hodgkin Lymphoma|2003
5-9|0.4|0.6|0.4|88|Incidence|19620851|Hodgkin Lymphoma|2003
5-9|.|.|.|.|Mortality|19620851|Kaposi Sarcoma|2003
5-9|~|~|~|~|Incidence|19620851|Kaposi Sarcoma|2003
5-9|0.1|0.2|0.1|28|Mortality|19620851|Kidney and Renal Pelvis|2003
5-9|0.4|0.6|0.5|104|Incidence|19620851|Kidney and Renal Pelvis|2003
5-9|~|~|~|~|Mortality|19620851|Larynx|2003
5-9|~|~|~|~|Incidence|19620851|Larynx|2003
5-9|0.7|0.9|0.8|156|Mortality|19620851|Leukemias|2003
5-9|3.6|4.2|3.9|759|Incidence|19620851|Leukemias|2003
5-9|~|~|~|~|Mortality|19620851|Liver and Intrahepatic Bile Duct|2003
5-9|0.1|0.1|0.1|17|Incidence|19620851|Liver and Intrahepatic Bile Duct|2003
5-9|~|~|~|~|Mortality|19620851|Lung and Bronchus|2003
5-9|~|~|~|~|Incidence|19620851|Lung and Bronchus|2003
5-9|~|~|~|~|Mortality|9581247|Male and Female Breast|2003
5-9|~|~|~|~|Incidence|9581247|Male and Female Breast|2003
5-9|~|~|~|~|Incidence|9581247|Male and Female Breast, <i>in situ</i>|2003
5-9|~|~|~|~|Mortality|19620851|Melanomas of the Skin|2003
5-9|~|~|~|~|Incidence|19620851|Melanomas of the Skin|2003
5-9|~|~|~|~|Mortality|19620851|Mesothelioma|2003
5-9|~|~|~|~|Incidence|19620851|Mesothelioma|2003
5-9|~|~|~|~|Mortality|19620851|Myeloma|2003
5-9|~|~|~|~|Incidence|19620851|Myeloma|2003
5-9|0.1|0.1|0.1|17|Mortality|19620851|Non-Hodgkin Lymphoma|2003
5-9|0.9|1.2|1.0|204|Incidence|19620851|Non-Hodgkin Lymphoma|2003
5-9|~|~|~|~|Mortality|19620851|Oral Cavity and Pharynx|2003
5-9|0.1|0.2|0.2|31|Incidence|19620851|Oral Cavity and Pharynx|2003
5-9|~|~|~|~|Mortality|9581247|Ovary|2003
5-9|~|~|~|~|Incidence|9581247|Ovary|2003
5-9|~|~|~|~|Mortality|19620851|Pancreas|2003
5-9|~|~|~|~|Incidence|19620851|Pancreas|2003
5-9|~|~|~|~|Mortality|10039604|Prostate|2003
5-9|~|~|~|~|Incidence|10039604|Prostate|2003
5-9|~|~|~|~|Mortality|19620851|Stomach|2003
5-9|~|~|~|~|Incidence|19620851|Stomach|2003
5-9|~|~|~|~|Mortality|10039604|Testis|2003
5-9|~|~|~|~|Incidence|10039604|Testis|2003
5-9|~|~|~|~|Mortality|19620851|Thyroid|2003
5-9|~|~|~|~|Incidence|19620851|Thyroid|2003
5-9|~|~|~|~|Mortality|19620851|Urinary Bladder|2003
5-9|~|~|~|~|Incidence|19620851|Urinary Bladder|2003
<1|1.5|2.4|1.9|75|Mortality|3975871|All Cancer Sites Combined|2003
<1|23.7|26.9|25.3|1004|Incidence|3975871|All Cancer Sites Combined|2003
<1|0.3|0.7|0.5|18|Mortality|3975871|Brain and Other Nervous System|2003
<1|3.2|4.5|3.8|151|Incidence|3975871|Brain and Other Nervous System|2003
<1|~|~|~|~|Mortality|1942634|Cervix|2003
<1|~|~|~|~|Incidence|1942634|Cervix|2003
<1|~|~|~|~|Mortality|3975871|Colon and Rectum|2003
<1|~|~|~|~|Incidence|3975871|Colon and Rectum|2003
<1|~|~|~|~|Mortality|1942634|Corpus and Uterus, NOS|2003
<1|~|~|~|~|Incidence|1942634|Corpus and Uterus, NOS|2003
<1|~|~|~|~|Mortality|3975871|Esophagus|2003
<1|~|~|~|~|Incidence|3975871|Esophagus|2003
<1|~|~|~|~|Mortality|1942634|Female Breast|2003
<1|~|~|~|~|Incidence|1942634|Female Breast|2003
<1|~|~|~|~|Incidence|1942634|Female Breast, <i>in situ</i>|2003
<1|~|~|~|~|Mortality|3975871|Hodgkin Lymphoma|2003
<1|~|~|~|~|Incidence|3975871|Hodgkin Lymphoma|2003
<1|.|.|.|.|Mortality|3975871|Kaposi Sarcoma|2003
<1|~|~|~|~|Incidence|3975871|Kaposi Sarcoma|2003
<1|~|~|~|~|Mortality|3975871|Kidney and Renal Pelvis|2003
<1|1.5|2.3|1.9|74|Incidence|3975871|Kidney and Renal Pelvis|2003
<1|~|~|~|~|Mortality|3975871|Larynx|2003
<1|~|~|~|~|Incidence|3975871|Larynx|2003
<1|0.5|1.1|0.8|30|Mortality|3975871|Leukemias|2003
<1|3.8|5.2|4.5|177|Incidence|3975871|Leukemias|2003
<1|~|~|~|~|Mortality|3975871|Liver and Intrahepatic Bile Duct|2003
<1|1.0|1.8|1.4|55|Incidence|3975871|Liver and Intrahepatic Bile Duct|2003
<1|~|~|~|~|Mortality|3975871|Lung and Bronchus|2003
<1|~|~|~|~|Incidence|3975871|Lung and Bronchus|2003
<1|~|~|~|~|Mortality|1942634|Male and Female Breast|2003
<1|~|~|~|~|Incidence|1942634|Male and Female Breast|2003
<1|~|~|~|~|Incidence|1942634|Male and Female Breast, <i>in situ</i>|2003
<1|~|~|~|~|Mortality|3975871|Melanomas of the Skin|2003
<1|~|~|~|~|Incidence|3975871|Melanomas of the Skin|2003
<1|~|~|~|~|Mortality|3975871|Mesothelioma|2003
<1|~|~|~|~|Incidence|3975871|Mesothelioma|2003
<1|~|~|~|~|Mortality|3975871|Myeloma|2003
<1|~|~|~|~|Incidence|3975871|Myeloma|2003
<1|~|~|~|~|Mortality|3975871|Non-Hodgkin Lymphoma|2003
<1|~|~|~|~|Incidence|3975871|Non-Hodgkin Lymphoma|2003
<1|~|~|~|~|Mortality|3975871|Oral Cavity and Pharynx|2003
<1|~|~|~|~|Incidence|3975871|Oral Cavity and Pharynx|2003
<1|~|~|~|~|Mortality|1942634|Ovary|2003
<1|~|~|~|~|Incidence|1942634|Ovary|2003
<1|~|~|~|~|Mortality|3975871|Pancreas|2003
<1|~|~|~|~|Incidence|3975871|Pancreas|2003
<1|~|~|~|~|Mortality|2033237|Prostate|2003
<1|~|~|~|~|Incidence|2033237|Prostate|2003
<1|~|~|~|~|Mortality|3975871|Stomach|2003
<1|~|~|~|~|Incidence|3975871|Stomach|2003
<1|~|~|~|~|Mortality|2033237|Testis|2003
<1|0.4|1.3|0.8|16|Incidence|2033237|Testis|2003
<1|~|~|~|~|Mortality|3975871|Thyroid|2003
<1|~|~|~|~|Incidence|3975871|Thyroid|2003
<1|~|~|~|~|Mortality|3975871|Urinary Bladder|2003
<1|~|~|~|~|Incidence|3975871|Urinary Bladder|2003
1-4|2.3|2.8|2.5|399|Mortality|15771627|All Cancer Sites Combined|2004
1-4|21.6|23.1|22.3|3524|Incidence|15771627|All Cancer Sites Combined|2004
1-4|0.5|0.8|0.6|102|Mortality|15771627|Brain and Other Nervous System|2004
1-4|4.3|5.0|4.6|727|Incidence|15771627|Brain and Other Nervous System|2004
1-4|~|~|~|~|Mortality|7713175|Cervix|2004
1-4|~|~|~|~|Incidence|7713175|Cervix|2004
1-4|~|~|~|~|Mortality|15771627|Colon and Rectum|2004
1-4|~|~|~|~|Incidence|15771627|Colon and Rectum|2004
1-4|~|~|~|~|Mortality|7713175|Corpus and Uterus, NOS|2004
1-4|~|~|~|~|Incidence|7713175|Corpus and Uterus, NOS|2004
1-4|~|~|~|~|Mortality|15771627|Esophagus|2004
1-4|~|~|~|~|Incidence|15771627|Esophagus|2004
1-4|~|~|~|~|Mortality|7713175|Female Breast|2004
1-4|~|~|~|~|Incidence|7713175|Female Breast|2004
1-4|~|~|~|~|Incidence|7713175|Female Breast, <i>in situ</i>|2004
1-4|~|~|~|~|Mortality|15771627|Hodgkin Lymphoma|2004
1-4|~|~|~|~|Incidence|15771627|Hodgkin Lymphoma|2004
1-4|.|.|.|.|Mortality|15771627|Kaposi Sarcoma|2004
1-4|~|~|~|~|Incidence|15771627|Kaposi Sarcoma|2004
1-4|0.1|0.2|0.1|18|Mortality|15771627|Kidney and Renal Pelvis|2004
1-4|1.8|2.3|2.1|324|Incidence|15771627|Kidney and Renal Pelvis|2004
1-4|~|~|~|~|Mortality|15771627|Larynx|2004
1-4|~|~|~|~|Incidence|15771627|Larynx|2004
1-4|0.6|0.9|0.8|120|Mortality|15771627|Leukemias|2004
1-4|8.7|9.7|9.2|1446|Incidence|15771627|Leukemias|2004
1-4|0.1|0.2|0.1|22|Mortality|15771627|Liver and Intrahepatic Bile Duct|2004
1-4|0.5|0.7|0.6|94|Incidence|15771627|Liver and Intrahepatic Bile Duct|2004
1-4|~|~|~|~|Mortality|15771627|Lung and Bronchus|2004
1-4|~|~|~|~|Incidence|15771627|Lung and Bronchus|2004
1-4|~|~|~|~|Mortality|7713175|Male and Female Breast|2004
1-4|~|~|~|~|Incidence|7713175|Male and Female Breast|2004
1-4|~|~|~|~|Incidence|7713175|Male and Female Breast, <i>in situ</i>|2004
1-4|~|~|~|~|Mortality|15771627|Melanomas of the Skin|2004
1-4|0.1|0.2|0.1|20|Incidence|15771627|Melanomas of the Skin|2004
1-4|~|~|~|~|Mortality|15771627|Mesothelioma|2004
1-4|~|~|~|~|Incidence|15771627|Mesothelioma|2004
1-4|~|~|~|~|Mortality|15771627|Myeloma|2004
1-4|~|~|~|~|Incidence|15771627|Myeloma|2004
1-4|~|~|~|~|Mortality|15771627|Non-Hodgkin Lymphoma|2004
1-4|0.6|0.8|0.7|109|Incidence|15771627|Non-Hodgkin Lymphoma|2004
1-4|~|~|~|~|Mortality|15771627|Oral Cavity and Pharynx|2004
1-4|~|~|~|~|Incidence|15771627|Oral Cavity and Pharynx|2004
1-4|~|~|~|~|Mortality|7713175|Ovary|2004
1-4|~|~|~|~|Incidence|7713175|Ovary|2004
1-4|~|~|~|~|Mortality|15771627|Pancreas|2004
1-4|~|~|~|~|Incidence|15771627|Pancreas|2004
1-4|~|~|~|~|Mortality|8058452|Prostate|2004
1-4|~|~|~|~|Incidence|8058452|Prostate|2004
1-4|~|~|~|~|Mortality|15771627|Stomach|2004
1-4|~|~|~|~|Incidence|15771627|Stomach|2004
1-4|~|~|~|~|Mortality|8058452|Testis|2004
1-4|0.2|0.4|0.3|21|Incidence|8058452|Testis|2004
1-4|~|~|~|~|Mortality|15771627|Thyroid|2004
1-4|~|~|~|~|Incidence|15771627|Thyroid|2004
1-4|~|~|~|~|Mortality|15771627|Urinary Bladder|2004
1-4|~|~|~|~|Incidence|15771627|Urinary Bladder|2004
10-14|2.1|2.5|2.3|493|Mortality|21411680|All Cancer Sites Combined|2004
10-14|12.9|13.9|13.4|2866|Incidence|21411680|All Cancer Sites Combined|2004
10-14|0.5|0.8|0.6|139|Mortality|21411680|Brain and Other Nervous System|2004
10-14|2.5|2.9|2.7|580|Incidence|21411680|Brain and Other Nervous System|2004
10-14|~|~|~|~|Mortality|10443706|Cervix|2004
10-14|~|~|~|~|Incidence|10443706|Cervix|2004
10-14|~|~|~|~|Mortality|21411680|Colon and Rectum|2004
10-14|~|~|~|~|Incidence|21411680|Colon and Rectum|2004
10-14|~|~|~|~|Mortality|10443706|Corpus and Uterus, NOS|2004
10-14|~|~|~|~|Incidence|10443706|Corpus and Uterus, NOS|2004
10-14|~|~|~|~|Mortality|21411680|Esophagus|2004
10-14|~|~|~|~|Incidence|21411680|Esophagus|2004
10-14|~|~|~|~|Mortality|10443706|Female Breast|2004
10-14|~|~|~|~|Incidence|10443706|Female Breast|2004
10-14|~|~|~|~|Incidence|10443706|Female Breast, <i>in situ</i>|2004
10-14|~|~|~|~|Mortality|21411680|Hodgkin Lymphoma|2004
10-14|1.0|1.3|1.1|242|Incidence|21411680|Hodgkin Lymphoma|2004
10-14|.|.|.|.|Mortality|21411680|Kaposi Sarcoma|2004
10-14|~|~|~|~|Incidence|21411680|Kaposi Sarcoma|2004
10-14|~|~|~|~|Mortality|21411680|Kidney and Renal Pelvis|2004
10-14|0.1|0.2|0.2|39|Incidence|21411680|Kidney and Renal Pelvis|2004
10-14|~|~|~|~|Mortality|21411680|Larynx|2004
10-14|~|~|~|~|Incidence|21411680|Larynx|2004
10-14|0.6|0.9|0.7|156|Mortality|21411680|Leukemias|2004
10-14|2.6|3.1|2.8|606|Incidence|21411680|Leukemias|2004
10-14|~|~|~|~|Mortality|21411680|Liver and Intrahepatic Bile Duct|2004
10-14|~|~|~|~|Incidence|21411680|Liver and Intrahepatic Bile Duct|2004
10-14|~|~|~|~|Mortality|21411680|Lung and Bronchus|2004
10-14|~|~|~|~|Incidence|21411680|Lung and Bronchus|2004
10-14|~|~|~|~|Mortality|10443706|Male and Female Breast|2004
10-14|~|~|~|~|Incidence|10443706|Male and Female Breast|2004
10-14|~|~|~|~|Incidence|10443706|Male and Female Breast, <i>in situ</i>|2004
10-14|~|~|~|~|Mortality|21411680|Melanomas of the Skin|2004
10-14|0.3|0.5|0.4|84|Incidence|21411680|Melanomas of the Skin|2004
10-14|~|~|~|~|Mortality|21411680|Mesothelioma|2004
10-14|~|~|~|~|Incidence|21411680|Mesothelioma|2004
10-14|~|~|~|~|Mortality|21411680|Myeloma|2004
10-14|~|~|~|~|Incidence|21411680|Myeloma|2004
10-14|0.1|0.1|0.1|19|Mortality|21411680|Non-Hodgkin Lymphoma|2004
10-14|1.1|1.4|1.3|275|Incidence|21411680|Non-Hodgkin Lymphoma|2004
10-14|~|~|~|~|Mortality|21411680|Oral Cavity and Pharynx|2004
10-14|0.2|0.3|0.3|54|Incidence|21411680|Oral Cavity and Pharynx|2004
10-14|~|~|~|~|Mortality|10443706|Ovary|2004
10-14|0.7|1.1|0.9|92|Incidence|10443706|Ovary|2004
10-14|~|~|~|~|Mortality|21411680|Pancreas|2004
10-14|~|~|~|~|Incidence|21411680|Pancreas|2004
10-14|~|~|~|~|Mortality|10967974|Prostate|2004
10-14|~|~|~|~|Incidence|10967974|Prostate|2004
10-14|~|~|~|~|Mortality|21411680|Stomach|2004
10-14|~|~|~|~|Incidence|21411680|Stomach|2004
10-14|~|~|~|~|Mortality|10967974|Testis|2004
10-14|0.2|0.4|0.3|30|Incidence|10967974|Testis|2004
10-14|~|~|~|~|Mortality|21411680|Thyroid|2004
10-14|0.4|0.6|0.5|116|Incidence|21411680|Thyroid|2004
10-14|~|~|~|~|Mortality|21411680|Urinary Bladder|2004
10-14|~|~|~|~|Incidence|21411680|Urinary Bladder|2004
15-19|3.2|3.7|3.5|731|Mortality|21102552|All Cancer Sites Combined|2004
15-19|21.1|22.4|21.7|4584|Incidence|21102552|All Cancer Sites Combined|2004
15-19|0.4|0.6|0.5|109|Mortality|21102552|Brain and Other Nervous System|2004
15-19|2.1|2.6|2.3|495|Incidence|21102552|Brain and Other Nervous System|2004
15-19|~|~|~|~|Mortality|10242793|Cervix|2004
15-19|0.1|0.3|0.2|17|Incidence|10242793|Cervix|2004
15-19|~|~|~|~|Mortality|21102552|Colon and Rectum|2004
15-19|0.2|0.3|0.3|54|Incidence|21102552|Colon and Rectum|2004
15-19|~|~|~|~|Mortality|10242793|Corpus and Uterus, NOS|2004
15-19|~|~|~|~|Incidence|10242793|Corpus and Uterus, NOS|2004
15-19|~|~|~|~|Mortality|21102552|Esophagus|2004
15-19|~|~|~|~|Incidence|21102552|Esophagus|2004
15-19|~|~|~|~|Mortality|10242793|Female Breast|2004
15-19|0.1|0.3|0.2|17|Incidence|10242793|Female Breast|2004
15-19|~|~|~|~|Incidence|10242793|Female Breast, <i>in situ</i>|2004
15-19|0.0|0.1|0.1|17|Mortality|21102552|Hodgkin Lymphoma|2004
15-19|2.9|3.4|3.2|666|Incidence|21102552|Hodgkin Lymphoma|2004
15-19|.|.|.|.|Mortality|21102552|Kaposi Sarcoma|2004
15-19|~|~|~|~|Incidence|21102552|Kaposi Sarcoma|2004
15-19|~|~|~|~|Mortality|21102552|Kidney and Renal Pelvis|2004
15-19|0.1|0.3|0.2|42|Incidence|21102552|Kidney and Renal Pelvis|2004
15-19|~|~|~|~|Mortality|21102552|Larynx|2004
15-19|~|~|~|~|Incidence|21102552|Larynx|2004
15-19|0.9|1.1|1.0|210|Mortality|21102552|Leukemias|2004
15-19|2.6|3.1|2.9|604|Incidence|21102552|Leukemias|2004
15-19|0.0|0.1|0.1|16|Mortality|21102552|Liver and Intrahepatic Bile Duct|2004
15-19|0.1|0.3|0.2|39|Incidence|21102552|Liver and Intrahepatic Bile Duct|2004
15-19|~|~|~|~|Mortality|21102552|Lung and Bronchus|2004
15-19|0.1|0.2|0.1|23|Incidence|21102552|Lung and Bronchus|2004
15-19|~|~|~|~|Mortality|10242793|Male and Female Breast|2004
15-19|0.1|0.3|0.2|17|Incidence|10242793|Male and Female Breast|2004
15-19|~|~|~|~|Incidence|10242793|Male and Female Breast, <i>in situ</i>|2004
15-19|~|~|~|~|Mortality|21102552|Melanomas of the Skin|2004
15-19|1.6|2.0|1.8|378|Incidence|21102552|Melanomas of the Skin|2004
15-19|~|~|~|~|Mortality|21102552|Mesothelioma|2004
15-19|~|~|~|~|Incidence|21102552|Mesothelioma|2004
15-19|~|~|~|~|Mortality|21102552|Myeloma|2004
15-19|~|~|~|~|Incidence|21102552|Myeloma|2004
15-19|0.2|0.3|0.3|56|Mortality|21102552|Non-Hodgkin Lymphoma|2004
15-19|1.5|1.8|1.6|346|Incidence|21102552|Non-Hodgkin Lymphoma|2004
15-19|~|~|~|~|Mortality|21102552|Oral Cavity and Pharynx|2004
15-19|0.3|0.5|0.4|85|Incidence|21102552|Oral Cavity and Pharynx|2004
15-19|~|~|~|~|Mortality|10242793|Ovary|2004
15-19|1.0|1.5|1.2|126|Incidence|10242793|Ovary|2004
15-19|~|~|~|~|Mortality|21102552|Pancreas|2004
15-19|~|~|~|~|Incidence|21102552|Pancreas|2004
15-19|~|~|~|~|Mortality|10859759|Prostate|2004
15-19|~|~|~|~|Incidence|10859759|Prostate|2004
15-19|~|~|~|~|Mortality|21102552|Stomach|2004
15-19|~|~|~|~|Incidence|21102552|Stomach|2004
15-19|~|~|~|~|Mortality|10859759|Testis|2004
15-19|3.2|3.9|3.5|383|Incidence|10859759|Testis|2004
15-19|~|~|~|~|Mortality|21102552|Thyroid|2004
15-19|1.8|2.1|1.9|408|Incidence|21102552|Thyroid|2004
15-19|~|~|~|~|Mortality|21102552|Urinary Bladder|2004
15-19|0.1|0.2|0.1|22|Incidence|21102552|Urinary Bladder|2004
5-9|2.5|2.9|2.7|526|Mortality|19454237|All Cancer Sites Combined|2004
5-9|11.5|12.4|12.0|2325|Incidence|19454237|All Cancer Sites Combined|2004
5-9|0.8|1.1|1.0|186|Mortality|19454237|Brain and Other Nervous System|2004
5-9|3.3|3.9|3.6|697|Incidence|19454237|Brain and Other Nervous System|2004
5-9|~|~|~|~|Mortality|9503231|Cervix|2004
5-9|~|~|~|~|Incidence|9503231|Cervix|2004
5-9|~|~|~|~|Mortality|19454237|Colon and Rectum|2004
5-9|~|~|~|~|Incidence|19454237|Colon and Rectum|2004
5-9|~|~|~|~|Mortality|9503231|Corpus and Uterus, NOS|2004
5-9|~|~|~|~|Incidence|9503231|Corpus and Uterus, NOS|2004
5-9|~|~|~|~|Mortality|19454237|Esophagus|2004
5-9|~|~|~|~|Incidence|19454237|Esophagus|2004
5-9|~|~|~|~|Mortality|9503231|Female Breast|2004
5-9|~|~|~|~|Incidence|9503231|Female Breast|2004
5-9|~|~|~|~|Incidence|9503231|Female Breast, <i>in situ</i>|2004
5-9|~|~|~|~|Mortality|19454237|Hodgkin Lymphoma|2004
5-9|0.3|0.4|0.3|68|Incidence|19454237|Hodgkin Lymphoma|2004
5-9|.|.|.|.|Mortality|19454237|Kaposi Sarcoma|2004
5-9|~|~|~|~|Incidence|19454237|Kaposi Sarcoma|2004
5-9|0.1|0.2|0.1|23|Mortality|19454237|Kidney and Renal Pelvis|2004
5-9|0.4|0.6|0.5|93|Incidence|19454237|Kidney and Renal Pelvis|2004
5-9|~|~|~|~|Mortality|19454237|Larynx|2004
5-9|~|~|~|~|Incidence|19454237|Larynx|2004
5-9|0.7|0.9|0.8|156|Mortality|19454237|Leukemias|2004
5-9|3.7|4.2|4.0|770|Incidence|19454237|Leukemias|2004
5-9|~|~|~|~|Mortality|19454237|Liver and Intrahepatic Bile Duct|2004
5-9|0.1|0.2|0.1|19|Incidence|19454237|Liver and Intrahepatic Bile Duct|2004
5-9|~|~|~|~|Mortality|19454237|Lung and Bronchus|2004
5-9|~|~|~|~|Incidence|19454237|Lung and Bronchus|2004
5-9|~|~|~|~|Mortality|9503231|Male and Female Breast|2004
5-9|~|~|~|~|Incidence|9503231|Male and Female Breast|2004
5-9|~|~|~|~|Incidence|9503231|Male and Female Breast, <i>in situ</i>|2004
5-9|~|~|~|~|Mortality|19454237|Melanomas of the Skin|2004
5-9|0.1|0.2|0.2|31|Incidence|19454237|Melanomas of the Skin|2004
5-9|~|~|~|~|Mortality|19454237|Mesothelioma|2004
5-9|~|~|~|~|Incidence|19454237|Mesothelioma|2004
5-9|~|~|~|~|Mortality|19454237|Myeloma|2004
5-9|~|~|~|~|Incidence|19454237|Myeloma|2004
5-9|0.1|0.2|0.1|22|Mortality|19454237|Non-Hodgkin Lymphoma|2004
5-9|0.8|1.1|0.9|183|Incidence|19454237|Non-Hodgkin Lymphoma|2004
5-9|~|~|~|~|Mortality|19454237|Oral Cavity and Pharynx|2004
5-9|~|~|~|~|Incidence|19454237|Oral Cavity and Pharynx|2004
5-9|~|~|~|~|Mortality|9503231|Ovary|2004
5-9|0.1|0.3|0.2|21|Incidence|9503231|Ovary|2004
5-9|~|~|~|~|Mortality|19454237|Pancreas|2004
5-9|~|~|~|~|Incidence|19454237|Pancreas|2004
5-9|~|~|~|~|Mortality|9951006|Prostate|2004
5-9|~|~|~|~|Incidence|9951006|Prostate|2004
5-9|~|~|~|~|Mortality|19454237|Stomach|2004
5-9|~|~|~|~|Incidence|19454237|Stomach|2004
5-9|~|~|~|~|Mortality|9951006|Testis|2004
5-9|~|~|~|~|Incidence|9951006|Testis|2004
5-9|~|~|~|~|Mortality|19454237|Thyroid|2004
5-9|0.1|0.3|0.2|39|Incidence|19454237|Thyroid|2004
5-9|~|~|~|~|Mortality|19454237|Urinary Bladder|2004
5-9|~|~|~|~|Incidence|19454237|Urinary Bladder|2004
<1|1.4|2.3|1.8|74|Mortality|4014258|All Cancer Sites Combined|2004
<1|23.9|27.1|25.5|1022|Incidence|4014258|All Cancer Sites Combined|2004
<1|0.3|0.7|0.5|19|Mortality|4014258|Brain and Other Nervous System|2004
<1|3.6|4.9|4.3|171|Incidence|4014258|Brain and Other Nervous System|2004
<1|~|~|~|~|Mortality|1962216|Cervix|2004
<1|~|~|~|~|Incidence|1962216|Cervix|2004
<1|~|~|~|~|Mortality|4014258|Colon and Rectum|2004
<1|~|~|~|~|Incidence|4014258|Colon and Rectum|2004
<1|~|~|~|~|Mortality|1962216|Corpus and Uterus, NOS|2004
<1|~|~|~|~|Incidence|1962216|Corpus and Uterus, NOS|2004
<1|~|~|~|~|Mortality|4014258|Esophagus|2004
<1|~|~|~|~|Incidence|4014258|Esophagus|2004
<1|~|~|~|~|Mortality|1962216|Female Breast|2004
<1|~|~|~|~|Incidence|1962216|Female Breast|2004
<1|~|~|~|~|Incidence|1962216|Female Breast, <i>in situ</i>|2004
<1|~|~|~|~|Mortality|4014258|Hodgkin Lymphoma|2004
<1|~|~|~|~|Incidence|4014258|Hodgkin Lymphoma|2004
<1|.|.|.|.|Mortality|4014258|Kaposi Sarcoma|2004
<1|~|~|~|~|Incidence|4014258|Kaposi Sarcoma|2004
<1|~|~|~|~|Mortality|4014258|Kidney and Renal Pelvis|2004
<1|1.0|1.7|1.3|52|Incidence|4014258|Kidney and Renal Pelvis|2004
<1|~|~|~|~|Mortality|4014258|Larynx|2004
<1|~|~|~|~|Incidence|4014258|Larynx|2004
<1|0.4|0.9|0.6|23|Mortality|4014258|Leukemias|2004
<1|3.8|5.1|4.4|178|Incidence|4014258|Leukemias|2004
<1|~|~|~|~|Mortality|4014258|Liver and Intrahepatic Bile Duct|2004
<1|1.1|1.9|1.4|58|Incidence|4014258|Liver and Intrahepatic Bile Duct|2004
<1|~|~|~|~|Mortality|4014258|Lung and Bronchus|2004
<1|~|~|~|~|Incidence|4014258|Lung and Bronchus|2004
<1|~|~|~|~|Mortality|1962216|Male and Female Breast|2004
<1|~|~|~|~|Incidence|1962216|Male and Female Breast|2004
<1|~|~|~|~|Incidence|1962216|Male and Female Breast, <i>in situ</i>|2004
<1|~|~|~|~|Mortality|4014258|Melanomas of the Skin|2004
<1|~|~|~|~|Incidence|4014258|Melanomas of the Skin|2004
<1|~|~|~|~|Mortality|4014258|Mesothelioma|2004
<1|~|~|~|~|Incidence|4014258|Mesothelioma|2004
<1|~|~|~|~|Mortality|4014258|Myeloma|2004
<1|~|~|~|~|Incidence|4014258|Myeloma|2004
<1|~|~|~|~|Mortality|4014258|Non-Hodgkin Lymphoma|2004
<1|~|~|~|~|Incidence|4014258|Non-Hodgkin Lymphoma|2004
<1|~|~|~|~|Mortality|4014258|Oral Cavity and Pharynx|2004
<1|~|~|~|~|Incidence|4014258|Oral Cavity and Pharynx|2004
<1|~|~|~|~|Mortality|1962216|Ovary|2004
<1|~|~|~|~|Incidence|1962216|Ovary|2004
<1|~|~|~|~|Mortality|4014258|Pancreas|2004
<1|~|~|~|~|Incidence|4014258|Pancreas|2004
<1|~|~|~|~|Mortality|2052042|Prostate|2004
<1|~|~|~|~|Incidence|2052042|Prostate|2004
<1|~|~|~|~|Mortality|4014258|Stomach|2004
<1|~|~|~|~|Incidence|4014258|Stomach|2004
<1|~|~|~|~|Mortality|2052042|Testis|2004
<1|~|~|~|~|Incidence|2052042|Testis|2004
<1|~|~|~|~|Mortality|4014258|Thyroid|2004
<1|~|~|~|~|Incidence|4014258|Thyroid|2004
<1|~|~|~|~|Mortality|4014258|Urinary Bladder|2004
<1|~|~|~|~|Incidence|4014258|Urinary Bladder|2004
1-4|2.1|2.6|2.4|377|Mortality|15913007|All Cancer Sites Combined|2005
1-4|20.8|22.3|21.5|3428|Incidence|15913007|All Cancer Sites Combined|2005
1-4|0.4|0.7|0.5|84|Mortality|15913007|Brain and Other Nervous System|2005
1-4|4.0|4.6|4.3|684|Incidence|15913007|Brain and Other Nervous System|2005
1-4|~|~|~|~|Mortality|7785123|Cervix|2005
1-4|~|~|~|~|Incidence|7785123|Cervix|2005
1-4|~|~|~|~|Mortality|15913007|Colon and Rectum|2005
1-4|~|~|~|~|Incidence|15913007|Colon and Rectum|2005
1-4|~|~|~|~|Mortality|7785123|Corpus and Uterus, NOS|2005
1-4|~|~|~|~|Incidence|7785123|Corpus and Uterus, NOS|2005
1-4|~|~|~|~|Mortality|15913007|Esophagus|2005
1-4|~|~|~|~|Incidence|15913007|Esophagus|2005
1-4|~|~|~|~|Mortality|7785123|Female Breast|2005
1-4|~|~|~|~|Incidence|7785123|Female Breast|2005
1-4|~|~|~|~|Incidence|7785123|Female Breast, <i>in situ</i>|2005
1-4|~|~|~|~|Mortality|15913007|Hodgkin Lymphoma|2005
1-4|0.1|0.2|0.1|16|Incidence|15913007|Hodgkin Lymphoma|2005
1-4|.|.|.|.|Mortality|15913007|Kaposi Sarcoma|2005
1-4|~|~|~|~|Incidence|15913007|Kaposi Sarcoma|2005
1-4|0.1|0.2|0.1|16|Mortality|15913007|Kidney and Renal Pelvis|2005
1-4|1.8|2.3|2.0|325|Incidence|15913007|Kidney and Renal Pelvis|2005
1-4|~|~|~|~|Mortality|15913007|Larynx|2005
1-4|~|~|~|~|Incidence|15913007|Larynx|2005
1-4|0.6|0.9|0.8|120|Mortality|15913007|Leukemias|2005
1-4|8.2|9.2|8.7|1383|Incidence|15913007|Leukemias|2005
1-4|0.1|0.2|0.1|21|Mortality|15913007|Liver and Intrahepatic Bile Duct|2005
1-4|0.4|0.6|0.5|80|Incidence|15913007|Liver and Intrahepatic Bile Duct|2005
1-4|~|~|~|~|Mortality|15913007|Lung and Bronchus|2005
1-4|~|~|~|~|Incidence|15913007|Lung and Bronchus|2005
1-4|~|~|~|~|Mortality|7785123|Male and Female Breast|2005
1-4|~|~|~|~|Incidence|7785123|Male and Female Breast|2005
1-4|~|~|~|~|Incidence|7785123|Male and Female Breast, <i>in situ</i>|2005
1-4|~|~|~|~|Mortality|15913007|Melanomas of the Skin|2005
1-4|0.1|0.2|0.1|19|Incidence|15913007|Melanomas of the Skin|2005
1-4|~|~|~|~|Mortality|15913007|Mesothelioma|2005
1-4|~|~|~|~|Incidence|15913007|Mesothelioma|2005
1-4|~|~|~|~|Mortality|15913007|Myeloma|2005
1-4|~|~|~|~|Incidence|15913007|Myeloma|2005
1-4|~|~|~|~|Mortality|15913007|Non-Hodgkin Lymphoma|2005
1-4|0.5|0.8|0.7|106|Incidence|15913007|Non-Hodgkin Lymphoma|2005
1-4|~|~|~|~|Mortality|15913007|Oral Cavity and Pharynx|2005
1-4|~|~|~|~|Incidence|15913007|Oral Cavity and Pharynx|2005
1-4|~|~|~|~|Mortality|7785123|Ovary|2005
1-4|~|~|~|~|Incidence|7785123|Ovary|2005
1-4|~|~|~|~|Mortality|15913007|Pancreas|2005
1-4|~|~|~|~|Incidence|15913007|Pancreas|2005
1-4|~|~|~|~|Mortality|8127884|Prostate|2005
1-4|~|~|~|~|Incidence|8127884|Prostate|2005
1-4|~|~|~|~|Mortality|15913007|Stomach|2005
1-4|~|~|~|~|Incidence|15913007|Stomach|2005
1-4|~|~|~|~|Mortality|8127884|Testis|2005
1-4|0.3|0.5|0.4|31|Incidence|8127884|Testis|2005
1-4|~|~|~|~|Mortality|15913007|Thyroid|2005
1-4|~|~|~|~|Incidence|15913007|Thyroid|2005
1-4|~|~|~|~|Mortality|15913007|Urinary Bladder|2005
1-4|~|~|~|~|Incidence|15913007|Urinary Bladder|2005
10-14|2.2|2.6|2.4|515|Mortality|21212579|All Cancer Sites Combined|2005
10-14|12.5|13.5|13.0|2764|Incidence|21212579|All Cancer Sites Combined|2005
10-14|0.5|0.8|0.6|136|Mortality|21212579|Brain and Other Nervous System|2005
10-14|2.4|2.9|2.7|564|Incidence|21212579|Brain and Other Nervous System|2005
10-14|~|~|~|~|Mortality|10348382|Cervix|2005
10-14|~|~|~|~|Incidence|10348382|Cervix|2005
10-14|~|~|~|~|Mortality|21212579|Colon and Rectum|2005
10-14|~|~|~|~|Incidence|21212579|Colon and Rectum|2005
10-14|~|~|~|~|Mortality|10348382|Corpus and Uterus, NOS|2005
10-14|~|~|~|~|Incidence|10348382|Corpus and Uterus, NOS|2005
10-14|~|~|~|~|Mortality|21212579|Esophagus|2005
10-14|~|~|~|~|Incidence|21212579|Esophagus|2005
10-14|~|~|~|~|Mortality|10348382|Female Breast|2005
10-14|~|~|~|~|Incidence|10348382|Female Breast|2005
10-14|~|~|~|~|Incidence|10348382|Female Breast, <i>in situ</i>|2005
10-14|~|~|~|~|Mortality|21212579|Hodgkin Lymphoma|2005
10-14|1.1|1.4|1.3|267|Incidence|21212579|Hodgkin Lymphoma|2005
10-14|.|.|.|.|Mortality|21212579|Kaposi Sarcoma|2005
10-14|~|~|~|~|Incidence|21212579|Kaposi Sarcoma|2005
10-14|~|~|~|~|Mortality|21212579|Kidney and Renal Pelvis|2005
10-14|0.1|0.2|0.1|26|Incidence|21212579|Kidney and Renal Pelvis|2005
10-14|~|~|~|~|Mortality|21212579|Larynx|2005
10-14|~|~|~|~|Incidence|21212579|Larynx|2005
10-14|0.6|0.8|0.7|150|Mortality|21212579|Leukemias|2005
10-14|2.6|3.1|2.8|602|Incidence|21212579|Leukemias|2005
10-14|~|~|~|~|Mortality|21212579|Liver and Intrahepatic Bile Duct|2005
10-14|0.1|0.2|0.1|26|Incidence|21212579|Liver and Intrahepatic Bile Duct|2005
10-14|~|~|~|~|Mortality|21212579|Lung and Bronchus|2005
10-14|~|~|~|~|Incidence|21212579|Lung and Bronchus|2005
10-14|~|~|~|~|Mortality|10348382|Male and Female Breast|2005
10-14|~|~|~|~|Incidence|10348382|Male and Female Breast|2005
10-14|~|~|~|~|Incidence|10348382|Male and Female Breast, <i>in situ</i>|2005
10-14|~|~|~|~|Mortality|21212579|Melanomas of the Skin|2005
10-14|0.3|0.4|0.3|73|Incidence|21212579|Melanomas of the Skin|2005
10-14|~|~|~|~|Mortality|21212579|Mesothelioma|2005
10-14|~|~|~|~|Incidence|21212579|Mesothelioma|2005
10-14|~|~|~|~|Mortality|21212579|Myeloma|2005
10-14|~|~|~|~|Incidence|21212579|Myeloma|2005
10-14|0.1|0.2|0.1|29|Mortality|21212579|Non-Hodgkin Lymphoma|2005
10-14|1.1|1.4|1.2|261|Incidence|21212579|Non-Hodgkin Lymphoma|2005
10-14|~|~|~|~|Mortality|21212579|Oral Cavity and Pharynx|2005
10-14|0.3|0.4|0.3|73|Incidence|21212579|Oral Cavity and Pharynx|2005
10-14|~|~|~|~|Mortality|10348382|Ovary|2005
10-14|0.5|0.9|0.7|71|Incidence|10348382|Ovary|2005
10-14|~|~|~|~|Mortality|21212579|Pancreas|2005
10-14|~|~|~|~|Incidence|21212579|Pancreas|2005
10-14|~|~|~|~|Mortality|10864197|Prostate|2005
10-14|~|~|~|~|Incidence|10864197|Prostate|2005
10-14|~|~|~|~|Mortality|21212579|Stomach|2005
10-14|~|~|~|~|Incidence|21212579|Stomach|2005
10-14|~|~|~|~|Mortality|10864197|Testis|2005
10-14|0.1|0.3|0.2|25|Incidence|10864197|Testis|2005
10-14|~|~|~|~|Mortality|21212579|Thyroid|2005
10-14|0.4|0.7|0.5|115|Incidence|21212579|Thyroid|2005
10-14|~|~|~|~|Mortality|21212579|Urinary Bladder|2005
10-14|~|~|~|~|Incidence|21212579|Urinary Bladder|2005
15-19|3.2|3.7|3.4|731|Mortality|21486214|All Cancer Sites Combined|2005
15-19|21.6|22.9|22.2|4777|Incidence|21486214|All Cancer Sites Combined|2005
15-19|0.5|0.7|0.5|118|Mortality|21486214|Brain and Other Nervous System|2005
15-19|2.0|2.4|2.2|479|Incidence|21486214|Brain and Other Nervous System|2005
15-19|~|~|~|~|Mortality|10434789|Cervix|2005
15-19|0.1|0.3|0.2|18|Incidence|10434789|Cervix|2005
15-19|~|~|~|~|Mortality|21486214|Colon and Rectum|2005
15-19|0.3|0.4|0.3|70|Incidence|21486214|Colon and Rectum|2005
15-19|~|~|~|~|Mortality|10434789|Corpus and Uterus, NOS|2005
15-19|~|~|~|~|Incidence|10434789|Corpus and Uterus, NOS|2005
15-19|~|~|~|~|Mortality|21486214|Esophagus|2005
15-19|~|~|~|~|Incidence|21486214|Esophagus|2005
15-19|~|~|~|~|Mortality|10434789|Female Breast|2005
15-19|~|~|~|~|Incidence|10434789|Female Breast|2005
15-19|~|~|~|~|Incidence|10434789|Female Breast, <i>in situ</i>|2005
15-19|~|~|~|~|Mortality|21486214|Hodgkin Lymphoma|2005
15-19|3.1|3.6|3.3|709|Incidence|21486214|Hodgkin Lymphoma|2005
15-19|.|.|.|.|Mortality|21486214|Kaposi Sarcoma|2005
15-19|~|~|~|~|Incidence|21486214|Kaposi Sarcoma|2005
15-19|~|~|~|~|Mortality|21486214|Kidney and Renal Pelvis|2005
15-19|0.2|0.3|0.2|49|Incidence|21486214|Kidney and Renal Pelvis|2005
15-19|~|~|~|~|Mortality|21486214|Larynx|2005
15-19|~|~|~|~|Incidence|21486214|Larynx|2005
15-19|0.9|1.2|1.0|223|Mortality|21486214|Leukemias|2005
15-19|2.6|3.0|2.8|597|Incidence|21486214|Leukemias|2005
15-19|~|~|~|~|Mortality|21486214|Liver and Intrahepatic Bile Duct|2005
15-19|0.1|0.2|0.1|26|Incidence|21486214|Liver and Intrahepatic Bile Duct|2005
15-19|~|~|~|~|Mortality|21486214|Lung and Bronchus|2005
15-19|0.1|0.2|0.1|31|Incidence|21486214|Lung and Bronchus|2005
15-19|~|~|~|~|Mortality|10434789|Male and Female Breast|2005
15-19|~|~|~|~|Incidence|10434789|Male and Female Breast|2005
15-19|~|~|~|~|Incidence|10434789|Male and Female Breast, <i>in situ</i>|2005
15-19|~|~|~|~|Mortality|21486214|Melanomas of the Skin|2005
15-19|1.7|2.0|1.8|396|Incidence|21486214|Melanomas of the Skin|2005
15-19|~|~|~|~|Mortality|21486214|Mesothelioma|2005
15-19|~|~|~|~|Incidence|21486214|Mesothelioma|2005
15-19|~|~|~|~|Mortality|21486214|Myeloma|2005
15-19|~|~|~|~|Incidence|21486214|Myeloma|2005
15-19|0.2|0.3|0.2|47|Mortality|21486214|Non-Hodgkin Lymphoma|2005
15-19|1.8|2.1|2.0|419|Incidence|21486214|Non-Hodgkin Lymphoma|2005
15-19|~|~|~|~|Mortality|21486214|Oral Cavity and Pharynx|2005
15-19|0.4|0.5|0.4|96|Incidence|21486214|Oral Cavity and Pharynx|2005
15-19|~|~|~|~|Mortality|10434789|Ovary|2005
15-19|1.3|1.8|1.5|157|Incidence|10434789|Ovary|2005
15-19|~|~|~|~|Mortality|21486214|Pancreas|2005
15-19|~|~|~|~|Incidence|21486214|Pancreas|2005
15-19|~|~|~|~|Mortality|11051425|Prostate|2005
15-19|~|~|~|~|Incidence|11051425|Prostate|2005
15-19|~|~|~|~|Mortality|21486214|Stomach|2005
15-19|~|~|~|~|Incidence|21486214|Stomach|2005
15-19|~|~|~|~|Mortality|11051425|Testis|2005
15-19|3.3|4.0|3.6|398|Incidence|11051425|Testis|2005
15-19|~|~|~|~|Mortality|21486214|Thyroid|2005
15-19|1.6|2.0|1.8|385|Incidence|21486214|Thyroid|2005
15-19|~|~|~|~|Mortality|21486214|Urinary Bladder|2005
15-19|0.1|0.2|0.1|26|Incidence|21486214|Urinary Bladder|2005
5-9|2.3|2.7|2.5|485|Mortality|19389067|All Cancer Sites Combined|2005
5-9|11.4|12.4|11.9|2309|Incidence|19389067|All Cancer Sites Combined|2005
5-9|0.8|1.1|1.0|188|Mortality|19389067|Brain and Other Nervous System|2005
5-9|3.2|3.7|3.5|671|Incidence|19389067|Brain and Other Nervous System|2005
5-9|~|~|~|~|Mortality|9473900|Cervix|2005
5-9|~|~|~|~|Incidence|9473900|Cervix|2005
5-9|~|~|~|~|Mortality|19389067|Colon and Rectum|2005
5-9|~|~|~|~|Incidence|19389067|Colon and Rectum|2005
5-9|~|~|~|~|Mortality|9473900|Corpus and Uterus, NOS|2005
5-9|~|~|~|~|Incidence|9473900|Corpus and Uterus, NOS|2005
5-9|~|~|~|~|Mortality|19389067|Esophagus|2005
5-9|~|~|~|~|Incidence|19389067|Esophagus|2005
5-9|~|~|~|~|Mortality|9473900|Female Breast|2005
5-9|~|~|~|~|Incidence|9473900|Female Breast|2005
5-9|~|~|~|~|Incidence|9473900|Female Breast, <i>in situ</i>|2005
5-9|~|~|~|~|Mortality|19389067|Hodgkin Lymphoma|2005
5-9|0.3|0.5|0.4|77|Incidence|19389067|Hodgkin Lymphoma|2005
5-9|.|.|.|.|Mortality|19389067|Kaposi Sarcoma|2005
5-9|~|~|~|~|Incidence|19389067|Kaposi Sarcoma|2005
5-9|0.1|0.2|0.1|20|Mortality|19389067|Kidney and Renal Pelvis|2005
5-9|0.4|0.6|0.5|101|Incidence|19389067|Kidney and Renal Pelvis|2005
5-9|~|~|~|~|Mortality|19389067|Larynx|2005
5-9|~|~|~|~|Incidence|19389067|Larynx|2005
5-9|0.5|0.8|0.6|125|Mortality|19389067|Leukemias|2005
5-9|3.5|4.1|3.8|732|Incidence|19389067|Leukemias|2005
5-9|~|~|~|~|Mortality|19389067|Liver and Intrahepatic Bile Duct|2005
5-9|0.0|0.1|0.1|16|Incidence|19389067|Liver and Intrahepatic Bile Duct|2005
5-9|~|~|~|~|Mortality|19389067|Lung and Bronchus|2005
5-9|~|~|~|~|Incidence|19389067|Lung and Bronchus|2005
5-9|~|~|~|~|Mortality|9473900|Male and Female Breast|2005
5-9|~|~|~|~|Incidence|9473900|Male and Female Breast|2005
5-9|~|~|~|~|Incidence|9473900|Male and Female Breast, <i>in situ</i>|2005
5-9|~|~|~|~|Mortality|19389067|Melanomas of the Skin|2005
5-9|0.1|0.3|0.2|39|Incidence|19389067|Melanomas of the Skin|2005
5-9|~|~|~|~|Mortality|19389067|Mesothelioma|2005
5-9|~|~|~|~|Incidence|19389067|Mesothelioma|2005
5-9|~|~|~|~|Mortality|19389067|Myeloma|2005
5-9|~|~|~|~|Incidence|19389067|Myeloma|2005
5-9|0.1|0.2|0.1|19|Mortality|19389067|Non-Hodgkin Lymphoma|2005
5-9|0.8|1.1|0.9|176|Incidence|19389067|Non-Hodgkin Lymphoma|2005
5-9|~|~|~|~|Mortality|19389067|Oral Cavity and Pharynx|2005
5-9|0.1|0.2|0.1|23|Incidence|19389067|Oral Cavity and Pharynx|2005
5-9|~|~|~|~|Mortality|9473900|Ovary|2005
5-9|0.1|0.3|0.2|18|Incidence|9473900|Ovary|2005
5-9|~|~|~|~|Mortality|19389067|Pancreas|2005
5-9|~|~|~|~|Incidence|19389067|Pancreas|2005
5-9|~|~|~|~|Mortality|9915167|Prostate|2005
5-9|~|~|~|~|Incidence|9915167|Prostate|2005
5-9|~|~|~|~|Mortality|19389067|Stomach|2005
5-9|~|~|~|~|Incidence|19389067|Stomach|2005
5-9|~|~|~|~|Mortality|9915167|Testis|2005
5-9|~|~|~|~|Incidence|9915167|Testis|2005
5-9|~|~|~|~|Mortality|19389067|Thyroid|2005
5-9|0.1|0.1|0.1|18|Incidence|19389067|Thyroid|2005
5-9|~|~|~|~|Mortality|19389067|Urinary Bladder|2005
5-9|~|~|~|~|Incidence|19389067|Urinary Bladder|2005
<1|1.5|2.3|1.9|75|Mortality|4004393|All Cancer Sites Combined|2005
<1|23.3|26.4|24.8|992|Incidence|4004393|All Cancer Sites Combined|2005
<1|0.3|0.7|0.4|18|Mortality|4004393|Brain and Other Nervous System|2005
<1|3.0|4.2|3.6|144|Incidence|4004393|Brain and Other Nervous System|2005
<1|~|~|~|~|Mortality|1956682|Cervix|2005
<1|~|~|~|~|Incidence|1956682|Cervix|2005
<1|~|~|~|~|Mortality|4004393|Colon and Rectum|2005
<1|~|~|~|~|Incidence|4004393|Colon and Rectum|2005
<1|~|~|~|~|Mortality|1956682|Corpus and Uterus, NOS|2005
<1|~|~|~|~|Incidence|1956682|Corpus and Uterus, NOS|2005
<1|~|~|~|~|Mortality|4004393|Esophagus|2005
<1|~|~|~|~|Incidence|4004393|Esophagus|2005
<1|~|~|~|~|Mortality|1956682|Female Breast|2005
<1|~|~|~|~|Incidence|1956682|Female Breast|2005
<1|~|~|~|~|Incidence|1956682|Female Breast, <i>in situ</i>|2005
<1|~|~|~|~|Mortality|4004393|Hodgkin Lymphoma|2005
<1|~|~|~|~|Incidence|4004393|Hodgkin Lymphoma|2005
<1|.|.|.|.|Mortality|4004393|Kaposi Sarcoma|2005
<1|~|~|~|~|Incidence|4004393|Kaposi Sarcoma|2005
<1|~|~|~|~|Mortality|4004393|Kidney and Renal Pelvis|2005
<1|1.3|2.1|1.7|67|Incidence|4004393|Kidney and Renal Pelvis|2005
<1|~|~|~|~|Mortality|4004393|Larynx|2005
<1|~|~|~|~|Incidence|4004393|Larynx|2005
<1|0.3|0.8|0.5|22|Mortality|4004393|Leukemias|2005
<1|3.7|5.0|4.3|174|Incidence|4004393|Leukemias|2005
<1|~|~|~|~|Mortality|4004393|Liver and Intrahepatic Bile Duct|2005
<1|0.8|1.4|1.0|42|Incidence|4004393|Liver and Intrahepatic Bile Duct|2005
<1|~|~|~|~|Mortality|4004393|Lung and Bronchus|2005
<1|~|~|~|~|Incidence|4004393|Lung and Bronchus|2005
<1|~|~|~|~|Mortality|1956682|Male and Female Breast|2005
<1|~|~|~|~|Incidence|1956682|Male and Female Breast|2005
<1|~|~|~|~|Incidence|1956682|Male and Female Breast, <i>in situ</i>|2005
<1|~|~|~|~|Mortality|4004393|Melanomas of the Skin|2005
<1|~|~|~|~|Incidence|4004393|Melanomas of the Skin|2005
<1|~|~|~|~|Mortality|4004393|Mesothelioma|2005
<1|~|~|~|~|Incidence|4004393|Mesothelioma|2005
<1|~|~|~|~|Mortality|4004393|Myeloma|2005
<1|~|~|~|~|Incidence|4004393|Myeloma|2005
<1|~|~|~|~|Mortality|4004393|Non-Hodgkin Lymphoma|2005
<1|~|~|~|~|Incidence|4004393|Non-Hodgkin Lymphoma|2005
<1|~|~|~|~|Mortality|4004393|Oral Cavity and Pharynx|2005
<1|~|~|~|~|Incidence|4004393|Oral Cavity and Pharynx|2005
<1|~|~|~|~|Mortality|1956682|Ovary|2005
<1|~|~|~|~|Incidence|1956682|Ovary|2005
<1|~|~|~|~|Mortality|4004393|Pancreas|2005
<1|~|~|~|~|Incidence|4004393|Pancreas|2005
<1|~|~|~|~|Mortality|2047711|Prostate|2005
<1|~|~|~|~|Incidence|2047711|Prostate|2005
<1|~|~|~|~|Mortality|4004393|Stomach|2005
<1|~|~|~|~|Incidence|4004393|Stomach|2005
<1|~|~|~|~|Mortality|2047711|Testis|2005
<1|0.6|1.5|1.0|20|Incidence|2047711|Testis|2005
<1|~|~|~|~|Mortality|4004393|Thyroid|2005
<1|~|~|~|~|Incidence|4004393|Thyroid|2005
<1|~|~|~|~|Mortality|4004393|Urinary Bladder|2005
<1|~|~|~|~|Incidence|4004393|Urinary Bladder|2005
1-4|2.1|2.6|2.4|377|Mortality|15897145|All Cancer Sites Combined|2006
1-4|20.7|22.1|21.4|3397|Incidence|15897145|All Cancer Sites Combined|2006
1-4|0.5|0.8|0.6|101|Mortality|15897145|Brain and Other Nervous System|2006
1-4|4.3|5.0|4.6|737|Incidence|15897145|Brain and Other Nervous System|2006
1-4|~|~|~|~|Mortality|7775092|Cervix|2006
1-4|~|~|~|~|Incidence|7775092|Cervix|2006
1-4|~|~|~|~|Mortality|15897145|Colon and Rectum|2006
1-4|~|~|~|~|Incidence|15897145|Colon and Rectum|2006
1-4|~|~|~|~|Mortality|7775092|Corpus and Uterus, NOS|2006
1-4|~|~|~|~|Incidence|7775092|Corpus and Uterus, NOS|2006
1-4|~|~|~|~|Mortality|15897145|Esophagus|2006
1-4|~|~|~|~|Incidence|15897145|Esophagus|2006
1-4|~|~|~|~|Mortality|7775092|Female Breast|2006
1-4|~|~|~|~|Incidence|7775092|Female Breast|2006
1-4|~|~|~|~|Incidence|7775092|Female Breast, <i>in situ</i>|2006
1-4|~|~|~|~|Mortality|15897145|Hodgkin Lymphoma|2006
1-4|0.1|0.2|0.1|17|Incidence|15897145|Hodgkin Lymphoma|2006
1-4|.|.|.|.|Mortality|15897145|Kaposi Sarcoma|2006
1-4|~|~|~|~|Incidence|15897145|Kaposi Sarcoma|2006
1-4|~|~|~|~|Mortality|15897145|Kidney and Renal Pelvis|2006
1-4|1.8|2.3|2.0|322|Incidence|15897145|Kidney and Renal Pelvis|2006
1-4|~|~|~|~|Mortality|15897145|Larynx|2006
1-4|~|~|~|~|Incidence|15897145|Larynx|2006
1-4|0.6|0.9|0.8|124|Mortality|15897145|Leukemias|2006
1-4|8.3|9.2|8.7|1384|Incidence|15897145|Leukemias|2006
1-4|~|~|~|~|Mortality|15897145|Liver and Intrahepatic Bile Duct|2006
1-4|0.4|0.6|0.5|83|Incidence|15897145|Liver and Intrahepatic Bile Duct|2006
1-4|~|~|~|~|Mortality|15897145|Lung and Bronchus|2006
1-4|~|~|~|~|Incidence|15897145|Lung and Bronchus|2006
1-4|~|~|~|~|Mortality|7775092|Male and Female Breast|2006
1-4|~|~|~|~|Incidence|7775092|Male and Female Breast|2006
1-4|~|~|~|~|Incidence|7775092|Male and Female Breast, <i>in situ</i>|2006
1-4|~|~|~|~|Mortality|15897145|Melanomas of the Skin|2006
1-4|~|~|~|~|Incidence|15897145|Melanomas of the Skin|2006
1-4|~|~|~|~|Mortality|15897145|Mesothelioma|2006
1-4|~|~|~|~|Incidence|15897145|Mesothelioma|2006
1-4|~|~|~|~|Mortality|15897145|Myeloma|2006
1-4|~|~|~|~|Incidence|15897145|Myeloma|2006
1-4|~|~|~|~|Mortality|15897145|Non-Hodgkin Lymphoma|2006
1-4|0.5|0.7|0.6|97|Incidence|15897145|Non-Hodgkin Lymphoma|2006
1-4|~|~|~|~|Mortality|15897145|Oral Cavity and Pharynx|2006
1-4|~|~|~|~|Incidence|15897145|Oral Cavity and Pharynx|2006
1-4|~|~|~|~|Mortality|7775092|Ovary|2006
1-4|~|~|~|~|Incidence|7775092|Ovary|2006
1-4|~|~|~|~|Mortality|15897145|Pancreas|2006
1-4|~|~|~|~|Incidence|15897145|Pancreas|2006
1-4|~|~|~|~|Mortality|8122053|Prostate|2006
1-4|~|~|~|~|Incidence|8122053|Prostate|2006
1-4|~|~|~|~|Mortality|15897145|Stomach|2006
1-4|~|~|~|~|Incidence|15897145|Stomach|2006
1-4|~|~|~|~|Mortality|8122053|Testis|2006
1-4|0.1|0.4|0.2|19|Incidence|8122053|Testis|2006
1-4|~|~|~|~|Mortality|15897145|Thyroid|2006
1-4|~|~|~|~|Incidence|15897145|Thyroid|2006
1-4|~|~|~|~|Mortality|15897145|Urinary Bladder|2006
1-4|~|~|~|~|Incidence|15897145|Urinary Bladder|2006
10-14|1.9|2.3|2.1|448|Mortality|21033138|All Cancer Sites Combined|2006
10-14|13.0|14.0|13.5|2847|Incidence|21033138|All Cancer Sites Combined|2006
10-14|0.5|0.7|0.6|129|Mortality|21033138|Brain and Other Nervous System|2006
10-14|2.5|3.0|2.7|573|Incidence|21033138|Brain and Other Nervous System|2006
10-14|~|~|~|~|Mortality|10261944|Cervix|2006
10-14|~|~|~|~|Incidence|10261944|Cervix|2006
10-14|~|~|~|~|Mortality|21033138|Colon and Rectum|2006
10-14|0.1|0.1|0.1|18|Incidence|21033138|Colon and Rectum|2006
10-14|~|~|~|~|Mortality|10261944|Corpus and Uterus, NOS|2006
10-14|~|~|~|~|Incidence|10261944|Corpus and Uterus, NOS|2006
10-14|~|~|~|~|Mortality|21033138|Esophagus|2006
10-14|~|~|~|~|Incidence|21033138|Esophagus|2006
10-14|~|~|~|~|Mortality|10261944|Female Breast|2006
10-14|~|~|~|~|Incidence|10261944|Female Breast|2006
10-14|~|~|~|~|Incidence|10261944|Female Breast, <i>in situ</i>|2006
10-14|~|~|~|~|Mortality|21033138|Hodgkin Lymphoma|2006
10-14|1.1|1.4|1.3|266|Incidence|21033138|Hodgkin Lymphoma|2006
10-14|.|.|.|.|Mortality|21033138|Kaposi Sarcoma|2006
10-14|~|~|~|~|Incidence|21033138|Kaposi Sarcoma|2006
10-14|~|~|~|~|Mortality|21033138|Kidney and Renal Pelvis|2006
10-14|0.1|0.2|0.1|26|Incidence|21033138|Kidney and Renal Pelvis|2006
10-14|~|~|~|~|Mortality|21033138|Larynx|2006
10-14|~|~|~|~|Incidence|21033138|Larynx|2006
10-14|0.6|0.8|0.7|152|Mortality|21033138|Leukemias|2006
10-14|3.0|3.5|3.2|678|Incidence|21033138|Leukemias|2006
10-14|~|~|~|~|Mortality|21033138|Liver and Intrahepatic Bile Duct|2006
10-14|0.1|0.2|0.1|21|Incidence|21033138|Liver and Intrahepatic Bile Duct|2006
10-14|~|~|~|~|Mortality|21033138|Lung and Bronchus|2006
10-14|~|~|~|~|Incidence|21033138|Lung and Bronchus|2006
10-14|~|~|~|~|Mortality|10261944|Male and Female Breast|2006
10-14|~|~|~|~|Incidence|10261944|Male and Female Breast|2006
10-14|~|~|~|~|Incidence|10261944|Male and Female Breast, <i>in situ</i>|2006
10-14|~|~|~|~|Mortality|21033138|Melanomas of the Skin|2006
10-14|0.3|0.5|0.4|90|Incidence|21033138|Melanomas of the Skin|2006
10-14|~|~|~|~|Mortality|21033138|Mesothelioma|2006
10-14|~|~|~|~|Incidence|21033138|Mesothelioma|2006
10-14|~|~|~|~|Mortality|21033138|Myeloma|2006
10-14|~|~|~|~|Incidence|21033138|Myeloma|2006
10-14|0.1|0.2|0.1|25|Mortality|21033138|Non-Hodgkin Lymphoma|2006
10-14|1.1|1.4|1.2|258|Incidence|21033138|Non-Hodgkin Lymphoma|2006
10-14|~|~|~|~|Mortality|21033138|Oral Cavity and Pharynx|2006
10-14|0.2|0.4|0.3|61|Incidence|21033138|Oral Cavity and Pharynx|2006
10-14|~|~|~|~|Mortality|10261944|Ovary|2006
10-14|0.6|0.9|0.7|76|Incidence|10261944|Ovary|2006
10-14|~|~|~|~|Mortality|21033138|Pancreas|2006
10-14|~|~|~|~|Incidence|21033138|Pancreas|2006
10-14|~|~|~|~|Mortality|10771194|Prostate|2006
10-14|~|~|~|~|Incidence|10771194|Prostate|2006
10-14|~|~|~|~|Mortality|21033138|Stomach|2006
10-14|~|~|~|~|Incidence|21033138|Stomach|2006
10-14|~|~|~|~|Mortality|10771194|Testis|2006
10-14|~|~|~|~|Incidence|10771194|Testis|2006
10-14|~|~|~|~|Mortality|21033138|Thyroid|2006
10-14|0.5|0.7|0.6|128|Incidence|21033138|Thyroid|2006
10-14|~|~|~|~|Mortality|21033138|Urinary Bladder|2006
10-14|~|~|~|~|Incidence|21033138|Urinary Bladder|2006
15-19|2.9|3.3|3.1|675|Mortality|21807709|All Cancer Sites Combined|2006
15-19|20.9|22.2|21.6|4700|Incidence|21807709|All Cancer Sites Combined|2006
15-19|0.4|0.6|0.5|102|Mortality|21807709|Brain and Other Nervous System|2006
15-19|2.1|2.5|2.3|509|Incidence|21807709|Brain and Other Nervous System|2006
15-19|~|~|~|~|Mortality|10597293|Cervix|2006
15-19|0.1|0.3|0.2|24|Incidence|10597293|Cervix|2006
15-19|~|~|~|~|Mortality|21807709|Colon and Rectum|2006
15-19|0.2|0.4|0.3|62|Incidence|21807709|Colon and Rectum|2006
15-19|~|~|~|~|Mortality|10597293|Corpus and Uterus, NOS|2006
15-19|~|~|~|~|Incidence|10597293|Corpus and Uterus, NOS|2006
15-19|~|~|~|~|Mortality|21807709|Esophagus|2006
15-19|~|~|~|~|Incidence|21807709|Esophagus|2006
15-19|~|~|~|~|Mortality|10597293|Female Breast|2006
15-19|0.1|0.3|0.2|20|Incidence|10597293|Female Breast|2006
15-19|~|~|~|~|Incidence|10597293|Female Breast, <i>in situ</i>|2006
15-19|0.0|0.1|0.1|18|Mortality|21807709|Hodgkin Lymphoma|2006
15-19|2.9|3.4|3.1|683|Incidence|21807709|Hodgkin Lymphoma|2006
15-19|.|.|.|.|Mortality|21807709|Kaposi Sarcoma|2006
15-19|~|~|~|~|Incidence|21807709|Kaposi Sarcoma|2006
15-19|~|~|~|~|Mortality|21807709|Kidney and Renal Pelvis|2006
15-19|0.2|0.3|0.2|48|Incidence|21807709|Kidney and Renal Pelvis|2006
15-19|~|~|~|~|Mortality|21807709|Larynx|2006
15-19|~|~|~|~|Incidence|21807709|Larynx|2006
15-19|0.8|1.1|0.9|207|Mortality|21807709|Leukemias|2006
15-19|2.8|3.2|3.0|656|Incidence|21807709|Leukemias|2006
15-19|~|~|~|~|Mortality|21807709|Liver and Intrahepatic Bile Duct|2006
15-19|0.1|0.2|0.2|34|Incidence|21807709|Liver and Intrahepatic Bile Duct|2006
15-19|~|~|~|~|Mortality|21807709|Lung and Bronchus|2006
15-19|0.1|0.2|0.1|28|Incidence|21807709|Lung and Bronchus|2006
15-19|~|~|~|~|Mortality|10597293|Male and Female Breast|2006
15-19|0.1|0.3|0.2|20|Incidence|10597293|Male and Female Breast|2006
15-19|~|~|~|~|Incidence|10597293|Male and Female Breast, <i>in situ</i>|2006
15-19|~|~|~|~|Mortality|21807709|Melanomas of the Skin|2006
15-19|1.3|1.6|1.4|306|Incidence|21807709|Melanomas of the Skin|2006
15-19|~|~|~|~|Mortality|21807709|Mesothelioma|2006
15-19|~|~|~|~|Incidence|21807709|Mesothelioma|2006
15-19|~|~|~|~|Mortality|21807709|Myeloma|2006
15-19|~|~|~|~|Incidence|21807709|Myeloma|2006
15-19|0.2|0.3|0.2|45|Mortality|21807709|Non-Hodgkin Lymphoma|2006
15-19|1.6|2.0|1.8|393|Incidence|21807709|Non-Hodgkin Lymphoma|2006
15-19|~|~|~|~|Mortality|21807709|Oral Cavity and Pharynx|2006
15-19|0.4|0.6|0.5|107|Incidence|21807709|Oral Cavity and Pharynx|2006
15-19|~|~|~|~|Mortality|10597293|Ovary|2006
15-19|1.2|1.7|1.4|149|Incidence|10597293|Ovary|2006
15-19|~|~|~|~|Mortality|21807709|Pancreas|2006
15-19|~|~|~|~|Incidence|21807709|Pancreas|2006
15-19|~|~|~|~|Mortality|11210416|Prostate|2006
15-19|~|~|~|~|Incidence|11210416|Prostate|2006
15-19|~|~|~|~|Mortality|21807709|Stomach|2006
15-19|~|~|~|~|Incidence|21807709|Stomach|2006
15-19|~|~|~|~|Mortality|11210416|Testis|2006
15-19|2.7|3.4|3.0|339|Incidence|11210416|Testis|2006
15-19|~|~|~|~|Mortality|21807709|Thyroid|2006
15-19|1.7|2.1|1.9|416|Incidence|21807709|Thyroid|2006
15-19|~|~|~|~|Mortality|21807709|Urinary Bladder|2006
15-19|0.1|0.2|0.1|22|Incidence|21807709|Urinary Bladder|2006
5-9|2.1|2.6|2.3|459|Mortality|19544688|All Cancer Sites Combined|2006
5-9|11.7|12.6|12.1|2372|Incidence|19544688|All Cancer Sites Combined|2006
5-9|0.8|1.0|0.9|176|Mortality|19544688|Brain and Other Nervous System|2006
5-9|3.1|3.6|3.4|656|Incidence|19544688|Brain and Other Nervous System|2006
5-9|~|~|~|~|Mortality|9555173|Cervix|2006
5-9|~|~|~|~|Incidence|9555173|Cervix|2006
5-9|~|~|~|~|Mortality|19544688|Colon and Rectum|2006
5-9|~|~|~|~|Incidence|19544688|Colon and Rectum|2006
5-9|~|~|~|~|Mortality|9555173|Corpus and Uterus, NOS|2006
5-9|~|~|~|~|Incidence|9555173|Corpus and Uterus, NOS|2006
5-9|~|~|~|~|Mortality|19544688|Esophagus|2006
5-9|~|~|~|~|Incidence|19544688|Esophagus|2006
5-9|~|~|~|~|Mortality|9555173|Female Breast|2006
5-9|~|~|~|~|Incidence|9555173|Female Breast|2006
5-9|~|~|~|~|Incidence|9555173|Female Breast, <i>in situ</i>|2006
5-9|~|~|~|~|Mortality|19544688|Hodgkin Lymphoma|2006
5-9|0.4|0.6|0.5|92|Incidence|19544688|Hodgkin Lymphoma|2006
5-9|.|.|.|.|Mortality|19544688|Kaposi Sarcoma|2006
5-9|~|~|~|~|Incidence|19544688|Kaposi Sarcoma|2006
5-9|0.1|0.2|0.1|23|Mortality|19544688|Kidney and Renal Pelvis|2006
5-9|0.5|0.7|0.6|109|Incidence|19544688|Kidney and Renal Pelvis|2006
5-9|~|~|~|~|Mortality|19544688|Larynx|2006
5-9|~|~|~|~|Incidence|19544688|Larynx|2006
5-9|0.4|0.6|0.5|104|Mortality|19544688|Leukemias|2006
5-9|3.6|4.1|3.9|755|Incidence|19544688|Leukemias|2006
5-9|~|~|~|~|Mortality|19544688|Liver and Intrahepatic Bile Duct|2006
5-9|0.1|0.2|0.1|20|Incidence|19544688|Liver and Intrahepatic Bile Duct|2006
5-9|~|~|~|~|Mortality|19544688|Lung and Bronchus|2006
5-9|~|~|~|~|Incidence|19544688|Lung and Bronchus|2006
5-9|~|~|~|~|Mortality|9555173|Male and Female Breast|2006
5-9|~|~|~|~|Incidence|9555173|Male and Female Breast|2006
5-9|~|~|~|~|Incidence|9555173|Male and Female Breast, <i>in situ</i>|2006
5-9|~|~|~|~|Mortality|19544688|Melanomas of the Skin|2006
5-9|0.1|0.2|0.2|31|Incidence|19544688|Melanomas of the Skin|2006
5-9|~|~|~|~|Mortality|19544688|Mesothelioma|2006
5-9|~|~|~|~|Incidence|19544688|Mesothelioma|2006
5-9|~|~|~|~|Mortality|19544688|Myeloma|2006
5-9|~|~|~|~|Incidence|19544688|Myeloma|2006
5-9|~|~|~|~|Mortality|19544688|Non-Hodgkin Lymphoma|2006
5-9|0.8|1.1|0.9|180|Incidence|19544688|Non-Hodgkin Lymphoma|2006
5-9|~|~|~|~|Mortality|19544688|Oral Cavity and Pharynx|2006
5-9|0.1|0.2|0.2|30|Incidence|19544688|Oral Cavity and Pharynx|2006
5-9|~|~|~|~|Mortality|9555173|Ovary|2006
5-9|0.2|0.4|0.3|25|Incidence|9555173|Ovary|2006
5-9|~|~|~|~|Mortality|19544688|Pancreas|2006
5-9|~|~|~|~|Incidence|19544688|Pancreas|2006
5-9|~|~|~|~|Mortality|9989515|Prostate|2006
5-9|~|~|~|~|Incidence|9989515|Prostate|2006
5-9|~|~|~|~|Mortality|19544688|Stomach|2006
5-9|~|~|~|~|Incidence|19544688|Stomach|2006
5-9|~|~|~|~|Mortality|9989515|Testis|2006
5-9|~|~|~|~|Incidence|9989515|Testis|2006
5-9|~|~|~|~|Mortality|19544688|Thyroid|2006
5-9|0.1|0.2|0.2|30|Incidence|19544688|Thyroid|2006
5-9|~|~|~|~|Mortality|19544688|Urinary Bladder|2006
5-9|~|~|~|~|Incidence|19544688|Urinary Bladder|2006
<1|1.5|2.4|1.9|76|Mortality|4041738|All Cancer Sites Combined|2006
<1|24.7|27.9|26.3|1063|Incidence|4041738|All Cancer Sites Combined|2006
<1|0.2|0.6|0.4|16|Mortality|4041738|Brain and Other Nervous System|2006
<1|3.3|4.5|3.8|155|Incidence|4041738|Brain and Other Nervous System|2006
<1|~|~|~|~|Mortality|1975919|Cervix|2006
<1|~|~|~|~|Incidence|1975919|Cervix|2006
<1|~|~|~|~|Mortality|4041738|Colon and Rectum|2006
<1|~|~|~|~|Incidence|4041738|Colon and Rectum|2006
<1|~|~|~|~|Mortality|1975919|Corpus and Uterus, NOS|2006
<1|~|~|~|~|Incidence|1975919|Corpus and Uterus, NOS|2006
<1|~|~|~|~|Mortality|4041738|Esophagus|2006
<1|~|~|~|~|Incidence|4041738|Esophagus|2006
<1|~|~|~|~|Mortality|1975919|Female Breast|2006
<1|~|~|~|~|Incidence|1975919|Female Breast|2006
<1|~|~|~|~|Incidence|1975919|Female Breast, <i>in situ</i>|2006
<1|~|~|~|~|Mortality|4041738|Hodgkin Lymphoma|2006
<1|~|~|~|~|Incidence|4041738|Hodgkin Lymphoma|2006
<1|.|.|.|.|Mortality|4041738|Kaposi Sarcoma|2006
<1|~|~|~|~|Incidence|4041738|Kaposi Sarcoma|2006
<1|~|~|~|~|Mortality|4041738|Kidney and Renal Pelvis|2006
<1|1.3|2.1|1.7|68|Incidence|4041738|Kidney and Renal Pelvis|2006
<1|~|~|~|~|Mortality|4041738|Larynx|2006
<1|~|~|~|~|Incidence|4041738|Larynx|2006
<1|0.5|1.1|0.8|31|Mortality|4041738|Leukemias|2006
<1|4.1|5.5|4.8|194|Incidence|4041738|Leukemias|2006
<1|~|~|~|~|Mortality|4041738|Liver and Intrahepatic Bile Duct|2006
<1|1.2|2.0|1.6|64|Incidence|4041738|Liver and Intrahepatic Bile Duct|2006
<1|~|~|~|~|Mortality|4041738|Lung and Bronchus|2006
<1|~|~|~|~|Incidence|4041738|Lung and Bronchus|2006
<1|~|~|~|~|Mortality|1975919|Male and Female Breast|2006
<1|~|~|~|~|Incidence|1975919|Male and Female Breast|2006
<1|~|~|~|~|Incidence|1975919|Male and Female Breast, <i>in situ</i>|2006
<1|~|~|~|~|Mortality|4041738|Melanomas of the Skin|2006
<1|~|~|~|~|Incidence|4041738|Melanomas of the Skin|2006
<1|~|~|~|~|Mortality|4041738|Mesothelioma|2006
<1|~|~|~|~|Incidence|4041738|Mesothelioma|2006
<1|~|~|~|~|Mortality|4041738|Myeloma|2006
<1|~|~|~|~|Incidence|4041738|Myeloma|2006
<1|~|~|~|~|Mortality|4041738|Non-Hodgkin Lymphoma|2006
<1|~|~|~|~|Incidence|4041738|Non-Hodgkin Lymphoma|2006
<1|~|~|~|~|Mortality|4041738|Oral Cavity and Pharynx|2006
<1|~|~|~|~|Incidence|4041738|Oral Cavity and Pharynx|2006
<1|~|~|~|~|Mortality|1975919|Ovary|2006
<1|~|~|~|~|Incidence|1975919|Ovary|2006
<1|~|~|~|~|Mortality|4041738|Pancreas|2006
<1|~|~|~|~|Incidence|4041738|Pancreas|2006
<1|~|~|~|~|Mortality|2065819|Prostate|2006
<1|~|~|~|~|Incidence|2065819|Prostate|2006
<1|~|~|~|~|Mortality|4041738|Stomach|2006
<1|~|~|~|~|Incidence|4041738|Stomach|2006
<1|~|~|~|~|Mortality|2065819|Testis|2006
<1|~|~|~|~|Incidence|2065819|Testis|2006
<1|~|~|~|~|Mortality|4041738|Thyroid|2006
<1|~|~|~|~|Incidence|4041738|Thyroid|2006
<1|~|~|~|~|Mortality|4041738|Urinary Bladder|2006
<1|~|~|~|~|Incidence|4041738|Urinary Bladder|2006
1-4|2.1|2.5|2.3|364|Mortality|15977965|All Cancer Sites Combined|2007
1-4|21.9|23.4|22.6|3614|Incidence|15977965|All Cancer Sites Combined|2007
1-4|0.6|0.8|0.7|109|Mortality|15977965|Brain and Other Nervous System|2007
1-4|4.3|5.0|4.6|736|Incidence|15977965|Brain and Other Nervous System|2007
1-4|~|~|~|~|Mortality|7813088|Cervix|2007
1-4|~|~|~|~|Incidence|7813088|Cervix|2007
1-4|~|~|~|~|Mortality|15977965|Colon and Rectum|2007
1-4|~|~|~|~|Incidence|15977965|Colon and Rectum|2007
1-4|~|~|~|~|Mortality|7813088|Corpus and Uterus, NOS|2007
1-4|~|~|~|~|Incidence|7813088|Corpus and Uterus, NOS|2007
1-4|~|~|~|~|Mortality|15977965|Esophagus|2007
1-4|~|~|~|~|Incidence|15977965|Esophagus|2007
1-4|~|~|~|~|Mortality|7813088|Female Breast|2007
1-4|~|~|~|~|Incidence|7813088|Female Breast|2007
1-4|~|~|~|~|Incidence|7813088|Female Breast, <i>in situ</i>|2007
1-4|~|~|~|~|Mortality|15977965|Hodgkin Lymphoma|2007
1-4|~|~|~|~|Incidence|15977965|Hodgkin Lymphoma|2007
1-4|.|.|.|.|Mortality|15977965|Kaposi Sarcoma|2007
1-4|~|~|~|~|Incidence|15977965|Kaposi Sarcoma|2007
1-4|~|~|~|~|Mortality|15977965|Kidney and Renal Pelvis|2007
1-4|1.8|2.2|2.0|314|Incidence|15977965|Kidney and Renal Pelvis|2007
1-4|~|~|~|~|Mortality|15977965|Larynx|2007
1-4|~|~|~|~|Incidence|15977965|Larynx|2007
1-4|0.5|0.8|0.7|106|Mortality|15977965|Leukemias|2007
1-4|8.8|9.8|9.3|1485|Incidence|15977965|Leukemias|2007
1-4|0.1|0.2|0.1|19|Mortality|15977965|Liver and Intrahepatic Bile Duct|2007
1-4|0.5|0.7|0.6|92|Incidence|15977965|Liver and Intrahepatic Bile Duct|2007
1-4|~|~|~|~|Mortality|15977965|Lung and Bronchus|2007
1-4|~|~|~|~|Incidence|15977965|Lung and Bronchus|2007
1-4|~|~|~|~|Mortality|7813088|Male and Female Breast|2007
1-4|~|~|~|~|Incidence|7813088|Male and Female Breast|2007
1-4|~|~|~|~|Incidence|7813088|Male and Female Breast, <i>in situ</i>|2007
1-4|~|~|~|~|Mortality|15977965|Melanomas of the Skin|2007
1-4|~|~|~|~|Incidence|15977965|Melanomas of the Skin|2007
1-4|~|~|~|~|Mortality|15977965|Mesothelioma|2007
1-4|~|~|~|~|Incidence|15977965|Mesothelioma|2007
1-4|~|~|~|~|Mortality|15977965|Myeloma|2007
1-4|~|~|~|~|Incidence|15977965|Myeloma|2007
1-4|~|~|~|~|Mortality|15977965|Non-Hodgkin Lymphoma|2007
1-4|0.5|0.7|0.6|93|Incidence|15977965|Non-Hodgkin Lymphoma|2007
1-4|~|~|~|~|Mortality|15977965|Oral Cavity and Pharynx|2007
1-4|~|~|~|~|Incidence|15977965|Oral Cavity and Pharynx|2007
1-4|~|~|~|~|Mortality|7813088|Ovary|2007
1-4|~|~|~|~|Incidence|7813088|Ovary|2007
1-4|~|~|~|~|Mortality|15977965|Pancreas|2007
1-4|~|~|~|~|Incidence|15977965|Pancreas|2007
1-4|~|~|~|~|Mortality|8164877|Prostate|2007
1-4|~|~|~|~|Incidence|8164877|Prostate|2007
1-4|~|~|~|~|Mortality|15977965|Stomach|2007
1-4|~|~|~|~|Incidence|15977965|Stomach|2007
1-4|~|~|~|~|Mortality|8164877|Testis|2007
1-4|0.2|0.5|0.3|28|Incidence|8164877|Testis|2007
1-4|~|~|~|~|Mortality|15977965|Thyroid|2007
1-4|~|~|~|~|Incidence|15977965|Thyroid|2007
1-4|~|~|~|~|Mortality|15977965|Urinary Bladder|2007
1-4|~|~|~|~|Incidence|15977965|Urinary Bladder|2007
10-14|2.1|2.5|2.3|479|Mortality|20841042|All Cancer Sites Combined|2007
10-14|12.8|13.8|13.3|2769|Incidence|20841042|All Cancer Sites Combined|2007
10-14|0.5|0.7|0.6|130|Mortality|20841042|Brain and Other Nervous System|2007
10-14|2.7|3.1|2.9|602|Incidence|20841042|Brain and Other Nervous System|2007
10-14|~|~|~|~|Mortality|10170082|Cervix|2007
10-14|~|~|~|~|Incidence|10170082|Cervix|2007
10-14|~|~|~|~|Mortality|20841042|Colon and Rectum|2007
10-14|0.0|0.1|0.1|16|Incidence|20841042|Colon and Rectum|2007
10-14|~|~|~|~|Mortality|10170082|Corpus and Uterus, NOS|2007
10-14|~|~|~|~|Incidence|10170082|Corpus and Uterus, NOS|2007
10-14|~|~|~|~|Mortality|20841042|Esophagus|2007
10-14|~|~|~|~|Incidence|20841042|Esophagus|2007
10-14|~|~|~|~|Mortality|10170082|Female Breast|2007
10-14|~|~|~|~|Incidence|10170082|Female Breast|2007
10-14|~|~|~|~|Incidence|10170082|Female Breast, <i>in situ</i>|2007
10-14|~|~|~|~|Mortality|20841042|Hodgkin Lymphoma|2007
10-14|1.1|1.4|1.2|250|Incidence|20841042|Hodgkin Lymphoma|2007
10-14|.|.|.|.|Mortality|20841042|Kaposi Sarcoma|2007
10-14|~|~|~|~|Incidence|20841042|Kaposi Sarcoma|2007
10-14|~|~|~|~|Mortality|20841042|Kidney and Renal Pelvis|2007
10-14|0.1|0.2|0.2|33|Incidence|20841042|Kidney and Renal Pelvis|2007
10-14|~|~|~|~|Mortality|20841042|Larynx|2007
10-14|~|~|~|~|Incidence|20841042|Larynx|2007
10-14|0.7|1.0|0.8|175|Mortality|20841042|Leukemias|2007
10-14|2.7|3.1|2.9|605|Incidence|20841042|Leukemias|2007
10-14|~|~|~|~|Mortality|20841042|Liver and Intrahepatic Bile Duct|2007
10-14|0.0|0.1|0.1|17|Incidence|20841042|Liver and Intrahepatic Bile Duct|2007
10-14|~|~|~|~|Mortality|20841042|Lung and Bronchus|2007
10-14|0.0|0.1|0.1|17|Incidence|20841042|Lung and Bronchus|2007
10-14|~|~|~|~|Mortality|10170082|Male and Female Breast|2007
10-14|~|~|~|~|Incidence|10170082|Male and Female Breast|2007
10-14|~|~|~|~|Incidence|10170082|Male and Female Breast, <i>in situ</i>|2007
10-14|~|~|~|~|Mortality|20841042|Melanomas of the Skin|2007
10-14|0.2|0.4|0.3|67|Incidence|20841042|Melanomas of the Skin|2007
10-14|~|~|~|~|Mortality|20841042|Mesothelioma|2007
10-14|~|~|~|~|Incidence|20841042|Mesothelioma|2007
10-14|~|~|~|~|Mortality|20841042|Myeloma|2007
10-14|~|~|~|~|Incidence|20841042|Myeloma|2007
10-14|0.1|0.1|0.1|20|Mortality|20841042|Non-Hodgkin Lymphoma|2007
10-14|1.2|1.5|1.3|279|Incidence|20841042|Non-Hodgkin Lymphoma|2007
10-14|~|~|~|~|Mortality|20841042|Oral Cavity and Pharynx|2007
10-14|0.2|0.3|0.2|47|Incidence|20841042|Oral Cavity and Pharynx|2007
10-14|~|~|~|~|Mortality|10170082|Ovary|2007
10-14|0.6|0.9|0.7|72|Incidence|10170082|Ovary|2007
10-14|~|~|~|~|Mortality|20841042|Pancreas|2007
10-14|~|~|~|~|Incidence|20841042|Pancreas|2007
10-14|~|~|~|~|Mortality|10670960|Prostate|2007
10-14|~|~|~|~|Incidence|10670960|Prostate|2007
10-14|~|~|~|~|Mortality|20841042|Stomach|2007
10-14|~|~|~|~|Incidence|20841042|Stomach|2007
10-14|~|~|~|~|Mortality|10670960|Testis|2007
10-14|0.2|0.4|0.3|33|Incidence|10670960|Testis|2007
10-14|~|~|~|~|Mortality|20841042|Thyroid|2007
10-14|0.5|0.7|0.6|117|Incidence|20841042|Thyroid|2007
10-14|~|~|~|~|Mortality|20841042|Urinary Bladder|2007
10-14|~|~|~|~|Incidence|20841042|Urinary Bladder|2007
15-19|2.8|3.3|3.0|673|Mortality|22067816|All Cancer Sites Combined|2007
15-19|21.5|22.8|22.1|4882|Incidence|22067816|All Cancer Sites Combined|2007
15-19|0.3|0.5|0.4|95|Mortality|22067816|Brain and Other Nervous System|2007
15-19|2.1|2.5|2.3|500|Incidence|22067816|Brain and Other Nervous System|2007
15-19|~|~|~|~|Mortality|10731326|Cervix|2007
15-19|0.1|0.3|0.2|21|Incidence|10731326|Cervix|2007
15-19|~|~|~|~|Mortality|22067816|Colon and Rectum|2007
15-19|0.2|0.4|0.3|63|Incidence|22067816|Colon and Rectum|2007
15-19|~|~|~|~|Mortality|10731326|Corpus and Uterus, NOS|2007
15-19|~|~|~|~|Incidence|10731326|Corpus and Uterus, NOS|2007
15-19|~|~|~|~|Mortality|22067816|Esophagus|2007
15-19|~|~|~|~|Incidence|22067816|Esophagus|2007
15-19|~|~|~|~|Mortality|10731326|Female Breast|2007
15-19|0.1|0.3|0.2|21|Incidence|10731326|Female Breast|2007
15-19|~|~|~|~|Incidence|10731326|Female Breast, <i>in situ</i>|2007
15-19|0.0|0.1|0.1|16|Mortality|22067816|Hodgkin Lymphoma|2007
15-19|3.0|3.4|3.2|706|Incidence|22067816|Hodgkin Lymphoma|2007
15-19|.|.|.|.|Mortality|22067816|Kaposi Sarcoma|2007
15-19|~|~|~|~|Incidence|22067816|Kaposi Sarcoma|2007
15-19|~|~|~|~|Mortality|22067816|Kidney and Renal Pelvis|2007
15-19|0.1|0.3|0.2|43|Incidence|22067816|Kidney and Renal Pelvis|2007
15-19|~|~|~|~|Mortality|22067816|Larynx|2007
15-19|~|~|~|~|Incidence|22067816|Larynx|2007
15-19|0.8|1.1|0.9|202|Mortality|22067816|Leukemias|2007
15-19|2.7|3.2|3.0|652|Incidence|22067816|Leukemias|2007
15-19|~|~|~|~|Mortality|22067816|Liver and Intrahepatic Bile Duct|2007
15-19|0.1|0.2|0.2|38|Incidence|22067816|Liver and Intrahepatic Bile Duct|2007
15-19|~|~|~|~|Mortality|22067816|Lung and Bronchus|2007
15-19|0.1|0.2|0.1|27|Incidence|22067816|Lung and Bronchus|2007
15-19|~|~|~|~|Mortality|10731326|Male and Female Breast|2007
15-19|0.1|0.3|0.2|21|Incidence|10731326|Male and Female Breast|2007
15-19|~|~|~|~|Incidence|10731326|Male and Female Breast, <i>in situ</i>|2007
15-19|~|~|~|~|Mortality|22067816|Melanomas of the Skin|2007
15-19|1.3|1.6|1.5|325|Incidence|22067816|Melanomas of the Skin|2007
15-19|~|~|~|~|Mortality|22067816|Mesothelioma|2007
15-19|~|~|~|~|Incidence|22067816|Mesothelioma|2007
15-19|~|~|~|~|Mortality|22067816|Myeloma|2007
15-19|~|~|~|~|Incidence|22067816|Myeloma|2007
15-19|0.2|0.3|0.2|47|Mortality|22067816|Non-Hodgkin Lymphoma|2007
15-19|1.6|1.9|1.7|381|Incidence|22067816|Non-Hodgkin Lymphoma|2007
15-19|~|~|~|~|Mortality|22067816|Oral Cavity and Pharynx|2007
15-19|0.4|0.6|0.5|105|Incidence|22067816|Oral Cavity and Pharynx|2007
15-19|~|~|~|~|Mortality|10731326|Ovary|2007
15-19|1.0|1.4|1.2|129|Incidence|10731326|Ovary|2007
15-19|~|~|~|~|Mortality|22067816|Pancreas|2007
15-19|~|~|~|~|Incidence|22067816|Pancreas|2007
15-19|~|~|~|~|Mortality|11336490|Prostate|2007
15-19|~|~|~|~|Incidence|11336490|Prostate|2007
15-19|~|~|~|~|Mortality|22067816|Stomach|2007
15-19|~|~|~|~|Incidence|22067816|Stomach|2007
15-19|~|~|~|~|Mortality|11336490|Testis|2007
15-19|3.3|4.0|3.7|414|Incidence|11336490|Testis|2007
15-19|~|~|~|~|Mortality|22067816|Thyroid|2007
15-19|2.1|2.5|2.3|498|Incidence|22067816|Thyroid|2007
15-19|~|~|~|~|Mortality|22067816|Urinary Bladder|2007
15-19|0.0|0.1|0.1|16|Incidence|22067816|Urinary Bladder|2007
5-9|2.2|2.7|2.4|480|Mortality|19714611|All Cancer Sites Combined|2007
5-9|11.9|12.9|12.4|2447|Incidence|19714611|All Cancer Sites Combined|2007
5-9|0.7|1.0|0.9|172|Mortality|19714611|Brain and Other Nervous System|2007
5-9|3.3|3.8|3.5|697|Incidence|19714611|Brain and Other Nervous System|2007
5-9|~|~|~|~|Mortality|9640683|Cervix|2007
5-9|~|~|~|~|Incidence|9640683|Cervix|2007
5-9|~|~|~|~|Mortality|19714611|Colon and Rectum|2007
5-9|~|~|~|~|Incidence|19714611|Colon and Rectum|2007
5-9|~|~|~|~|Mortality|9640683|Corpus and Uterus, NOS|2007
5-9|~|~|~|~|Incidence|9640683|Corpus and Uterus, NOS|2007
5-9|~|~|~|~|Mortality|19714611|Esophagus|2007
5-9|~|~|~|~|Incidence|19714611|Esophagus|2007
5-9|~|~|~|~|Mortality|9640683|Female Breast|2007
5-9|~|~|~|~|Incidence|9640683|Female Breast|2007
5-9|~|~|~|~|Incidence|9640683|Female Breast, <i>in situ</i>|2007
5-9|~|~|~|~|Mortality|19714611|Hodgkin Lymphoma|2007
5-9|0.3|0.4|0.3|69|Incidence|19714611|Hodgkin Lymphoma|2007
5-9|.|.|.|.|Mortality|19714611|Kaposi Sarcoma|2007
5-9|~|~|~|~|Incidence|19714611|Kaposi Sarcoma|2007
5-9|0.1|0.1|0.1|17|Mortality|19714611|Kidney and Renal Pelvis|2007
5-9|0.5|0.7|0.6|124|Incidence|19714611|Kidney and Renal Pelvis|2007
5-9|~|~|~|~|Mortality|19714611|Larynx|2007
5-9|~|~|~|~|Incidence|19714611|Larynx|2007
5-9|0.6|0.8|0.7|139|Mortality|19714611|Leukemias|2007
5-9|3.8|4.3|4.1|799|Incidence|19714611|Leukemias|2007
5-9|~|~|~|~|Mortality|19714611|Liver and Intrahepatic Bile Duct|2007
5-9|0.1|0.2|0.1|21|Incidence|19714611|Liver and Intrahepatic Bile Duct|2007
5-9|~|~|~|~|Mortality|19714611|Lung and Bronchus|2007
5-9|~|~|~|~|Incidence|19714611|Lung and Bronchus|2007
5-9|~|~|~|~|Mortality|9640683|Male and Female Breast|2007
5-9|~|~|~|~|Incidence|9640683|Male and Female Breast|2007
5-9|~|~|~|~|Incidence|9640683|Male and Female Breast, <i>in situ</i>|2007
5-9|~|~|~|~|Mortality|19714611|Melanomas of the Skin|2007
5-9|0.1|0.2|0.2|31|Incidence|19714611|Melanomas of the Skin|2007
5-9|~|~|~|~|Mortality|19714611|Mesothelioma|2007
5-9|~|~|~|~|Incidence|19714611|Mesothelioma|2007
5-9|~|~|~|~|Mortality|19714611|Myeloma|2007
5-9|~|~|~|~|Incidence|19714611|Myeloma|2007
5-9|~|~|~|~|Mortality|19714611|Non-Hodgkin Lymphoma|2007
5-9|0.9|1.2|1.1|209|Incidence|19714611|Non-Hodgkin Lymphoma|2007
5-9|~|~|~|~|Mortality|19714611|Oral Cavity and Pharynx|2007
5-9|0.1|0.2|0.1|22|Incidence|19714611|Oral Cavity and Pharynx|2007
5-9|~|~|~|~|Mortality|9640683|Ovary|2007
5-9|0.2|0.4|0.3|29|Incidence|9640683|Ovary|2007
5-9|~|~|~|~|Mortality|19714611|Pancreas|2007
5-9|~|~|~|~|Incidence|19714611|Pancreas|2007
5-9|~|~|~|~|Mortality|10073928|Prostate|2007
5-9|~|~|~|~|Incidence|10073928|Prostate|2007
5-9|~|~|~|~|Mortality|19714611|Stomach|2007
5-9|~|~|~|~|Incidence|19714611|Stomach|2007
5-9|~|~|~|~|Mortality|10073928|Testis|2007
5-9|~|~|~|~|Incidence|10073928|Testis|2007
5-9|~|~|~|~|Mortality|19714611|Thyroid|2007
5-9|0.1|0.1|0.1|18|Incidence|19714611|Thyroid|2007
5-9|~|~|~|~|Mortality|19714611|Urinary Bladder|2007
5-9|~|~|~|~|Incidence|19714611|Urinary Bladder|2007
<1|1.4|2.2|1.7|72|Mortality|4147997|All Cancer Sites Combined|2007
<1|24.8|28.0|26.4|1093|Incidence|4147997|All Cancer Sites Combined|2007
<1|~|~|~|~|Mortality|4147997|Brain and Other Nervous System|2007
<1|3.7|4.9|4.3|177|Incidence|4147997|Brain and Other Nervous System|2007
<1|~|~|~|~|Mortality|2027181|Cervix|2007
<1|~|~|~|~|Incidence|2027181|Cervix|2007
<1|~|~|~|~|Mortality|4147997|Colon and Rectum|2007
<1|~|~|~|~|Incidence|4147997|Colon and Rectum|2007
<1|~|~|~|~|Mortality|2027181|Corpus and Uterus, NOS|2007
<1|~|~|~|~|Incidence|2027181|Corpus and Uterus, NOS|2007
<1|~|~|~|~|Mortality|4147997|Esophagus|2007
<1|~|~|~|~|Incidence|4147997|Esophagus|2007
<1|~|~|~|~|Mortality|2027181|Female Breast|2007
<1|~|~|~|~|Incidence|2027181|Female Breast|2007
<1|~|~|~|~|Incidence|2027181|Female Breast, <i>in situ</i>|2007
<1|~|~|~|~|Mortality|4147997|Hodgkin Lymphoma|2007
<1|~|~|~|~|Incidence|4147997|Hodgkin Lymphoma|2007
<1|.|.|.|.|Mortality|4147997|Kaposi Sarcoma|2007
<1|~|~|~|~|Incidence|4147997|Kaposi Sarcoma|2007
<1|~|~|~|~|Mortality|4147997|Kidney and Renal Pelvis|2007
<1|1.4|2.2|1.8|73|Incidence|4147997|Kidney and Renal Pelvis|2007
<1|~|~|~|~|Mortality|4147997|Larynx|2007
<1|~|~|~|~|Incidence|4147997|Larynx|2007
<1|0.3|0.8|0.5|21|Mortality|4147997|Leukemias|2007
<1|3.8|5.0|4.4|181|Incidence|4147997|Leukemias|2007
<1|~|~|~|~|Mortality|4147997|Liver and Intrahepatic Bile Duct|2007
<1|0.9|1.5|1.2|48|Incidence|4147997|Liver and Intrahepatic Bile Duct|2007
<1|~|~|~|~|Mortality|4147997|Lung and Bronchus|2007
<1|~|~|~|~|Incidence|4147997|Lung and Bronchus|2007
<1|~|~|~|~|Mortality|2027181|Male and Female Breast|2007
<1|~|~|~|~|Incidence|2027181|Male and Female Breast|2007
<1|~|~|~|~|Incidence|2027181|Male and Female Breast, <i>in situ</i>|2007
<1|~|~|~|~|Mortality|4147997|Melanomas of the Skin|2007
<1|~|~|~|~|Incidence|4147997|Melanomas of the Skin|2007
<1|~|~|~|~|Mortality|4147997|Mesothelioma|2007
<1|~|~|~|~|Incidence|4147997|Mesothelioma|2007
<1|~|~|~|~|Mortality|4147997|Myeloma|2007
<1|~|~|~|~|Incidence|4147997|Myeloma|2007
<1|~|~|~|~|Mortality|4147997|Non-Hodgkin Lymphoma|2007
<1|~|~|~|~|Incidence|4147997|Non-Hodgkin Lymphoma|2007
<1|~|~|~|~|Mortality|4147997|Oral Cavity and Pharynx|2007
<1|~|~|~|~|Incidence|4147997|Oral Cavity and Pharynx|2007
<1|~|~|~|~|Mortality|2027181|Ovary|2007
<1|~|~|~|~|Incidence|2027181|Ovary|2007
<1|~|~|~|~|Mortality|4147997|Pancreas|2007
<1|~|~|~|~|Incidence|4147997|Pancreas|2007
<1|~|~|~|~|Mortality|2120816|Prostate|2007
<1|~|~|~|~|Incidence|2120816|Prostate|2007
<1|~|~|~|~|Mortality|4147997|Stomach|2007
<1|~|~|~|~|Incidence|4147997|Stomach|2007
<1|~|~|~|~|Mortality|2120816|Testis|2007
<1|0.6|1.5|1.0|21|Incidence|2120816|Testis|2007
<1|~|~|~|~|Mortality|4147997|Thyroid|2007
<1|~|~|~|~|Incidence|4147997|Thyroid|2007
<1|~|~|~|~|Mortality|4147997|Urinary Bladder|2007
<1|~|~|~|~|Incidence|4147997|Urinary Bladder|2007
1-4|2.2|2.7|2.4|394|Mortality|16138392|All Cancer Sites Combined|2008
1-4|22.0|23.5|22.7|3671|Incidence|16138392|All Cancer Sites Combined|2008
1-4|0.6|0.9|0.7|119|Mortality|16138392|Brain and Other Nervous System|2008
1-4|4.4|5.1|4.7|763|Incidence|16138392|Brain and Other Nervous System|2008
1-4|~|~|~|~|Mortality|7891294|Cervix|2008
1-4|~|~|~|~|Incidence|7891294|Cervix|2008
1-4|~|~|~|~|Mortality|16138392|Colon and Rectum|2008
1-4|~|~|~|~|Incidence|16138392|Colon and Rectum|2008
1-4|~|~|~|~|Mortality|7891294|Corpus and Uterus, NOS|2008
1-4|~|~|~|~|Incidence|7891294|Corpus and Uterus, NOS|2008
1-4|~|~|~|~|Mortality|16138392|Esophagus|2008
1-4|~|~|~|~|Incidence|16138392|Esophagus|2008
1-4|~|~|~|~|Mortality|7891294|Female Breast|2008
1-4|~|~|~|~|Incidence|7891294|Female Breast|2008
1-4|~|~|~|~|Incidence|7891294|Female Breast, <i>in situ</i>|2008
1-4|~|~|~|~|Mortality|16138392|Hodgkin Lymphoma|2008
1-4|0.1|0.2|0.1|16|Incidence|16138392|Hodgkin Lymphoma|2008
1-4|.|.|.|.|Mortality|16138392|Kaposi Sarcoma|2008
1-4|~|~|~|~|Incidence|16138392|Kaposi Sarcoma|2008
1-4|~|~|~|~|Mortality|16138392|Kidney and Renal Pelvis|2008
1-4|2.0|2.4|2.2|353|Incidence|16138392|Kidney and Renal Pelvis|2008
1-4|~|~|~|~|Mortality|16138392|Larynx|2008
1-4|~|~|~|~|Incidence|16138392|Larynx|2008
1-4|0.6|0.9|0.8|123|Mortality|16138392|Leukemias|2008
1-4|8.8|9.7|9.2|1491|Incidence|16138392|Leukemias|2008
1-4|0.1|0.2|0.1|20|Mortality|16138392|Liver and Intrahepatic Bile Duct|2008
1-4|0.5|0.7|0.6|91|Incidence|16138392|Liver and Intrahepatic Bile Duct|2008
1-4|~|~|~|~|Mortality|16138392|Lung and Bronchus|2008
1-4|~|~|~|~|Incidence|16138392|Lung and Bronchus|2008
1-4|~|~|~|~|Mortality|7891294|Male and Female Breast|2008
1-4|~|~|~|~|Incidence|7891294|Male and Female Breast|2008
1-4|~|~|~|~|Incidence|7891294|Male and Female Breast, <i>in situ</i>|2008
1-4|~|~|~|~|Mortality|16138392|Melanomas of the Skin|2008
1-4|~|~|~|~|Incidence|16138392|Melanomas of the Skin|2008
1-4|~|~|~|~|Mortality|16138392|Mesothelioma|2008
1-4|~|~|~|~|Incidence|16138392|Mesothelioma|2008
1-4|~|~|~|~|Mortality|16138392|Myeloma|2008
1-4|~|~|~|~|Incidence|16138392|Myeloma|2008
1-4|~|~|~|~|Mortality|16138392|Non-Hodgkin Lymphoma|2008
1-4|0.6|0.8|0.7|114|Incidence|16138392|Non-Hodgkin Lymphoma|2008
1-4|~|~|~|~|Mortality|16138392|Oral Cavity and Pharynx|2008
1-4|~|~|~|~|Incidence|16138392|Oral Cavity and Pharynx|2008
1-4|~|~|~|~|Mortality|7891294|Ovary|2008
1-4|~|~|~|~|Incidence|7891294|Ovary|2008
1-4|~|~|~|~|Mortality|16138392|Pancreas|2008
1-4|~|~|~|~|Incidence|16138392|Pancreas|2008
1-4|~|~|~|~|Mortality|8247098|Prostate|2008
1-4|~|~|~|~|Incidence|8247098|Prostate|2008
1-4|~|~|~|~|Mortality|16138392|Stomach|2008
1-4|~|~|~|~|Incidence|16138392|Stomach|2008
1-4|~|~|~|~|Mortality|8247098|Testis|2008
1-4|0.2|0.5|0.3|28|Incidence|8247098|Testis|2008
1-4|~|~|~|~|Mortality|16138392|Thyroid|2008
1-4|~|~|~|~|Incidence|16138392|Thyroid|2008
1-4|~|~|~|~|Mortality|16138392|Urinary Bladder|2008
1-4|~|~|~|~|Incidence|16138392|Urinary Bladder|2008
10-14|1.9|2.3|2.1|433|Mortality|20706655|All Cancer Sites Combined|2008
10-14|12.9|13.9|13.4|2777|Incidence|20706655|All Cancer Sites Combined|2008
10-14|0.5|0.7|0.6|125|Mortality|20706655|Brain and Other Nervous System|2008
10-14|2.5|3.0|2.7|563|Incidence|20706655|Brain and Other Nervous System|2008
10-14|~|~|~|~|Mortality|10108474|Cervix|2008
10-14|~|~|~|~|Incidence|10108474|Cervix|2008
10-14|~|~|~|~|Mortality|20706655|Colon and Rectum|2008
10-14|~|~|~|~|Incidence|20706655|Colon and Rectum|2008
10-14|~|~|~|~|Mortality|10108474|Corpus and Uterus, NOS|2008
10-14|~|~|~|~|Incidence|10108474|Corpus and Uterus, NOS|2008
10-14|~|~|~|~|Mortality|20706655|Esophagus|2008
10-14|~|~|~|~|Incidence|20706655|Esophagus|2008
10-14|~|~|~|~|Mortality|10108474|Female Breast|2008
10-14|~|~|~|~|Incidence|10108474|Female Breast|2008
10-14|~|~|~|~|Incidence|10108474|Female Breast, <i>in situ</i>|2008
10-14|~|~|~|~|Mortality|20706655|Hodgkin Lymphoma|2008
10-14|1.2|1.5|1.3|277|Incidence|20706655|Hodgkin Lymphoma|2008
10-14|.|.|.|.|Mortality|20706655|Kaposi Sarcoma|2008
10-14|~|~|~|~|Incidence|20706655|Kaposi Sarcoma|2008
10-14|~|~|~|~|Mortality|20706655|Kidney and Renal Pelvis|2008
10-14|0.1|0.2|0.1|25|Incidence|20706655|Kidney and Renal Pelvis|2008
10-14|~|~|~|~|Mortality|20706655|Larynx|2008
10-14|~|~|~|~|Incidence|20706655|Larynx|2008
10-14|0.6|0.9|0.7|152|Mortality|20706655|Leukemias|2008
10-14|2.9|3.4|3.2|656|Incidence|20706655|Leukemias|2008
10-14|~|~|~|~|Mortality|20706655|Liver and Intrahepatic Bile Duct|2008
10-14|0.1|0.1|0.1|18|Incidence|20706655|Liver and Intrahepatic Bile Duct|2008
10-14|~|~|~|~|Mortality|20706655|Lung and Bronchus|2008
10-14|~|~|~|~|Incidence|20706655|Lung and Bronchus|2008
10-14|~|~|~|~|Mortality|10108474|Male and Female Breast|2008
10-14|~|~|~|~|Incidence|10108474|Male and Female Breast|2008
10-14|~|~|~|~|Incidence|10108474|Male and Female Breast, <i>in situ</i>|2008
10-14|~|~|~|~|Mortality|20706655|Melanomas of the Skin|2008
10-14|0.3|0.4|0.4|74|Incidence|20706655|Melanomas of the Skin|2008
10-14|~|~|~|~|Mortality|20706655|Mesothelioma|2008
10-14|~|~|~|~|Incidence|20706655|Mesothelioma|2008
10-14|~|~|~|~|Mortality|20706655|Myeloma|2008
10-14|~|~|~|~|Incidence|20706655|Myeloma|2008
10-14|~|~|~|~|Mortality|20706655|Non-Hodgkin Lymphoma|2008
10-14|1.0|1.3|1.2|243|Incidence|20706655|Non-Hodgkin Lymphoma|2008
10-14|~|~|~|~|Mortality|20706655|Oral Cavity and Pharynx|2008
10-14|0.2|0.4|0.3|60|Incidence|20706655|Oral Cavity and Pharynx|2008
10-14|~|~|~|~|Mortality|10108474|Ovary|2008
10-14|0.5|0.9|0.7|68|Incidence|10108474|Ovary|2008
10-14|~|~|~|~|Mortality|20706655|Pancreas|2008
10-14|~|~|~|~|Incidence|20706655|Pancreas|2008
10-14|~|~|~|~|Mortality|10598181|Prostate|2008
10-14|~|~|~|~|Incidence|10598181|Prostate|2008
10-14|~|~|~|~|Mortality|20706655|Stomach|2008
10-14|~|~|~|~|Incidence|20706655|Stomach|2008
10-14|~|~|~|~|Mortality|10598181|Testis|2008
10-14|0.1|0.3|0.2|19|Incidence|10598181|Testis|2008
10-14|~|~|~|~|Mortality|20706655|Thyroid|2008
10-14|0.5|0.7|0.6|126|Incidence|20706655|Thyroid|2008
10-14|~|~|~|~|Mortality|20706655|Urinary Bladder|2008
10-14|~|~|~|~|Incidence|20706655|Urinary Bladder|2008
15-19|2.9|3.3|3.1|685|Mortality|22210880|All Cancer Sites Combined|2008
15-19|21.5|22.8|22.2|4922|Incidence|22210880|All Cancer Sites Combined|2008
15-19|0.4|0.6|0.5|104|Mortality|22210880|Brain and Other Nervous System|2008
15-19|2.2|2.6|2.4|523|Incidence|22210880|Brain and Other Nervous System|2008
15-19|~|~|~|~|Mortality|10805148|Cervix|2008
15-19|0.1|0.3|0.2|22|Incidence|10805148|Cervix|2008
15-19|~|~|~|~|Mortality|22210880|Colon and Rectum|2008
15-19|0.2|0.4|0.3|65|Incidence|22210880|Colon and Rectum|2008
15-19|~|~|~|~|Mortality|10805148|Corpus and Uterus, NOS|2008
15-19|~|~|~|~|Incidence|10805148|Corpus and Uterus, NOS|2008
15-19|~|~|~|~|Mortality|22210880|Esophagus|2008
15-19|~|~|~|~|Incidence|22210880|Esophagus|2008
15-19|~|~|~|~|Mortality|10805148|Female Breast|2008
15-19|0.1|0.2|0.1|16|Incidence|10805148|Female Breast|2008
15-19|~|~|~|~|Incidence|10805148|Female Breast, <i>in situ</i>|2008
15-19|~|~|~|~|Mortality|22210880|Hodgkin Lymphoma|2008
15-19|3.0|3.5|3.3|723|Incidence|22210880|Hodgkin Lymphoma|2008
15-19|.|.|.|.|Mortality|22210880|Kaposi Sarcoma|2008
15-19|~|~|~|~|Incidence|22210880|Kaposi Sarcoma|2008
15-19|~|~|~|~|Mortality|22210880|Kidney and Renal Pelvis|2008
15-19|0.2|0.3|0.2|49|Incidence|22210880|Kidney and Renal Pelvis|2008
15-19|~|~|~|~|Mortality|22210880|Larynx|2008
15-19|~|~|~|~|Incidence|22210880|Larynx|2008
15-19|0.8|1.0|0.9|196|Mortality|22210880|Leukemias|2008
15-19|2.8|3.3|3.1|678|Incidence|22210880|Leukemias|2008
15-19|0.0|0.1|0.1|16|Mortality|22210880|Liver and Intrahepatic Bile Duct|2008
15-19|0.1|0.2|0.1|30|Incidence|22210880|Liver and Intrahepatic Bile Duct|2008
15-19|~|~|~|~|Mortality|22210880|Lung and Bronchus|2008
15-19|0.1|0.3|0.2|41|Incidence|22210880|Lung and Bronchus|2008
15-19|~|~|~|~|Mortality|10805148|Male and Female Breast|2008
15-19|0.1|0.2|0.1|16|Incidence|10805148|Male and Female Breast|2008
15-19|~|~|~|~|Incidence|10805148|Male and Female Breast, <i>in situ</i>|2008
15-19|~|~|~|~|Mortality|22210880|Melanomas of the Skin|2008
15-19|1.1|1.4|1.2|277|Incidence|22210880|Melanomas of the Skin|2008
15-19|~|~|~|~|Mortality|22210880|Mesothelioma|2008
15-19|~|~|~|~|Incidence|22210880|Mesothelioma|2008
15-19|~|~|~|~|Mortality|22210880|Myeloma|2008
15-19|~|~|~|~|Incidence|22210880|Myeloma|2008
15-19|0.2|0.3|0.2|54|Mortality|22210880|Non-Hodgkin Lymphoma|2008
15-19|1.6|1.9|1.7|387|Incidence|22210880|Non-Hodgkin Lymphoma|2008
15-19|~|~|~|~|Mortality|22210880|Oral Cavity and Pharynx|2008
15-19|0.4|0.6|0.5|101|Incidence|22210880|Oral Cavity and Pharynx|2008
15-19|~|~|~|~|Mortality|10805148|Ovary|2008
15-19|1.0|1.4|1.2|125|Incidence|10805148|Ovary|2008
15-19|~|~|~|~|Mortality|22210880|Pancreas|2008
15-19|~|~|~|~|Incidence|22210880|Pancreas|2008
15-19|~|~|~|~|Mortality|11405732|Prostate|2008
15-19|~|~|~|~|Incidence|11405732|Prostate|2008
15-19|~|~|~|~|Mortality|22210880|Stomach|2008
15-19|0.0|0.1|0.1|16|Incidence|22210880|Stomach|2008
15-19|~|~|~|~|Mortality|11405732|Testis|2008
15-19|3.3|4.0|3.6|414|Incidence|11405732|Testis|2008
15-19|~|~|~|~|Mortality|22210880|Thyroid|2008
15-19|2.3|2.7|2.5|546|Incidence|22210880|Thyroid|2008
15-19|~|~|~|~|Mortality|22210880|Urinary Bladder|2008
15-19|0.0|0.1|0.1|18|Incidence|22210880|Urinary Bladder|2008
5-9|2.1|2.5|2.3|457|Mortality|19929602|All Cancer Sites Combined|2008
5-9|12.4|13.4|12.9|2569|Incidence|19929602|All Cancer Sites Combined|2008
5-9|0.7|1.0|0.9|174|Mortality|19929602|Brain and Other Nervous System|2008
5-9|3.4|4.0|3.7|735|Incidence|19929602|Brain and Other Nervous System|2008
5-9|~|~|~|~|Mortality|9748488|Cervix|2008
5-9|~|~|~|~|Incidence|9748488|Cervix|2008
5-9|~|~|~|~|Mortality|19929602|Colon and Rectum|2008
5-9|~|~|~|~|Incidence|19929602|Colon and Rectum|2008
5-9|~|~|~|~|Mortality|9748488|Corpus and Uterus, NOS|2008
5-9|~|~|~|~|Incidence|9748488|Corpus and Uterus, NOS|2008
5-9|~|~|~|~|Mortality|19929602|Esophagus|2008
5-9|~|~|~|~|Incidence|19929602|Esophagus|2008
5-9|~|~|~|~|Mortality|9748488|Female Breast|2008
5-9|~|~|~|~|Incidence|9748488|Female Breast|2008
5-9|~|~|~|~|Incidence|9748488|Female Breast, <i>in situ</i>|2008
5-9|~|~|~|~|Mortality|19929602|Hodgkin Lymphoma|2008
5-9|0.4|0.6|0.5|90|Incidence|19929602|Hodgkin Lymphoma|2008
5-9|.|.|.|.|Mortality|19929602|Kaposi Sarcoma|2008
5-9|~|~|~|~|Incidence|19929602|Kaposi Sarcoma|2008
5-9|0.1|0.2|0.1|26|Mortality|19929602|Kidney and Renal Pelvis|2008
5-9|0.5|0.7|0.6|117|Incidence|19929602|Kidney and Renal Pelvis|2008
5-9|~|~|~|~|Mortality|19929602|Larynx|2008
5-9|~|~|~|~|Incidence|19929602|Larynx|2008
5-9|0.4|0.6|0.5|100|Mortality|19929602|Leukemias|2008
5-9|3.9|4.5|4.2|832|Incidence|19929602|Leukemias|2008
5-9|~|~|~|~|Mortality|19929602|Liver and Intrahepatic Bile Duct|2008
5-9|0.1|0.2|0.1|20|Incidence|19929602|Liver and Intrahepatic Bile Duct|2008
5-9|~|~|~|~|Mortality|19929602|Lung and Bronchus|2008
5-9|~|~|~|~|Incidence|19929602|Lung and Bronchus|2008
5-9|~|~|~|~|Mortality|9748488|Male and Female Breast|2008
5-9|~|~|~|~|Incidence|9748488|Male and Female Breast|2008
5-9|~|~|~|~|Incidence|9748488|Male and Female Breast, <i>in situ</i>|2008
5-9|~|~|~|~|Mortality|19929602|Melanomas of the Skin|2008
5-9|0.1|0.2|0.1|25|Incidence|19929602|Melanomas of the Skin|2008
5-9|~|~|~|~|Mortality|19929602|Mesothelioma|2008
5-9|~|~|~|~|Incidence|19929602|Mesothelioma|2008
5-9|~|~|~|~|Mortality|19929602|Myeloma|2008
5-9|~|~|~|~|Incidence|19929602|Myeloma|2008
5-9|0.1|0.2|0.1|20|Mortality|19929602|Non-Hodgkin Lymphoma|2008
5-9|0.9|1.2|1.1|212|Incidence|19929602|Non-Hodgkin Lymphoma|2008
5-9|~|~|~|~|Mortality|19929602|Oral Cavity and Pharynx|2008
5-9|0.0|0.1|0.1|17|Incidence|19929602|Oral Cavity and Pharynx|2008
5-9|~|~|~|~|Mortality|9748488|Ovary|2008
5-9|0.1|0.4|0.2|23|Incidence|9748488|Ovary|2008
5-9|~|~|~|~|Mortality|19929602|Pancreas|2008
5-9|~|~|~|~|Incidence|19929602|Pancreas|2008
5-9|~|~|~|~|Mortality|10181114|Prostate|2008
5-9|~|~|~|~|Incidence|10181114|Prostate|2008
5-9|~|~|~|~|Mortality|19929602|Stomach|2008
5-9|~|~|~|~|Incidence|19929602|Stomach|2008
5-9|~|~|~|~|Mortality|10181114|Testis|2008
5-9|~|~|~|~|Incidence|10181114|Testis|2008
5-9|~|~|~|~|Mortality|19929602|Thyroid|2008
5-9|0.1|0.2|0.1|26|Incidence|19929602|Thyroid|2008
5-9|~|~|~|~|Mortality|19929602|Urinary Bladder|2008
5-9|~|~|~|~|Incidence|19929602|Urinary Bladder|2008
<1|1.3|2.1|1.7|70|Mortality|4132735|All Cancer Sites Combined|2008
<1|25.4|28.6|27.0|1115|Incidence|4132735|All Cancer Sites Combined|2008
<1|~|~|~|~|Mortality|4132735|Brain and Other Nervous System|2008
<1|3.5|4.8|4.1|170|Incidence|4132735|Brain and Other Nervous System|2008
<1|~|~|~|~|Mortality|2022889|Cervix|2008
<1|~|~|~|~|Incidence|2022889|Cervix|2008
<1|~|~|~|~|Mortality|4132735|Colon and Rectum|2008
<1|~|~|~|~|Incidence|4132735|Colon and Rectum|2008
<1|~|~|~|~|Mortality|2022889|Corpus and Uterus, NOS|2008
<1|~|~|~|~|Incidence|2022889|Corpus and Uterus, NOS|2008
<1|~|~|~|~|Mortality|4132735|Esophagus|2008
<1|~|~|~|~|Incidence|4132735|Esophagus|2008
<1|~|~|~|~|Mortality|2022889|Female Breast|2008
<1|~|~|~|~|Incidence|2022889|Female Breast|2008
<1|~|~|~|~|Incidence|2022889|Female Breast, <i>in situ</i>|2008
<1|~|~|~|~|Mortality|4132735|Hodgkin Lymphoma|2008
<1|~|~|~|~|Incidence|4132735|Hodgkin Lymphoma|2008
<1|.|.|.|.|Mortality|4132735|Kaposi Sarcoma|2008
<1|~|~|~|~|Incidence|4132735|Kaposi Sarcoma|2008
<1|~|~|~|~|Mortality|4132735|Kidney and Renal Pelvis|2008
<1|1.4|2.3|1.8|76|Incidence|4132735|Kidney and Renal Pelvis|2008
<1|~|~|~|~|Mortality|4132735|Larynx|2008
<1|~|~|~|~|Incidence|4132735|Larynx|2008
<1|0.4|1.0|0.7|27|Mortality|4132735|Leukemias|2008
<1|4.0|5.3|4.6|190|Incidence|4132735|Leukemias|2008
<1|~|~|~|~|Mortality|4132735|Liver and Intrahepatic Bile Duct|2008
<1|0.9|1.6|1.2|49|Incidence|4132735|Liver and Intrahepatic Bile Duct|2008
<1|~|~|~|~|Mortality|4132735|Lung and Bronchus|2008
<1|~|~|~|~|Incidence|4132735|Lung and Bronchus|2008
<1|~|~|~|~|Mortality|2022889|Male and Female Breast|2008
<1|~|~|~|~|Incidence|2022889|Male and Female Breast|2008
<1|~|~|~|~|Incidence|2022889|Male and Female Breast, <i>in situ</i>|2008
<1|~|~|~|~|Mortality|4132735|Melanomas of the Skin|2008
<1|0.3|0.7|0.5|19|Incidence|4132735|Melanomas of the Skin|2008
<1|~|~|~|~|Mortality|4132735|Mesothelioma|2008
<1|~|~|~|~|Incidence|4132735|Mesothelioma|2008
<1|~|~|~|~|Mortality|4132735|Myeloma|2008
<1|~|~|~|~|Incidence|4132735|Myeloma|2008
<1|~|~|~|~|Mortality|4132735|Non-Hodgkin Lymphoma|2008
<1|~|~|~|~|Incidence|4132735|Non-Hodgkin Lymphoma|2008
<1|~|~|~|~|Mortality|4132735|Oral Cavity and Pharynx|2008
<1|~|~|~|~|Incidence|4132735|Oral Cavity and Pharynx|2008
<1|~|~|~|~|Mortality|2022889|Ovary|2008
<1|~|~|~|~|Incidence|2022889|Ovary|2008
<1|~|~|~|~|Mortality|4132735|Pancreas|2008
<1|~|~|~|~|Incidence|4132735|Pancreas|2008
<1|~|~|~|~|Mortality|2109846|Prostate|2008
<1|~|~|~|~|Incidence|2109846|Prostate|2008
<1|~|~|~|~|Mortality|4132735|Stomach|2008
<1|~|~|~|~|Incidence|4132735|Stomach|2008
<1|~|~|~|~|Mortality|2109846|Testis|2008
<1|0.7|1.6|1.1|23|Incidence|2109846|Testis|2008
<1|~|~|~|~|Mortality|4132735|Thyroid|2008
<1|~|~|~|~|Incidence|4132735|Thyroid|2008
<1|~|~|~|~|Mortality|4132735|Urinary Bladder|2008
<1|~|~|~|~|Incidence|4132735|Urinary Bladder|2008
1-4|1.9|2.4|2.2|350|Mortality|16240931|All Cancer Sites Combined|2009
1-4|21.6|23.0|22.3|3621|Incidence|16240931|All Cancer Sites Combined|2009
1-4|0.4|0.6|0.5|84|Mortality|16240931|Brain and Other Nervous System|2009
1-4|4.2|4.8|4.5|726|Incidence|16240931|Brain and Other Nervous System|2009
1-4|~|~|~|~|Mortality|7943260|Cervix|2009
1-4|~|~|~|~|Incidence|7943260|Cervix|2009
1-4|~|~|~|~|Mortality|16240931|Colon and Rectum|2009
1-4|~|~|~|~|Incidence|16240931|Colon and Rectum|2009
1-4|~|~|~|~|Mortality|7943260|Corpus and Uterus, NOS|2009
1-4|~|~|~|~|Incidence|7943260|Corpus and Uterus, NOS|2009
1-4|~|~|~|~|Mortality|16240931|Esophagus|2009
1-4|~|~|~|~|Incidence|16240931|Esophagus|2009
1-4|~|~|~|~|Mortality|7943260|Female Breast|2009
1-4|~|~|~|~|Incidence|7943260|Female Breast|2009
1-4|~|~|~|~|Incidence|7943260|Female Breast, <i>in situ</i>|2009
1-4|~|~|~|~|Mortality|16240931|Hodgkin Lymphoma|2009
1-4|0.1|0.2|0.1|22|Incidence|16240931|Hodgkin Lymphoma|2009
1-4|.|.|.|.|Mortality|16240931|Kaposi Sarcoma|2009
1-4|~|~|~|~|Incidence|16240931|Kaposi Sarcoma|2009
1-4|~|~|~|~|Mortality|16240931|Kidney and Renal Pelvis|2009
1-4|2.0|2.4|2.2|355|Incidence|16240931|Kidney and Renal Pelvis|2009
1-4|~|~|~|~|Mortality|16240931|Larynx|2009
1-4|~|~|~|~|Incidence|16240931|Larynx|2009
1-4|0.6|0.9|0.7|118|Mortality|16240931|Leukemias|2009
1-4|8.8|9.7|9.2|1498|Incidence|16240931|Leukemias|2009
1-4|~|~|~|~|Mortality|16240931|Liver and Intrahepatic Bile Duct|2009
1-4|0.4|0.6|0.5|81|Incidence|16240931|Liver and Intrahepatic Bile Duct|2009
1-4|~|~|~|~|Mortality|16240931|Lung and Bronchus|2009
1-4|~|~|~|~|Incidence|16240931|Lung and Bronchus|2009
1-4|~|~|~|~|Mortality|7943260|Male and Female Breast|2009
1-4|~|~|~|~|Incidence|7943260|Male and Female Breast|2009
1-4|~|~|~|~|Incidence|7943260|Male and Female Breast, <i>in situ</i>|2009
1-4|~|~|~|~|Mortality|16240931|Melanomas of the Skin|2009
1-4|~|~|~|~|Incidence|16240931|Melanomas of the Skin|2009
1-4|~|~|~|~|Mortality|16240931|Mesothelioma|2009
1-4|~|~|~|~|Incidence|16240931|Mesothelioma|2009
1-4|~|~|~|~|Mortality|16240931|Myeloma|2009
1-4|~|~|~|~|Incidence|16240931|Myeloma|2009
1-4|~|~|~|~|Mortality|16240931|Non-Hodgkin Lymphoma|2009
1-4|0.5|0.8|0.6|105|Incidence|16240931|Non-Hodgkin Lymphoma|2009
1-4|~|~|~|~|Mortality|16240931|Oral Cavity and Pharynx|2009
1-4|~|~|~|~|Incidence|16240931|Oral Cavity and Pharynx|2009
1-4|~|~|~|~|Mortality|7943260|Ovary|2009
1-4|~|~|~|~|Incidence|7943260|Ovary|2009
1-4|~|~|~|~|Mortality|16240931|Pancreas|2009
1-4|~|~|~|~|Incidence|16240931|Pancreas|2009
1-4|~|~|~|~|Mortality|8297671|Prostate|2009
1-4|~|~|~|~|Incidence|8297671|Prostate|2009
1-4|~|~|~|~|Mortality|16240931|Stomach|2009
1-4|~|~|~|~|Incidence|16240931|Stomach|2009
1-4|~|~|~|~|Mortality|8297671|Testis|2009
1-4|0.3|0.6|0.4|33|Incidence|8297671|Testis|2009
1-4|~|~|~|~|Mortality|16240931|Thyroid|2009
1-4|~|~|~|~|Incidence|16240931|Thyroid|2009
1-4|~|~|~|~|Mortality|16240931|Urinary Bladder|2009
1-4|~|~|~|~|Incidence|16240931|Urinary Bladder|2009
10-14|1.8|2.2|2.0|419|Mortality|20660564|All Cancer Sites Combined|2009
10-14|13.2|14.2|13.7|2830|Incidence|20660564|All Cancer Sites Combined|2009
10-14|0.5|0.7|0.5|113|Mortality|20660564|Brain and Other Nervous System|2009
10-14|2.6|3.1|2.8|585|Incidence|20660564|Brain and Other Nervous System|2009
10-14|~|~|~|~|Mortality|10088732|Cervix|2009
10-14|~|~|~|~|Incidence|10088732|Cervix|2009
10-14|~|~|~|~|Mortality|20660564|Colon and Rectum|2009
10-14|0.0|0.1|0.1|17|Incidence|20660564|Colon and Rectum|2009
10-14|~|~|~|~|Mortality|10088732|Corpus and Uterus, NOS|2009
10-14|~|~|~|~|Incidence|10088732|Corpus and Uterus, NOS|2009
10-14|~|~|~|~|Mortality|20660564|Esophagus|2009
10-14|~|~|~|~|Incidence|20660564|Esophagus|2009
10-14|~|~|~|~|Mortality|10088732|Female Breast|2009
10-14|~|~|~|~|Incidence|10088732|Female Breast|2009
10-14|~|~|~|~|Incidence|10088732|Female Breast, <i>in situ</i>|2009
10-14|~|~|~|~|Mortality|20660564|Hodgkin Lymphoma|2009
10-14|1.0|1.3|1.2|240|Incidence|20660564|Hodgkin Lymphoma|2009
10-14|.|.|.|.|Mortality|20660564|Kaposi Sarcoma|2009
10-14|~|~|~|~|Incidence|20660564|Kaposi Sarcoma|2009
10-14|~|~|~|~|Mortality|20660564|Kidney and Renal Pelvis|2009
10-14|0.1|0.2|0.2|32|Incidence|20660564|Kidney and Renal Pelvis|2009
10-14|~|~|~|~|Mortality|20660564|Larynx|2009
10-14|~|~|~|~|Incidence|20660564|Larynx|2009
10-14|0.5|0.7|0.6|127|Mortality|20660564|Leukemias|2009
10-14|2.8|3.3|3.1|633|Incidence|20660564|Leukemias|2009
10-14|~|~|~|~|Mortality|20660564|Liver and Intrahepatic Bile Duct|2009
10-14|0.1|0.2|0.1|25|Incidence|20660564|Liver and Intrahepatic Bile Duct|2009
10-14|~|~|~|~|Mortality|20660564|Lung and Bronchus|2009
10-14|~|~|~|~|Incidence|20660564|Lung and Bronchus|2009
10-14|~|~|~|~|Mortality|10088732|Male and Female Breast|2009
10-14|~|~|~|~|Incidence|10088732|Male and Female Breast|2009
10-14|~|~|~|~|Incidence|10088732|Male and Female Breast, <i>in situ</i>|2009
10-14|~|~|~|~|Mortality|20660564|Melanomas of the Skin|2009
10-14|0.2|0.3|0.2|48|Incidence|20660564|Melanomas of the Skin|2009
10-14|~|~|~|~|Mortality|20660564|Mesothelioma|2009
10-14|~|~|~|~|Incidence|20660564|Mesothelioma|2009
10-14|~|~|~|~|Mortality|20660564|Myeloma|2009
10-14|~|~|~|~|Incidence|20660564|Myeloma|2009
10-14|0.1|0.1|0.1|20|Mortality|20660564|Non-Hodgkin Lymphoma|2009
10-14|1.1|1.4|1.3|260|Incidence|20660564|Non-Hodgkin Lymphoma|2009
10-14|~|~|~|~|Mortality|20660564|Oral Cavity and Pharynx|2009
10-14|0.3|0.4|0.4|73|Incidence|20660564|Oral Cavity and Pharynx|2009
10-14|~|~|~|~|Mortality|10088732|Ovary|2009
10-14|0.6|0.9|0.7|73|Incidence|10088732|Ovary|2009
10-14|~|~|~|~|Mortality|20660564|Pancreas|2009
10-14|~|~|~|~|Incidence|20660564|Pancreas|2009
10-14|~|~|~|~|Mortality|10571832|Prostate|2009
10-14|~|~|~|~|Incidence|10571832|Prostate|2009
10-14|~|~|~|~|Mortality|20660564|Stomach|2009
10-14|~|~|~|~|Incidence|20660564|Stomach|2009
10-14|~|~|~|~|Mortality|10571832|Testis|2009
10-14|0.2|0.3|0.2|25|Incidence|10571832|Testis|2009
10-14|~|~|~|~|Mortality|20660564|Thyroid|2009
10-14|0.6|0.8|0.7|148|Incidence|20660564|Thyroid|2009
10-14|~|~|~|~|Mortality|20660564|Urinary Bladder|2009
10-14|~|~|~|~|Incidence|20660564|Urinary Bladder|2009
15-19|2.7|3.1|2.9|644|Mortality|22192810|All Cancer Sites Combined|2009
15-19|21.6|22.9|22.3|4940|Incidence|22192810|All Cancer Sites Combined|2009
15-19|0.4|0.6|0.5|120|Mortality|22192810|Brain and Other Nervous System|2009
15-19|2.1|2.5|2.2|499|Incidence|22192810|Brain and Other Nervous System|2009
15-19|~|~|~|~|Mortality|10804571|Cervix|2009
15-19|0.1|0.3|0.2|24|Incidence|10804571|Cervix|2009
15-19|~|~|~|~|Mortality|22192810|Colon and Rectum|2009
15-19|0.2|0.3|0.2|54|Incidence|22192810|Colon and Rectum|2009
15-19|~|~|~|~|Mortality|10804571|Corpus and Uterus, NOS|2009
15-19|~|~|~|~|Incidence|10804571|Corpus and Uterus, NOS|2009
15-19|~|~|~|~|Mortality|22192810|Esophagus|2009
15-19|~|~|~|~|Incidence|22192810|Esophagus|2009
15-19|~|~|~|~|Mortality|10804571|Female Breast|2009
15-19|0.1|0.3|0.2|19|Incidence|10804571|Female Breast|2009
15-19|~|~|~|~|Incidence|10804571|Female Breast, <i>in situ</i>|2009
15-19|~|~|~|~|Mortality|22192810|Hodgkin Lymphoma|2009
15-19|3.1|3.6|3.3|734|Incidence|22192810|Hodgkin Lymphoma|2009
15-19|.|.|.|.|Mortality|22192810|Kaposi Sarcoma|2009
15-19|~|~|~|~|Incidence|22192810|Kaposi Sarcoma|2009
15-19|~|~|~|~|Mortality|22192810|Kidney and Renal Pelvis|2009
15-19|0.1|0.3|0.2|45|Incidence|22192810|Kidney and Renal Pelvis|2009
15-19|~|~|~|~|Mortality|22192810|Larynx|2009
15-19|~|~|~|~|Incidence|22192810|Larynx|2009
15-19|0.7|0.9|0.8|172|Mortality|22192810|Leukemias|2009
15-19|2.6|3.1|2.8|632|Incidence|22192810|Leukemias|2009
15-19|0.0|0.1|0.1|16|Mortality|22192810|Liver and Intrahepatic Bile Duct|2009
15-19|0.1|0.2|0.1|31|Incidence|22192810|Liver and Intrahepatic Bile Duct|2009
15-19|~|~|~|~|Mortality|22192810|Lung and Bronchus|2009
15-19|0.1|0.3|0.2|41|Incidence|22192810|Lung and Bronchus|2009
15-19|~|~|~|~|Mortality|10804571|Male and Female Breast|2009
15-19|0.1|0.3|0.2|19|Incidence|10804571|Male and Female Breast|2009
15-19|~|~|~|~|Incidence|10804571|Male and Female Breast, <i>in situ</i>|2009
15-19|~|~|~|~|Mortality|22192810|Melanomas of the Skin|2009
15-19|1.1|1.4|1.2|272|Incidence|22192810|Melanomas of the Skin|2009
15-19|~|~|~|~|Mortality|22192810|Mesothelioma|2009
15-19|~|~|~|~|Incidence|22192810|Mesothelioma|2009
15-19|~|~|~|~|Mortality|22192810|Myeloma|2009
15-19|~|~|~|~|Incidence|22192810|Myeloma|2009
15-19|0.1|0.2|0.2|37|Mortality|22192810|Non-Hodgkin Lymphoma|2009
15-19|1.5|1.9|1.7|372|Incidence|22192810|Non-Hodgkin Lymphoma|2009
15-19|~|~|~|~|Mortality|22192810|Oral Cavity and Pharynx|2009
15-19|0.4|0.6|0.5|119|Incidence|22192810|Oral Cavity and Pharynx|2009
15-19|~|~|~|~|Mortality|10804571|Ovary|2009
15-19|1.3|1.8|1.5|165|Incidence|10804571|Ovary|2009
15-19|~|~|~|~|Mortality|22192810|Pancreas|2009
15-19|~|~|~|~|Incidence|22192810|Pancreas|2009
15-19|~|~|~|~|Mortality|11388239|Prostate|2009
15-19|~|~|~|~|Incidence|11388239|Prostate|2009
15-19|~|~|~|~|Mortality|22192810|Stomach|2009
15-19|~|~|~|~|Incidence|22192810|Stomach|2009
15-19|~|~|~|~|Mortality|11388239|Testis|2009
15-19|3.2|3.9|3.6|407|Incidence|11388239|Testis|2009
15-19|~|~|~|~|Mortality|22192810|Thyroid|2009
15-19|2.3|2.7|2.5|546|Incidence|22192810|Thyroid|2009
15-19|~|~|~|~|Mortality|22192810|Urinary Bladder|2009
15-19|~|~|~|~|Incidence|22192810|Urinary Bladder|2009
5-9|2.2|2.6|2.4|477|Mortality|20182499|All Cancer Sites Combined|2009
5-9|12.1|13.1|12.6|2539|Incidence|20182499|All Cancer Sites Combined|2009
5-9|0.8|1.1|1.0|193|Mortality|20182499|Brain and Other Nervous System|2009
5-9|3.4|3.9|3.6|730|Incidence|20182499|Brain and Other Nervous System|2009
5-9|~|~|~|~|Mortality|9874744|Cervix|2009
5-9|~|~|~|~|Incidence|9874744|Cervix|2009
5-9|~|~|~|~|Mortality|20182499|Colon and Rectum|2009
5-9|~|~|~|~|Incidence|20182499|Colon and Rectum|2009
5-9|~|~|~|~|Mortality|9874744|Corpus and Uterus, NOS|2009
5-9|~|~|~|~|Incidence|9874744|Corpus and Uterus, NOS|2009
5-9|~|~|~|~|Mortality|20182499|Esophagus|2009
5-9|~|~|~|~|Incidence|20182499|Esophagus|2009
5-9|~|~|~|~|Mortality|9874744|Female Breast|2009
5-9|~|~|~|~|Incidence|9874744|Female Breast|2009
5-9|~|~|~|~|Incidence|9874744|Female Breast, <i>in situ</i>|2009
5-9|~|~|~|~|Mortality|20182499|Hodgkin Lymphoma|2009
5-9|0.3|0.5|0.4|87|Incidence|20182499|Hodgkin Lymphoma|2009
5-9|.|.|.|.|Mortality|20182499|Kaposi Sarcoma|2009
5-9|~|~|~|~|Incidence|20182499|Kaposi Sarcoma|2009
5-9|0.0|0.1|0.1|17|Mortality|20182499|Kidney and Renal Pelvis|2009
5-9|0.5|0.7|0.6|123|Incidence|20182499|Kidney and Renal Pelvis|2009
5-9|~|~|~|~|Mortality|20182499|Larynx|2009
5-9|~|~|~|~|Incidence|20182499|Larynx|2009
5-9|0.5|0.7|0.6|117|Mortality|20182499|Leukemias|2009
5-9|3.9|4.5|4.2|842|Incidence|20182499|Leukemias|2009
5-9|~|~|~|~|Mortality|20182499|Liver and Intrahepatic Bile Duct|2009
5-9|~|~|~|~|Incidence|20182499|Liver and Intrahepatic Bile Duct|2009
5-9|~|~|~|~|Mortality|20182499|Lung and Bronchus|2009
5-9|~|~|~|~|Incidence|20182499|Lung and Bronchus|2009
5-9|~|~|~|~|Mortality|9874744|Male and Female Breast|2009
5-9|~|~|~|~|Incidence|9874744|Male and Female Breast|2009
5-9|~|~|~|~|Incidence|9874744|Male and Female Breast, <i>in situ</i>|2009
5-9|~|~|~|~|Mortality|20182499|Melanomas of the Skin|2009
5-9|0.1|0.2|0.1|25|Incidence|20182499|Melanomas of the Skin|2009
5-9|~|~|~|~|Mortality|20182499|Mesothelioma|2009
5-9|~|~|~|~|Incidence|20182499|Mesothelioma|2009
5-9|~|~|~|~|Mortality|20182499|Myeloma|2009
5-9|~|~|~|~|Incidence|20182499|Myeloma|2009
5-9|~|~|~|~|Mortality|20182499|Non-Hodgkin Lymphoma|2009
5-9|0.8|1.1|1.0|198|Incidence|20182499|Non-Hodgkin Lymphoma|2009
5-9|~|~|~|~|Mortality|20182499|Oral Cavity and Pharynx|2009
5-9|0.1|0.2|0.1|27|Incidence|20182499|Oral Cavity and Pharynx|2009
5-9|~|~|~|~|Mortality|9874744|Ovary|2009
5-9|0.1|0.3|0.2|23|Incidence|9874744|Ovary|2009
5-9|~|~|~|~|Mortality|20182499|Pancreas|2009
5-9|~|~|~|~|Incidence|20182499|Pancreas|2009
5-9|~|~|~|~|Mortality|10307755|Prostate|2009
5-9|~|~|~|~|Incidence|10307755|Prostate|2009
5-9|~|~|~|~|Mortality|20182499|Stomach|2009
5-9|~|~|~|~|Incidence|20182499|Stomach|2009
5-9|~|~|~|~|Mortality|10307755|Testis|2009
5-9|~|~|~|~|Incidence|10307755|Testis|2009
5-9|~|~|~|~|Mortality|20182499|Thyroid|2009
5-9|0.1|0.2|0.1|28|Incidence|20182499|Thyroid|2009
5-9|~|~|~|~|Mortality|20182499|Urinary Bladder|2009
5-9|~|~|~|~|Incidence|20182499|Urinary Bladder|2009
<1|1.5|2.3|1.8|74|Mortality|4003587|All Cancer Sites Combined|2009
<1|25.1|28.3|26.7|1067|Incidence|4003587|All Cancer Sites Combined|2009
<1|~|~|~|~|Mortality|4003587|Brain and Other Nervous System|2009
<1|3.8|5.1|4.4|178|Incidence|4003587|Brain and Other Nervous System|2009
<1|~|~|~|~|Mortality|1959169|Cervix|2009
<1|~|~|~|~|Incidence|1959169|Cervix|2009
<1|~|~|~|~|Mortality|4003587|Colon and Rectum|2009
<1|~|~|~|~|Incidence|4003587|Colon and Rectum|2009
<1|~|~|~|~|Mortality|1959169|Corpus and Uterus, NOS|2009
<1|~|~|~|~|Incidence|1959169|Corpus and Uterus, NOS|2009
<1|~|~|~|~|Mortality|4003587|Esophagus|2009
<1|~|~|~|~|Incidence|4003587|Esophagus|2009
<1|~|~|~|~|Mortality|1959169|Female Breast|2009
<1|~|~|~|~|Incidence|1959169|Female Breast|2009
<1|~|~|~|~|Incidence|1959169|Female Breast, <i>in situ</i>|2009
<1|~|~|~|~|Mortality|4003587|Hodgkin Lymphoma|2009
<1|~|~|~|~|Incidence|4003587|Hodgkin Lymphoma|2009
<1|.|.|.|.|Mortality|4003587|Kaposi Sarcoma|2009
<1|~|~|~|~|Incidence|4003587|Kaposi Sarcoma|2009
<1|~|~|~|~|Mortality|4003587|Kidney and Renal Pelvis|2009
<1|1.6|2.5|2.0|82|Incidence|4003587|Kidney and Renal Pelvis|2009
<1|~|~|~|~|Mortality|4003587|Larynx|2009
<1|~|~|~|~|Incidence|4003587|Larynx|2009
<1|0.4|1.0|0.7|27|Mortality|4003587|Leukemias|2009
<1|3.5|4.7|4.1|163|Incidence|4003587|Leukemias|2009
<1|~|~|~|~|Mortality|4003587|Liver and Intrahepatic Bile Duct|2009
<1|0.7|1.3|0.9|38|Incidence|4003587|Liver and Intrahepatic Bile Duct|2009
<1|~|~|~|~|Mortality|4003587|Lung and Bronchus|2009
<1|~|~|~|~|Incidence|4003587|Lung and Bronchus|2009
<1|~|~|~|~|Mortality|1959169|Male and Female Breast|2009
<1|~|~|~|~|Incidence|1959169|Male and Female Breast|2009
<1|~|~|~|~|Incidence|1959169|Male and Female Breast, <i>in situ</i>|2009
<1|~|~|~|~|Mortality|4003587|Melanomas of the Skin|2009
<1|~|~|~|~|Incidence|4003587|Melanomas of the Skin|2009
<1|~|~|~|~|Mortality|4003587|Mesothelioma|2009
<1|~|~|~|~|Incidence|4003587|Mesothelioma|2009
<1|~|~|~|~|Mortality|4003587|Myeloma|2009
<1|~|~|~|~|Incidence|4003587|Myeloma|2009
<1|~|~|~|~|Mortality|4003587|Non-Hodgkin Lymphoma|2009
<1|~|~|~|~|Incidence|4003587|Non-Hodgkin Lymphoma|2009
<1|~|~|~|~|Mortality|4003587|Oral Cavity and Pharynx|2009
<1|~|~|~|~|Incidence|4003587|Oral Cavity and Pharynx|2009
<1|~|~|~|~|Mortality|1959169|Ovary|2009
<1|~|~|~|~|Incidence|1959169|Ovary|2009
<1|~|~|~|~|Mortality|4003587|Pancreas|2009
<1|~|~|~|~|Incidence|4003587|Pancreas|2009
<1|~|~|~|~|Mortality|2044418|Prostate|2009
<1|~|~|~|~|Incidence|2044418|Prostate|2009
<1|~|~|~|~|Mortality|4003587|Stomach|2009
<1|~|~|~|~|Incidence|4003587|Stomach|2009
<1|~|~|~|~|Mortality|2044418|Testis|2009
<1|0.8|1.8|1.2|25|Incidence|2044418|Testis|2009
<1|~|~|~|~|Mortality|4003587|Thyroid|2009
<1|~|~|~|~|Incidence|4003587|Thyroid|2009
<1|~|~|~|~|Mortality|4003587|Urinary Bladder|2009
<1|~|~|~|~|Incidence|4003587|Urinary Bladder|2009
1-4|1.9|2.4|2.1|346|Mortality|16237385|All Cancer Sites Combined|2010
1-4|22.7|24.2|23.5|3814|Incidence|16237385|All Cancer Sites Combined|2010
1-4|0.5|0.8|0.6|101|Mortality|16237385|Brain and Other Nervous System|2010
1-4|4.5|5.2|4.8|787|Incidence|16237385|Brain and Other Nervous System|2010
1-4|~|~|~|~|Mortality|7943242|Cervix|2010
1-4|~|~|~|~|Incidence|7943242|Cervix|2010
1-4|~|~|~|~|Mortality|16237385|Colon and Rectum|2010
1-4|~|~|~|~|Incidence|16237385|Colon and Rectum|2010
1-4|~|~|~|~|Mortality|7943242|Corpus and Uterus, NOS|2010
1-4|~|~|~|~|Incidence|7943242|Corpus and Uterus, NOS|2010
1-4|~|~|~|~|Mortality|16237385|Esophagus|2010
1-4|~|~|~|~|Incidence|16237385|Esophagus|2010
1-4|~|~|~|~|Mortality|7943242|Female Breast|2010
1-4|~|~|~|~|Incidence|7943242|Female Breast|2010
1-4|~|~|~|~|Incidence|7943242|Female Breast, <i>in situ</i>|2010
1-4|~|~|~|~|Mortality|16237385|Hodgkin Lymphoma|2010
1-4|~|~|~|~|Incidence|16237385|Hodgkin Lymphoma|2010
1-4|.|.|.|.|Mortality|16237385|Kaposi Sarcoma|2010
1-4|~|~|~|~|Incidence|16237385|Kaposi Sarcoma|2010
1-4|0.1|0.2|0.1|16|Mortality|16237385|Kidney and Renal Pelvis|2010
1-4|1.9|2.3|2.1|340|Incidence|16237385|Kidney and Renal Pelvis|2010
1-4|~|~|~|~|Mortality|16237385|Larynx|2010
1-4|~|~|~|~|Incidence|16237385|Larynx|2010
1-4|0.6|0.8|0.7|112|Mortality|16237385|Leukemias|2010
1-4|8.5|9.5|9.0|1460|Incidence|16237385|Leukemias|2010
1-4|0.1|0.2|0.1|19|Mortality|16237385|Liver and Intrahepatic Bile Duct|2010
1-4|0.5|0.8|0.6|103|Incidence|16237385|Liver and Intrahepatic Bile Duct|2010
1-4|~|~|~|~|Mortality|16237385|Lung and Bronchus|2010
1-4|~|~|~|~|Incidence|16237385|Lung and Bronchus|2010
1-4|~|~|~|~|Mortality|7943242|Male and Female Breast|2010
1-4|~|~|~|~|Incidence|7943242|Male and Female Breast|2010
1-4|~|~|~|~|Incidence|7943242|Male and Female Breast, <i>in situ</i>|2010
1-4|~|~|~|~|Mortality|16237385|Melanomas of the Skin|2010
1-4|~|~|~|~|Incidence|16237385|Melanomas of the Skin|2010
1-4|~|~|~|~|Mortality|16237385|Mesothelioma|2010
1-4|~|~|~|~|Incidence|16237385|Mesothelioma|2010
1-4|~|~|~|~|Mortality|16237385|Myeloma|2010
1-4|~|~|~|~|Incidence|16237385|Myeloma|2010
1-4|~|~|~|~|Mortality|16237385|Non-Hodgkin Lymphoma|2010
1-4|0.6|0.9|0.7|115|Incidence|16237385|Non-Hodgkin Lymphoma|2010
1-4|~|~|~|~|Mortality|16237385|Oral Cavity and Pharynx|2010
1-4|~|~|~|~|Incidence|16237385|Oral Cavity and Pharynx|2010
1-4|~|~|~|~|Mortality|7943242|Ovary|2010
1-4|~|~|~|~|Incidence|7943242|Ovary|2010
1-4|~|~|~|~|Mortality|16237385|Pancreas|2010
1-4|~|~|~|~|Incidence|16237385|Pancreas|2010
1-4|~|~|~|~|Mortality|8294143|Prostate|2010
1-4|~|~|~|~|Incidence|8294143|Prostate|2010
1-4|~|~|~|~|Mortality|16237385|Stomach|2010
1-4|~|~|~|~|Incidence|16237385|Stomach|2010
1-4|~|~|~|~|Mortality|8294143|Testis|2010
1-4|0.2|0.5|0.3|29|Incidence|8294143|Testis|2010
1-4|~|~|~|~|Mortality|16237385|Thyroid|2010
1-4|~|~|~|~|Incidence|16237385|Thyroid|2010
1-4|~|~|~|~|Mortality|16237385|Urinary Bladder|2010
1-4|~|~|~|~|Incidence|16237385|Urinary Bladder|2010
10-14|2.1|2.5|2.3|477|Mortality|20680606|All Cancer Sites Combined|2010
10-14|13.7|14.7|14.2|2941|Incidence|20680606|All Cancer Sites Combined|2010
10-14|0.5|0.7|0.6|129|Mortality|20680606|Brain and Other Nervous System|2010
10-14|2.7|3.2|2.9|609|Incidence|20680606|Brain and Other Nervous System|2010
10-14|~|~|~|~|Mortality|10102400|Cervix|2010
10-14|~|~|~|~|Incidence|10102400|Cervix|2010
10-14|~|~|~|~|Mortality|20680606|Colon and Rectum|2010
10-14|0.0|0.1|0.1|16|Incidence|20680606|Colon and Rectum|2010
10-14|~|~|~|~|Mortality|10102400|Corpus and Uterus, NOS|2010
10-14|~|~|~|~|Incidence|10102400|Corpus and Uterus, NOS|2010
10-14|~|~|~|~|Mortality|20680606|Esophagus|2010
10-14|~|~|~|~|Incidence|20680606|Esophagus|2010
10-14|~|~|~|~|Mortality|10102400|Female Breast|2010
10-14|~|~|~|~|Incidence|10102400|Female Breast|2010
10-14|~|~|~|~|Incidence|10102400|Female Breast, <i>in situ</i>|2010
10-14|~|~|~|~|Mortality|20680606|Hodgkin Lymphoma|2010
10-14|1.0|1.3|1.1|233|Incidence|20680606|Hodgkin Lymphoma|2010
10-14|.|.|.|.|Mortality|20680606|Kaposi Sarcoma|2010
10-14|~|~|~|~|Incidence|20680606|Kaposi Sarcoma|2010
10-14|~|~|~|~|Mortality|20680606|Kidney and Renal Pelvis|2010
10-14|0.1|0.2|0.1|26|Incidence|20680606|Kidney and Renal Pelvis|2010
10-14|~|~|~|~|Mortality|20680606|Larynx|2010
10-14|~|~|~|~|Incidence|20680606|Larynx|2010
10-14|0.6|0.8|0.7|142|Mortality|20680606|Leukemias|2010
10-14|3.0|3.5|3.2|667|Incidence|20680606|Leukemias|2010
10-14|~|~|~|~|Mortality|20680606|Liver and Intrahepatic Bile Duct|2010
10-14|0.1|0.2|0.1|29|Incidence|20680606|Liver and Intrahepatic Bile Duct|2010
10-14|~|~|~|~|Mortality|20680606|Lung and Bronchus|2010
10-14|~|~|~|~|Incidence|20680606|Lung and Bronchus|2010
10-14|~|~|~|~|Mortality|10102400|Male and Female Breast|2010
10-14|~|~|~|~|Incidence|10102400|Male and Female Breast|2010
10-14|~|~|~|~|Incidence|10102400|Male and Female Breast, <i>in situ</i>|2010
10-14|~|~|~|~|Mortality|20680606|Melanomas of the Skin|2010
10-14|0.2|0.3|0.2|49|Incidence|20680606|Melanomas of the Skin|2010
10-14|~|~|~|~|Mortality|20680606|Mesothelioma|2010
10-14|~|~|~|~|Incidence|20680606|Mesothelioma|2010
10-14|~|~|~|~|Mortality|20680606|Myeloma|2010
10-14|~|~|~|~|Incidence|20680606|Myeloma|2010
10-14|0.1|0.1|0.1|19|Mortality|20680606|Non-Hodgkin Lymphoma|2010
10-14|1.0|1.3|1.2|238|Incidence|20680606|Non-Hodgkin Lymphoma|2010
10-14|~|~|~|~|Mortality|20680606|Oral Cavity and Pharynx|2010
10-14|0.3|0.4|0.3|68|Incidence|20680606|Oral Cavity and Pharynx|2010
10-14|~|~|~|~|Mortality|10102400|Ovary|2010
10-14|0.6|1.0|0.8|77|Incidence|10102400|Ovary|2010
10-14|~|~|~|~|Mortality|20680606|Pancreas|2010
10-14|~|~|~|~|Incidence|20680606|Pancreas|2010
10-14|~|~|~|~|Mortality|10578206|Prostate|2010
10-14|~|~|~|~|Incidence|10578206|Prostate|2010
10-14|~|~|~|~|Mortality|20680606|Stomach|2010
10-14|~|~|~|~|Incidence|20680606|Stomach|2010
10-14|~|~|~|~|Mortality|10578206|Testis|2010
10-14|0.1|0.3|0.2|23|Incidence|10578206|Testis|2010
10-14|~|~|~|~|Mortality|20680606|Thyroid|2010
10-14|0.6|0.9|0.7|151|Incidence|20680606|Thyroid|2010
10-14|~|~|~|~|Mortality|20680606|Urinary Bladder|2010
10-14|~|~|~|~|Incidence|20680606|Urinary Bladder|2010
15-19|2.5|3.0|2.7|601|Mortality|21981099|All Cancer Sites Combined|2010
15-19|21.1|22.3|21.7|4773|Incidence|21981099|All Cancer Sites Combined|2010
15-19|0.3|0.5|0.4|88|Mortality|21981099|Brain and Other Nervous System|2010
15-19|2.0|2.4|2.2|477|Incidence|21981099|Brain and Other Nervous System|2010
15-19|~|~|~|~|Mortality|10703205|Cervix|2010
15-19|~|~|~|~|Incidence|10703205|Cervix|2010
15-19|~|~|~|~|Mortality|21981099|Colon and Rectum|2010
15-19|0.3|0.5|0.4|83|Incidence|21981099|Colon and Rectum|2010
15-19|~|~|~|~|Mortality|10703205|Corpus and Uterus, NOS|2010
15-19|~|~|~|~|Incidence|10703205|Corpus and Uterus, NOS|2010
15-19|~|~|~|~|Mortality|21981099|Esophagus|2010
15-19|~|~|~|~|Incidence|21981099|Esophagus|2010
15-19|~|~|~|~|Mortality|10703205|Female Breast|2010
15-19|0.1|0.3|0.2|21|Incidence|10703205|Female Breast|2010
15-19|~|~|~|~|Incidence|10703205|Female Breast, <i>in situ</i>|2010
15-19|~|~|~|~|Mortality|21981099|Hodgkin Lymphoma|2010
15-19|3.0|3.5|3.2|711|Incidence|21981099|Hodgkin Lymphoma|2010
15-19|.|.|.|.|Mortality|21981099|Kaposi Sarcoma|2010
15-19|~|~|~|~|Incidence|21981099|Kaposi Sarcoma|2010
15-19|~|~|~|~|Mortality|21981099|Kidney and Renal Pelvis|2010
15-19|0.1|0.2|0.2|34|Incidence|21981099|Kidney and Renal Pelvis|2010
15-19|~|~|~|~|Mortality|21981099|Larynx|2010
15-19|~|~|~|~|Incidence|21981099|Larynx|2010
15-19|0.6|0.9|0.7|163|Mortality|21981099|Leukemias|2010
15-19|2.7|3.2|2.9|643|Incidence|21981099|Leukemias|2010
15-19|~|~|~|~|Mortality|21981099|Liver and Intrahepatic Bile Duct|2010
15-19|0.1|0.2|0.2|38|Incidence|21981099|Liver and Intrahepatic Bile Duct|2010
15-19|~|~|~|~|Mortality|21981099|Lung and Bronchus|2010
15-19|0.1|0.2|0.1|31|Incidence|21981099|Lung and Bronchus|2010
15-19|~|~|~|~|Mortality|10703205|Male and Female Breast|2010
15-19|0.1|0.3|0.2|21|Incidence|10703205|Male and Female Breast|2010
15-19|~|~|~|~|Incidence|10703205|Male and Female Breast, <i>in situ</i>|2010
15-19|~|~|~|~|Mortality|21981099|Melanomas of the Skin|2010
15-19|0.9|1.2|1.0|228|Incidence|21981099|Melanomas of the Skin|2010
15-19|~|~|~|~|Mortality|21981099|Mesothelioma|2010
15-19|~|~|~|~|Incidence|21981099|Mesothelioma|2010
15-19|~|~|~|~|Mortality|21981099|Myeloma|2010
15-19|~|~|~|~|Incidence|21981099|Myeloma|2010
15-19|0.1|0.2|0.2|40|Mortality|21981099|Non-Hodgkin Lymphoma|2010
15-19|1.5|1.8|1.6|356|Incidence|21981099|Non-Hodgkin Lymphoma|2010
15-19|~|~|~|~|Mortality|21981099|Oral Cavity and Pharynx|2010
15-19|0.4|0.6|0.5|111|Incidence|21981099|Oral Cavity and Pharynx|2010
15-19|~|~|~|~|Mortality|10703205|Ovary|2010
15-19|1.1|1.5|1.3|138|Incidence|10703205|Ovary|2010
15-19|~|~|~|~|Mortality|21981099|Pancreas|2010
15-19|~|~|~|~|Incidence|21981099|Pancreas|2010
15-19|~|~|~|~|Mortality|11277894|Prostate|2010
15-19|~|~|~|~|Incidence|11277894|Prostate|2010
15-19|~|~|~|~|Mortality|21981099|Stomach|2010
15-19|0.1|0.1|0.1|19|Incidence|21981099|Stomach|2010
15-19|~|~|~|~|Mortality|11277894|Testis|2010
15-19|3.2|3.9|3.5|397|Incidence|11277894|Testis|2010
15-19|~|~|~|~|Mortality|21981099|Thyroid|2010
15-19|2.4|2.8|2.6|569|Incidence|21981099|Thyroid|2010
15-19|~|~|~|~|Mortality|21981099|Urinary Bladder|2010
15-19|0.1|0.1|0.1|19|Incidence|21981099|Urinary Bladder|2010
5-9|2.0|2.4|2.2|439|Mortality|20331228|All Cancer Sites Combined|2010
5-9|12.8|13.8|13.3|2705|Incidence|20331228|All Cancer Sites Combined|2010
5-9|0.7|1.0|0.8|167|Mortality|20331228|Brain and Other Nervous System|2010
5-9|3.5|4.0|3.7|757|Incidence|20331228|Brain and Other Nervous System|2010
5-9|~|~|~|~|Mortality|9950930|Cervix|2010
5-9|~|~|~|~|Incidence|9950930|Cervix|2010
5-9|~|~|~|~|Mortality|20331228|Colon and Rectum|2010
5-9|~|~|~|~|Incidence|20331228|Colon and Rectum|2010
5-9|~|~|~|~|Mortality|9950930|Corpus and Uterus, NOS|2010
5-9|~|~|~|~|Incidence|9950930|Corpus and Uterus, NOS|2010
5-9|~|~|~|~|Mortality|20331228|Esophagus|2010
5-9|~|~|~|~|Incidence|20331228|Esophagus|2010
5-9|~|~|~|~|Mortality|9950930|Female Breast|2010
5-9|~|~|~|~|Incidence|9950930|Female Breast|2010
5-9|~|~|~|~|Incidence|9950930|Female Breast, <i>in situ</i>|2010
5-9|~|~|~|~|Mortality|20331228|Hodgkin Lymphoma|2010
5-9|0.3|0.5|0.4|77|Incidence|20331228|Hodgkin Lymphoma|2010
5-9|.|.|.|.|Mortality|20331228|Kaposi Sarcoma|2010
5-9|~|~|~|~|Incidence|20331228|Kaposi Sarcoma|2010
5-9|0.1|0.1|0.1|19|Mortality|20331228|Kidney and Renal Pelvis|2010
5-9|0.5|0.7|0.6|116|Incidence|20331228|Kidney and Renal Pelvis|2010
5-9|~|~|~|~|Mortality|20331228|Larynx|2010
5-9|~|~|~|~|Incidence|20331228|Larynx|2010
5-9|0.4|0.7|0.5|111|Mortality|20331228|Leukemias|2010
5-9|4.0|4.6|4.3|867|Incidence|20331228|Leukemias|2010
5-9|~|~|~|~|Mortality|20331228|Liver and Intrahepatic Bile Duct|2010
5-9|0.1|0.2|0.1|25|Incidence|20331228|Liver and Intrahepatic Bile Duct|2010
5-9|~|~|~|~|Mortality|20331228|Lung and Bronchus|2010
5-9|~|~|~|~|Incidence|20331228|Lung and Bronchus|2010
5-9|~|~|~|~|Mortality|9950930|Male and Female Breast|2010
5-9|~|~|~|~|Incidence|9950930|Male and Female Breast|2010
5-9|~|~|~|~|Incidence|9950930|Male and Female Breast, <i>in situ</i>|2010
5-9|~|~|~|~|Mortality|20331228|Melanomas of the Skin|2010
5-9|0.1|0.2|0.1|30|Incidence|20331228|Melanomas of the Skin|2010
5-9|~|~|~|~|Mortality|20331228|Mesothelioma|2010
5-9|~|~|~|~|Incidence|20331228|Mesothelioma|2010
5-9|~|~|~|~|Mortality|20331228|Myeloma|2010
5-9|~|~|~|~|Incidence|20331228|Myeloma|2010
5-9|~|~|~|~|Mortality|20331228|Non-Hodgkin Lymphoma|2010
5-9|1.0|1.3|1.1|230|Incidence|20331228|Non-Hodgkin Lymphoma|2010
5-9|~|~|~|~|Mortality|20331228|Oral Cavity and Pharynx|2010
5-9|0.1|0.2|0.1|21|Incidence|20331228|Oral Cavity and Pharynx|2010
5-9|~|~|~|~|Mortality|9950930|Ovary|2010
5-9|0.1|0.3|0.2|22|Incidence|9950930|Ovary|2010
5-9|~|~|~|~|Mortality|20331228|Pancreas|2010
5-9|~|~|~|~|Incidence|20331228|Pancreas|2010
5-9|~|~|~|~|Mortality|10380298|Prostate|2010
5-9|~|~|~|~|Incidence|10380298|Prostate|2010
5-9|~|~|~|~|Mortality|20331228|Stomach|2010
5-9|~|~|~|~|Incidence|20331228|Stomach|2010
5-9|~|~|~|~|Mortality|10380298|Testis|2010
5-9|~|~|~|~|Incidence|10380298|Testis|2010
5-9|~|~|~|~|Mortality|20331228|Thyroid|2010
5-9|0.1|0.2|0.1|24|Incidence|20331228|Thyroid|2010
5-9|~|~|~|~|Mortality|20331228|Urinary Bladder|2010
5-9|~|~|~|~|Incidence|20331228|Urinary Bladder|2010
<1|1.2|2.0|1.6|62|Mortality|3951430|All Cancer Sites Combined|2010
<1|24.9|28.2|26.5|1047|Incidence|3951430|All Cancer Sites Combined|2010
<1|~|~|~|~|Mortality|3951430|Brain and Other Nervous System|2010
<1|3.1|4.3|3.7|146|Incidence|3951430|Brain and Other Nervous System|2010
<1|~|~|~|~|Mortality|1932956|Cervix|2010
<1|~|~|~|~|Incidence|1932956|Cervix|2010
<1|~|~|~|~|Mortality|3951430|Colon and Rectum|2010
<1|~|~|~|~|Incidence|3951430|Colon and Rectum|2010
<1|~|~|~|~|Mortality|1932956|Corpus and Uterus, NOS|2010
<1|~|~|~|~|Incidence|1932956|Corpus and Uterus, NOS|2010
<1|~|~|~|~|Mortality|3951430|Esophagus|2010
<1|~|~|~|~|Incidence|3951430|Esophagus|2010
<1|~|~|~|~|Mortality|1932956|Female Breast|2010
<1|~|~|~|~|Incidence|1932956|Female Breast|2010
<1|~|~|~|~|Incidence|1932956|Female Breast, <i>in situ</i>|2010
<1|~|~|~|~|Mortality|3951430|Hodgkin Lymphoma|2010
<1|~|~|~|~|Incidence|3951430|Hodgkin Lymphoma|2010
<1|.|.|.|.|Mortality|3951430|Kaposi Sarcoma|2010
<1|~|~|~|~|Incidence|3951430|Kaposi Sarcoma|2010
<1|~|~|~|~|Mortality|3951430|Kidney and Renal Pelvis|2010
<1|1.2|2.0|1.5|61|Incidence|3951430|Kidney and Renal Pelvis|2010
<1|~|~|~|~|Mortality|3951430|Larynx|2010
<1|~|~|~|~|Incidence|3951430|Larynx|2010
<1|0.4|0.9|0.6|25|Mortality|3951430|Leukemias|2010
<1|3.7|5.0|4.3|169|Incidence|3951430|Leukemias|2010
<1|~|~|~|~|Mortality|3951430|Liver and Intrahepatic Bile Duct|2010
<1|1.2|2.0|1.6|62|Incidence|3951430|Liver and Intrahepatic Bile Duct|2010
<1|~|~|~|~|Mortality|3951430|Lung and Bronchus|2010
<1|~|~|~|~|Incidence|3951430|Lung and Bronchus|2010
<1|~|~|~|~|Mortality|1932956|Male and Female Breast|2010
<1|~|~|~|~|Incidence|1932956|Male and Female Breast|2010
<1|~|~|~|~|Incidence|1932956|Male and Female Breast, <i>in situ</i>|2010
<1|~|~|~|~|Mortality|3951430|Melanomas of the Skin|2010
<1|~|~|~|~|Incidence|3951430|Melanomas of the Skin|2010
<1|~|~|~|~|Mortality|3951430|Mesothelioma|2010
<1|~|~|~|~|Incidence|3951430|Mesothelioma|2010
<1|~|~|~|~|Mortality|3951430|Myeloma|2010
<1|~|~|~|~|Incidence|3951430|Myeloma|2010
<1|~|~|~|~|Mortality|3951430|Non-Hodgkin Lymphoma|2010
<1|~|~|~|~|Incidence|3951430|Non-Hodgkin Lymphoma|2010
<1|~|~|~|~|Mortality|3951430|Oral Cavity and Pharynx|2010
<1|~|~|~|~|Incidence|3951430|Oral Cavity and Pharynx|2010
<1|~|~|~|~|Mortality|1932956|Ovary|2010
<1|~|~|~|~|Incidence|1932956|Ovary|2010
<1|~|~|~|~|Mortality|3951430|Pancreas|2010
<1|~|~|~|~|Incidence|3951430|Pancreas|2010
<1|~|~|~|~|Mortality|2018474|Prostate|2010
<1|~|~|~|~|Incidence|2018474|Prostate|2010
<1|~|~|~|~|Mortality|3951430|Stomach|2010
<1|~|~|~|~|Incidence|3951430|Stomach|2010
<1|~|~|~|~|Mortality|2018474|Testis|2010
<1|1.0|2.1|1.5|30|Incidence|2018474|Testis|2010
<1|~|~|~|~|Mortality|3951430|Thyroid|2010
<1|~|~|~|~|Incidence|3951430|Thyroid|2010
<1|~|~|~|~|Mortality|3951430|Urinary Bladder|2010
<1|~|~|~|~|Incidence|3951430|Urinary Bladder|2010
1-4|2.0|2.4|2.2|353|Mortality|16160011|All Cancer Sites Combined|2011
1-4|22.8|24.3|23.5|3797|Incidence|16160011|All Cancer Sites Combined|2011
1-4|0.6|0.8|0.7|111|Mortality|16160011|Brain and Other Nervous System|2011
1-4|4.3|5.0|4.7|754|Incidence|16160011|Brain and Other Nervous System|2011
1-4|~|~|~|~|Mortality|7908722|Cervix|2011
1-4|~|~|~|~|Incidence|7908722|Cervix|2011
1-4|~|~|~|~|Mortality|16160011|Colon and Rectum|2011
1-4|~|~|~|~|Incidence|16160011|Colon and Rectum|2011
1-4|~|~|~|~|Mortality|7908722|Corpus and Uterus, NOS|2011
1-4|~|~|~|~|Incidence|7908722|Corpus and Uterus, NOS|2011
1-4|~|~|~|~|Mortality|16160011|Esophagus|2011
1-4|~|~|~|~|Incidence|16160011|Esophagus|2011
1-4|~|~|~|~|Mortality|7908722|Female Breast|2011
1-4|~|~|~|~|Incidence|7908722|Female Breast|2011
1-4|~|~|~|~|Incidence|7908722|Female Breast, <i>in situ</i>|2011
1-4|~|~|~|~|Mortality|16160011|Hodgkin Lymphoma|2011
1-4|~|~|~|~|Incidence|16160011|Hodgkin Lymphoma|2011
1-4|.|.|.|.|Mortality|16160011|Kaposi Sarcoma|2011
1-4|~|~|~|~|Incidence|16160011|Kaposi Sarcoma|2011
1-4|~|~|~|~|Mortality|16160011|Kidney and Renal Pelvis|2011
1-4|2.0|2.5|2.2|358|Incidence|16160011|Kidney and Renal Pelvis|2011
1-4|~|~|~|~|Mortality|16160011|Larynx|2011
1-4|~|~|~|~|Incidence|16160011|Larynx|2011
1-4|0.5|0.7|0.6|95|Mortality|16160011|Leukemias|2011
1-4|8.7|9.7|9.2|1483|Incidence|16160011|Leukemias|2011
1-4|0.1|0.2|0.2|27|Mortality|16160011|Liver and Intrahepatic Bile Duct|2011
1-4|0.6|0.8|0.7|112|Incidence|16160011|Liver and Intrahepatic Bile Duct|2011
1-4|~|~|~|~|Mortality|16160011|Lung and Bronchus|2011
1-4|~|~|~|~|Incidence|16160011|Lung and Bronchus|2011
1-4|~|~|~|~|Mortality|7908722|Male and Female Breast|2011
1-4|~|~|~|~|Incidence|7908722|Male and Female Breast|2011
1-4|~|~|~|~|Incidence|7908722|Male and Female Breast, <i>in situ</i>|2011
1-4|~|~|~|~|Mortality|16160011|Melanomas of the Skin|2011
1-4|~|~|~|~|Incidence|16160011|Melanomas of the Skin|2011
1-4|~|~|~|~|Mortality|16160011|Mesothelioma|2011
1-4|~|~|~|~|Incidence|16160011|Mesothelioma|2011
1-4|~|~|~|~|Mortality|16160011|Myeloma|2011
1-4|~|~|~|~|Incidence|16160011|Myeloma|2011
1-4|~|~|~|~|Mortality|16160011|Non-Hodgkin Lymphoma|2011
1-4|0.5|0.8|0.6|105|Incidence|16160011|Non-Hodgkin Lymphoma|2011
1-4|~|~|~|~|Mortality|16160011|Oral Cavity and Pharynx|2011
1-4|~|~|~|~|Incidence|16160011|Oral Cavity and Pharynx|2011
1-4|~|~|~|~|Mortality|7908722|Ovary|2011
1-4|~|~|~|~|Incidence|7908722|Ovary|2011
1-4|~|~|~|~|Mortality|16160011|Pancreas|2011
1-4|~|~|~|~|Incidence|16160011|Pancreas|2011
1-4|~|~|~|~|Mortality|8251289|Prostate|2011
1-4|~|~|~|~|Incidence|8251289|Prostate|2011
1-4|~|~|~|~|Mortality|16160011|Stomach|2011
1-4|~|~|~|~|Incidence|16160011|Stomach|2011
1-4|~|~|~|~|Mortality|8251289|Testis|2011
1-4|0.2|0.4|0.3|24|Incidence|8251289|Testis|2011
1-4|~|~|~|~|Mortality|16160011|Thyroid|2011
1-4|~|~|~|~|Incidence|16160011|Thyroid|2011
1-4|~|~|~|~|Mortality|16160011|Urinary Bladder|2011
1-4|~|~|~|~|Incidence|16160011|Urinary Bladder|2011
10-14|1.8|2.2|2.0|419|Mortality|20712798|All Cancer Sites Combined|2011
10-14|13.7|14.7|14.2|2933|Incidence|20712798|All Cancer Sites Combined|2011
10-14|0.5|0.7|0.6|116|Mortality|20712798|Brain and Other Nervous System|2011
10-14|2.7|3.2|2.9|607|Incidence|20712798|Brain and Other Nervous System|2011
10-14|~|~|~|~|Mortality|10126019|Cervix|2011
10-14|~|~|~|~|Incidence|10126019|Cervix|2011
10-14|~|~|~|~|Mortality|20712798|Colon and Rectum|2011
10-14|0.1|0.2|0.1|24|Incidence|20712798|Colon and Rectum|2011
10-14|~|~|~|~|Mortality|10126019|Corpus and Uterus, NOS|2011
10-14|~|~|~|~|Incidence|10126019|Corpus and Uterus, NOS|2011
10-14|~|~|~|~|Mortality|20712798|Esophagus|2011
10-14|~|~|~|~|Incidence|20712798|Esophagus|2011
10-14|~|~|~|~|Mortality|10126019|Female Breast|2011
10-14|~|~|~|~|Incidence|10126019|Female Breast|2011
10-14|~|~|~|~|Incidence|10126019|Female Breast, <i>in situ</i>|2011
10-14|~|~|~|~|Mortality|20712798|Hodgkin Lymphoma|2011
10-14|1.0|1.3|1.1|228|Incidence|20712798|Hodgkin Lymphoma|2011
10-14|.|.|.|.|Mortality|20712798|Kaposi Sarcoma|2011
10-14|~|~|~|~|Incidence|20712798|Kaposi Sarcoma|2011
10-14|~|~|~|~|Mortality|20712798|Kidney and Renal Pelvis|2011
10-14|0.1|0.2|0.2|34|Incidence|20712798|Kidney and Renal Pelvis|2011
10-14|~|~|~|~|Mortality|20712798|Larynx|2011
10-14|~|~|~|~|Incidence|20712798|Larynx|2011
10-14|0.5|0.7|0.6|127|Mortality|20712798|Leukemias|2011
10-14|2.9|3.4|3.1|647|Incidence|20712798|Leukemias|2011
10-14|~|~|~|~|Mortality|20712798|Liver and Intrahepatic Bile Duct|2011
10-14|0.1|0.2|0.1|31|Incidence|20712798|Liver and Intrahepatic Bile Duct|2011
10-14|~|~|~|~|Mortality|20712798|Lung and Bronchus|2011
10-14|~|~|~|~|Incidence|20712798|Lung and Bronchus|2011
10-14|~|~|~|~|Mortality|10126019|Male and Female Breast|2011
10-14|~|~|~|~|Incidence|10126019|Male and Female Breast|2011
10-14|~|~|~|~|Incidence|10126019|Male and Female Breast, <i>in situ</i>|2011
10-14|~|~|~|~|Mortality|20712798|Melanomas of the Skin|2011
10-14|0.2|0.4|0.3|63|Incidence|20712798|Melanomas of the Skin|2011
10-14|~|~|~|~|Mortality|20712798|Mesothelioma|2011
10-14|~|~|~|~|Incidence|20712798|Mesothelioma|2011
10-14|~|~|~|~|Mortality|20712798|Myeloma|2011
10-14|~|~|~|~|Incidence|20712798|Myeloma|2011
10-14|0.0|0.1|0.1|16|Mortality|20712798|Non-Hodgkin Lymphoma|2011
10-14|1.0|1.3|1.1|234|Incidence|20712798|Non-Hodgkin Lymphoma|2011
10-14|~|~|~|~|Mortality|20712798|Oral Cavity and Pharynx|2011
10-14|0.2|0.3|0.3|53|Incidence|20712798|Oral Cavity and Pharynx|2011
10-14|~|~|~|~|Mortality|10126019|Ovary|2011
10-14|0.5|0.8|0.7|66|Incidence|10126019|Ovary|2011
10-14|~|~|~|~|Mortality|20712798|Pancreas|2011
10-14|~|~|~|~|Incidence|20712798|Pancreas|2011
10-14|~|~|~|~|Mortality|10586779|Prostate|2011
10-14|~|~|~|~|Incidence|10586779|Prostate|2011
10-14|~|~|~|~|Mortality|20712798|Stomach|2011
10-14|~|~|~|~|Incidence|20712798|Stomach|2011
10-14|~|~|~|~|Mortality|10586779|Testis|2011
10-14|0.1|0.3|0.2|19|Incidence|10586779|Testis|2011
10-14|~|~|~|~|Mortality|20712798|Thyroid|2011
10-14|0.7|1.0|0.8|171|Incidence|20712798|Thyroid|2011
10-14|~|~|~|~|Mortality|20712798|Urinary Bladder|2011
10-14|~|~|~|~|Incidence|20712798|Urinary Bladder|2011
15-19|2.7|3.2|3.0|639|Mortality|21658481|All Cancer Sites Combined|2011
15-19|21.9|23.2|22.6|4888|Incidence|21658481|All Cancer Sites Combined|2011
15-19|0.4|0.6|0.5|111|Mortality|21658481|Brain and Other Nervous System|2011
15-19|2.4|2.8|2.6|562|Incidence|21658481|Brain and Other Nervous System|2011
15-19|~|~|~|~|Mortality|10539012|Cervix|2011
15-19|~|~|~|~|Incidence|10539012|Cervix|2011
15-19|~|~|~|~|Mortality|21658481|Colon and Rectum|2011
15-19|0.3|0.4|0.3|74|Incidence|21658481|Colon and Rectum|2011
15-19|~|~|~|~|Mortality|10539012|Corpus and Uterus, NOS|2011
15-19|~|~|~|~|Incidence|10539012|Corpus and Uterus, NOS|2011
15-19|~|~|~|~|Mortality|21658481|Esophagus|2011
15-19|~|~|~|~|Incidence|21658481|Esophagus|2011
15-19|~|~|~|~|Mortality|10539012|Female Breast|2011
15-19|~|~|~|~|Incidence|10539012|Female Breast|2011
15-19|~|~|~|~|Incidence|10539012|Female Breast, <i>in situ</i>|2011
15-19|0.0|0.1|0.1|16|Mortality|21658481|Hodgkin Lymphoma|2011
15-19|2.9|3.4|3.2|687|Incidence|21658481|Hodgkin Lymphoma|2011
15-19|.|.|.|.|Mortality|21658481|Kaposi Sarcoma|2011
15-19|~|~|~|~|Incidence|21658481|Kaposi Sarcoma|2011
15-19|~|~|~|~|Mortality|21658481|Kidney and Renal Pelvis|2011
15-19|0.1|0.3|0.2|44|Incidence|21658481|Kidney and Renal Pelvis|2011
15-19|~|~|~|~|Mortality|21658481|Larynx|2011
15-19|~|~|~|~|Incidence|21658481|Larynx|2011
15-19|0.7|0.9|0.8|177|Mortality|21658481|Leukemias|2011
15-19|2.9|3.4|3.1|681|Incidence|21658481|Leukemias|2011
15-19|~|~|~|~|Mortality|21658481|Liver and Intrahepatic Bile Duct|2011
15-19|0.1|0.2|0.1|24|Incidence|21658481|Liver and Intrahepatic Bile Duct|2011
15-19|~|~|~|~|Mortality|21658481|Lung and Bronchus|2011
15-19|0.1|0.2|0.1|26|Incidence|21658481|Lung and Bronchus|2011
15-19|~|~|~|~|Mortality|10539012|Male and Female Breast|2011
15-19|~|~|~|~|Incidence|10539012|Male and Female Breast|2011
15-19|~|~|~|~|Incidence|10539012|Male and Female Breast, <i>in situ</i>|2011
15-19|~|~|~|~|Mortality|21658481|Melanomas of the Skin|2011
15-19|0.9|1.2|1.0|224|Incidence|21658481|Melanomas of the Skin|2011
15-19|~|~|~|~|Mortality|21658481|Mesothelioma|2011
15-19|~|~|~|~|Incidence|21658481|Mesothelioma|2011
15-19|~|~|~|~|Mortality|21658481|Myeloma|2011
15-19|~|~|~|~|Incidence|21658481|Myeloma|2011
15-19|0.1|0.2|0.1|32|Mortality|21658481|Non-Hodgkin Lymphoma|2011
15-19|1.6|1.9|1.7|375|Incidence|21658481|Non-Hodgkin Lymphoma|2011
15-19|~|~|~|~|Mortality|21658481|Oral Cavity and Pharynx|2011
15-19|0.4|0.6|0.5|104|Incidence|21658481|Oral Cavity and Pharynx|2011
15-19|~|~|~|~|Mortality|10539012|Ovary|2011
15-19|1.0|1.4|1.2|126|Incidence|10539012|Ovary|2011
15-19|~|~|~|~|Mortality|21658481|Pancreas|2011
15-19|0.1|0.1|0.1|21|Incidence|21658481|Pancreas|2011
15-19|~|~|~|~|Mortality|11119469|Prostate|2011
15-19|~|~|~|~|Incidence|11119469|Prostate|2011
15-19|~|~|~|~|Mortality|21658481|Stomach|2011
15-19|0.0|0.1|0.1|16|Incidence|21658481|Stomach|2011
15-19|~|~|~|~|Mortality|11119469|Testis|2011
15-19|3.3|4.0|3.6|404|Incidence|11119469|Testis|2011
15-19|~|~|~|~|Mortality|21658481|Thyroid|2011
15-19|2.5|3.0|2.7|594|Incidence|21658481|Thyroid|2011
15-19|~|~|~|~|Mortality|21658481|Urinary Bladder|2011
15-19|0.1|0.2|0.1|27|Incidence|21658481|Urinary Bladder|2011
5-9|2.0|2.4|2.2|441|Mortality|20332498|All Cancer Sites Combined|2011
5-9|12.9|13.9|13.4|2729|Incidence|20332498|All Cancer Sites Combined|2011
5-9|0.8|1.1|1.0|198|Mortality|20332498|Brain and Other Nervous System|2011
5-9|3.4|3.9|3.6|740|Incidence|20332498|Brain and Other Nervous System|2011
5-9|~|~|~|~|Mortality|9951142|Cervix|2011
5-9|~|~|~|~|Incidence|9951142|Cervix|2011
5-9|~|~|~|~|Mortality|20332498|Colon and Rectum|2011
5-9|~|~|~|~|Incidence|20332498|Colon and Rectum|2011
5-9|~|~|~|~|Mortality|9951142|Corpus and Uterus, NOS|2011
5-9|~|~|~|~|Incidence|9951142|Corpus and Uterus, NOS|2011
5-9|~|~|~|~|Mortality|20332498|Esophagus|2011
5-9|~|~|~|~|Incidence|20332498|Esophagus|2011
5-9|~|~|~|~|Mortality|9951142|Female Breast|2011
5-9|~|~|~|~|Incidence|9951142|Female Breast|2011
5-9|~|~|~|~|Incidence|9951142|Female Breast, <i>in situ</i>|2011
5-9|~|~|~|~|Mortality|20332498|Hodgkin Lymphoma|2011
5-9|0.3|0.5|0.4|73|Incidence|20332498|Hodgkin Lymphoma|2011
5-9|.|.|.|.|Mortality|20332498|Kaposi Sarcoma|2011
5-9|~|~|~|~|Incidence|20332498|Kaposi Sarcoma|2011
5-9|0.1|0.2|0.1|21|Mortality|20332498|Kidney and Renal Pelvis|2011
5-9|0.5|0.7|0.6|119|Incidence|20332498|Kidney and Renal Pelvis|2011
5-9|~|~|~|~|Mortality|20332498|Larynx|2011
5-9|~|~|~|~|Incidence|20332498|Larynx|2011
5-9|0.4|0.6|0.5|98|Mortality|20332498|Leukemias|2011
5-9|4.2|4.8|4.5|906|Incidence|20332498|Leukemias|2011
5-9|~|~|~|~|Mortality|20332498|Liver and Intrahepatic Bile Duct|2011
5-9|0.1|0.2|0.1|21|Incidence|20332498|Liver and Intrahepatic Bile Duct|2011
5-9|~|~|~|~|Mortality|20332498|Lung and Bronchus|2011
5-9|~|~|~|~|Incidence|20332498|Lung and Bronchus|2011
5-9|~|~|~|~|Mortality|9951142|Male and Female Breast|2011
5-9|~|~|~|~|Incidence|9951142|Male and Female Breast|2011
5-9|~|~|~|~|Incidence|9951142|Male and Female Breast, <i>in situ</i>|2011
5-9|~|~|~|~|Mortality|20332498|Melanomas of the Skin|2011
5-9|0.1|0.2|0.2|35|Incidence|20332498|Melanomas of the Skin|2011
5-9|~|~|~|~|Mortality|20332498|Mesothelioma|2011
5-9|~|~|~|~|Incidence|20332498|Mesothelioma|2011
5-9|~|~|~|~|Mortality|20332498|Myeloma|2011
5-9|~|~|~|~|Incidence|20332498|Myeloma|2011
5-9|~|~|~|~|Mortality|20332498|Non-Hodgkin Lymphoma|2011
5-9|0.9|1.2|1.0|213|Incidence|20332498|Non-Hodgkin Lymphoma|2011
5-9|~|~|~|~|Mortality|20332498|Oral Cavity and Pharynx|2011
5-9|0.1|0.1|0.1|19|Incidence|20332498|Oral Cavity and Pharynx|2011
5-9|~|~|~|~|Mortality|9951142|Ovary|2011
5-9|0.2|0.5|0.3|33|Incidence|9951142|Ovary|2011
5-9|~|~|~|~|Mortality|20332498|Pancreas|2011
5-9|~|~|~|~|Incidence|20332498|Pancreas|2011
5-9|~|~|~|~|Mortality|10381356|Prostate|2011
5-9|~|~|~|~|Incidence|10381356|Prostate|2011
5-9|~|~|~|~|Mortality|20332498|Stomach|2011
5-9|~|~|~|~|Incidence|20332498|Stomach|2011
5-9|~|~|~|~|Mortality|10381356|Testis|2011
5-9|~|~|~|~|Incidence|10381356|Testis|2011
5-9|~|~|~|~|Mortality|20332498|Thyroid|2011
5-9|0.1|0.2|0.1|29|Incidence|20332498|Thyroid|2011
5-9|~|~|~|~|Mortality|20332498|Urinary Bladder|2011
5-9|~|~|~|~|Incidence|20332498|Urinary Bladder|2011
<1|1.4|2.2|1.8|70|Mortality|3963092|All Cancer Sites Combined|2011
<1|24.1|27.3|25.7|1017|Incidence|3963092|All Cancer Sites Combined|2011
<1|~|~|~|~|Mortality|3963092|Brain and Other Nervous System|2011
<1|3.3|4.5|3.9|153|Incidence|3963092|Brain and Other Nervous System|2011
<1|~|~|~|~|Mortality|1934662|Cervix|2011
<1|~|~|~|~|Incidence|1934662|Cervix|2011
<1|~|~|~|~|Mortality|3963092|Colon and Rectum|2011
<1|~|~|~|~|Incidence|3963092|Colon and Rectum|2011
<1|~|~|~|~|Mortality|1934662|Corpus and Uterus, NOS|2011
<1|~|~|~|~|Incidence|1934662|Corpus and Uterus, NOS|2011
<1|~|~|~|~|Mortality|3963092|Esophagus|2011
<1|~|~|~|~|Incidence|3963092|Esophagus|2011
<1|~|~|~|~|Mortality|1934662|Female Breast|2011
<1|~|~|~|~|Incidence|1934662|Female Breast|2011
<1|~|~|~|~|Incidence|1934662|Female Breast, <i>in situ</i>|2011
<1|~|~|~|~|Mortality|3963092|Hodgkin Lymphoma|2011
<1|~|~|~|~|Incidence|3963092|Hodgkin Lymphoma|2011
<1|.|.|.|.|Mortality|3963092|Kaposi Sarcoma|2011
<1|~|~|~|~|Incidence|3963092|Kaposi Sarcoma|2011
<1|~|~|~|~|Mortality|3963092|Kidney and Renal Pelvis|2011
<1|1.2|2.0|1.6|63|Incidence|3963092|Kidney and Renal Pelvis|2011
<1|~|~|~|~|Mortality|3963092|Larynx|2011
<1|~|~|~|~|Incidence|3963092|Larynx|2011
<1|0.3|0.8|0.6|22|Mortality|3963092|Leukemias|2011
<1|3.6|5.0|4.3|169|Incidence|3963092|Leukemias|2011
<1|~|~|~|~|Mortality|3963092|Liver and Intrahepatic Bile Duct|2011
<1|1.0|1.8|1.4|55|Incidence|3963092|Liver and Intrahepatic Bile Duct|2011
<1|~|~|~|~|Mortality|3963092|Lung and Bronchus|2011
<1|~|~|~|~|Incidence|3963092|Lung and Bronchus|2011
<1|~|~|~|~|Mortality|1934662|Male and Female Breast|2011
<1|~|~|~|~|Incidence|1934662|Male and Female Breast|2011
<1|~|~|~|~|Incidence|1934662|Male and Female Breast, <i>in situ</i>|2011
<1|~|~|~|~|Mortality|3963092|Melanomas of the Skin|2011
<1|~|~|~|~|Incidence|3963092|Melanomas of the Skin|2011
<1|~|~|~|~|Mortality|3963092|Mesothelioma|2011
<1|~|~|~|~|Incidence|3963092|Mesothelioma|2011
<1|~|~|~|~|Mortality|3963092|Myeloma|2011
<1|~|~|~|~|Incidence|3963092|Myeloma|2011
<1|~|~|~|~|Mortality|3963092|Non-Hodgkin Lymphoma|2011
<1|~|~|~|~|Incidence|3963092|Non-Hodgkin Lymphoma|2011
<1|~|~|~|~|Mortality|3963092|Oral Cavity and Pharynx|2011
<1|~|~|~|~|Incidence|3963092|Oral Cavity and Pharynx|2011
<1|~|~|~|~|Mortality|1934662|Ovary|2011
<1|~|~|~|~|Incidence|1934662|Ovary|2011
<1|~|~|~|~|Mortality|3963092|Pancreas|2011
<1|~|~|~|~|Incidence|3963092|Pancreas|2011
<1|~|~|~|~|Mortality|2028430|Prostate|2011
<1|~|~|~|~|Incidence|2028430|Prostate|2011
<1|~|~|~|~|Mortality|3963092|Stomach|2011
<1|~|~|~|~|Incidence|3963092|Stomach|2011
<1|~|~|~|~|Mortality|2028430|Testis|2011
<1|~|~|~|~|Incidence|2028430|Testis|2011
<1|~|~|~|~|Mortality|3963092|Thyroid|2011
<1|~|~|~|~|Incidence|3963092|Thyroid|2011
<1|~|~|~|~|Mortality|3963092|Urinary Bladder|2011
<1|~|~|~|~|Incidence|3963092|Urinary Bladder|2011
1-4|2.2|2.7|2.4|392|Mortality|16049495|All Cancer Sites Combined|2012
1-4|22.9|24.4|23.7|3798|Incidence|16049495|All Cancer Sites Combined|2012
1-4|0.6|0.8|0.7|108|Mortality|16049495|Brain and Other Nervous System|2012
1-4|4.5|5.2|4.9|781|Incidence|16049495|Brain and Other Nervous System|2012
1-4|~|~|~|~|Mortality|7852897|Cervix|2012
1-4|~|~|~|~|Incidence|7852897|Cervix|2012
1-4|~|~|~|~|Mortality|16049495|Colon and Rectum|2012
1-4|~|~|~|~|Incidence|16049495|Colon and Rectum|2012
1-4|~|~|~|~|Mortality|7852897|Corpus and Uterus, NOS|2012
1-4|~|~|~|~|Incidence|7852897|Corpus and Uterus, NOS|2012
1-4|~|~|~|~|Mortality|16049495|Esophagus|2012
1-4|~|~|~|~|Incidence|16049495|Esophagus|2012
1-4|~|~|~|~|Mortality|7852897|Female Breast|2012
1-4|~|~|~|~|Incidence|7852897|Female Breast|2012
1-4|~|~|~|~|Incidence|7852897|Female Breast, <i>in situ</i>|2012
1-4|~|~|~|~|Mortality|16049495|Hodgkin Lymphoma|2012
1-4|0.1|0.2|0.1|21|Incidence|16049495|Hodgkin Lymphoma|2012
1-4|.|.|.|.|Mortality|16049495|Kaposi Sarcoma|2012
1-4|~|~|~|~|Incidence|16049495|Kaposi Sarcoma|2012
1-4|~|~|~|~|Mortality|16049495|Kidney and Renal Pelvis|2012
1-4|1.8|2.3|2.0|327|Incidence|16049495|Kidney and Renal Pelvis|2012
1-4|~|~|~|~|Mortality|16049495|Larynx|2012
1-4|~|~|~|~|Incidence|16049495|Larynx|2012
1-4|0.7|1.0|0.8|136|Mortality|16049495|Leukemias|2012
1-4|8.6|9.6|9.1|1457|Incidence|16049495|Leukemias|2012
1-4|0.1|0.2|0.1|17|Mortality|16049495|Liver and Intrahepatic Bile Duct|2012
1-4|0.6|0.9|0.7|119|Incidence|16049495|Liver and Intrahepatic Bile Duct|2012
1-4|~|~|~|~|Mortality|16049495|Lung and Bronchus|2012
1-4|~|~|~|~|Incidence|16049495|Lung and Bronchus|2012
1-4|~|~|~|~|Mortality|7852897|Male and Female Breast|2012
1-4|~|~|~|~|Incidence|7852897|Male and Female Breast|2012
1-4|~|~|~|~|Incidence|7852897|Male and Female Breast, <i>in situ</i>|2012
1-4|~|~|~|~|Mortality|16049495|Melanomas of the Skin|2012
1-4|0.1|0.2|0.1|18|Incidence|16049495|Melanomas of the Skin|2012
1-4|~|~|~|~|Mortality|16049495|Mesothelioma|2012
1-4|~|~|~|~|Incidence|16049495|Mesothelioma|2012
1-4|~|~|~|~|Mortality|16049495|Myeloma|2012
1-4|~|~|~|~|Incidence|16049495|Myeloma|2012
1-4|~|~|~|~|Mortality|16049495|Non-Hodgkin Lymphoma|2012
1-4|0.5|0.8|0.7|105|Incidence|16049495|Non-Hodgkin Lymphoma|2012
1-4|~|~|~|~|Mortality|16049495|Oral Cavity and Pharynx|2012
1-4|~|~|~|~|Incidence|16049495|Oral Cavity and Pharynx|2012
1-4|~|~|~|~|Mortality|7852897|Ovary|2012
1-4|~|~|~|~|Incidence|7852897|Ovary|2012
1-4|~|~|~|~|Mortality|16049495|Pancreas|2012
1-4|~|~|~|~|Incidence|16049495|Pancreas|2012
1-4|~|~|~|~|Mortality|8196598|Prostate|2012
1-4|~|~|~|~|Incidence|8196598|Prostate|2012
1-4|~|~|~|~|Mortality|16049495|Stomach|2012
1-4|~|~|~|~|Incidence|16049495|Stomach|2012
1-4|~|~|~|~|Mortality|8196598|Testis|2012
1-4|0.2|0.4|0.3|21|Incidence|8196598|Testis|2012
1-4|~|~|~|~|Mortality|16049495|Thyroid|2012
1-4|~|~|~|~|Incidence|16049495|Thyroid|2012
1-4|~|~|~|~|Mortality|16049495|Urinary Bladder|2012
1-4|~|~|~|~|Incidence|16049495|Urinary Bladder|2012
10-14|2.1|2.5|2.3|472|Mortality|20669745|All Cancer Sites Combined|2012
10-14|13.9|14.9|14.4|2979|Incidence|20669745|All Cancer Sites Combined|2012
10-14|0.6|0.9|0.7|151|Mortality|20669745|Brain and Other Nervous System|2012
10-14|2.6|3.1|2.9|593|Incidence|20669745|Brain and Other Nervous System|2012
10-14|~|~|~|~|Mortality|10109546|Cervix|2012
10-14|~|~|~|~|Incidence|10109546|Cervix|2012
10-14|~|~|~|~|Mortality|20669745|Colon and Rectum|2012
10-14|0.1|0.2|0.1|29|Incidence|20669745|Colon and Rectum|2012
10-14|~|~|~|~|Mortality|10109546|Corpus and Uterus, NOS|2012
10-14|~|~|~|~|Incidence|10109546|Corpus and Uterus, NOS|2012
10-14|~|~|~|~|Mortality|20669745|Esophagus|2012
10-14|~|~|~|~|Incidence|20669745|Esophagus|2012
10-14|~|~|~|~|Mortality|10109546|Female Breast|2012
10-14|~|~|~|~|Incidence|10109546|Female Breast|2012
10-14|~|~|~|~|Incidence|10109546|Female Breast, <i>in situ</i>|2012
10-14|~|~|~|~|Mortality|20669745|Hodgkin Lymphoma|2012
10-14|1.1|1.4|1.3|263|Incidence|20669745|Hodgkin Lymphoma|2012
10-14|.|.|.|.|Mortality|20669745|Kaposi Sarcoma|2012
10-14|~|~|~|~|Incidence|20669745|Kaposi Sarcoma|2012
10-14|~|~|~|~|Mortality|20669745|Kidney and Renal Pelvis|2012
10-14|0.1|0.2|0.2|34|Incidence|20669745|Kidney and Renal Pelvis|2012
10-14|~|~|~|~|Mortality|20669745|Larynx|2012
10-14|~|~|~|~|Incidence|20669745|Larynx|2012
10-14|0.5|0.7|0.6|126|Mortality|20669745|Leukemias|2012
10-14|2.7|3.2|3.0|614|Incidence|20669745|Leukemias|2012
10-14|~|~|~|~|Mortality|20669745|Liver and Intrahepatic Bile Duct|2012
10-14|0.1|0.2|0.1|26|Incidence|20669745|Liver and Intrahepatic Bile Duct|2012
10-14|~|~|~|~|Mortality|20669745|Lung and Bronchus|2012
10-14|~|~|~|~|Incidence|20669745|Lung and Bronchus|2012
10-14|~|~|~|~|Mortality|10109546|Male and Female Breast|2012
10-14|~|~|~|~|Incidence|10109546|Male and Female Breast|2012
10-14|~|~|~|~|Incidence|10109546|Male and Female Breast, <i>in situ</i>|2012
10-14|~|~|~|~|Mortality|20669745|Melanomas of the Skin|2012
10-14|0.2|0.3|0.2|44|Incidence|20669745|Melanomas of the Skin|2012
10-14|~|~|~|~|Mortality|20669745|Mesothelioma|2012
10-14|~|~|~|~|Incidence|20669745|Mesothelioma|2012
10-14|~|~|~|~|Mortality|20669745|Myeloma|2012
10-14|~|~|~|~|Incidence|20669745|Myeloma|2012
10-14|0.1|0.1|0.1|18|Mortality|20669745|Non-Hodgkin Lymphoma|2012
10-14|1.2|1.5|1.4|285|Incidence|20669745|Non-Hodgkin Lymphoma|2012
10-14|~|~|~|~|Mortality|20669745|Oral Cavity and Pharynx|2012
10-14|0.2|0.3|0.3|55|Incidence|20669745|Oral Cavity and Pharynx|2012
10-14|~|~|~|~|Mortality|10109546|Ovary|2012
10-14|0.6|1.0|0.8|77|Incidence|10109546|Ovary|2012
10-14|~|~|~|~|Mortality|20669745|Pancreas|2012
10-14|~|~|~|~|Incidence|20669745|Pancreas|2012
10-14|~|~|~|~|Mortality|10560199|Prostate|2012
10-14|~|~|~|~|Incidence|10560199|Prostate|2012
10-14|~|~|~|~|Mortality|20669745|Stomach|2012
10-14|~|~|~|~|Incidence|20669745|Stomach|2012
10-14|~|~|~|~|Mortality|10560199|Testis|2012
10-14|~|~|~|~|Incidence|10560199|Testis|2012
10-14|~|~|~|~|Mortality|20669745|Thyroid|2012
10-14|0.7|0.9|0.8|165|Incidence|20669745|Thyroid|2012
10-14|~|~|~|~|Mortality|20669745|Urinary Bladder|2012
10-14|~|~|~|~|Incidence|20669745|Urinary Bladder|2012
15-19|2.7|3.2|2.9|628|Mortality|21369214|All Cancer Sites Combined|2012
15-19|22.6|23.9|23.3|4971|Incidence|21369214|All Cancer Sites Combined|2012
15-19|0.5|0.7|0.5|117|Mortality|21369214|Brain and Other Nervous System|2012
15-19|2.2|2.6|2.4|503|Incidence|21369214|Brain and Other Nervous System|2012
15-19|~|~|~|~|Mortality|10408505|Cervix|2012
15-19|~|~|~|~|Incidence|10408505|Cervix|2012
15-19|~|~|~|~|Mortality|21369214|Colon and Rectum|2012
15-19|0.4|0.6|0.5|110|Incidence|21369214|Colon and Rectum|2012
15-19|~|~|~|~|Mortality|10408505|Corpus and Uterus, NOS|2012
15-19|~|~|~|~|Incidence|10408505|Corpus and Uterus, NOS|2012
15-19|~|~|~|~|Mortality|21369214|Esophagus|2012
15-19|~|~|~|~|Incidence|21369214|Esophagus|2012
15-19|~|~|~|~|Mortality|10408505|Female Breast|2012
15-19|0.1|0.3|0.2|17|Incidence|10408505|Female Breast|2012
15-19|~|~|~|~|Incidence|10408505|Female Breast, <i>in situ</i>|2012
15-19|~|~|~|~|Mortality|21369214|Hodgkin Lymphoma|2012
15-19|3.0|3.5|3.3|700|Incidence|21369214|Hodgkin Lymphoma|2012
15-19|.|.|.|.|Mortality|21369214|Kaposi Sarcoma|2012
15-19|~|~|~|~|Incidence|21369214|Kaposi Sarcoma|2012
15-19|~|~|~|~|Mortality|21369214|Kidney and Renal Pelvis|2012
15-19|0.2|0.3|0.3|55|Incidence|21369214|Kidney and Renal Pelvis|2012
15-19|~|~|~|~|Mortality|21369214|Larynx|2012
15-19|~|~|~|~|Incidence|21369214|Larynx|2012
15-19|0.6|0.9|0.7|156|Mortality|21369214|Leukemias|2012
15-19|2.8|3.2|3.0|639|Incidence|21369214|Leukemias|2012
15-19|~|~|~|~|Mortality|21369214|Liver and Intrahepatic Bile Duct|2012
15-19|0.1|0.2|0.1|28|Incidence|21369214|Liver and Intrahepatic Bile Duct|2012
15-19|~|~|~|~|Mortality|21369214|Lung and Bronchus|2012
15-19|0.1|0.2|0.1|30|Incidence|21369214|Lung and Bronchus|2012
15-19|~|~|~|~|Mortality|10408505|Male and Female Breast|2012
15-19|0.1|0.3|0.2|17|Incidence|10408505|Male and Female Breast|2012
15-19|~|~|~|~|Incidence|10408505|Male and Female Breast, <i>in situ</i>|2012
15-19|~|~|~|~|Mortality|21369214|Melanomas of the Skin|2012
15-19|0.9|1.2|1.1|226|Incidence|21369214|Melanomas of the Skin|2012
15-19|~|~|~|~|Mortality|21369214|Mesothelioma|2012
15-19|~|~|~|~|Incidence|21369214|Mesothelioma|2012
15-19|~|~|~|~|Mortality|21369214|Myeloma|2012
15-19|~|~|~|~|Incidence|21369214|Myeloma|2012
15-19|0.1|0.2|0.1|24|Mortality|21369214|Non-Hodgkin Lymphoma|2012
15-19|1.8|2.2|2.0|421|Incidence|21369214|Non-Hodgkin Lymphoma|2012
15-19|~|~|~|~|Mortality|21369214|Oral Cavity and Pharynx|2012
15-19|0.4|0.6|0.5|106|Incidence|21369214|Oral Cavity and Pharynx|2012
15-19|~|~|~|~|Mortality|10408505|Ovary|2012
15-19|1.3|1.8|1.5|160|Incidence|10408505|Ovary|2012
15-19|~|~|~|~|Mortality|21369214|Pancreas|2012
15-19|0.0|0.1|0.1|18|Incidence|21369214|Pancreas|2012
15-19|~|~|~|~|Mortality|10960709|Prostate|2012
15-19|~|~|~|~|Incidence|10960709|Prostate|2012
15-19|~|~|~|~|Mortality|21369214|Stomach|2012
15-19|~|~|~|~|Incidence|21369214|Stomach|2012
15-19|~|~|~|~|Mortality|10960709|Testis|2012
15-19|3.4|4.2|3.8|415|Incidence|10960709|Testis|2012
15-19|~|~|~|~|Mortality|21369214|Thyroid|2012
15-19|2.7|3.1|2.9|622|Incidence|21369214|Thyroid|2012
15-19|~|~|~|~|Mortality|21369214|Urinary Bladder|2012
15-19|0.1|0.2|0.1|24|Incidence|21369214|Urinary Bladder|2012
5-9|2.0|2.4|2.1|440|Mortality|20467140|All Cancer Sites Combined|2012
5-9|12.1|13.1|12.6|2582|Incidence|20467140|All Cancer Sites Combined|2012
5-9|0.8|1.0|0.9|185|Mortality|20467140|Brain and Other Nervous System|2012
5-9|3.2|3.7|3.4|701|Incidence|20467140|Brain and Other Nervous System|2012
5-9|~|~|~|~|Mortality|10015432|Cervix|2012
5-9|~|~|~|~|Incidence|10015432|Cervix|2012
5-9|~|~|~|~|Mortality|20467140|Colon and Rectum|2012
5-9|~|~|~|~|Incidence|20467140|Colon and Rectum|2012
5-9|~|~|~|~|Mortality|10015432|Corpus and Uterus, NOS|2012
5-9|~|~|~|~|Incidence|10015432|Corpus and Uterus, NOS|2012
5-9|~|~|~|~|Mortality|20467140|Esophagus|2012
5-9|~|~|~|~|Incidence|20467140|Esophagus|2012
5-9|~|~|~|~|Mortality|10015432|Female Breast|2012
5-9|~|~|~|~|Incidence|10015432|Female Breast|2012
5-9|~|~|~|~|Incidence|10015432|Female Breast, <i>in situ</i>|2012
5-9|~|~|~|~|Mortality|20467140|Hodgkin Lymphoma|2012
5-9|0.3|0.4|0.3|67|Incidence|20467140|Hodgkin Lymphoma|2012
5-9|.|.|.|.|Mortality|20467140|Kaposi Sarcoma|2012
5-9|~|~|~|~|Incidence|20467140|Kaposi Sarcoma|2012
5-9|~|~|~|~|Mortality|20467140|Kidney and Renal Pelvis|2012
5-9|0.5|0.7|0.6|114|Incidence|20467140|Kidney and Renal Pelvis|2012
5-9|~|~|~|~|Mortality|20467140|Larynx|2012
5-9|~|~|~|~|Incidence|20467140|Larynx|2012
5-9|0.4|0.6|0.5|97|Mortality|20467140|Leukemias|2012
5-9|3.7|4.3|4.0|822|Incidence|20467140|Leukemias|2012
5-9|~|~|~|~|Mortality|20467140|Liver and Intrahepatic Bile Duct|2012
5-9|0.1|0.2|0.1|21|Incidence|20467140|Liver and Intrahepatic Bile Duct|2012
5-9|~|~|~|~|Mortality|20467140|Lung and Bronchus|2012
5-9|~|~|~|~|Incidence|20467140|Lung and Bronchus|2012
5-9|~|~|~|~|Mortality|10015432|Male and Female Breast|2012
5-9|~|~|~|~|Incidence|10015432|Male and Female Breast|2012
5-9|~|~|~|~|Incidence|10015432|Male and Female Breast, <i>in situ</i>|2012
5-9|~|~|~|~|Mortality|20467140|Melanomas of the Skin|2012
5-9|0.1|0.3|0.2|38|Incidence|20467140|Melanomas of the Skin|2012
5-9|~|~|~|~|Mortality|20467140|Mesothelioma|2012
5-9|~|~|~|~|Incidence|20467140|Mesothelioma|2012
5-9|~|~|~|~|Mortality|20467140|Myeloma|2012
5-9|~|~|~|~|Incidence|20467140|Myeloma|2012
5-9|~|~|~|~|Mortality|20467140|Non-Hodgkin Lymphoma|2012
5-9|0.9|1.2|1.1|216|Incidence|20467140|Non-Hodgkin Lymphoma|2012
5-9|~|~|~|~|Mortality|20467140|Oral Cavity and Pharynx|2012
5-9|~|~|~|~|Incidence|20467140|Oral Cavity and Pharynx|2012
5-9|~|~|~|~|Mortality|10015432|Ovary|2012
5-9|0.2|0.4|0.2|25|Incidence|10015432|Ovary|2012
5-9|~|~|~|~|Mortality|20467140|Pancreas|2012
5-9|~|~|~|~|Incidence|20467140|Pancreas|2012
5-9|~|~|~|~|Mortality|10451708|Prostate|2012
5-9|~|~|~|~|Incidence|10451708|Prostate|2012
5-9|~|~|~|~|Mortality|20467140|Stomach|2012
5-9|~|~|~|~|Incidence|20467140|Stomach|2012
5-9|~|~|~|~|Mortality|10451708|Testis|2012
5-9|~|~|~|~|Incidence|10451708|Testis|2012
5-9|~|~|~|~|Mortality|20467140|Thyroid|2012
5-9|0.1|0.2|0.1|27|Incidence|20467140|Thyroid|2012
5-9|~|~|~|~|Mortality|20467140|Urinary Bladder|2012
5-9|~|~|~|~|Incidence|20467140|Urinary Bladder|2012
<1|1.2|2.1|1.6|63|Mortality|3926570|All Cancer Sites Combined|2012
<1|25.4|28.7|27.0|1062|Incidence|3926570|All Cancer Sites Combined|2012
<1|~|~|~|~|Mortality|3926570|Brain and Other Nervous System|2012
<1|3.3|4.5|3.8|151|Incidence|3926570|Brain and Other Nervous System|2012
<1|~|~|~|~|Mortality|1918828|Cervix|2012
<1|~|~|~|~|Incidence|1918828|Cervix|2012
<1|~|~|~|~|Mortality|3926570|Colon and Rectum|2012
<1|~|~|~|~|Incidence|3926570|Colon and Rectum|2012
<1|~|~|~|~|Mortality|1918828|Corpus and Uterus, NOS|2012
<1|~|~|~|~|Incidence|1918828|Corpus and Uterus, NOS|2012
<1|~|~|~|~|Mortality|3926570|Esophagus|2012
<1|~|~|~|~|Incidence|3926570|Esophagus|2012
<1|~|~|~|~|Mortality|1918828|Female Breast|2012
<1|~|~|~|~|Incidence|1918828|Female Breast|2012
<1|~|~|~|~|Incidence|1918828|Female Breast, <i>in situ</i>|2012
<1|~|~|~|~|Mortality|3926570|Hodgkin Lymphoma|2012
<1|~|~|~|~|Incidence|3926570|Hodgkin Lymphoma|2012
<1|.|.|.|.|Mortality|3926570|Kaposi Sarcoma|2012
<1|~|~|~|~|Incidence|3926570|Kaposi Sarcoma|2012
<1|~|~|~|~|Mortality|3926570|Kidney and Renal Pelvis|2012
<1|1.4|2.3|1.8|70|Incidence|3926570|Kidney and Renal Pelvis|2012
<1|~|~|~|~|Mortality|3926570|Larynx|2012
<1|~|~|~|~|Incidence|3926570|Larynx|2012
<1|0.3|0.8|0.5|19|Mortality|3926570|Leukemias|2012
<1|3.5|4.8|4.1|162|Incidence|3926570|Leukemias|2012
<1|~|~|~|~|Mortality|3926570|Liver and Intrahepatic Bile Duct|2012
<1|1.1|1.9|1.5|59|Incidence|3926570|Liver and Intrahepatic Bile Duct|2012
<1|~|~|~|~|Mortality|3926570|Lung and Bronchus|2012
<1|~|~|~|~|Incidence|3926570|Lung and Bronchus|2012
<1|~|~|~|~|Mortality|1918828|Male and Female Breast|2012
<1|~|~|~|~|Incidence|1918828|Male and Female Breast|2012
<1|~|~|~|~|Incidence|1918828|Male and Female Breast, <i>in situ</i>|2012
<1|~|~|~|~|Mortality|3926570|Melanomas of the Skin|2012
<1|~|~|~|~|Incidence|3926570|Melanomas of the Skin|2012
<1|~|~|~|~|Mortality|3926570|Mesothelioma|2012
<1|~|~|~|~|Incidence|3926570|Mesothelioma|2012
<1|~|~|~|~|Mortality|3926570|Myeloma|2012
<1|~|~|~|~|Incidence|3926570|Myeloma|2012
<1|~|~|~|~|Mortality|3926570|Non-Hodgkin Lymphoma|2012
<1|0.2|0.7|0.4|16|Incidence|3926570|Non-Hodgkin Lymphoma|2012
<1|~|~|~|~|Mortality|3926570|Oral Cavity and Pharynx|2012
<1|~|~|~|~|Incidence|3926570|Oral Cavity and Pharynx|2012
<1|~|~|~|~|Mortality|1918828|Ovary|2012
<1|~|~|~|~|Incidence|1918828|Ovary|2012
<1|~|~|~|~|Mortality|3926570|Pancreas|2012
<1|~|~|~|~|Incidence|3926570|Pancreas|2012
<1|~|~|~|~|Mortality|2007742|Prostate|2012
<1|~|~|~|~|Incidence|2007742|Prostate|2012
<1|~|~|~|~|Mortality|3926570|Stomach|2012
<1|~|~|~|~|Incidence|3926570|Stomach|2012
<1|~|~|~|~|Mortality|2007742|Testis|2012
<1|~|~|~|~|Incidence|2007742|Testis|2012
<1|~|~|~|~|Mortality|3926570|Thyroid|2012
<1|~|~|~|~|Incidence|3926570|Thyroid|2012
<1|~|~|~|~|Mortality|3926570|Urinary Bladder|2012
<1|~|~|~|~|Incidence|3926570|Urinary Bladder|2012
1-4|1.8|2.3|2.1|328|Mortality|15917957|All Cancer Sites Combined|2013
1-4|22.3|23.8|23.0|3665|Incidence|15917957|All Cancer Sites Combined|2013
1-4|0.5|0.7|0.6|92|Mortality|15917957|Brain and Other Nervous System|2013
1-4|4.4|5.1|4.7|753|Incidence|15917957|Brain and Other Nervous System|2013
1-4|~|~|~|~|Mortality|7786102|Cervix|2013
1-4|~|~|~|~|Incidence|7786102|Cervix|2013
1-4|~|~|~|~|Mortality|15917957|Colon and Rectum|2013
1-4|~|~|~|~|Incidence|15917957|Colon and Rectum|2013
1-4|~|~|~|~|Mortality|7786102|Corpus and Uterus, NOS|2013
1-4|~|~|~|~|Incidence|7786102|Corpus and Uterus, NOS|2013
1-4|~|~|~|~|Mortality|15917957|Esophagus|2013
1-4|~|~|~|~|Incidence|15917957|Esophagus|2013
1-4|~|~|~|~|Mortality|7786102|Female Breast|2013
1-4|~|~|~|~|Incidence|7786102|Female Breast|2013
1-4|~|~|~|~|Incidence|7786102|Female Breast, <i>in situ</i>|2013
1-4|~|~|~|~|Mortality|15917957|Hodgkin Lymphoma|2013
1-4|0.1|0.2|0.1|16|Incidence|15917957|Hodgkin Lymphoma|2013
1-4|.|.|.|.|Mortality|15917957|Kaposi Sarcoma|2013
1-4|~|~|~|~|Incidence|15917957|Kaposi Sarcoma|2013
1-4|0.1|0.2|0.1|17|Mortality|15917957|Kidney and Renal Pelvis|2013
1-4|1.9|2.3|2.1|334|Incidence|15917957|Kidney and Renal Pelvis|2013
1-4|~|~|~|~|Mortality|15917957|Larynx|2013
1-4|~|~|~|~|Incidence|15917957|Larynx|2013
1-4|0.5|0.7|0.6|96|Mortality|15917957|Leukemias|2013
1-4|8.0|8.9|8.4|1345|Incidence|15917957|Leukemias|2013
1-4|0.1|0.2|0.1|19|Mortality|15917957|Liver and Intrahepatic Bile Duct|2013
1-4|0.5|0.7|0.6|92|Incidence|15917957|Liver and Intrahepatic Bile Duct|2013
1-4|~|~|~|~|Mortality|15917957|Lung and Bronchus|2013
1-4|~|~|~|~|Incidence|15917957|Lung and Bronchus|2013
1-4|~|~|~|~|Mortality|7786102|Male and Female Breast|2013
1-4|~|~|~|~|Incidence|7786102|Male and Female Breast|2013
1-4|~|~|~|~|Incidence|7786102|Male and Female Breast, <i>in situ</i>|2013
1-4|~|~|~|~|Mortality|15917957|Melanomas of the Skin|2013
1-4|~|~|~|~|Incidence|15917957|Melanomas of the Skin|2013
1-4|~|~|~|~|Mortality|15917957|Mesothelioma|2013
1-4|~|~|~|~|Incidence|15917957|Mesothelioma|2013
1-4|~|~|~|~|Mortality|15917957|Myeloma|2013
1-4|~|~|~|~|Incidence|15917957|Myeloma|2013
1-4|~|~|~|~|Mortality|15917957|Non-Hodgkin Lymphoma|2013
1-4|0.7|1.0|0.8|131|Incidence|15917957|Non-Hodgkin Lymphoma|2013
1-4|~|~|~|~|Mortality|15917957|Oral Cavity and Pharynx|2013
1-4|~|~|~|~|Incidence|15917957|Oral Cavity and Pharynx|2013
1-4|~|~|~|~|Mortality|7786102|Ovary|2013
1-4|~|~|~|~|Incidence|7786102|Ovary|2013
1-4|~|~|~|~|Mortality|15917957|Pancreas|2013
1-4|~|~|~|~|Incidence|15917957|Pancreas|2013
1-4|~|~|~|~|Mortality|8131855|Prostate|2013
1-4|~|~|~|~|Incidence|8131855|Prostate|2013
1-4|~|~|~|~|Mortality|15917957|Stomach|2013
1-4|~|~|~|~|Incidence|15917957|Stomach|2013
1-4|~|~|~|~|Mortality|8131855|Testis|2013
1-4|0.2|0.4|0.3|24|Incidence|8131855|Testis|2013
1-4|~|~|~|~|Mortality|15917957|Thyroid|2013
1-4|~|~|~|~|Incidence|15917957|Thyroid|2013
1-4|~|~|~|~|Mortality|15917957|Urinary Bladder|2013
1-4|~|~|~|~|Incidence|15917957|Urinary Bladder|2013
10-14|2.0|2.4|2.2|448|Mortality|20650890|All Cancer Sites Combined|2013
10-14|14.2|15.3|14.7|3046|Incidence|20650890|All Cancer Sites Combined|2013
10-14|0.5|0.7|0.6|129|Mortality|20650890|Brain and Other Nervous System|2013
10-14|3.0|3.5|3.2|663|Incidence|20650890|Brain and Other Nervous System|2013
10-14|~|~|~|~|Mortality|10106714|Cervix|2013
10-14|~|~|~|~|Incidence|10106714|Cervix|2013
10-14|~|~|~|~|Mortality|20650890|Colon and Rectum|2013
10-14|0.1|0.2|0.2|37|Incidence|20650890|Colon and Rectum|2013
10-14|~|~|~|~|Mortality|10106714|Corpus and Uterus, NOS|2013
10-14|~|~|~|~|Incidence|10106714|Corpus and Uterus, NOS|2013
10-14|~|~|~|~|Mortality|20650890|Esophagus|2013
10-14|~|~|~|~|Incidence|20650890|Esophagus|2013
10-14|~|~|~|~|Mortality|10106714|Female Breast|2013
10-14|~|~|~|~|Incidence|10106714|Female Breast|2013
10-14|~|~|~|~|Incidence|10106714|Female Breast, <i>in situ</i>|2013
10-14|~|~|~|~|Mortality|20650890|Hodgkin Lymphoma|2013
10-14|0.9|1.2|1.1|223|Incidence|20650890|Hodgkin Lymphoma|2013
10-14|.|.|.|.|Mortality|20650890|Kaposi Sarcoma|2013
10-14|~|~|~|~|Incidence|20650890|Kaposi Sarcoma|2013
10-14|~|~|~|~|Mortality|20650890|Kidney and Renal Pelvis|2013
10-14|0.1|0.2|0.2|34|Incidence|20650890|Kidney and Renal Pelvis|2013
10-14|~|~|~|~|Mortality|20650890|Larynx|2013
10-14|~|~|~|~|Incidence|20650890|Larynx|2013
10-14|0.6|0.8|0.7|139|Mortality|20650890|Leukemias|2013
10-14|2.8|3.3|3.0|627|Incidence|20650890|Leukemias|2013
10-14|~|~|~|~|Mortality|20650890|Liver and Intrahepatic Bile Duct|2013
10-14|0.1|0.2|0.1|21|Incidence|20650890|Liver and Intrahepatic Bile Duct|2013
10-14|~|~|~|~|Mortality|20650890|Lung and Bronchus|2013
10-14|~|~|~|~|Incidence|20650890|Lung and Bronchus|2013
10-14|~|~|~|~|Mortality|10106714|Male and Female Breast|2013
10-14|~|~|~|~|Incidence|10106714|Male and Female Breast|2013
10-14|~|~|~|~|Incidence|10106714|Male and Female Breast, <i>in situ</i>|2013
10-14|~|~|~|~|Mortality|20650890|Melanomas of the Skin|2013
10-14|0.2|0.4|0.3|57|Incidence|20650890|Melanomas of the Skin|2013
10-14|~|~|~|~|Mortality|20650890|Mesothelioma|2013
10-14|~|~|~|~|Incidence|20650890|Mesothelioma|2013
10-14|~|~|~|~|Mortality|20650890|Myeloma|2013
10-14|~|~|~|~|Incidence|20650890|Myeloma|2013
10-14|0.0|0.1|0.1|17|Mortality|20650890|Non-Hodgkin Lymphoma|2013
10-14|1.1|1.5|1.3|268|Incidence|20650890|Non-Hodgkin Lymphoma|2013
10-14|~|~|~|~|Mortality|20650890|Oral Cavity and Pharynx|2013
10-14|0.3|0.4|0.3|72|Incidence|20650890|Oral Cavity and Pharynx|2013
10-14|~|~|~|~|Mortality|10106714|Ovary|2013
10-14|0.7|1.1|0.9|87|Incidence|10106714|Ovary|2013
10-14|~|~|~|~|Mortality|20650890|Pancreas|2013
10-14|~|~|~|~|Incidence|20650890|Pancreas|2013
10-14|~|~|~|~|Mortality|10544176|Prostate|2013
10-14|~|~|~|~|Incidence|10544176|Prostate|2013
10-14|~|~|~|~|Mortality|20650890|Stomach|2013
10-14|~|~|~|~|Incidence|20650890|Stomach|2013
10-14|~|~|~|~|Mortality|10544176|Testis|2013
10-14|0.1|0.3|0.2|19|Incidence|10544176|Testis|2013
10-14|~|~|~|~|Mortality|20650890|Thyroid|2013
10-14|0.8|1.0|0.9|181|Incidence|20650890|Thyroid|2013
10-14|~|~|~|~|Mortality|20650890|Urinary Bladder|2013
10-14|~|~|~|~|Incidence|20650890|Urinary Bladder|2013
15-19|2.7|3.2|3.0|627|Mortality|21177456|All Cancer Sites Combined|2013
15-19|21.6|22.9|22.2|4711|Incidence|21177456|All Cancer Sites Combined|2013
15-19|0.5|0.7|0.6|119|Mortality|21177456|Brain and Other Nervous System|2013
15-19|2.1|2.6|2.3|497|Incidence|21177456|Brain and Other Nervous System|2013
15-19|~|~|~|~|Mortality|10329460|Cervix|2013
15-19|~|~|~|~|Incidence|10329460|Cervix|2013
15-19|~|~|~|~|Mortality|21177456|Colon and Rectum|2013
15-19|0.5|0.7|0.6|120|Incidence|21177456|Colon and Rectum|2013
15-19|~|~|~|~|Mortality|10329460|Corpus and Uterus, NOS|2013
15-19|~|~|~|~|Incidence|10329460|Corpus and Uterus, NOS|2013
15-19|~|~|~|~|Mortality|21177456|Esophagus|2013
15-19|~|~|~|~|Incidence|21177456|Esophagus|2013
15-19|~|~|~|~|Mortality|10329460|Female Breast|2013
15-19|~|~|~|~|Incidence|10329460|Female Breast|2013
15-19|~|~|~|~|Incidence|10329460|Female Breast, <i>in situ</i>|2013
15-19|~|~|~|~|Mortality|21177456|Hodgkin Lymphoma|2013
15-19|2.7|3.2|3.0|627|Incidence|21177456|Hodgkin Lymphoma|2013
15-19|.|.|.|.|Mortality|21177456|Kaposi Sarcoma|2013
15-19|~|~|~|~|Incidence|21177456|Kaposi Sarcoma|2013
15-19|~|~|~|~|Mortality|21177456|Kidney and Renal Pelvis|2013
15-19|0.2|0.3|0.3|57|Incidence|21177456|Kidney and Renal Pelvis|2013
15-19|~|~|~|~|Mortality|21177456|Larynx|2013
15-19|~|~|~|~|Incidence|21177456|Larynx|2013
15-19|0.6|0.9|0.8|159|Mortality|21177456|Leukemias|2013
15-19|2.8|3.3|3.0|642|Incidence|21177456|Leukemias|2013
15-19|~|~|~|~|Mortality|21177456|Liver and Intrahepatic Bile Duct|2013
15-19|0.1|0.2|0.1|28|Incidence|21177456|Liver and Intrahepatic Bile Duct|2013
15-19|~|~|~|~|Mortality|21177456|Lung and Bronchus|2013
15-19|0.1|0.2|0.2|38|Incidence|21177456|Lung and Bronchus|2013
15-19|~|~|~|~|Mortality|10329460|Male and Female Breast|2013
15-19|~|~|~|~|Incidence|10329460|Male and Female Breast|2013
15-19|~|~|~|~|Incidence|10329460|Male and Female Breast, <i>in situ</i>|2013
15-19|~|~|~|~|Mortality|21177456|Melanomas of the Skin|2013
15-19|0.9|1.2|1.0|215|Incidence|21177456|Melanomas of the Skin|2013
15-19|~|~|~|~|Mortality|21177456|Mesothelioma|2013
15-19|~|~|~|~|Incidence|21177456|Mesothelioma|2013
15-19|~|~|~|~|Mortality|21177456|Myeloma|2013
15-19|~|~|~|~|Incidence|21177456|Myeloma|2013
15-19|0.1|0.2|0.1|31|Mortality|21177456|Non-Hodgkin Lymphoma|2013
15-19|1.6|1.9|1.7|366|Incidence|21177456|Non-Hodgkin Lymphoma|2013
15-19|~|~|~|~|Mortality|21177456|Oral Cavity and Pharynx|2013
15-19|0.3|0.5|0.4|87|Incidence|21177456|Oral Cavity and Pharynx|2013
15-19|~|~|~|~|Mortality|10329460|Ovary|2013
15-19|1.2|1.7|1.4|149|Incidence|10329460|Ovary|2013
15-19|~|~|~|~|Mortality|21177456|Pancreas|2013
15-19|~|~|~|~|Incidence|21177456|Pancreas|2013
15-19|~|~|~|~|Mortality|10847996|Prostate|2013
15-19|~|~|~|~|Incidence|10847996|Prostate|2013
15-19|~|~|~|~|Mortality|21177456|Stomach|2013
15-19|~|~|~|~|Incidence|21177456|Stomach|2013
15-19|~|~|~|~|Mortality|10847996|Testis|2013
15-19|3.4|4.2|3.8|409|Incidence|10847996|Testis|2013
15-19|~|~|~|~|Mortality|21177456|Thyroid|2013
15-19|2.5|2.9|2.7|568|Incidence|21177456|Thyroid|2013
15-19|~|~|~|~|Mortality|21177456|Urinary Bladder|2013
15-19|0.1|0.1|0.1|18|Incidence|21177456|Urinary Bladder|2013
5-9|2.0|2.4|2.2|447|Mortality|20567323|All Cancer Sites Combined|2013
5-9|12.7|13.7|13.2|2714|Incidence|20567323|All Cancer Sites Combined|2013
5-9|0.8|1.1|0.9|193|Mortality|20567323|Brain and Other Nervous System|2013
5-9|3.4|3.9|3.6|745|Incidence|20567323|Brain and Other Nervous System|2013
5-9|~|~|~|~|Mortality|10064945|Cervix|2013
5-9|~|~|~|~|Incidence|10064945|Cervix|2013
5-9|~|~|~|~|Mortality|20567323|Colon and Rectum|2013
5-9|~|~|~|~|Incidence|20567323|Colon and Rectum|2013
5-9|~|~|~|~|Mortality|10064945|Corpus and Uterus, NOS|2013
5-9|~|~|~|~|Incidence|10064945|Corpus and Uterus, NOS|2013
5-9|~|~|~|~|Mortality|20567323|Esophagus|2013
5-9|~|~|~|~|Incidence|20567323|Esophagus|2013
5-9|~|~|~|~|Mortality|10064945|Female Breast|2013
5-9|~|~|~|~|Incidence|10064945|Female Breast|2013
5-9|~|~|~|~|Incidence|10064945|Female Breast, <i>in situ</i>|2013
5-9|~|~|~|~|Mortality|20567323|Hodgkin Lymphoma|2013
5-9|0.4|0.6|0.5|97|Incidence|20567323|Hodgkin Lymphoma|2013
5-9|.|.|.|.|Mortality|20567323|Kaposi Sarcoma|2013
5-9|~|~|~|~|Incidence|20567323|Kaposi Sarcoma|2013
5-9|0.0|0.1|0.1|17|Mortality|20567323|Kidney and Renal Pelvis|2013
5-9|0.5|0.7|0.6|129|Incidence|20567323|Kidney and Renal Pelvis|2013
5-9|~|~|~|~|Mortality|20567323|Larynx|2013
5-9|~|~|~|~|Incidence|20567323|Larynx|2013
5-9|0.4|0.6|0.5|94|Mortality|20567323|Leukemias|2013
5-9|3.9|4.4|4.1|848|Incidence|20567323|Leukemias|2013
5-9|~|~|~|~|Mortality|20567323|Liver and Intrahepatic Bile Duct|2013
5-9|0.1|0.2|0.1|28|Incidence|20567323|Liver and Intrahepatic Bile Duct|2013
5-9|~|~|~|~|Mortality|20567323|Lung and Bronchus|2013
5-9|~|~|~|~|Incidence|20567323|Lung and Bronchus|2013
5-9|~|~|~|~|Mortality|10064945|Male and Female Breast|2013
5-9|~|~|~|~|Incidence|10064945|Male and Female Breast|2013
5-9|~|~|~|~|Incidence|10064945|Male and Female Breast, <i>in situ</i>|2013
5-9|~|~|~|~|Mortality|20567323|Melanomas of the Skin|2013
5-9|0.1|0.3|0.2|39|Incidence|20567323|Melanomas of the Skin|2013
5-9|~|~|~|~|Mortality|20567323|Mesothelioma|2013
5-9|~|~|~|~|Incidence|20567323|Mesothelioma|2013
5-9|~|~|~|~|Mortality|20567323|Myeloma|2013
5-9|~|~|~|~|Incidence|20567323|Myeloma|2013
5-9|~|~|~|~|Mortality|20567323|Non-Hodgkin Lymphoma|2013
5-9|0.8|1.1|0.9|192|Incidence|20567323|Non-Hodgkin Lymphoma|2013
5-9|~|~|~|~|Mortality|20567323|Oral Cavity and Pharynx|2013
5-9|0.1|0.2|0.1|21|Incidence|20567323|Oral Cavity and Pharynx|2013
5-9|~|~|~|~|Mortality|10064945|Ovary|2013
5-9|0.2|0.4|0.2|24|Incidence|10064945|Ovary|2013
5-9|~|~|~|~|Mortality|20567323|Pancreas|2013
5-9|~|~|~|~|Incidence|20567323|Pancreas|2013
5-9|~|~|~|~|Mortality|10502378|Prostate|2013
5-9|~|~|~|~|Incidence|10502378|Prostate|2013
5-9|~|~|~|~|Mortality|20567323|Stomach|2013
5-9|~|~|~|~|Incidence|20567323|Stomach|2013
5-9|~|~|~|~|Mortality|10502378|Testis|2013
5-9|~|~|~|~|Incidence|10502378|Testis|2013
5-9|~|~|~|~|Mortality|20567323|Thyroid|2013
5-9|0.1|0.2|0.2|34|Incidence|20567323|Thyroid|2013
5-9|~|~|~|~|Mortality|20567323|Urinary Bladder|2013
5-9|~|~|~|~|Incidence|20567323|Urinary Bladder|2013
<1|1.3|2.1|1.6|64|Mortality|3931258|All Cancer Sites Combined|2013
<1|27.2|30.6|28.8|1134|Incidence|3931258|All Cancer Sites Combined|2013
<1|0.4|0.9|0.6|23|Mortality|3931258|Brain and Other Nervous System|2013
<1|3.5|4.8|4.1|163|Incidence|3931258|Brain and Other Nervous System|2013
<1|~|~|~|~|Mortality|1921535|Cervix|2013
<1|~|~|~|~|Incidence|1921535|Cervix|2013
<1|~|~|~|~|Mortality|3931258|Colon and Rectum|2013
<1|~|~|~|~|Incidence|3931258|Colon and Rectum|2013
<1|~|~|~|~|Mortality|1921535|Corpus and Uterus, NOS|2013
<1|~|~|~|~|Incidence|1921535|Corpus and Uterus, NOS|2013
<1|~|~|~|~|Mortality|3931258|Esophagus|2013
<1|~|~|~|~|Incidence|3931258|Esophagus|2013
<1|~|~|~|~|Mortality|1921535|Female Breast|2013
<1|~|~|~|~|Incidence|1921535|Female Breast|2013
<1|~|~|~|~|Incidence|1921535|Female Breast, <i>in situ</i>|2013
<1|~|~|~|~|Mortality|3931258|Hodgkin Lymphoma|2013
<1|~|~|~|~|Incidence|3931258|Hodgkin Lymphoma|2013
<1|.|.|.|.|Mortality|3931258|Kaposi Sarcoma|2013
<1|~|~|~|~|Incidence|3931258|Kaposi Sarcoma|2013
<1|~|~|~|~|Mortality|3931258|Kidney and Renal Pelvis|2013
<1|1.3|2.1|1.6|64|Incidence|3931258|Kidney and Renal Pelvis|2013
<1|~|~|~|~|Mortality|3931258|Larynx|2013
<1|~|~|~|~|Incidence|3931258|Larynx|2013
<1|0.3|0.8|0.5|21|Mortality|3931258|Leukemias|2013
<1|3.7|5.0|4.3|170|Incidence|3931258|Leukemias|2013
<1|~|~|~|~|Mortality|3931258|Liver and Intrahepatic Bile Duct|2013
<1|1.0|1.7|1.3|51|Incidence|3931258|Liver and Intrahepatic Bile Duct|2013
<1|~|~|~|~|Mortality|3931258|Lung and Bronchus|2013
<1|~|~|~|~|Incidence|3931258|Lung and Bronchus|2013
<1|~|~|~|~|Mortality|1921535|Male and Female Breast|2013
<1|~|~|~|~|Incidence|1921535|Male and Female Breast|2013
<1|~|~|~|~|Incidence|1921535|Male and Female Breast, <i>in situ</i>|2013
<1|~|~|~|~|Mortality|3931258|Melanomas of the Skin|2013
<1|~|~|~|~|Incidence|3931258|Melanomas of the Skin|2013
<1|~|~|~|~|Mortality|3931258|Mesothelioma|2013
<1|~|~|~|~|Incidence|3931258|Mesothelioma|2013
<1|~|~|~|~|Mortality|3931258|Myeloma|2013
<1|~|~|~|~|Incidence|3931258|Myeloma|2013
<1|~|~|~|~|Mortality|3931258|Non-Hodgkin Lymphoma|2013
<1|~|~|~|~|Incidence|3931258|Non-Hodgkin Lymphoma|2013
<1|~|~|~|~|Mortality|3931258|Oral Cavity and Pharynx|2013
<1|~|~|~|~|Incidence|3931258|Oral Cavity and Pharynx|2013
<1|~|~|~|~|Mortality|1921535|Ovary|2013
<1|~|~|~|~|Incidence|1921535|Ovary|2013
<1|~|~|~|~|Mortality|3931258|Pancreas|2013
<1|~|~|~|~|Incidence|3931258|Pancreas|2013
<1|~|~|~|~|Mortality|2009723|Prostate|2013
<1|~|~|~|~|Incidence|2009723|Prostate|2013
<1|~|~|~|~|Mortality|3931258|Stomach|2013
<1|~|~|~|~|Incidence|3931258|Stomach|2013
<1|~|~|~|~|Mortality|2009723|Testis|2013
<1|0.6|1.6|1.0|21|Incidence|2009723|Testis|2013
<1|~|~|~|~|Mortality|3931258|Thyroid|2013
<1|~|~|~|~|Incidence|3931258|Thyroid|2013
<1|~|~|~|~|Mortality|3931258|Urinary Bladder|2013
<1|~|~|~|~|Incidence|3931258|Urinary Bladder|2013
1-4|1.8|2.2|2.0|321|Mortality|15917562|All Cancer Sites Combined|2014
1-4|22.2|23.7|22.9|3647|Incidence|15917562|All Cancer Sites Combined|2014
1-4|0.4|0.7|0.5|87|Mortality|15917562|Brain and Other Nervous System|2014
1-4|4.3|5.0|4.6|737|Incidence|15917562|Brain and Other Nervous System|2014
1-4|~|~|~|~|Mortality|7782525|Cervix|2014
1-4|~|~|~|~|Incidence|7782525|Cervix|2014
1-4|~|~|~|~|Mortality|15917562|Colon and Rectum|2014
1-4|~|~|~|~|Incidence|15917562|Colon and Rectum|2014
1-4|~|~|~|~|Mortality|7782525|Corpus and Uterus, NOS|2014
1-4|~|~|~|~|Incidence|7782525|Corpus and Uterus, NOS|2014
1-4|~|~|~|~|Mortality|15917562|Esophagus|2014
1-4|~|~|~|~|Incidence|15917562|Esophagus|2014
1-4|~|~|~|~|Mortality|7782525|Female Breast|2014
1-4|~|~|~|~|Incidence|7782525|Female Breast|2014
1-4|~|~|~|~|Incidence|7782525|Female Breast, <i>in situ</i>|2014
1-4|~|~|~|~|Mortality|15917562|Hodgkin Lymphoma|2014
1-4|~|~|~|~|Incidence|15917562|Hodgkin Lymphoma|2014
1-4|.|.|.|.|Mortality|15917562|Kaposi Sarcoma|2014
1-4|~|~|~|~|Incidence|15917562|Kaposi Sarcoma|2014
1-4|~|~|~|~|Mortality|15917562|Kidney and Renal Pelvis|2014
1-4|1.8|2.3|2.1|329|Incidence|15917562|Kidney and Renal Pelvis|2014
1-4|~|~|~|~|Mortality|15917562|Larynx|2014
1-4|~|~|~|~|Incidence|15917562|Larynx|2014
1-4|0.5|0.8|0.6|101|Mortality|15917562|Leukemias|2014
1-4|8.3|9.3|8.8|1401|Incidence|15917562|Leukemias|2014
1-4|~|~|~|~|Mortality|15917562|Liver and Intrahepatic Bile Duct|2014
1-4|0.5|0.8|0.6|101|Incidence|15917562|Liver and Intrahepatic Bile Duct|2014
1-4|~|~|~|~|Mortality|15917562|Lung and Bronchus|2014
1-4|~|~|~|~|Incidence|15917562|Lung and Bronchus|2014
1-4|~|~|~|~|Mortality|7782525|Male and Female Breast|2014
1-4|~|~|~|~|Incidence|7782525|Male and Female Breast|2014
1-4|~|~|~|~|Incidence|7782525|Male and Female Breast, <i>in situ</i>|2014
1-4|~|~|~|~|Mortality|15917562|Melanomas of the Skin|2014
1-4|0.1|0.2|0.2|27|Incidence|15917562|Melanomas of the Skin|2014
1-4|~|~|~|~|Mortality|15917562|Mesothelioma|2014
1-4|~|~|~|~|Incidence|15917562|Mesothelioma|2014
1-4|~|~|~|~|Mortality|15917562|Myeloma|2014
1-4|~|~|~|~|Incidence|15917562|Myeloma|2014
1-4|~|~|~|~|Mortality|15917562|Non-Hodgkin Lymphoma|2014
1-4|0.7|1.0|0.8|129|Incidence|15917562|Non-Hodgkin Lymphoma|2014
1-4|~|~|~|~|Mortality|15917562|Oral Cavity and Pharynx|2014
1-4|~|~|~|~|Incidence|15917562|Oral Cavity and Pharynx|2014
1-4|~|~|~|~|Mortality|7782525|Ovary|2014
1-4|~|~|~|~|Incidence|7782525|Ovary|2014
1-4|~|~|~|~|Mortality|15917562|Pancreas|2014
1-4|~|~|~|~|Incidence|15917562|Pancreas|2014
1-4|~|~|~|~|Mortality|8135037|Prostate|2014
1-4|~|~|~|~|Incidence|8135037|Prostate|2014
1-4|~|~|~|~|Mortality|15917562|Stomach|2014
1-4|~|~|~|~|Incidence|15917562|Stomach|2014
1-4|~|~|~|~|Mortality|8135037|Testis|2014
1-4|0.2|0.4|0.3|23|Incidence|8135037|Testis|2014
1-4|~|~|~|~|Mortality|15917562|Thyroid|2014
1-4|~|~|~|~|Incidence|15917562|Thyroid|2014
1-4|~|~|~|~|Mortality|15917562|Urinary Bladder|2014
1-4|~|~|~|~|Incidence|15917562|Urinary Bladder|2014
10-14|1.8|2.2|2.0|416|Mortality|20665650|All Cancer Sites Combined|2014
10-14|14.9|15.9|15.4|3180|Incidence|20665650|All Cancer Sites Combined|2014
10-14|0.5|0.8|0.6|133|Mortality|20665650|Brain and Other Nervous System|2014
10-14|2.9|3.4|3.1|648|Incidence|20665650|Brain and Other Nervous System|2014
10-14|~|~|~|~|Mortality|10118709|Cervix|2014
10-14|~|~|~|~|Incidence|10118709|Cervix|2014
10-14|~|~|~|~|Mortality|20665650|Colon and Rectum|2014
10-14|0.2|0.4|0.3|62|Incidence|20665650|Colon and Rectum|2014
10-14|~|~|~|~|Mortality|10118709|Corpus and Uterus, NOS|2014
10-14|~|~|~|~|Incidence|10118709|Corpus and Uterus, NOS|2014
10-14|~|~|~|~|Mortality|20665650|Esophagus|2014
10-14|~|~|~|~|Incidence|20665650|Esophagus|2014
10-14|~|~|~|~|Mortality|10118709|Female Breast|2014
10-14|~|~|~|~|Incidence|10118709|Female Breast|2014
10-14|~|~|~|~|Incidence|10118709|Female Breast, <i>in situ</i>|2014
10-14|~|~|~|~|Mortality|20665650|Hodgkin Lymphoma|2014
10-14|1.1|1.4|1.2|253|Incidence|20665650|Hodgkin Lymphoma|2014
10-14|.|.|.|.|Mortality|20665650|Kaposi Sarcoma|2014
10-14|~|~|~|~|Incidence|20665650|Kaposi Sarcoma|2014
10-14|~|~|~|~|Mortality|20665650|Kidney and Renal Pelvis|2014
10-14|0.1|0.2|0.2|34|Incidence|20665650|Kidney and Renal Pelvis|2014
10-14|~|~|~|~|Mortality|20665650|Larynx|2014
10-14|~|~|~|~|Incidence|20665650|Larynx|2014
10-14|0.4|0.6|0.5|97|Mortality|20665650|Leukemias|2014
10-14|2.8|3.3|3.1|635|Incidence|20665650|Leukemias|2014
10-14|~|~|~|~|Mortality|20665650|Liver and Intrahepatic Bile Duct|2014
10-14|0.1|0.2|0.1|23|Incidence|20665650|Liver and Intrahepatic Bile Duct|2014
10-14|~|~|~|~|Mortality|20665650|Lung and Bronchus|2014
10-14|~|~|~|~|Incidence|20665650|Lung and Bronchus|2014
10-14|~|~|~|~|Mortality|10118709|Male and Female Breast|2014
10-14|~|~|~|~|Incidence|10118709|Male and Female Breast|2014
10-14|~|~|~|~|Incidence|10118709|Male and Female Breast, <i>in situ</i>|2014
10-14|~|~|~|~|Mortality|20665650|Melanomas of the Skin|2014
10-14|0.2|0.3|0.3|53|Incidence|20665650|Melanomas of the Skin|2014
10-14|~|~|~|~|Mortality|20665650|Mesothelioma|2014
10-14|~|~|~|~|Incidence|20665650|Mesothelioma|2014
10-14|~|~|~|~|Mortality|20665650|Myeloma|2014
10-14|~|~|~|~|Incidence|20665650|Myeloma|2014
10-14|0.1|0.1|0.1|19|Mortality|20665650|Non-Hodgkin Lymphoma|2014
10-14|1.3|1.7|1.5|312|Incidence|20665650|Non-Hodgkin Lymphoma|2014
10-14|~|~|~|~|Mortality|20665650|Oral Cavity and Pharynx|2014
10-14|0.2|0.3|0.2|44|Incidence|20665650|Oral Cavity and Pharynx|2014
10-14|~|~|~|~|Mortality|10118709|Ovary|2014
10-14|0.7|1.0|0.8|84|Incidence|10118709|Ovary|2014
10-14|~|~|~|~|Mortality|20665650|Pancreas|2014
10-14|0.0|0.1|0.1|16|Incidence|20665650|Pancreas|2014
10-14|~|~|~|~|Mortality|10546941|Prostate|2014
10-14|~|~|~|~|Incidence|10546941|Prostate|2014
10-14|~|~|~|~|Mortality|20665650|Stomach|2014
10-14|~|~|~|~|Incidence|20665650|Stomach|2014
10-14|~|~|~|~|Mortality|10546941|Testis|2014
10-14|0.1|0.2|0.2|16|Incidence|10546941|Testis|2014
10-14|~|~|~|~|Mortality|20665650|Thyroid|2014
10-14|0.8|1.1|0.9|192|Incidence|20665650|Thyroid|2014
10-14|~|~|~|~|Mortality|20665650|Urinary Bladder|2014
10-14|~|~|~|~|Incidence|20665650|Urinary Bladder|2014
15-19|2.7|3.1|2.9|612|Mortality|21052826|All Cancer Sites Combined|2014
15-19|22.8|24.2|23.5|4947|Incidence|21052826|All Cancer Sites Combined|2014
15-19|0.6|0.8|0.7|139|Mortality|21052826|Brain and Other Nervous System|2014
15-19|2.2|2.6|2.4|511|Incidence|21052826|Brain and Other Nervous System|2014
15-19|~|~|~|~|Mortality|10278274|Cervix|2014
15-19|~|~|~|~|Incidence|10278274|Cervix|2014
15-19|~|~|~|~|Mortality|21052826|Colon and Rectum|2014
15-19|0.6|0.8|0.7|146|Incidence|21052826|Colon and Rectum|2014
15-19|~|~|~|~|Mortality|10278274|Corpus and Uterus, NOS|2014
15-19|~|~|~|~|Incidence|10278274|Corpus and Uterus, NOS|2014
15-19|~|~|~|~|Mortality|21052826|Esophagus|2014
15-19|~|~|~|~|Incidence|21052826|Esophagus|2014
15-19|~|~|~|~|Mortality|10278274|Female Breast|2014
15-19|0.1|0.3|0.2|16|Incidence|10278274|Female Breast|2014
15-19|~|~|~|~|Incidence|10278274|Female Breast, <i>in situ</i>|2014
15-19|~|~|~|~|Mortality|21052826|Hodgkin Lymphoma|2014
15-19|2.9|3.3|3.1|652|Incidence|21052826|Hodgkin Lymphoma|2014
15-19|.|.|.|.|Mortality|21052826|Kaposi Sarcoma|2014
15-19|~|~|~|~|Incidence|21052826|Kaposi Sarcoma|2014
15-19|~|~|~|~|Mortality|21052826|Kidney and Renal Pelvis|2014
15-19|0.2|0.3|0.2|50|Incidence|21052826|Kidney and Renal Pelvis|2014
15-19|~|~|~|~|Mortality|21052826|Larynx|2014
15-19|~|~|~|~|Incidence|21052826|Larynx|2014
15-19|0.6|0.9|0.8|160|Mortality|21052826|Leukemias|2014
15-19|3.0|3.5|3.2|679|Incidence|21052826|Leukemias|2014
15-19|~|~|~|~|Mortality|21052826|Liver and Intrahepatic Bile Duct|2014
15-19|0.1|0.2|0.1|24|Incidence|21052826|Liver and Intrahepatic Bile Duct|2014
15-19|~|~|~|~|Mortality|21052826|Lung and Bronchus|2014
15-19|0.1|0.1|0.1|19|Incidence|21052826|Lung and Bronchus|2014
15-19|~|~|~|~|Mortality|10278274|Male and Female Breast|2014
15-19|0.1|0.3|0.2|16|Incidence|10278274|Male and Female Breast|2014
15-19|~|~|~|~|Incidence|10278274|Male and Female Breast, <i>in situ</i>|2014
15-19|~|~|~|~|Mortality|21052826|Melanomas of the Skin|2014
15-19|0.8|1.0|0.9|191|Incidence|21052826|Melanomas of the Skin|2014
15-19|~|~|~|~|Mortality|21052826|Mesothelioma|2014
15-19|~|~|~|~|Incidence|21052826|Mesothelioma|2014
15-19|~|~|~|~|Mortality|21052826|Myeloma|2014
15-19|~|~|~|~|Incidence|21052826|Myeloma|2014
15-19|0.1|0.2|0.1|30|Mortality|21052826|Non-Hodgkin Lymphoma|2014
15-19|1.9|2.3|2.1|444|Incidence|21052826|Non-Hodgkin Lymphoma|2014
15-19|~|~|~|~|Mortality|21052826|Oral Cavity and Pharynx|2014
15-19|0.3|0.5|0.4|88|Incidence|21052826|Oral Cavity and Pharynx|2014
15-19|~|~|~|~|Mortality|10278274|Ovary|2014
15-19|1.0|1.4|1.2|122|Incidence|10278274|Ovary|2014
15-19|~|~|~|~|Mortality|21052826|Pancreas|2014
15-19|0.1|0.2|0.2|32|Incidence|21052826|Pancreas|2014
15-19|~|~|~|~|Mortality|10774552|Prostate|2014
15-19|~|~|~|~|Incidence|10774552|Prostate|2014
15-19|~|~|~|~|Mortality|21052826|Stomach|2014
15-19|~|~|~|~|Incidence|21052826|Stomach|2014
15-19|~|~|~|~|Mortality|10774552|Testis|2014
15-19|3.2|3.9|3.6|384|Incidence|10774552|Testis|2014
15-19|~|~|~|~|Mortality|21052826|Thyroid|2014
15-19|2.9|3.3|3.1|650|Incidence|21052826|Thyroid|2014
15-19|~|~|~|~|Mortality|21052826|Urinary Bladder|2014
15-19|0.1|0.1|0.1|18|Incidence|21052826|Urinary Bladder|2014
5-9|1.9|2.3|2.1|436|Mortality|20515031|All Cancer Sites Combined|2014
5-9|13.3|14.3|13.8|2829|Incidence|20515031|All Cancer Sites Combined|2014
5-9|0.8|1.1|0.9|188|Mortality|20515031|Brain and Other Nervous System|2014
5-9|3.4|4.0|3.7|755|Incidence|20515031|Brain and Other Nervous System|2014
5-9|~|~|~|~|Mortality|10040750|Cervix|2014
5-9|~|~|~|~|Incidence|10040750|Cervix|2014
5-9|~|~|~|~|Mortality|20515031|Colon and Rectum|2014
5-9|~|~|~|~|Incidence|20515031|Colon and Rectum|2014
5-9|~|~|~|~|Mortality|10040750|Corpus and Uterus, NOS|2014
5-9|~|~|~|~|Incidence|10040750|Corpus and Uterus, NOS|2014
5-9|~|~|~|~|Mortality|20515031|Esophagus|2014
5-9|~|~|~|~|Incidence|20515031|Esophagus|2014
5-9|~|~|~|~|Mortality|10040750|Female Breast|2014
5-9|~|~|~|~|Incidence|10040750|Female Breast|2014
5-9|~|~|~|~|Incidence|10040750|Female Breast, <i>in situ</i>|2014
5-9|~|~|~|~|Mortality|20515031|Hodgkin Lymphoma|2014
5-9|0.3|0.5|0.4|80|Incidence|20515031|Hodgkin Lymphoma|2014
5-9|.|.|.|.|Mortality|20515031|Kaposi Sarcoma|2014
5-9|~|~|~|~|Incidence|20515031|Kaposi Sarcoma|2014
5-9|~|~|~|~|Mortality|20515031|Kidney and Renal Pelvis|2014
5-9|0.6|0.8|0.7|138|Incidence|20515031|Kidney and Renal Pelvis|2014
5-9|~|~|~|~|Mortality|20515031|Larynx|2014
5-9|~|~|~|~|Incidence|20515031|Larynx|2014
5-9|0.3|0.5|0.4|87|Mortality|20515031|Leukemias|2014
5-9|3.9|4.5|4.2|859|Incidence|20515031|Leukemias|2014
5-9|~|~|~|~|Mortality|20515031|Liver and Intrahepatic Bile Duct|2014
5-9|0.1|0.2|0.1|22|Incidence|20515031|Liver and Intrahepatic Bile Duct|2014
5-9|~|~|~|~|Mortality|20515031|Lung and Bronchus|2014
5-9|~|~|~|~|Incidence|20515031|Lung and Bronchus|2014
5-9|~|~|~|~|Mortality|10040750|Male and Female Breast|2014
5-9|~|~|~|~|Incidence|10040750|Male and Female Breast|2014
5-9|~|~|~|~|Incidence|10040750|Male and Female Breast, <i>in situ</i>|2014
5-9|~|~|~|~|Mortality|20515031|Melanomas of the Skin|2014
5-9|0.1|0.3|0.2|38|Incidence|20515031|Melanomas of the Skin|2014
5-9|~|~|~|~|Mortality|20515031|Mesothelioma|2014
5-9|~|~|~|~|Incidence|20515031|Mesothelioma|2014
5-9|~|~|~|~|Mortality|20515031|Myeloma|2014
5-9|~|~|~|~|Incidence|20515031|Myeloma|2014
5-9|~|~|~|~|Mortality|20515031|Non-Hodgkin Lymphoma|2014
5-9|1.0|1.3|1.2|241|Incidence|20515031|Non-Hodgkin Lymphoma|2014
5-9|~|~|~|~|Mortality|20515031|Oral Cavity and Pharynx|2014
5-9|0.1|0.1|0.1|18|Incidence|20515031|Oral Cavity and Pharynx|2014
5-9|~|~|~|~|Mortality|10040750|Ovary|2014
5-9|0.2|0.4|0.2|24|Incidence|10040750|Ovary|2014
5-9|~|~|~|~|Mortality|20515031|Pancreas|2014
5-9|~|~|~|~|Incidence|20515031|Pancreas|2014
5-9|~|~|~|~|Mortality|10474281|Prostate|2014
5-9|~|~|~|~|Incidence|10474281|Prostate|2014
5-9|~|~|~|~|Mortality|20515031|Stomach|2014
5-9|~|~|~|~|Incidence|20515031|Stomach|2014
5-9|~|~|~|~|Mortality|10474281|Testis|2014
5-9|~|~|~|~|Incidence|10474281|Testis|2014
5-9|~|~|~|~|Mortality|20515031|Thyroid|2014
5-9|0.1|0.2|0.2|37|Incidence|20515031|Thyroid|2014
5-9|~|~|~|~|Mortality|20515031|Urinary Bladder|2014
5-9|~|~|~|~|Incidence|20515031|Urinary Bladder|2014
<1|1.0|1.7|1.3|52|Mortality|3954787|All Cancer Sites Combined|2014
<1|27.0|30.3|28.6|1132|Incidence|3954787|All Cancer Sites Combined|2014
<1|~|~|~|~|Mortality|3954787|Brain and Other Nervous System|2014
<1|3.6|4.9|4.2|165|Incidence|3954787|Brain and Other Nervous System|2014
<1|~|~|~|~|Mortality|1930276|Cervix|2014
<1|~|~|~|~|Incidence|1930276|Cervix|2014
<1|~|~|~|~|Mortality|3954787|Colon and Rectum|2014
<1|~|~|~|~|Incidence|3954787|Colon and Rectum|2014
<1|~|~|~|~|Mortality|1930276|Corpus and Uterus, NOS|2014
<1|~|~|~|~|Incidence|1930276|Corpus and Uterus, NOS|2014
<1|~|~|~|~|Mortality|3954787|Esophagus|2014
<1|~|~|~|~|Incidence|3954787|Esophagus|2014
<1|~|~|~|~|Mortality|1930276|Female Breast|2014
<1|~|~|~|~|Incidence|1930276|Female Breast|2014
<1|~|~|~|~|Incidence|1930276|Female Breast, <i>in situ</i>|2014
<1|~|~|~|~|Mortality|3954787|Hodgkin Lymphoma|2014
<1|~|~|~|~|Incidence|3954787|Hodgkin Lymphoma|2014
<1|.|.|.|.|Mortality|3954787|Kaposi Sarcoma|2014
<1|~|~|~|~|Incidence|3954787|Kaposi Sarcoma|2014
<1|~|~|~|~|Mortality|3954787|Kidney and Renal Pelvis|2014
<1|1.5|2.3|1.9|74|Incidence|3954787|Kidney and Renal Pelvis|2014
<1|~|~|~|~|Mortality|3954787|Larynx|2014
<1|~|~|~|~|Incidence|3954787|Larynx|2014
<1|~|~|~|~|Mortality|3954787|Leukemias|2014
<1|3.3|4.6|3.9|156|Incidence|3954787|Leukemias|2014
<1|~|~|~|~|Mortality|3954787|Liver and Intrahepatic Bile Duct|2014
<1|1.2|2.0|1.6|63|Incidence|3954787|Liver and Intrahepatic Bile Duct|2014
<1|~|~|~|~|Mortality|3954787|Lung and Bronchus|2014
<1|~|~|~|~|Incidence|3954787|Lung and Bronchus|2014
<1|~|~|~|~|Mortality|1930276|Male and Female Breast|2014
<1|~|~|~|~|Incidence|1930276|Male and Female Breast|2014
<1|~|~|~|~|Incidence|1930276|Male and Female Breast, <i>in situ</i>|2014
<1|~|~|~|~|Mortality|3954787|Melanomas of the Skin|2014
<1|~|~|~|~|Incidence|3954787|Melanomas of the Skin|2014
<1|~|~|~|~|Mortality|3954787|Mesothelioma|2014
<1|~|~|~|~|Incidence|3954787|Mesothelioma|2014
<1|~|~|~|~|Mortality|3954787|Myeloma|2014
<1|~|~|~|~|Incidence|3954787|Myeloma|2014
<1|~|~|~|~|Mortality|3954787|Non-Hodgkin Lymphoma|2014
<1|0.2|0.7|0.4|16|Incidence|3954787|Non-Hodgkin Lymphoma|2014
<1|~|~|~|~|Mortality|3954787|Oral Cavity and Pharynx|2014
<1|~|~|~|~|Incidence|3954787|Oral Cavity and Pharynx|2014
<1|~|~|~|~|Mortality|1930276|Ovary|2014
<1|~|~|~|~|Incidence|1930276|Ovary|2014
<1|~|~|~|~|Mortality|3954787|Pancreas|2014
<1|~|~|~|~|Incidence|3954787|Pancreas|2014
<1|~|~|~|~|Mortality|2024511|Prostate|2014
<1|~|~|~|~|Incidence|2024511|Prostate|2014
<1|~|~|~|~|Mortality|3954787|Stomach|2014
<1|~|~|~|~|Incidence|3954787|Stomach|2014
<1|~|~|~|~|Mortality|2024511|Testis|2014
<1|~|~|~|~|Incidence|2024511|Testis|2014
<1|~|~|~|~|Mortality|3954787|Thyroid|2014
<1|~|~|~|~|Incidence|3954787|Thyroid|2014
<1|~|~|~|~|Mortality|3954787|Urinary Bladder|2014
<1|~|~|~|~|Incidence|3954787|Urinary Bladder|2014
1-4|2.0|2.2|2.1|1703|Mortality|79763246|All Cancer Sites Combined|2014-2018
1-4|22.3|23.0|22.7|17916|Incidence|79030316|All Cancer Sites Combined|2014-2018
1-4|0.5|0.6|0.5|427|Mortality|79763246|Brain and Other Nervous System|2014-2018
1-4|4.4|4.7|4.5|3565|Incidence|79030316|Brain and Other Nervous System|2014-2018
1-4|~|~|~|~|Mortality|38980481|Cervix|2014-2018
1-4|~|~|~|~|Incidence|38623321|Cervix|2014-2018
1-4|~|~|~|~|Mortality|79763246|Colon and Rectum|2014-2018
1-4|~|~|~|~|Incidence|79030316|Colon and Rectum|2014-2018
1-4|~|~|~|~|Mortality|38980481|Corpus and Uterus, NOS|2014-2018
1-4|~|~|~|~|Incidence|38623321|Corpus and Uterus, NOS|2014-2018
1-4|~|~|~|~|Mortality|79763246|Esophagus|2014-2018
1-4|~|~|~|~|Incidence|79030316|Esophagus|2014-2018
1-4|~|~|~|~|Mortality|38980481|Female Breast|2014-2018
1-4|~|~|~|~|Incidence|38623321|Female Breast|2014-2018
1-4|~|~|~|~|Incidence|38623321|Female Breast, <i>in situ</i>|2014-2018
1-4|~|~|~|~|Mortality|79763246|Hodgkin Lymphoma|2014-2018
1-4|0.1|0.1|0.1|63|Incidence|79030316|Hodgkin Lymphoma|2014-2018
1-4|.|.|.|.|Mortality|79763246|Kaposi Sarcoma|2014-2018
1-4|~|~|~|~|Incidence|79030316|Kaposi Sarcoma|2014-2018
1-4|0.1|0.1|0.1|56|Mortality|79763246|Kidney and Renal Pelvis|2014-2018
1-4|1.9|2.1|2.0|1542|Incidence|79030316|Kidney and Renal Pelvis|2014-2018
1-4|~|~|~|~|Mortality|79763246|Larynx|2014-2018
1-4|~|~|~|~|Incidence|79030316|Larynx|2014-2018
1-4|0.6|0.7|0.7|540|Mortality|79763246|Leukemias|2014-2018
1-4|8.7|9.1|8.9|7053|Incidence|79030316|Leukemias|2014-2018
1-4|0.1|0.1|0.1|79|Mortality|79763246|Liver and Intrahepatic Bile Duct|2014-2018
1-4|0.6|0.7|0.6|500|Incidence|79030316|Liver and Intrahepatic Bile Duct|2014-2018
1-4|~|~|~|~|Mortality|79763246|Lung and Bronchus|2014-2018
1-4|0.1|0.1|0.1|66|Incidence|79030316|Lung and Bronchus|2014-2018
1-4|~|~|~|~|Mortality|38980481|Male and Female Breast|2014-2018
1-4|~|~|~|~|Incidence|38623321|Male and Female Breast|2014-2018
1-4|~|~|~|~|Incidence|38623321|Male and Female Breast, <i>in situ</i>|2014-2018
1-4|~|~|~|~|Mortality|79763246|Melanomas of the Skin|2014-2018
1-4|0.1|0.1|0.1|93|Incidence|79030316|Melanomas of the Skin|2014-2018
1-4|~|~|~|~|Mortality|79763246|Mesothelioma|2014-2018
1-4|~|~|~|~|Incidence|79030316|Mesothelioma|2014-2018
1-4|~|~|~|~|Mortality|79763246|Myeloma|2014-2018
1-4|~|~|~|~|Incidence|79030316|Myeloma|2014-2018
1-4|0.0|0.1|0.0|28|Mortality|79763246|Non-Hodgkin Lymphoma|2014-2018
1-4|0.7|0.8|0.7|560|Incidence|79030316|Non-Hodgkin Lymphoma|2014-2018
1-4|~|~|~|~|Mortality|79763246|Oral Cavity and Pharynx|2014-2018
1-4|0.0|0.1|0.0|35|Incidence|79030316|Oral Cavity and Pharynx|2014-2018
1-4|~|~|~|~|Mortality|38980481|Ovary|2014-2018
1-4|0.0|0.1|0.1|25|Incidence|38623321|Ovary|2014-2018
1-4|~|~|~|~|Mortality|79763246|Pancreas|2014-2018
1-4|~|~|~|~|Incidence|79030316|Pancreas|2014-2018
1-4|~|~|~|~|Mortality|40782765|Prostate|2014-2018
1-4|~|~|~|~|Incidence|40406995|Prostate|2014-2018
1-4|~|~|~|~|Mortality|79763246|Stomach|2014-2018
1-4|~|~|~|~|Incidence|79030316|Stomach|2014-2018
1-4|~|~|~|~|Mortality|40782765|Testis|2014-2018
1-4|0.2|0.3|0.3|114|Incidence|40406995|Testis|2014-2018
1-4|~|~|~|~|Mortality|79763246|Thyroid|2014-2018
1-4|0.0|0.0|0.0|25|Incidence|79030316|Thyroid|2014-2018
1-4|~|~|~|~|Mortality|79763246|Urinary Bladder|2014-2018
1-4|0.0|0.1|0.1|49|Incidence|79030316|Urinary Bladder|2014-2018
10-14|2.0|2.2|2.1|2162|Mortality|103527771|All Cancer Sites Combined|2014-2018
10-14|15.4|15.9|15.6|16021|Incidence|102580702|All Cancer Sites Combined|2014-2018
10-14|0.6|0.7|0.7|689|Mortality|103527771|Brain and Other Nervous System|2014-2018
10-14|2.9|3.1|3.0|3073|Incidence|102580702|Brain and Other Nervous System|2014-2018
10-14|~|~|~|~|Mortality|50690862|Cervix|2014-2018
10-14|~|~|~|~|Incidence|50227035|Cervix|2014-2018
10-14|~|~|~|~|Mortality|103527771|Colon and Rectum|2014-2018
10-14|0.5|0.6|0.5|556|Incidence|102580702|Colon and Rectum|2014-2018
10-14|~|~|~|~|Mortality|50690862|Corpus and Uterus, NOS|2014-2018
10-14|~|~|~|~|Incidence|50227035|Corpus and Uterus, NOS|2014-2018
10-14|~|~|~|~|Mortality|103527771|Esophagus|2014-2018
10-14|~|~|~|~|Incidence|102580702|Esophagus|2014-2018
10-14|~|~|~|~|Mortality|50690862|Female Breast|2014-2018
10-14|~|~|~|~|Incidence|50227035|Female Breast|2014-2018
10-14|~|~|~|~|Incidence|50227035|Female Breast, <i>in situ</i>|2014-2018
10-14|~|~|~|~|Mortality|103527771|Hodgkin Lymphoma|2014-2018
10-14|1.2|1.3|1.3|1307|Incidence|102580702|Hodgkin Lymphoma|2014-2018
10-14|.|.|.|.|Mortality|103527771|Kaposi Sarcoma|2014-2018
10-14|~|~|~|~|Incidence|102580702|Kaposi Sarcoma|2014-2018
10-14|0.0|0.1|0.0|42|Mortality|103527771|Kidney and Renal Pelvis|2014-2018
10-14|0.2|0.2|0.2|201|Incidence|102580702|Kidney and Renal Pelvis|2014-2018
10-14|~|~|~|~|Mortality|103527771|Larynx|2014-2018
10-14|~|~|~|~|Incidence|102580702|Larynx|2014-2018
10-14|0.5|0.6|0.5|539|Mortality|103527771|Leukemias|2014-2018
10-14|3.2|3.4|3.3|3351|Incidence|102580702|Leukemias|2014-2018
10-14|0.0|0.0|0.0|36|Mortality|103527771|Liver and Intrahepatic Bile Duct|2014-2018
10-14|0.1|0.1|0.1|106|Incidence|102580702|Liver and Intrahepatic Bile Duct|2014-2018
10-14|~|~|~|~|Mortality|103527771|Lung and Bronchus|2014-2018
10-14|0.0|0.1|0.1|53|Incidence|102580702|Lung and Bronchus|2014-2018
10-14|~|~|~|~|Mortality|50690862|Male and Female Breast|2014-2018
10-14|~|~|~|~|Incidence|50227035|Male and Female Breast|2014-2018
10-14|~|~|~|~|Incidence|50227035|Male and Female Breast, <i>in situ</i>|2014-2018
10-14|~|~|~|~|Mortality|103527771|Melanomas of the Skin|2014-2018
10-14|0.2|0.3|0.2|254|Incidence|102580702|Melanomas of the Skin|2014-2018
10-14|~|~|~|~|Mortality|103527771|Mesothelioma|2014-2018
10-14|~|~|~|~|Incidence|102580702|Mesothelioma|2014-2018
10-14|~|~|~|~|Mortality|103527771|Myeloma|2014-2018
10-14|~|~|~|~|Incidence|102580702|Myeloma|2014-2018
10-14|0.1|0.1|0.1|89|Mortality|103527771|Non-Hodgkin Lymphoma|2014-2018
10-14|1.3|1.5|1.4|1453|Incidence|102580702|Non-Hodgkin Lymphoma|2014-2018
10-14|~|~|~|~|Mortality|103527771|Oral Cavity and Pharynx|2014-2018
10-14|0.2|0.3|0.3|258|Incidence|102580702|Oral Cavity and Pharynx|2014-2018
10-14|~|~|~|~|Mortality|50690862|Ovary|2014-2018
10-14|0.8|0.9|0.8|424|Incidence|50227035|Ovary|2014-2018
10-14|~|~|~|~|Mortality|103527771|Pancreas|2014-2018
10-14|0.1|0.1|0.1|79|Incidence|102580702|Pancreas|2014-2018
10-14|~|~|~|~|Mortality|52836909|Prostate|2014-2018
10-14|~|~|~|~|Incidence|52353667|Prostate|2014-2018
10-14|~|~|~|~|Mortality|103527771|Stomach|2014-2018
10-14|0.0|0.0|0.0|21|Incidence|102580702|Stomach|2014-2018
10-14|~|~|~|~|Mortality|52836909|Testis|2014-2018
10-14|0.2|0.3|0.2|115|Incidence|52353667|Testis|2014-2018
10-14|~|~|~|~|Mortality|103527771|Thyroid|2014-2018
10-14|0.8|1.0|0.9|918|Incidence|102580702|Thyroid|2014-2018
10-14|~|~|~|~|Mortality|103527771|Urinary Bladder|2014-2018
10-14|0.0|0.0|0.0|24|Incidence|102580702|Urinary Bladder|2014-2018
15-19|2.7|2.9|2.8|2972|Mortality|105422374|All Cancer Sites Combined|2014-2018
15-19|23.8|24.4|24.1|25143|Incidence|104535275|All Cancer Sites Combined|2014-2018
15-19|0.5|0.6|0.5|568|Mortality|105422374|Brain and Other Nervous System|2014-2018
15-19|2.2|2.4|2.3|2421|Incidence|104535275|Brain and Other Nervous System|2014-2018
15-19|~|~|~|~|Mortality|51532209|Cervix|2014-2018
15-19|0.0|0.1|0.1|34|Incidence|51102336|Cervix|2014-2018
15-19|0.0|0.0|0.0|36|Mortality|105422374|Colon and Rectum|2014-2018
15-19|1.1|1.3|1.2|1267|Incidence|104535275|Colon and Rectum|2014-2018
15-19|~|~|~|~|Mortality|51532209|Corpus and Uterus, NOS|2014-2018
15-19|0.0|0.1|0.1|33|Incidence|51102336|Corpus and Uterus, NOS|2014-2018
15-19|~|~|~|~|Mortality|105422374|Esophagus|2014-2018
15-19|~|~|~|~|Incidence|104535275|Esophagus|2014-2018
15-19|~|~|~|~|Mortality|51532209|Female Breast|2014-2018
15-19|0.1|0.2|0.2|88|Incidence|51102336|Female Breast|2014-2018
15-19|~|~|~|~|Incidence|51102336|Female Breast, <i>in situ</i>|2014-2018
15-19|0.0|0.0|0.0|36|Mortality|105422374|Hodgkin Lymphoma|2014-2018
15-19|3.0|3.3|3.2|3295|Incidence|104535275|Hodgkin Lymphoma|2014-2018
15-19|.|.|.|.|Mortality|105422374|Kaposi Sarcoma|2014-2018
15-19|~|~|~|~|Incidence|104535275|Kaposi Sarcoma|2014-2018
15-19|0.0|0.1|0.0|49|Mortality|105422374|Kidney and Renal Pelvis|2014-2018
15-19|0.2|0.3|0.2|236|Incidence|104535275|Kidney and Renal Pelvis|2014-2018
15-19|~|~|~|~|Mortality|105422374|Larynx|2014-2018
15-19|0.0|0.0|0.0|18|Incidence|104535275|Larynx|2014-2018
15-19|0.7|0.8|0.7|762|Mortality|105422374|Leukemias|2014-2018
15-19|3.1|3.3|3.2|3334|Incidence|104535275|Leukemias|2014-2018
15-19|0.0|0.1|0.1|53|Mortality|105422374|Liver and Intrahepatic Bile Duct|2014-2018
15-19|0.1|0.2|0.1|149|Incidence|104535275|Liver and Intrahepatic Bile Duct|2014-2018
15-19|0.0|0.1|0.0|40|Mortality|105422374|Lung and Bronchus|2014-2018
15-19|0.1|0.1|0.1|124|Incidence|104535275|Lung and Bronchus|2014-2018
15-19|~|~|~|~|Mortality|51532209|Male and Female Breast|2014-2018
15-19|0.1|0.2|0.2|88|Incidence|51102336|Male and Female Breast|2014-2018
15-19|~|~|~|~|Incidence|51102336|Male and Female Breast, <i>in situ</i>|2014-2018
15-19|0.0|0.0|0.0|24|Mortality|105422374|Melanomas of the Skin|2014-2018
15-19|0.8|0.9|0.9|890|Incidence|104535275|Melanomas of the Skin|2014-2018
15-19|~|~|~|~|Mortality|105422374|Mesothelioma|2014-2018
15-19|~|~|~|~|Incidence|104535275|Mesothelioma|2014-2018
15-19|~|~|~|~|Mortality|105422374|Myeloma|2014-2018
15-19|~|~|~|~|Incidence|104535275|Myeloma|2014-2018
15-19|0.1|0.2|0.1|147|Mortality|105422374|Non-Hodgkin Lymphoma|2014-2018
15-19|1.9|2.1|2.0|2058|Incidence|104535275|Non-Hodgkin Lymphoma|2014-2018
15-19|0.0|0.0|0.0|21|Mortality|105422374|Oral Cavity and Pharynx|2014-2018
15-19|0.4|0.5|0.5|479|Incidence|104535275|Oral Cavity and Pharynx|2014-2018
15-19|0.0|0.1|0.1|31|Mortality|51532209|Ovary|2014-2018
15-19|1.1|1.3|1.2|634|Incidence|51102336|Ovary|2014-2018
15-19|~|~|~|~|Mortality|105422374|Pancreas|2014-2018
15-19|0.1|0.2|0.2|165|Incidence|104535275|Pancreas|2014-2018
15-19|~|~|~|~|Mortality|53890165|Prostate|2014-2018
15-19|~|~|~|~|Incidence|53432939|Prostate|2014-2018
15-19|0.0|0.0|0.0|19|Mortality|105422374|Stomach|2014-2018
15-19|0.1|0.1|0.1|85|Incidence|104535275|Stomach|2014-2018
15-19|0.0|0.1|0.1|32|Mortality|53890165|Testis|2014-2018
15-19|3.3|3.6|3.4|1842|Incidence|53432939|Testis|2014-2018
15-19|~|~|~|~|Mortality|105422374|Thyroid|2014-2018
15-19|3.2|3.4|3.3|3464|Incidence|104535275|Thyroid|2014-2018
15-19|~|~|~|~|Mortality|105422374|Urinary Bladder|2014-2018
15-19|0.1|0.1|0.1|88|Incidence|104535275|Urinary Bladder|2014-2018
5-9|2.0|2.2|2.1|2133|Mortality|101923663|All Cancer Sites Combined|2014-2018
5-9|13.2|13.7|13.4|13555|Incidence|100972303|All Cancer Sites Combined|2014-2018
5-9|0.9|1.0|0.9|948|Mortality|101923663|Brain and Other Nervous System|2014-2018
5-9|3.5|3.7|3.6|3634|Incidence|100972303|Brain and Other Nervous System|2014-2018
5-9|~|~|~|~|Mortality|49877544|Cervix|2014-2018
5-9|~|~|~|~|Incidence|49412256|Cervix|2014-2018
5-9|~|~|~|~|Mortality|101923663|Colon and Rectum|2014-2018
5-9|0.1|0.1|0.1|92|Incidence|100972303|Colon and Rectum|2014-2018
5-9|~|~|~|~|Mortality|49877544|Corpus and Uterus, NOS|2014-2018
5-9|~|~|~|~|Incidence|49412256|Corpus and Uterus, NOS|2014-2018
5-9|~|~|~|~|Mortality|101923663|Esophagus|2014-2018
5-9|~|~|~|~|Incidence|100972303|Esophagus|2014-2018
5-9|~|~|~|~|Mortality|49877544|Female Breast|2014-2018
5-9|~|~|~|~|Incidence|49412256|Female Breast|2014-2018
5-9|~|~|~|~|Incidence|49412256|Female Breast, <i>in situ</i>|2014-2018
5-9|~|~|~|~|Mortality|101923663|Hodgkin Lymphoma|2014-2018
5-9|0.3|0.4|0.4|388|Incidence|100972303|Hodgkin Lymphoma|2014-2018
5-9|.|.|.|.|Mortality|101923663|Kaposi Sarcoma|2014-2018
5-9|~|~|~|~|Incidence|100972303|Kaposi Sarcoma|2014-2018
5-9|0.1|0.1|0.1|66|Mortality|101923663|Kidney and Renal Pelvis|2014-2018
5-9|0.6|0.7|0.7|678|Incidence|100972303|Kidney and Renal Pelvis|2014-2018
5-9|~|~|~|~|Mortality|101923663|Larynx|2014-2018
5-9|~|~|~|~|Incidence|100972303|Larynx|2014-2018
5-9|0.4|0.5|0.4|427|Mortality|101923663|Leukemias|2014-2018
5-9|4.0|4.3|4.1|4178|Incidence|100972303|Leukemias|2014-2018
5-9|0.0|0.1|0.0|46|Mortality|101923663|Liver and Intrahepatic Bile Duct|2014-2018
5-9|0.1|0.1|0.1|127|Incidence|100972303|Liver and Intrahepatic Bile Duct|2014-2018
5-9|~|~|~|~|Mortality|101923663|Lung and Bronchus|2014-2018
5-9|0.0|0.0|0.0|26|Incidence|100972303|Lung and Bronchus|2014-2018
5-9|~|~|~|~|Mortality|49877544|Male and Female Breast|2014-2018
5-9|~|~|~|~|Incidence|49412256|Male and Female Breast|2014-2018
5-9|~|~|~|~|Incidence|49412256|Male and Female Breast, <i>in situ</i>|2014-2018
5-9|~|~|~|~|Mortality|101923663|Melanomas of the Skin|2014-2018
5-9|0.1|0.2|0.1|139|Incidence|100972303|Melanomas of the Skin|2014-2018
5-9|~|~|~|~|Mortality|101923663|Mesothelioma|2014-2018
5-9|~|~|~|~|Incidence|100972303|Mesothelioma|2014-2018
5-9|~|~|~|~|Mortality|101923663|Myeloma|2014-2018
5-9|~|~|~|~|Incidence|100972303|Myeloma|2014-2018
5-9|0.0|0.1|0.0|49|Mortality|101923663|Non-Hodgkin Lymphoma|2014-2018
5-9|1.1|1.2|1.1|1130|Incidence|100972303|Non-Hodgkin Lymphoma|2014-2018
5-9|~|~|~|~|Mortality|101923663|Oral Cavity and Pharynx|2014-2018
5-9|0.1|0.1|0.1|97|Incidence|100972303|Oral Cavity and Pharynx|2014-2018
5-9|~|~|~|~|Mortality|49877544|Ovary|2014-2018
5-9|0.2|0.3|0.2|114|Incidence|49412256|Ovary|2014-2018
5-9|~|~|~|~|Mortality|101923663|Pancreas|2014-2018
5-9|0.0|0.0|0.0|20|Incidence|100972303|Pancreas|2014-2018
5-9|~|~|~|~|Mortality|52046119|Prostate|2014-2018
5-9|~|~|~|~|Incidence|51560047|Prostate|2014-2018
5-9|~|~|~|~|Mortality|101923663|Stomach|2014-2018
5-9|~|~|~|~|Incidence|100972303|Stomach|2014-2018
5-9|~|~|~|~|Mortality|52046119|Testis|2014-2018
5-9|0.0|0.1|0.1|34|Incidence|51560047|Testis|2014-2018
5-9|~|~|~|~|Mortality|101923663|Thyroid|2014-2018
5-9|0.1|0.2|0.2|152|Incidence|100972303|Thyroid|2014-2018
5-9|~|~|~|~|Mortality|101923663|Urinary Bladder|2014-2018
5-9|~|~|~|~|Incidence|100972303|Urinary Bladder|2014-2018
<1|1.3|1.6|1.4|280|Mortality|19602874|All Cancer Sites Combined|2014-2018
<1|27.0|28.5|27.7|5388|Incidence|19424309|All Cancer Sites Combined|2014-2018
<1|0.2|0.4|0.3|61|Mortality|19602874|Brain and Other Nervous System|2014-2018
<1|3.5|4.1|3.8|735|Incidence|19424309|Brain and Other Nervous System|2014-2018
<1|~|~|~|~|Mortality|9575918|Cervix|2014-2018
<1|~|~|~|~|Incidence|9488876|Cervix|2014-2018
<1|~|~|~|~|Mortality|19602874|Colon and Rectum|2014-2018
<1|~|~|~|~|Incidence|19424309|Colon and Rectum|2014-2018
<1|~|~|~|~|Mortality|9575918|Corpus and Uterus, NOS|2014-2018
<1|~|~|~|~|Incidence|9488876|Corpus and Uterus, NOS|2014-2018
<1|~|~|~|~|Mortality|19602874|Esophagus|2014-2018
<1|~|~|~|~|Incidence|19424309|Esophagus|2014-2018
<1|~|~|~|~|Mortality|9575918|Female Breast|2014-2018
<1|~|~|~|~|Incidence|9488876|Female Breast|2014-2018
<1|~|~|~|~|Incidence|9488876|Female Breast, <i>in situ</i>|2014-2018
<1|~|~|~|~|Mortality|19602874|Hodgkin Lymphoma|2014-2018
<1|~|~|~|~|Incidence|19424309|Hodgkin Lymphoma|2014-2018
<1|.|.|.|.|Mortality|19602874|Kaposi Sarcoma|2014-2018
<1|~|~|~|~|Incidence|19424309|Kaposi Sarcoma|2014-2018
<1|~|~|~|~|Mortality|19602874|Kidney and Renal Pelvis|2014-2018
<1|1.5|1.9|1.7|335|Incidence|19424309|Kidney and Renal Pelvis|2014-2018
<1|~|~|~|~|Mortality|19602874|Larynx|2014-2018
<1|~|~|~|~|Incidence|19424309|Larynx|2014-2018
<1|0.4|0.6|0.5|96|Mortality|19602874|Leukemias|2014-2018
<1|3.9|4.5|4.2|816|Incidence|19424309|Leukemias|2014-2018
<1|~|~|~|~|Mortality|19602874|Liver and Intrahepatic Bile Duct|2014-2018
<1|1.4|1.8|1.6|313|Incidence|19424309|Liver and Intrahepatic Bile Duct|2014-2018
<1|~|~|~|~|Mortality|19602874|Lung and Bronchus|2014-2018
<1|0.1|0.2|0.2|31|Incidence|19424309|Lung and Bronchus|2014-2018
<1|~|~|~|~|Mortality|9575918|Male and Female Breast|2014-2018
<1|~|~|~|~|Incidence|9488876|Male and Female Breast|2014-2018
<1|~|~|~|~|Incidence|9488876|Male and Female Breast, <i>in situ</i>|2014-2018
<1|~|~|~|~|Mortality|19602874|Melanomas of the Skin|2014-2018
<1|0.2|0.3|0.3|50|Incidence|19424309|Melanomas of the Skin|2014-2018
<1|~|~|~|~|Mortality|19602874|Mesothelioma|2014-2018
<1|~|~|~|~|Incidence|19424309|Mesothelioma|2014-2018
<1|~|~|~|~|Mortality|19602874|Myeloma|2014-2018
<1|~|~|~|~|Incidence|19424309|Myeloma|2014-2018
<1|~|~|~|~|Mortality|19602874|Non-Hodgkin Lymphoma|2014-2018
<1|0.2|0.4|0.3|61|Incidence|19424309|Non-Hodgkin Lymphoma|2014-2018
<1|~|~|~|~|Mortality|19602874|Oral Cavity and Pharynx|2014-2018
<1|0.1|0.2|0.1|26|Incidence|19424309|Oral Cavity and Pharynx|2014-2018
<1|~|~|~|~|Mortality|9575918|Ovary|2014-2018
<1|~|~|~|~|Incidence|9488876|Ovary|2014-2018
<1|~|~|~|~|Mortality|19602874|Pancreas|2014-2018
<1|~|~|~|~|Incidence|19424309|Pancreas|2014-2018
<1|~|~|~|~|Mortality|10026956|Prostate|2014-2018
<1|~|~|~|~|Incidence|9935433|Prostate|2014-2018
<1|~|~|~|~|Mortality|19602874|Stomach|2014-2018
<1|~|~|~|~|Incidence|19424309|Stomach|2014-2018
<1|~|~|~|~|Mortality|10026956|Testis|2014-2018
<1|0.5|0.8|0.6|62|Incidence|9935433|Testis|2014-2018
<1|~|~|~|~|Mortality|19602874|Thyroid|2014-2018
<1|~|~|~|~|Incidence|19424309|Thyroid|2014-2018
<1|~|~|~|~|Mortality|19602874|Urinary Bladder|2014-2018
<1|~|~|~|~|Incidence|19424309|Urinary Bladder|2014-2018
1-4|2.0|2.5|2.2|354|Mortality|15934097|All Cancer Sites Combined|2015
1-4|22.9|24.4|23.6|3767|Incidence|15934097|All Cancer Sites Combined|2015
1-4|0.5|0.7|0.6|94|Mortality|15934097|Brain and Other Nervous System|2015
1-4|4.1|4.8|4.5|710|Incidence|15934097|Brain and Other Nervous System|2015
1-4|~|~|~|~|Mortality|7784981|Cervix|2015
1-4|~|~|~|~|Incidence|7784981|Cervix|2015
1-4|~|~|~|~|Mortality|15934097|Colon and Rectum|2015
1-4|~|~|~|~|Incidence|15934097|Colon and Rectum|2015
1-4|~|~|~|~|Mortality|7784981|Corpus and Uterus, NOS|2015
1-4|~|~|~|~|Incidence|7784981|Corpus and Uterus, NOS|2015
1-4|~|~|~|~|Mortality|15934097|Esophagus|2015
1-4|~|~|~|~|Incidence|15934097|Esophagus|2015
1-4|~|~|~|~|Mortality|7784981|Female Breast|2015
1-4|~|~|~|~|Incidence|7784981|Female Breast|2015
1-4|~|~|~|~|Incidence|7784981|Female Breast, <i>in situ</i>|2015
1-4|~|~|~|~|Mortality|15934097|Hodgkin Lymphoma|2015
1-4|~|~|~|~|Incidence|15934097|Hodgkin Lymphoma|2015
1-4|.|.|.|.|Mortality|15934097|Kaposi Sarcoma|2015
1-4|~|~|~|~|Incidence|15934097|Kaposi Sarcoma|2015
1-4|~|~|~|~|Mortality|15934097|Kidney and Renal Pelvis|2015
1-4|1.9|2.4|2.2|344|Incidence|15934097|Kidney and Renal Pelvis|2015
1-4|~|~|~|~|Mortality|15934097|Larynx|2015
1-4|~|~|~|~|Incidence|15934097|Larynx|2015
1-4|0.6|0.9|0.7|115|Mortality|15934097|Leukemias|2015
1-4|8.9|9.8|9.3|1488|Incidence|15934097|Leukemias|2015
1-4|~|~|~|~|Mortality|15934097|Liver and Intrahepatic Bile Duct|2015
1-4|0.5|0.8|0.7|105|Incidence|15934097|Liver and Intrahepatic Bile Duct|2015
1-4|~|~|~|~|Mortality|15934097|Lung and Bronchus|2015
1-4|0.1|0.2|0.1|16|Incidence|15934097|Lung and Bronchus|2015
1-4|~|~|~|~|Mortality|7784981|Male and Female Breast|2015
1-4|~|~|~|~|Incidence|7784981|Male and Female Breast|2015
1-4|~|~|~|~|Incidence|7784981|Male and Female Breast, <i>in situ</i>|2015
1-4|~|~|~|~|Mortality|15934097|Melanomas of the Skin|2015
1-4|0.1|0.2|0.1|19|Incidence|15934097|Melanomas of the Skin|2015
1-4|~|~|~|~|Mortality|15934097|Mesothelioma|2015
1-4|~|~|~|~|Incidence|15934097|Mesothelioma|2015
1-4|~|~|~|~|Mortality|15934097|Myeloma|2015
1-4|~|~|~|~|Incidence|15934097|Myeloma|2015
1-4|~|~|~|~|Mortality|15934097|Non-Hodgkin Lymphoma|2015
1-4|0.6|0.9|0.7|113|Incidence|15934097|Non-Hodgkin Lymphoma|2015
1-4|~|~|~|~|Mortality|15934097|Oral Cavity and Pharynx|2015
1-4|~|~|~|~|Incidence|15934097|Oral Cavity and Pharynx|2015
1-4|~|~|~|~|Mortality|7784981|Ovary|2015
1-4|~|~|~|~|Incidence|7784981|Ovary|2015
1-4|~|~|~|~|Mortality|15934097|Pancreas|2015
1-4|~|~|~|~|Incidence|15934097|Pancreas|2015
1-4|~|~|~|~|Mortality|8149116|Prostate|2015
1-4|~|~|~|~|Incidence|8149116|Prostate|2015
1-4|~|~|~|~|Mortality|15934097|Stomach|2015
1-4|~|~|~|~|Incidence|15934097|Stomach|2015
1-4|~|~|~|~|Mortality|8149116|Testis|2015
1-4|0.1|0.3|0.2|16|Incidence|8149116|Testis|2015
1-4|~|~|~|~|Mortality|15934097|Thyroid|2015
1-4|~|~|~|~|Incidence|15934097|Thyroid|2015
1-4|~|~|~|~|Mortality|15934097|Urinary Bladder|2015
1-4|~|~|~|~|Incidence|15934097|Urinary Bladder|2015
10-14|1.9|2.3|2.1|428|Mortality|20604377|All Cancer Sites Combined|2015
10-14|14.9|15.9|15.4|3170|Incidence|20604377|All Cancer Sites Combined|2015
10-14|0.5|0.8|0.7|135|Mortality|20604377|Brain and Other Nervous System|2015
10-14|2.6|3.1|2.8|581|Incidence|20604377|Brain and Other Nervous System|2015
10-14|~|~|~|~|Mortality|10092363|Cervix|2015
10-14|~|~|~|~|Incidence|10092363|Cervix|2015
10-14|~|~|~|~|Mortality|20604377|Colon and Rectum|2015
10-14|0.4|0.7|0.5|112|Incidence|20604377|Colon and Rectum|2015
10-14|~|~|~|~|Mortality|10092363|Corpus and Uterus, NOS|2015
10-14|~|~|~|~|Incidence|10092363|Corpus and Uterus, NOS|2015
10-14|~|~|~|~|Mortality|20604377|Esophagus|2015
10-14|~|~|~|~|Incidence|20604377|Esophagus|2015
10-14|~|~|~|~|Mortality|10092363|Female Breast|2015
10-14|~|~|~|~|Incidence|10092363|Female Breast|2015
10-14|~|~|~|~|Incidence|10092363|Female Breast, <i>in situ</i>|2015
10-14|~|~|~|~|Mortality|20604377|Hodgkin Lymphoma|2015
10-14|1.1|1.5|1.3|266|Incidence|20604377|Hodgkin Lymphoma|2015
10-14|.|.|.|.|Mortality|20604377|Kaposi Sarcoma|2015
10-14|~|~|~|~|Incidence|20604377|Kaposi Sarcoma|2015
10-14|~|~|~|~|Mortality|20604377|Kidney and Renal Pelvis|2015
10-14|0.1|0.3|0.2|38|Incidence|20604377|Kidney and Renal Pelvis|2015
10-14|~|~|~|~|Mortality|20604377|Larynx|2015
10-14|~|~|~|~|Incidence|20604377|Larynx|2015
10-14|0.5|0.7|0.6|115|Mortality|20604377|Leukemias|2015
10-14|2.9|3.4|3.1|645|Incidence|20604377|Leukemias|2015
10-14|~|~|~|~|Mortality|20604377|Liver and Intrahepatic Bile Duct|2015
10-14|0.1|0.2|0.1|29|Incidence|20604377|Liver and Intrahepatic Bile Duct|2015
10-14|~|~|~|~|Mortality|20604377|Lung and Bronchus|2015
10-14|~|~|~|~|Incidence|20604377|Lung and Bronchus|2015
10-14|~|~|~|~|Mortality|10092363|Male and Female Breast|2015
10-14|~|~|~|~|Incidence|10092363|Male and Female Breast|2015
10-14|~|~|~|~|Incidence|10092363|Male and Female Breast, <i>in situ</i>|2015
10-14|~|~|~|~|Mortality|20604377|Melanomas of the Skin|2015
10-14|0.2|0.4|0.3|63|Incidence|20604377|Melanomas of the Skin|2015
10-14|~|~|~|~|Mortality|20604377|Mesothelioma|2015
10-14|~|~|~|~|Incidence|20604377|Mesothelioma|2015
10-14|~|~|~|~|Mortality|20604377|Myeloma|2015
10-14|~|~|~|~|Incidence|20604377|Myeloma|2015
10-14|0.1|0.1|0.1|18|Mortality|20604377|Non-Hodgkin Lymphoma|2015
10-14|1.2|1.5|1.3|273|Incidence|20604377|Non-Hodgkin Lymphoma|2015
10-14|~|~|~|~|Mortality|20604377|Oral Cavity and Pharynx|2015
10-14|0.2|0.3|0.3|54|Incidence|20604377|Oral Cavity and Pharynx|2015
10-14|~|~|~|~|Mortality|10092363|Ovary|2015
10-14|0.7|1.1|0.9|92|Incidence|10092363|Ovary|2015
10-14|~|~|~|~|Mortality|20604377|Pancreas|2015
10-14|~|~|~|~|Incidence|20604377|Pancreas|2015
10-14|~|~|~|~|Mortality|10512014|Prostate|2015
10-14|~|~|~|~|Incidence|10512014|Prostate|2015
10-14|~|~|~|~|Mortality|20604377|Stomach|2015
10-14|~|~|~|~|Incidence|20604377|Stomach|2015
10-14|~|~|~|~|Mortality|10512014|Testis|2015
10-14|0.1|0.3|0.2|21|Incidence|10512014|Testis|2015
10-14|~|~|~|~|Mortality|20604377|Thyroid|2015
10-14|0.8|1.0|0.9|182|Incidence|20604377|Thyroid|2015
10-14|~|~|~|~|Mortality|20604377|Urinary Bladder|2015
10-14|~|~|~|~|Incidence|20604377|Urinary Bladder|2015
15-19|2.5|3.0|2.8|583|Mortality|21081020|All Cancer Sites Combined|2015
15-19|24.2|25.5|24.9|5240|Incidence|21081020|All Cancer Sites Combined|2015
15-19|0.4|0.6|0.5|101|Mortality|21081020|Brain and Other Nervous System|2015
15-19|2.2|2.6|2.4|508|Incidence|21081020|Brain and Other Nervous System|2015
15-19|~|~|~|~|Mortality|10298487|Cervix|2015
15-19|~|~|~|~|Incidence|10298487|Cervix|2015
15-19|~|~|~|~|Mortality|21081020|Colon and Rectum|2015
15-19|1.2|1.5|1.3|276|Incidence|21081020|Colon and Rectum|2015
15-19|~|~|~|~|Mortality|10298487|Corpus and Uterus, NOS|2015
15-19|~|~|~|~|Incidence|10298487|Corpus and Uterus, NOS|2015
15-19|~|~|~|~|Mortality|21081020|Esophagus|2015
15-19|~|~|~|~|Incidence|21081020|Esophagus|2015
15-19|~|~|~|~|Mortality|10298487|Female Breast|2015
15-19|~|~|~|~|Incidence|10298487|Female Breast|2015
15-19|~|~|~|~|Incidence|10298487|Female Breast, <i>in situ</i>|2015
15-19|~|~|~|~|Mortality|21081020|Hodgkin Lymphoma|2015
15-19|2.9|3.4|3.2|670|Incidence|21081020|Hodgkin Lymphoma|2015
15-19|.|.|.|.|Mortality|21081020|Kaposi Sarcoma|2015
15-19|~|~|~|~|Incidence|21081020|Kaposi Sarcoma|2015
15-19|~|~|~|~|Mortality|21081020|Kidney and Renal Pelvis|2015
15-19|0.2|0.3|0.3|53|Incidence|21081020|Kidney and Renal Pelvis|2015
15-19|~|~|~|~|Mortality|21081020|Larynx|2015
15-19|~|~|~|~|Incidence|21081020|Larynx|2015
15-19|0.6|0.8|0.7|147|Mortality|21081020|Leukemias|2015
15-19|3.1|3.6|3.3|699|Incidence|21081020|Leukemias|2015
15-19|~|~|~|~|Mortality|21081020|Liver and Intrahepatic Bile Duct|2015
15-19|0.1|0.2|0.2|36|Incidence|21081020|Liver and Intrahepatic Bile Duct|2015
15-19|~|~|~|~|Mortality|21081020|Lung and Bronchus|2015
15-19|0.1|0.1|0.1|19|Incidence|21081020|Lung and Bronchus|2015
15-19|~|~|~|~|Mortality|10298487|Male and Female Breast|2015
15-19|~|~|~|~|Incidence|10298487|Male and Female Breast|2015
15-19|~|~|~|~|Incidence|10298487|Male and Female Breast, <i>in situ</i>|2015
15-19|~|~|~|~|Mortality|21081020|Melanomas of the Skin|2015
15-19|0.8|1.0|0.9|188|Incidence|21081020|Melanomas of the Skin|2015
15-19|~|~|~|~|Mortality|21081020|Mesothelioma|2015
15-19|~|~|~|~|Incidence|21081020|Mesothelioma|2015
15-19|~|~|~|~|Mortality|21081020|Myeloma|2015
15-19|~|~|~|~|Incidence|21081020|Myeloma|2015
15-19|0.1|0.2|0.2|38|Mortality|21081020|Non-Hodgkin Lymphoma|2015
15-19|1.8|2.2|2.0|427|Incidence|21081020|Non-Hodgkin Lymphoma|2015
15-19|~|~|~|~|Mortality|21081020|Oral Cavity and Pharynx|2015
15-19|0.4|0.6|0.5|104|Incidence|21081020|Oral Cavity and Pharynx|2015
15-19|~|~|~|~|Mortality|10298487|Ovary|2015
15-19|1.2|1.6|1.4|143|Incidence|10298487|Ovary|2015
15-19|~|~|~|~|Mortality|21081020|Pancreas|2015
15-19|0.1|0.2|0.1|28|Incidence|21081020|Pancreas|2015
15-19|~|~|~|~|Mortality|10782533|Prostate|2015
15-19|~|~|~|~|Incidence|10782533|Prostate|2015
15-19|~|~|~|~|Mortality|21081020|Stomach|2015
15-19|0.1|0.1|0.1|20|Incidence|21081020|Stomach|2015
15-19|~|~|~|~|Mortality|10782533|Testis|2015
15-19|3.5|4.2|3.9|416|Incidence|10782533|Testis|2015
15-19|~|~|~|~|Mortality|21081020|Thyroid|2015
15-19|3.0|3.5|3.3|692|Incidence|21081020|Thyroid|2015
15-19|~|~|~|~|Mortality|21081020|Urinary Bladder|2015
15-19|0.0|0.1|0.1|17|Incidence|21081020|Urinary Bladder|2015
5-9|1.9|2.3|2.1|437|Mortality|20476769|All Cancer Sites Combined|2015
5-9|13.3|14.3|13.8|2821|Incidence|20476769|All Cancer Sites Combined|2015
5-9|0.8|1.1|0.9|192|Mortality|20476769|Brain and Other Nervous System|2015
5-9|3.5|4.1|3.8|774|Incidence|20476769|Brain and Other Nervous System|2015
5-9|~|~|~|~|Mortality|10023239|Cervix|2015
5-9|~|~|~|~|Incidence|10023239|Cervix|2015
5-9|~|~|~|~|Mortality|20476769|Colon and Rectum|2015
5-9|0.1|0.2|0.1|24|Incidence|20476769|Colon and Rectum|2015
5-9|~|~|~|~|Mortality|10023239|Corpus and Uterus, NOS|2015
5-9|~|~|~|~|Incidence|10023239|Corpus and Uterus, NOS|2015
5-9|~|~|~|~|Mortality|20476769|Esophagus|2015
5-9|~|~|~|~|Incidence|20476769|Esophagus|2015
5-9|~|~|~|~|Mortality|10023239|Female Breast|2015
5-9|~|~|~|~|Incidence|10023239|Female Breast|2015
5-9|~|~|~|~|Incidence|10023239|Female Breast, <i>in situ</i>|2015
5-9|~|~|~|~|Mortality|20476769|Hodgkin Lymphoma|2015
5-9|0.3|0.5|0.4|82|Incidence|20476769|Hodgkin Lymphoma|2015
5-9|.|.|.|.|Mortality|20476769|Kaposi Sarcoma|2015
5-9|~|~|~|~|Incidence|20476769|Kaposi Sarcoma|2015
5-9|~|~|~|~|Mortality|20476769|Kidney and Renal Pelvis|2015
5-9|0.6|0.8|0.7|143|Incidence|20476769|Kidney and Renal Pelvis|2015
5-9|~|~|~|~|Mortality|20476769|Larynx|2015
5-9|~|~|~|~|Incidence|20476769|Larynx|2015
5-9|0.4|0.5|0.4|91|Mortality|20476769|Leukemias|2015
5-9|4.0|4.5|4.2|868|Incidence|20476769|Leukemias|2015
5-9|~|~|~|~|Mortality|20476769|Liver and Intrahepatic Bile Duct|2015
5-9|0.1|0.2|0.1|28|Incidence|20476769|Liver and Intrahepatic Bile Duct|2015
5-9|~|~|~|~|Mortality|20476769|Lung and Bronchus|2015
5-9|~|~|~|~|Incidence|20476769|Lung and Bronchus|2015
5-9|~|~|~|~|Mortality|10023239|Male and Female Breast|2015
5-9|~|~|~|~|Incidence|10023239|Male and Female Breast|2015
5-9|~|~|~|~|Incidence|10023239|Male and Female Breast, <i>in situ</i>|2015
5-9|~|~|~|~|Mortality|20476769|Melanomas of the Skin|2015
5-9|0.1|0.2|0.2|36|Incidence|20476769|Melanomas of the Skin|2015
5-9|~|~|~|~|Mortality|20476769|Mesothelioma|2015
5-9|~|~|~|~|Incidence|20476769|Mesothelioma|2015
5-9|~|~|~|~|Mortality|20476769|Myeloma|2015
5-9|~|~|~|~|Incidence|20476769|Myeloma|2015
5-9|~|~|~|~|Mortality|20476769|Non-Hodgkin Lymphoma|2015
5-9|1.0|1.3|1.1|231|Incidence|20476769|Non-Hodgkin Lymphoma|2015
5-9|~|~|~|~|Mortality|20476769|Oral Cavity and Pharynx|2015
5-9|0.1|0.2|0.1|23|Incidence|20476769|Oral Cavity and Pharynx|2015
5-9|~|~|~|~|Mortality|10023239|Ovary|2015
5-9|0.1|0.3|0.2|18|Incidence|10023239|Ovary|2015
5-9|~|~|~|~|Mortality|20476769|Pancreas|2015
5-9|~|~|~|~|Incidence|20476769|Pancreas|2015
5-9|~|~|~|~|Mortality|10453530|Prostate|2015
5-9|~|~|~|~|Incidence|10453530|Prostate|2015
5-9|~|~|~|~|Mortality|20476769|Stomach|2015
5-9|~|~|~|~|Incidence|20476769|Stomach|2015
5-9|~|~|~|~|Mortality|10453530|Testis|2015
5-9|~|~|~|~|Incidence|10453530|Testis|2015
5-9|~|~|~|~|Mortality|20476769|Thyroid|2015
5-9|0.1|0.2|0.1|24|Incidence|20476769|Thyroid|2015
5-9|~|~|~|~|Mortality|20476769|Urinary Bladder|2015
5-9|~|~|~|~|Incidence|20476769|Urinary Bladder|2015
<1|1.0|1.7|1.3|53|Mortality|3983981|All Cancer Sites Combined|2015
<1|28.0|31.4|29.6|1180|Incidence|3983981|All Cancer Sites Combined|2015
<1|~|~|~|~|Mortality|3983981|Brain and Other Nervous System|2015
<1|3.3|4.6|3.9|157|Incidence|3983981|Brain and Other Nervous System|2015
<1|~|~|~|~|Mortality|1946335|Cervix|2015
<1|~|~|~|~|Incidence|1946335|Cervix|2015
<1|~|~|~|~|Mortality|3983981|Colon and Rectum|2015
<1|~|~|~|~|Incidence|3983981|Colon and Rectum|2015
<1|~|~|~|~|Mortality|1946335|Corpus and Uterus, NOS|2015
<1|~|~|~|~|Incidence|1946335|Corpus and Uterus, NOS|2015
<1|~|~|~|~|Mortality|3983981|Esophagus|2015
<1|~|~|~|~|Incidence|3983981|Esophagus|2015
<1|~|~|~|~|Mortality|1946335|Female Breast|2015
<1|~|~|~|~|Incidence|1946335|Female Breast|2015
<1|~|~|~|~|Incidence|1946335|Female Breast, <i>in situ</i>|2015
<1|~|~|~|~|Mortality|3983981|Hodgkin Lymphoma|2015
<1|~|~|~|~|Incidence|3983981|Hodgkin Lymphoma|2015
<1|.|.|.|.|Mortality|3983981|Kaposi Sarcoma|2015
<1|~|~|~|~|Incidence|3983981|Kaposi Sarcoma|2015
<1|~|~|~|~|Mortality|3983981|Kidney and Renal Pelvis|2015
<1|1.7|2.6|2.1|84|Incidence|3983981|Kidney and Renal Pelvis|2015
<1|~|~|~|~|Mortality|3983981|Larynx|2015
<1|~|~|~|~|Incidence|3983981|Larynx|2015
<1|0.3|0.8|0.6|22|Mortality|3983981|Leukemias|2015
<1|3.8|5.1|4.4|176|Incidence|3983981|Leukemias|2015
<1|~|~|~|~|Mortality|3983981|Liver and Intrahepatic Bile Duct|2015
<1|1.3|2.1|1.6|65|Incidence|3983981|Liver and Intrahepatic Bile Duct|2015
<1|~|~|~|~|Mortality|3983981|Lung and Bronchus|2015
<1|~|~|~|~|Incidence|3983981|Lung and Bronchus|2015
<1|~|~|~|~|Mortality|1946335|Male and Female Breast|2015
<1|~|~|~|~|Incidence|1946335|Male and Female Breast|2015
<1|~|~|~|~|Incidence|1946335|Male and Female Breast, <i>in situ</i>|2015
<1|~|~|~|~|Mortality|3983981|Melanomas of the Skin|2015
<1|~|~|~|~|Incidence|3983981|Melanomas of the Skin|2015
<1|~|~|~|~|Mortality|3983981|Mesothelioma|2015
<1|~|~|~|~|Incidence|3983981|Mesothelioma|2015
<1|~|~|~|~|Mortality|3983981|Myeloma|2015
<1|~|~|~|~|Incidence|3983981|Myeloma|2015
<1|~|~|~|~|Mortality|3983981|Non-Hodgkin Lymphoma|2015
<1|~|~|~|~|Incidence|3983981|Non-Hodgkin Lymphoma|2015
<1|~|~|~|~|Mortality|3983981|Oral Cavity and Pharynx|2015
<1|~|~|~|~|Incidence|3983981|Oral Cavity and Pharynx|2015
<1|~|~|~|~|Mortality|1946335|Ovary|2015
<1|~|~|~|~|Incidence|1946335|Ovary|2015
<1|~|~|~|~|Mortality|3983981|Pancreas|2015
<1|~|~|~|~|Incidence|3983981|Pancreas|2015
<1|~|~|~|~|Mortality|2037646|Prostate|2015
<1|~|~|~|~|Incidence|2037646|Prostate|2015
<1|~|~|~|~|Mortality|3983981|Stomach|2015
<1|~|~|~|~|Incidence|3983981|Stomach|2015
<1|~|~|~|~|Mortality|2037646|Testis|2015
<1|~|~|~|~|Incidence|2037646|Testis|2015
<1|~|~|~|~|Mortality|3983981|Thyroid|2015
<1|~|~|~|~|Incidence|3983981|Thyroid|2015
<1|~|~|~|~|Mortality|3983981|Urinary Bladder|2015
<1|~|~|~|~|Incidence|3983981|Urinary Bladder|2015
1-4|2.1|2.6|2.4|377|Mortality|15966986|All Cancer Sites Combined|2016
1-4|22.0|23.5|22.8|3634|Incidence|15966986|All Cancer Sites Combined|2016
1-4|0.5|0.8|0.7|104|Mortality|15966986|Brain and Other Nervous System|2016
1-4|4.4|5.1|4.7|753|Incidence|15966986|Brain and Other Nervous System|2016
1-4|~|~|~|~|Mortality|7802134|Cervix|2016
1-4|~|~|~|~|Incidence|7802134|Cervix|2016
1-4|~|~|~|~|Mortality|15966986|Colon and Rectum|2016
1-4|~|~|~|~|Incidence|15966986|Colon and Rectum|2016
1-4|~|~|~|~|Mortality|7802134|Corpus and Uterus, NOS|2016
1-4|~|~|~|~|Incidence|7802134|Corpus and Uterus, NOS|2016
1-4|~|~|~|~|Mortality|15966986|Esophagus|2016
1-4|~|~|~|~|Incidence|15966986|Esophagus|2016
1-4|~|~|~|~|Mortality|7802134|Female Breast|2016
1-4|~|~|~|~|Incidence|7802134|Female Breast|2016
1-4|~|~|~|~|Incidence|7802134|Female Breast, <i>in situ</i>|2016
1-4|~|~|~|~|Mortality|15966986|Hodgkin Lymphoma|2016
1-4|~|~|~|~|Incidence|15966986|Hodgkin Lymphoma|2016
1-4|.|.|.|.|Mortality|15966986|Kaposi Sarcoma|2016
1-4|~|~|~|~|Incidence|15966986|Kaposi Sarcoma|2016
1-4|~|~|~|~|Mortality|15966986|Kidney and Renal Pelvis|2016
1-4|1.6|2.1|1.9|296|Incidence|15966986|Kidney and Renal Pelvis|2016
1-4|~|~|~|~|Mortality|15966986|Larynx|2016
1-4|~|~|~|~|Incidence|15966986|Larynx|2016
1-4|0.6|0.8|0.7|108|Mortality|15966986|Leukemias|2016
1-4|8.4|9.4|8.9|1419|Incidence|15966986|Leukemias|2016
1-4|0.1|0.2|0.2|25|Mortality|15966986|Liver and Intrahepatic Bile Duct|2016
1-4|0.5|0.7|0.6|97|Incidence|15966986|Liver and Intrahepatic Bile Duct|2016
1-4|~|~|~|~|Mortality|15966986|Lung and Bronchus|2016
1-4|0.1|0.2|0.1|17|Incidence|15966986|Lung and Bronchus|2016
1-4|~|~|~|~|Mortality|7802134|Male and Female Breast|2016
1-4|~|~|~|~|Incidence|7802134|Male and Female Breast|2016
1-4|~|~|~|~|Incidence|7802134|Male and Female Breast, <i>in situ</i>|2016
1-4|~|~|~|~|Mortality|15966986|Melanomas of the Skin|2016
1-4|0.1|0.2|0.1|17|Incidence|15966986|Melanomas of the Skin|2016
1-4|~|~|~|~|Mortality|15966986|Mesothelioma|2016
1-4|~|~|~|~|Incidence|15966986|Mesothelioma|2016
1-4|~|~|~|~|Mortality|15966986|Myeloma|2016
1-4|~|~|~|~|Incidence|15966986|Myeloma|2016
1-4|~|~|~|~|Mortality|15966986|Non-Hodgkin Lymphoma|2016
1-4|0.6|0.9|0.7|117|Incidence|15966986|Non-Hodgkin Lymphoma|2016
1-4|~|~|~|~|Mortality|15966986|Oral Cavity and Pharynx|2016
1-4|~|~|~|~|Incidence|15966986|Oral Cavity and Pharynx|2016
1-4|~|~|~|~|Mortality|7802134|Ovary|2016
1-4|~|~|~|~|Incidence|7802134|Ovary|2016
1-4|~|~|~|~|Mortality|15966986|Pancreas|2016
1-4|~|~|~|~|Incidence|15966986|Pancreas|2016
1-4|~|~|~|~|Mortality|8164852|Prostate|2016
1-4|~|~|~|~|Incidence|8164852|Prostate|2016
1-4|~|~|~|~|Mortality|15966986|Stomach|2016
1-4|~|~|~|~|Incidence|15966986|Stomach|2016
1-4|~|~|~|~|Mortality|8164852|Testis|2016
1-4|0.3|0.6|0.5|38|Incidence|8164852|Testis|2016
1-4|~|~|~|~|Mortality|15966986|Thyroid|2016
1-4|~|~|~|~|Incidence|15966986|Thyroid|2016
1-4|~|~|~|~|Mortality|15966986|Urinary Bladder|2016
1-4|~|~|~|~|Incidence|15966986|Urinary Bladder|2016
10-14|1.9|2.3|2.1|431|Mortality|20621321|All Cancer Sites Combined|2016
10-14|15.5|16.6|16.0|3305|Incidence|20621321|All Cancer Sites Combined|2016
10-14|0.6|0.8|0.7|141|Mortality|20621321|Brain and Other Nervous System|2016
10-14|2.7|3.2|2.9|601|Incidence|20621321|Brain and Other Nervous System|2016
10-14|~|~|~|~|Mortality|10098592|Cervix|2016
10-14|~|~|~|~|Incidence|10098592|Cervix|2016
10-14|~|~|~|~|Mortality|20621321|Colon and Rectum|2016
10-14|0.5|0.7|0.6|123|Incidence|20621321|Colon and Rectum|2016
10-14|~|~|~|~|Mortality|10098592|Corpus and Uterus, NOS|2016
10-14|~|~|~|~|Incidence|10098592|Corpus and Uterus, NOS|2016
10-14|~|~|~|~|Mortality|20621321|Esophagus|2016
10-14|~|~|~|~|Incidence|20621321|Esophagus|2016
10-14|~|~|~|~|Mortality|10098592|Female Breast|2016
10-14|~|~|~|~|Incidence|10098592|Female Breast|2016
10-14|~|~|~|~|Incidence|10098592|Female Breast, <i>in situ</i>|2016
10-14|~|~|~|~|Mortality|20621321|Hodgkin Lymphoma|2016
10-14|1.2|1.5|1.3|272|Incidence|20621321|Hodgkin Lymphoma|2016
10-14|.|.|.|.|Mortality|20621321|Kaposi Sarcoma|2016
10-14|~|~|~|~|Incidence|20621321|Kaposi Sarcoma|2016
10-14|~|~|~|~|Mortality|20621321|Kidney and Renal Pelvis|2016
10-14|0.2|0.3|0.2|43|Incidence|20621321|Kidney and Renal Pelvis|2016
10-14|~|~|~|~|Mortality|20621321|Larynx|2016
10-14|~|~|~|~|Incidence|20621321|Larynx|2016
10-14|0.4|0.6|0.5|108|Mortality|20621321|Leukemias|2016
10-14|3.4|3.9|3.6|747|Incidence|20621321|Leukemias|2016
10-14|~|~|~|~|Mortality|20621321|Liver and Intrahepatic Bile Duct|2016
10-14|0.1|0.2|0.1|21|Incidence|20621321|Liver and Intrahepatic Bile Duct|2016
10-14|~|~|~|~|Mortality|20621321|Lung and Bronchus|2016
10-14|~|~|~|~|Incidence|20621321|Lung and Bronchus|2016
10-14|~|~|~|~|Mortality|10098592|Male and Female Breast|2016
10-14|~|~|~|~|Incidence|10098592|Male and Female Breast|2016
10-14|~|~|~|~|Incidence|10098592|Male and Female Breast, <i>in situ</i>|2016
10-14|~|~|~|~|Mortality|20621321|Melanomas of the Skin|2016
10-14|0.2|0.3|0.3|54|Incidence|20621321|Melanomas of the Skin|2016
10-14|~|~|~|~|Mortality|20621321|Mesothelioma|2016
10-14|~|~|~|~|Incidence|20621321|Mesothelioma|2016
10-14|~|~|~|~|Mortality|20621321|Myeloma|2016
10-14|~|~|~|~|Incidence|20621321|Myeloma|2016
10-14|~|~|~|~|Mortality|20621321|Non-Hodgkin Lymphoma|2016
10-14|1.3|1.7|1.5|305|Incidence|20621321|Non-Hodgkin Lymphoma|2016
10-14|~|~|~|~|Mortality|20621321|Oral Cavity and Pharynx|2016
10-14|0.2|0.4|0.3|56|Incidence|20621321|Oral Cavity and Pharynx|2016
10-14|~|~|~|~|Mortality|10098592|Ovary|2016
10-14|0.6|0.9|0.7|72|Incidence|10098592|Ovary|2016
10-14|~|~|~|~|Mortality|20621321|Pancreas|2016
10-14|0.1|0.2|0.1|23|Incidence|20621321|Pancreas|2016
10-14|~|~|~|~|Mortality|10522729|Prostate|2016
10-14|~|~|~|~|Incidence|10522729|Prostate|2016
10-14|~|~|~|~|Mortality|20621321|Stomach|2016
10-14|~|~|~|~|Incidence|20621321|Stomach|2016
10-14|~|~|~|~|Mortality|10522729|Testis|2016
10-14|0.1|0.3|0.2|24|Incidence|10522729|Testis|2016
10-14|~|~|~|~|Mortality|20621321|Thyroid|2016
10-14|0.7|1.0|0.8|175|Incidence|20621321|Thyroid|2016
10-14|~|~|~|~|Mortality|20621321|Urinary Bladder|2016
10-14|~|~|~|~|Incidence|20621321|Urinary Bladder|2016
15-19|2.6|3.1|2.8|596|Mortality|21129270|All Cancer Sites Combined|2016
15-19|23.9|25.2|24.5|5186|Incidence|21129270|All Cancer Sites Combined|2016
15-19|0.4|0.6|0.5|108|Mortality|21129270|Brain and Other Nervous System|2016
15-19|1.9|2.3|2.1|447|Incidence|21129270|Brain and Other Nervous System|2016
15-19|~|~|~|~|Mortality|10329800|Cervix|2016
15-19|~|~|~|~|Incidence|10329800|Cervix|2016
15-19|~|~|~|~|Mortality|21129270|Colon and Rectum|2016
15-19|1.3|1.6|1.4|302|Incidence|21129270|Colon and Rectum|2016
15-19|~|~|~|~|Mortality|10329800|Corpus and Uterus, NOS|2016
15-19|~|~|~|~|Incidence|10329800|Corpus and Uterus, NOS|2016
15-19|~|~|~|~|Mortality|21129270|Esophagus|2016
15-19|~|~|~|~|Incidence|21129270|Esophagus|2016
15-19|~|~|~|~|Mortality|10329800|Female Breast|2016
15-19|0.1|0.3|0.2|19|Incidence|10329800|Female Breast|2016
15-19|~|~|~|~|Incidence|10329800|Female Breast, <i>in situ</i>|2016
15-19|~|~|~|~|Mortality|21129270|Hodgkin Lymphoma|2016
15-19|3.0|3.5|3.3|688|Incidence|21129270|Hodgkin Lymphoma|2016
15-19|.|.|.|.|Mortality|21129270|Kaposi Sarcoma|2016
15-19|~|~|~|~|Incidence|21129270|Kaposi Sarcoma|2016
15-19|~|~|~|~|Mortality|21129270|Kidney and Renal Pelvis|2016
15-19|0.2|0.3|0.2|47|Incidence|21129270|Kidney and Renal Pelvis|2016
15-19|~|~|~|~|Mortality|21129270|Larynx|2016
15-19|~|~|~|~|Incidence|21129270|Larynx|2016
15-19|0.6|0.8|0.7|148|Mortality|21129270|Leukemias|2016
15-19|3.0|3.5|3.2|678|Incidence|21129270|Leukemias|2016
15-19|~|~|~|~|Mortality|21129270|Liver and Intrahepatic Bile Duct|2016
15-19|0.1|0.2|0.1|26|Incidence|21129270|Liver and Intrahepatic Bile Duct|2016
15-19|~|~|~|~|Mortality|21129270|Lung and Bronchus|2016
15-19|0.1|0.2|0.1|30|Incidence|21129270|Lung and Bronchus|2016
15-19|~|~|~|~|Mortality|10329800|Male and Female Breast|2016
15-19|0.1|0.3|0.2|19|Incidence|10329800|Male and Female Breast|2016
15-19|~|~|~|~|Incidence|10329800|Male and Female Breast, <i>in situ</i>|2016
15-19|~|~|~|~|Mortality|21129270|Melanomas of the Skin|2016
15-19|0.8|1.1|0.9|196|Incidence|21129270|Melanomas of the Skin|2016
15-19|~|~|~|~|Mortality|21129270|Mesothelioma|2016
15-19|~|~|~|~|Incidence|21129270|Mesothelioma|2016
15-19|~|~|~|~|Mortality|21129270|Myeloma|2016
15-19|~|~|~|~|Incidence|21129270|Myeloma|2016
15-19|0.1|0.2|0.1|29|Mortality|21129270|Non-Hodgkin Lymphoma|2016
15-19|1.8|2.2|2.0|420|Incidence|21129270|Non-Hodgkin Lymphoma|2016
15-19|~|~|~|~|Mortality|21129270|Oral Cavity and Pharynx|2016
15-19|0.4|0.6|0.5|105|Incidence|21129270|Oral Cavity and Pharynx|2016
15-19|~|~|~|~|Mortality|10329800|Ovary|2016
15-19|1.0|1.5|1.2|129|Incidence|10329800|Ovary|2016
15-19|~|~|~|~|Mortality|21129270|Pancreas|2016
15-19|0.1|0.2|0.2|33|Incidence|21129270|Pancreas|2016
15-19|~|~|~|~|Mortality|10799470|Prostate|2016
15-19|~|~|~|~|Incidence|10799470|Prostate|2016
15-19|~|~|~|~|Mortality|21129270|Stomach|2016
15-19|0.1|0.1|0.1|18|Incidence|21129270|Stomach|2016
15-19|~|~|~|~|Mortality|10799470|Testis|2016
15-19|3.1|3.9|3.5|377|Incidence|10799470|Testis|2016
15-19|~|~|~|~|Mortality|21129270|Thyroid|2016
15-19|3.2|3.7|3.4|725|Incidence|21129270|Thyroid|2016
15-19|~|~|~|~|Mortality|21129270|Urinary Bladder|2016
15-19|~|~|~|~|Incidence|21129270|Urinary Bladder|2016
5-9|2.0|2.4|2.2|449|Mortality|20434232|All Cancer Sites Combined|2016
5-9|13.2|14.2|13.7|2790|Incidence|20434232|All Cancer Sites Combined|2016
5-9|0.8|1.1|0.9|186|Mortality|20434232|Brain and Other Nervous System|2016
5-9|3.3|3.8|3.5|716|Incidence|20434232|Brain and Other Nervous System|2016
5-9|~|~|~|~|Mortality|10000153|Cervix|2016
5-9|~|~|~|~|Incidence|10000153|Cervix|2016
5-9|~|~|~|~|Mortality|20434232|Colon and Rectum|2016
5-9|0.0|0.1|0.1|16|Incidence|20434232|Colon and Rectum|2016
5-9|~|~|~|~|Mortality|10000153|Corpus and Uterus, NOS|2016
5-9|~|~|~|~|Incidence|10000153|Corpus and Uterus, NOS|2016
5-9|~|~|~|~|Mortality|20434232|Esophagus|2016
5-9|~|~|~|~|Incidence|20434232|Esophagus|2016
5-9|~|~|~|~|Mortality|10000153|Female Breast|2016
5-9|~|~|~|~|Incidence|10000153|Female Breast|2016
5-9|~|~|~|~|Incidence|10000153|Female Breast, <i>in situ</i>|2016
5-9|~|~|~|~|Mortality|20434232|Hodgkin Lymphoma|2016
5-9|0.3|0.4|0.3|70|Incidence|20434232|Hodgkin Lymphoma|2016
5-9|.|.|.|.|Mortality|20434232|Kaposi Sarcoma|2016
5-9|~|~|~|~|Incidence|20434232|Kaposi Sarcoma|2016
5-9|~|~|~|~|Mortality|20434232|Kidney and Renal Pelvis|2016
5-9|0.6|0.8|0.7|142|Incidence|20434232|Kidney and Renal Pelvis|2016
5-9|~|~|~|~|Mortality|20434232|Larynx|2016
5-9|~|~|~|~|Incidence|20434232|Larynx|2016
5-9|0.4|0.6|0.5|106|Mortality|20434232|Leukemias|2016
5-9|4.0|4.6|4.3|880|Incidence|20434232|Leukemias|2016
5-9|~|~|~|~|Mortality|20434232|Liver and Intrahepatic Bile Duct|2016
5-9|0.1|0.2|0.1|28|Incidence|20434232|Liver and Intrahepatic Bile Duct|2016
5-9|~|~|~|~|Mortality|20434232|Lung and Bronchus|2016
5-9|~|~|~|~|Incidence|20434232|Lung and Bronchus|2016
5-9|~|~|~|~|Mortality|10000153|Male and Female Breast|2016
5-9|~|~|~|~|Incidence|10000153|Male and Female Breast|2016
5-9|~|~|~|~|Incidence|10000153|Male and Female Breast, <i>in situ</i>|2016
5-9|~|~|~|~|Mortality|20434232|Melanomas of the Skin|2016
5-9|0.1|0.2|0.1|29|Incidence|20434232|Melanomas of the Skin|2016
5-9|~|~|~|~|Mortality|20434232|Mesothelioma|2016
5-9|~|~|~|~|Incidence|20434232|Mesothelioma|2016
5-9|~|~|~|~|Mortality|20434232|Myeloma|2016
5-9|~|~|~|~|Incidence|20434232|Myeloma|2016
5-9|~|~|~|~|Mortality|20434232|Non-Hodgkin Lymphoma|2016
5-9|1.0|1.3|1.2|236|Incidence|20434232|Non-Hodgkin Lymphoma|2016
5-9|~|~|~|~|Mortality|20434232|Oral Cavity and Pharynx|2016
5-9|0.1|0.2|0.1|21|Incidence|20434232|Oral Cavity and Pharynx|2016
5-9|~|~|~|~|Mortality|10000153|Ovary|2016
5-9|0.2|0.4|0.3|31|Incidence|10000153|Ovary|2016
5-9|~|~|~|~|Mortality|20434232|Pancreas|2016
5-9|~|~|~|~|Incidence|20434232|Pancreas|2016
5-9|~|~|~|~|Mortality|10434079|Prostate|2016
5-9|~|~|~|~|Incidence|10434079|Prostate|2016
5-9|~|~|~|~|Mortality|20434232|Stomach|2016
5-9|~|~|~|~|Incidence|20434232|Stomach|2016
5-9|~|~|~|~|Mortality|10434079|Testis|2016
5-9|~|~|~|~|Incidence|10434079|Testis|2016
5-9|~|~|~|~|Mortality|20434232|Thyroid|2016
5-9|0.1|0.2|0.2|32|Incidence|20434232|Thyroid|2016
5-9|~|~|~|~|Mortality|20434232|Urinary Bladder|2016
5-9|~|~|~|~|Incidence|20434232|Urinary Bladder|2016
<1|1.3|2.2|1.7|67|Mortality|3954773|All Cancer Sites Combined|2016
<1|26.5|29.9|28.2|1114|Incidence|3954773|All Cancer Sites Combined|2016
<1|~|~|~|~|Mortality|3954773|Brain and Other Nervous System|2016
<1|3.7|5.0|4.3|169|Incidence|3954773|Brain and Other Nervous System|2016
<1|~|~|~|~|Mortality|1933398|Cervix|2016
<1|~|~|~|~|Incidence|1933398|Cervix|2016
<1|~|~|~|~|Mortality|3954773|Colon and Rectum|2016
<1|~|~|~|~|Incidence|3954773|Colon and Rectum|2016
<1|~|~|~|~|Mortality|1933398|Corpus and Uterus, NOS|2016
<1|~|~|~|~|Incidence|1933398|Corpus and Uterus, NOS|2016
<1|~|~|~|~|Mortality|3954773|Esophagus|2016
<1|~|~|~|~|Incidence|3954773|Esophagus|2016
<1|~|~|~|~|Mortality|1933398|Female Breast|2016
<1|~|~|~|~|Incidence|1933398|Female Breast|2016
<1|~|~|~|~|Incidence|1933398|Female Breast, <i>in situ</i>|2016
<1|~|~|~|~|Mortality|3954773|Hodgkin Lymphoma|2016
<1|~|~|~|~|Incidence|3954773|Hodgkin Lymphoma|2016
<1|.|.|.|.|Mortality|3954773|Kaposi Sarcoma|2016
<1|~|~|~|~|Incidence|3954773|Kaposi Sarcoma|2016
<1|~|~|~|~|Mortality|3954773|Kidney and Renal Pelvis|2016
<1|1.2|2.1|1.6|64|Incidence|3954773|Kidney and Renal Pelvis|2016
<1|~|~|~|~|Mortality|3954773|Larynx|2016
<1|~|~|~|~|Incidence|3954773|Larynx|2016
<1|0.5|1.1|0.7|29|Mortality|3954773|Leukemias|2016
<1|3.7|5.0|4.3|172|Incidence|3954773|Leukemias|2016
<1|~|~|~|~|Mortality|3954773|Liver and Intrahepatic Bile Duct|2016
<1|1.5|2.4|1.9|77|Incidence|3954773|Liver and Intrahepatic Bile Duct|2016
<1|~|~|~|~|Mortality|3954773|Lung and Bronchus|2016
<1|~|~|~|~|Incidence|3954773|Lung and Bronchus|2016
<1|~|~|~|~|Mortality|1933398|Male and Female Breast|2016
<1|~|~|~|~|Incidence|1933398|Male and Female Breast|2016
<1|~|~|~|~|Incidence|1933398|Male and Female Breast, <i>in situ</i>|2016
<1|~|~|~|~|Mortality|3954773|Melanomas of the Skin|2016
<1|~|~|~|~|Incidence|3954773|Melanomas of the Skin|2016
<1|~|~|~|~|Mortality|3954773|Mesothelioma|2016
<1|~|~|~|~|Incidence|3954773|Mesothelioma|2016
<1|~|~|~|~|Mortality|3954773|Myeloma|2016
<1|~|~|~|~|Incidence|3954773|Myeloma|2016
<1|~|~|~|~|Mortality|3954773|Non-Hodgkin Lymphoma|2016
<1|~|~|~|~|Incidence|3954773|Non-Hodgkin Lymphoma|2016
<1|~|~|~|~|Mortality|3954773|Oral Cavity and Pharynx|2016
<1|~|~|~|~|Incidence|3954773|Oral Cavity and Pharynx|2016
<1|~|~|~|~|Mortality|1933398|Ovary|2016
<1|~|~|~|~|Incidence|1933398|Ovary|2016
<1|~|~|~|~|Mortality|3954773|Pancreas|2016
<1|~|~|~|~|Incidence|3954773|Pancreas|2016
<1|~|~|~|~|Mortality|2021375|Prostate|2016
<1|~|~|~|~|Incidence|2021375|Prostate|2016
<1|~|~|~|~|Mortality|3954773|Stomach|2016
<1|~|~|~|~|Incidence|3954773|Stomach|2016
<1|~|~|~|~|Mortality|2021375|Testis|2016
<1|~|~|~|~|Incidence|2021375|Testis|2016
<1|~|~|~|~|Mortality|3954773|Thyroid|2016
<1|~|~|~|~|Incidence|3954773|Thyroid|2016
<1|~|~|~|~|Mortality|3954773|Urinary Bladder|2016
<1|~|~|~|~|Incidence|3954773|Urinary Bladder|2016
1-4|1.8|2.3|2.0|325|Mortality|15996982|All Cancer Sites Combined|2017
1-4|21.9|23.4|22.6|3617|Incidence|15996982|All Cancer Sites Combined|2017
1-4|0.4|0.6|0.5|73|Mortality|15996982|Brain and Other Nervous System|2017
1-4|4.3|5.0|4.6|743|Incidence|15996982|Brain and Other Nervous System|2017
1-4|~|~|~|~|Mortality|7817813|Cervix|2017
1-4|~|~|~|~|Incidence|7817813|Cervix|2017
1-4|~|~|~|~|Mortality|15996982|Colon and Rectum|2017
1-4|~|~|~|~|Incidence|15996982|Colon and Rectum|2017
1-4|~|~|~|~|Mortality|7817813|Corpus and Uterus, NOS|2017
1-4|~|~|~|~|Incidence|7817813|Corpus and Uterus, NOS|2017
1-4|~|~|~|~|Mortality|15996982|Esophagus|2017
1-4|~|~|~|~|Incidence|15996982|Esophagus|2017
1-4|~|~|~|~|Mortality|7817813|Female Breast|2017
1-4|~|~|~|~|Incidence|7817813|Female Breast|2017
1-4|~|~|~|~|Incidence|7817813|Female Breast, <i>in situ</i>|2017
1-4|~|~|~|~|Mortality|15996982|Hodgkin Lymphoma|2017
1-4|~|~|~|~|Incidence|15996982|Hodgkin Lymphoma|2017
1-4|.|.|.|.|Mortality|15996982|Kaposi Sarcoma|2017
1-4|~|~|~|~|Incidence|15996982|Kaposi Sarcoma|2017
1-4|0.1|0.2|0.1|16|Mortality|15996982|Kidney and Renal Pelvis|2017
1-4|1.7|2.1|1.9|305|Incidence|15996982|Kidney and Renal Pelvis|2017
1-4|~|~|~|~|Mortality|15996982|Larynx|2017
1-4|~|~|~|~|Incidence|15996982|Larynx|2017
1-4|0.6|0.8|0.7|110|Mortality|15996982|Leukemias|2017
1-4|8.2|9.1|8.6|1382|Incidence|15996982|Leukemias|2017
1-4|~|~|~|~|Mortality|15996982|Liver and Intrahepatic Bile Duct|2017
1-4|0.5|0.8|0.7|107|Incidence|15996982|Liver and Intrahepatic Bile Duct|2017
1-4|~|~|~|~|Mortality|15996982|Lung and Bronchus|2017
1-4|0.1|0.2|0.1|17|Incidence|15996982|Lung and Bronchus|2017
1-4|~|~|~|~|Mortality|7817813|Male and Female Breast|2017
1-4|~|~|~|~|Incidence|7817813|Male and Female Breast|2017
1-4|~|~|~|~|Incidence|7817813|Male and Female Breast, <i>in situ</i>|2017
1-4|~|~|~|~|Mortality|15996982|Melanomas of the Skin|2017
1-4|~|~|~|~|Incidence|15996982|Melanomas of the Skin|2017
1-4|~|~|~|~|Mortality|15996982|Mesothelioma|2017
1-4|~|~|~|~|Incidence|15996982|Mesothelioma|2017
1-4|~|~|~|~|Mortality|15996982|Myeloma|2017
1-4|~|~|~|~|Incidence|15996982|Myeloma|2017
1-4|~|~|~|~|Mortality|15996982|Non-Hodgkin Lymphoma|2017
1-4|0.6|0.8|0.7|108|Incidence|15996982|Non-Hodgkin Lymphoma|2017
1-4|~|~|~|~|Mortality|15996982|Oral Cavity and Pharynx|2017
1-4|~|~|~|~|Incidence|15996982|Oral Cavity and Pharynx|2017
1-4|~|~|~|~|Mortality|7817813|Ovary|2017
1-4|~|~|~|~|Incidence|7817813|Ovary|2017
1-4|~|~|~|~|Mortality|15996982|Pancreas|2017
1-4|~|~|~|~|Incidence|15996982|Pancreas|2017
1-4|~|~|~|~|Mortality|8179169|Prostate|2017
1-4|~|~|~|~|Incidence|8179169|Prostate|2017
1-4|~|~|~|~|Mortality|15996982|Stomach|2017
1-4|~|~|~|~|Incidence|15996982|Stomach|2017
1-4|~|~|~|~|Mortality|8179169|Testis|2017
1-4|0.2|0.4|0.3|21|Incidence|8179169|Testis|2017
1-4|~|~|~|~|Mortality|15996982|Thyroid|2017
1-4|~|~|~|~|Incidence|15996982|Thyroid|2017
1-4|~|~|~|~|Mortality|15996982|Urinary Bladder|2017
1-4|~|~|~|~|Incidence|15996982|Urinary Bladder|2017
10-14|1.9|2.3|2.1|437|Mortality|20767794|All Cancer Sites Combined|2017
10-14|15.0|16.1|15.5|3222|Incidence|20767794|All Cancer Sites Combined|2017
10-14|0.6|0.8|0.7|137|Mortality|20767794|Brain and Other Nervous System|2017
10-14|3.0|3.5|3.2|671|Incidence|20767794|Brain and Other Nervous System|2017
10-14|~|~|~|~|Mortality|10166733|Cervix|2017
10-14|~|~|~|~|Incidence|10166733|Cervix|2017
10-14|~|~|~|~|Mortality|20767794|Colon and Rectum|2017
10-14|0.5|0.7|0.6|123|Incidence|20767794|Colon and Rectum|2017
10-14|~|~|~|~|Mortality|10166733|Corpus and Uterus, NOS|2017
10-14|~|~|~|~|Incidence|10166733|Corpus and Uterus, NOS|2017
10-14|~|~|~|~|Mortality|20767794|Esophagus|2017
10-14|~|~|~|~|Incidence|20767794|Esophagus|2017
10-14|~|~|~|~|Mortality|10166733|Female Breast|2017
10-14|~|~|~|~|Incidence|10166733|Female Breast|2017
10-14|~|~|~|~|Incidence|10166733|Female Breast, <i>in situ</i>|2017
10-14|~|~|~|~|Mortality|20767794|Hodgkin Lymphoma|2017
10-14|1.1|1.4|1.3|261|Incidence|20767794|Hodgkin Lymphoma|2017
10-14|.|.|.|.|Mortality|20767794|Kaposi Sarcoma|2017
10-14|~|~|~|~|Incidence|20767794|Kaposi Sarcoma|2017
10-14|~|~|~|~|Mortality|20767794|Kidney and Renal Pelvis|2017
10-14|0.1|0.3|0.2|43|Incidence|20767794|Kidney and Renal Pelvis|2017
10-14|~|~|~|~|Mortality|20767794|Larynx|2017
10-14|~|~|~|~|Incidence|20767794|Larynx|2017
10-14|0.4|0.6|0.5|109|Mortality|20767794|Leukemias|2017
10-14|3.1|3.6|3.3|687|Incidence|20767794|Leukemias|2017
10-14|~|~|~|~|Mortality|20767794|Liver and Intrahepatic Bile Duct|2017
10-14|0.0|0.1|0.1|16|Incidence|20767794|Liver and Intrahepatic Bile Duct|2017
10-14|~|~|~|~|Mortality|20767794|Lung and Bronchus|2017
10-14|~|~|~|~|Incidence|20767794|Lung and Bronchus|2017
10-14|~|~|~|~|Mortality|10166733|Male and Female Breast|2017
10-14|~|~|~|~|Incidence|10166733|Male and Female Breast|2017
10-14|~|~|~|~|Incidence|10166733|Male and Female Breast, <i>in situ</i>|2017
10-14|~|~|~|~|Mortality|20767794|Melanomas of the Skin|2017
10-14|0.1|0.2|0.2|34|Incidence|20767794|Melanomas of the Skin|2017
10-14|~|~|~|~|Mortality|20767794|Mesothelioma|2017
10-14|~|~|~|~|Incidence|20767794|Mesothelioma|2017
10-14|~|~|~|~|Mortality|20767794|Myeloma|2017
10-14|~|~|~|~|Incidence|20767794|Myeloma|2017
10-14|0.1|0.2|0.1|22|Mortality|20767794|Non-Hodgkin Lymphoma|2017
10-14|1.1|1.5|1.3|268|Incidence|20767794|Non-Hodgkin Lymphoma|2017
10-14|~|~|~|~|Mortality|20767794|Oral Cavity and Pharynx|2017
10-14|0.2|0.4|0.3|63|Incidence|20767794|Oral Cavity and Pharynx|2017
10-14|~|~|~|~|Mortality|10166733|Ovary|2017
10-14|0.7|1.1|0.9|87|Incidence|10166733|Ovary|2017
10-14|~|~|~|~|Mortality|20767794|Pancreas|2017
10-14|0.1|0.1|0.1|18|Incidence|20767794|Pancreas|2017
10-14|~|~|~|~|Mortality|10601061|Prostate|2017
10-14|~|~|~|~|Incidence|10601061|Prostate|2017
10-14|~|~|~|~|Mortality|20767794|Stomach|2017
10-14|~|~|~|~|Incidence|20767794|Stomach|2017
10-14|~|~|~|~|Mortality|10601061|Testis|2017
10-14|0.2|0.3|0.2|25|Incidence|10601061|Testis|2017
10-14|~|~|~|~|Mortality|20767794|Thyroid|2017
10-14|0.7|0.9|0.8|161|Incidence|20767794|Thyroid|2017
10-14|~|~|~|~|Mortality|20767794|Urinary Bladder|2017
10-14|~|~|~|~|Incidence|20767794|Urinary Bladder|2017
15-19|2.4|2.9|2.7|560|Mortality|21094597|All Cancer Sites Combined|2017
15-19|22.9|24.2|23.5|4963|Incidence|21094597|All Cancer Sites Combined|2017
15-19|0.4|0.6|0.5|97|Mortality|21094597|Brain and Other Nervous System|2017
15-19|2.2|2.7|2.5|518|Incidence|21094597|Brain and Other Nervous System|2017
15-19|~|~|~|~|Mortality|10316950|Cervix|2017
15-19|~|~|~|~|Incidence|10316950|Cervix|2017
15-19|~|~|~|~|Mortality|21094597|Colon and Rectum|2017
15-19|1.1|1.4|1.2|260|Incidence|21094597|Colon and Rectum|2017
15-19|~|~|~|~|Mortality|10316950|Corpus and Uterus, NOS|2017
15-19|~|~|~|~|Incidence|10316950|Corpus and Uterus, NOS|2017
15-19|~|~|~|~|Mortality|21094597|Esophagus|2017
15-19|~|~|~|~|Incidence|21094597|Esophagus|2017
15-19|~|~|~|~|Mortality|10316950|Female Breast|2017
15-19|0.1|0.3|0.2|21|Incidence|10316950|Female Breast|2017
15-19|~|~|~|~|Incidence|10316950|Female Breast, <i>in situ</i>|2017
15-19|~|~|~|~|Mortality|21094597|Hodgkin Lymphoma|2017
15-19|2.9|3.4|3.1|659|Incidence|21094597|Hodgkin Lymphoma|2017
15-19|.|.|.|.|Mortality|21094597|Kaposi Sarcoma|2017
15-19|~|~|~|~|Incidence|21094597|Kaposi Sarcoma|2017
15-19|~|~|~|~|Mortality|21094597|Kidney and Renal Pelvis|2017
15-19|0.1|0.3|0.2|43|Incidence|21094597|Kidney and Renal Pelvis|2017
15-19|~|~|~|~|Mortality|21094597|Larynx|2017
15-19|~|~|~|~|Incidence|21094597|Larynx|2017
15-19|0.6|0.8|0.7|145|Mortality|21094597|Leukemias|2017
15-19|2.8|3.2|3.0|629|Incidence|21094597|Leukemias|2017
15-19|~|~|~|~|Mortality|21094597|Liver and Intrahepatic Bile Duct|2017
15-19|0.1|0.2|0.2|32|Incidence|21094597|Liver and Intrahepatic Bile Duct|2017
15-19|~|~|~|~|Mortality|21094597|Lung and Bronchus|2017
15-19|0.1|0.2|0.1|22|Incidence|21094597|Lung and Bronchus|2017
15-19|~|~|~|~|Mortality|10316950|Male and Female Breast|2017
15-19|0.1|0.3|0.2|21|Incidence|10316950|Male and Female Breast|2017
15-19|~|~|~|~|Incidence|10316950|Male and Female Breast, <i>in situ</i>|2017
15-19|~|~|~|~|Mortality|21094597|Melanomas of the Skin|2017
15-19|0.6|0.9|0.7|158|Incidence|21094597|Melanomas of the Skin|2017
15-19|~|~|~|~|Mortality|21094597|Mesothelioma|2017
15-19|~|~|~|~|Incidence|21094597|Mesothelioma|2017
15-19|~|~|~|~|Mortality|21094597|Myeloma|2017
15-19|~|~|~|~|Incidence|21094597|Myeloma|2017
15-19|0.1|0.2|0.1|24|Mortality|21094597|Non-Hodgkin Lymphoma|2017
15-19|1.8|2.1|1.9|409|Incidence|21094597|Non-Hodgkin Lymphoma|2017
15-19|~|~|~|~|Mortality|21094597|Oral Cavity and Pharynx|2017
15-19|0.4|0.5|0.4|94|Incidence|21094597|Oral Cavity and Pharynx|2017
15-19|~|~|~|~|Mortality|10316950|Ovary|2017
15-19|1.0|1.4|1.2|121|Incidence|10316950|Ovary|2017
15-19|~|~|~|~|Mortality|21094597|Pancreas|2017
15-19|0.1|0.2|0.1|29|Incidence|21094597|Pancreas|2017
15-19|~|~|~|~|Mortality|10777647|Prostate|2017
15-19|~|~|~|~|Incidence|10777647|Prostate|2017
15-19|~|~|~|~|Mortality|21094597|Stomach|2017
15-19|0.0|0.1|0.1|17|Incidence|21094597|Stomach|2017
15-19|~|~|~|~|Mortality|10777647|Testis|2017
15-19|3.0|3.7|3.3|360|Incidence|10777647|Testis|2017
15-19|~|~|~|~|Mortality|21094597|Thyroid|2017
15-19|2.9|3.3|3.1|653|Incidence|21094597|Thyroid|2017
15-19|~|~|~|~|Mortality|21094597|Urinary Bladder|2017
15-19|0.1|0.1|0.1|20|Incidence|21094597|Urinary Bladder|2017
5-9|1.9|2.3|2.1|418|Mortality|20309346|All Cancer Sites Combined|2017
5-9|12.5|13.5|13.0|2647|Incidence|20309346|All Cancer Sites Combined|2017
5-9|0.8|1.1|1.0|199|Mortality|20309346|Brain and Other Nervous System|2017
5-9|3.5|4.0|3.7|757|Incidence|20309346|Brain and Other Nervous System|2017
5-9|~|~|~|~|Mortality|9937741|Cervix|2017
5-9|~|~|~|~|Incidence|9937741|Cervix|2017
5-9|~|~|~|~|Mortality|20309346|Colon and Rectum|2017
5-9|0.1|0.2|0.1|20|Incidence|20309346|Colon and Rectum|2017
5-9|~|~|~|~|Mortality|9937741|Corpus and Uterus, NOS|2017
5-9|~|~|~|~|Incidence|9937741|Corpus and Uterus, NOS|2017
5-9|~|~|~|~|Mortality|20309346|Esophagus|2017
5-9|~|~|~|~|Incidence|20309346|Esophagus|2017
5-9|~|~|~|~|Mortality|9937741|Female Breast|2017
5-9|~|~|~|~|Incidence|9937741|Female Breast|2017
5-9|~|~|~|~|Incidence|9937741|Female Breast, <i>in situ</i>|2017
5-9|~|~|~|~|Mortality|20309346|Hodgkin Lymphoma|2017
5-9|0.3|0.5|0.4|79|Incidence|20309346|Hodgkin Lymphoma|2017
5-9|.|.|.|.|Mortality|20309346|Kaposi Sarcoma|2017
5-9|~|~|~|~|Incidence|20309346|Kaposi Sarcoma|2017
5-9|~|~|~|~|Mortality|20309346|Kidney and Renal Pelvis|2017
5-9|0.5|0.7|0.6|128|Incidence|20309346|Kidney and Renal Pelvis|2017
5-9|~|~|~|~|Mortality|20309346|Larynx|2017
5-9|~|~|~|~|Incidence|20309346|Larynx|2017
5-9|0.3|0.5|0.4|77|Mortality|20309346|Leukemias|2017
5-9|3.6|4.1|3.9|782|Incidence|20309346|Leukemias|2017
5-9|~|~|~|~|Mortality|20309346|Liver and Intrahepatic Bile Duct|2017
5-9|0.1|0.2|0.1|26|Incidence|20309346|Liver and Intrahepatic Bile Duct|2017
5-9|~|~|~|~|Mortality|20309346|Lung and Bronchus|2017
5-9|~|~|~|~|Incidence|20309346|Lung and Bronchus|2017
5-9|~|~|~|~|Mortality|9937741|Male and Female Breast|2017
5-9|~|~|~|~|Incidence|9937741|Male and Female Breast|2017
5-9|~|~|~|~|Incidence|9937741|Male and Female Breast, <i>in situ</i>|2017
5-9|~|~|~|~|Mortality|20309346|Melanomas of the Skin|2017
5-9|0.1|0.2|0.1|22|Incidence|20309346|Melanomas of the Skin|2017
5-9|~|~|~|~|Mortality|20309346|Mesothelioma|2017
5-9|~|~|~|~|Incidence|20309346|Mesothelioma|2017
5-9|~|~|~|~|Mortality|20309346|Myeloma|2017
5-9|~|~|~|~|Incidence|20309346|Myeloma|2017
5-9|~|~|~|~|Mortality|20309346|Non-Hodgkin Lymphoma|2017
5-9|0.9|1.2|1.1|219|Incidence|20309346|Non-Hodgkin Lymphoma|2017
5-9|~|~|~|~|Mortality|20309346|Oral Cavity and Pharynx|2017
5-9|0.1|0.1|0.1|18|Incidence|20309346|Oral Cavity and Pharynx|2017
5-9|~|~|~|~|Mortality|9937741|Ovary|2017
5-9|0.2|0.4|0.2|24|Incidence|9937741|Ovary|2017
5-9|~|~|~|~|Mortality|20309346|Pancreas|2017
5-9|~|~|~|~|Incidence|20309346|Pancreas|2017
5-9|~|~|~|~|Mortality|10371605|Prostate|2017
5-9|~|~|~|~|Incidence|10371605|Prostate|2017
5-9|~|~|~|~|Mortality|20309346|Stomach|2017
5-9|~|~|~|~|Incidence|20309346|Stomach|2017
5-9|~|~|~|~|Mortality|10371605|Testis|2017
5-9|~|~|~|~|Incidence|10371605|Testis|2017
5-9|~|~|~|~|Mortality|20309346|Thyroid|2017
5-9|0.1|0.2|0.1|29|Incidence|20309346|Thyroid|2017
5-9|~|~|~|~|Mortality|20309346|Urinary Bladder|2017
5-9|~|~|~|~|Incidence|20309346|Urinary Bladder|2017
<1|1.1|1.9|1.5|57|Mortality|3893990|All Cancer Sites Combined|2017
<1|24.9|28.2|26.5|1032|Incidence|3893990|All Cancer Sites Combined|2017
<1|~|~|~|~|Mortality|3893990|Brain and Other Nervous System|2017
<1|3.2|4.4|3.7|146|Incidence|3893990|Brain and Other Nervous System|2017
<1|~|~|~|~|Mortality|1902229|Cervix|2017
<1|~|~|~|~|Incidence|1902229|Cervix|2017
<1|~|~|~|~|Mortality|3893990|Colon and Rectum|2017
<1|~|~|~|~|Incidence|3893990|Colon and Rectum|2017
<1|~|~|~|~|Mortality|1902229|Corpus and Uterus, NOS|2017
<1|~|~|~|~|Incidence|1902229|Corpus and Uterus, NOS|2017
<1|~|~|~|~|Mortality|3893990|Esophagus|2017
<1|~|~|~|~|Incidence|3893990|Esophagus|2017
<1|~|~|~|~|Mortality|1902229|Female Breast|2017
<1|~|~|~|~|Incidence|1902229|Female Breast|2017
<1|~|~|~|~|Incidence|1902229|Female Breast, <i>in situ</i>|2017
<1|~|~|~|~|Mortality|3893990|Hodgkin Lymphoma|2017
<1|~|~|~|~|Incidence|3893990|Hodgkin Lymphoma|2017
<1|.|.|.|.|Mortality|3893990|Kaposi Sarcoma|2017
<1|~|~|~|~|Incidence|3893990|Kaposi Sarcoma|2017
<1|~|~|~|~|Mortality|3893990|Kidney and Renal Pelvis|2017
<1|1.2|2.0|1.6|61|Incidence|3893990|Kidney and Renal Pelvis|2017
<1|~|~|~|~|Mortality|3893990|Larynx|2017
<1|~|~|~|~|Incidence|3893990|Larynx|2017
<1|0.3|0.8|0.5|19|Mortality|3893990|Leukemias|2017
<1|3.6|4.9|4.2|163|Incidence|3893990|Leukemias|2017
<1|~|~|~|~|Mortality|3893990|Liver and Intrahepatic Bile Duct|2017
<1|1.0|1.7|1.3|50|Incidence|3893990|Liver and Intrahepatic Bile Duct|2017
<1|~|~|~|~|Mortality|3893990|Lung and Bronchus|2017
<1|~|~|~|~|Incidence|3893990|Lung and Bronchus|2017
<1|~|~|~|~|Mortality|1902229|Male and Female Breast|2017
<1|~|~|~|~|Incidence|1902229|Male and Female Breast|2017
<1|~|~|~|~|Incidence|1902229|Male and Female Breast, <i>in situ</i>|2017
<1|~|~|~|~|Mortality|3893990|Melanomas of the Skin|2017
<1|~|~|~|~|Incidence|3893990|Melanomas of the Skin|2017
<1|~|~|~|~|Mortality|3893990|Mesothelioma|2017
<1|~|~|~|~|Incidence|3893990|Mesothelioma|2017
<1|~|~|~|~|Mortality|3893990|Myeloma|2017
<1|~|~|~|~|Incidence|3893990|Myeloma|2017
<1|~|~|~|~|Mortality|3893990|Non-Hodgkin Lymphoma|2017
<1|~|~|~|~|Incidence|3893990|Non-Hodgkin Lymphoma|2017
<1|~|~|~|~|Mortality|3893990|Oral Cavity and Pharynx|2017
<1|~|~|~|~|Incidence|3893990|Oral Cavity and Pharynx|2017
<1|~|~|~|~|Mortality|1902229|Ovary|2017
<1|~|~|~|~|Incidence|1902229|Ovary|2017
<1|~|~|~|~|Mortality|3893990|Pancreas|2017
<1|~|~|~|~|Incidence|3893990|Pancreas|2017
<1|~|~|~|~|Mortality|1991761|Prostate|2017
<1|~|~|~|~|Incidence|1991761|Prostate|2017
<1|~|~|~|~|Mortality|3893990|Stomach|2017
<1|~|~|~|~|Incidence|3893990|Stomach|2017
<1|~|~|~|~|Mortality|1991761|Testis|2017
<1|~|~|~|~|Incidence|1991761|Testis|2017
<1|~|~|~|~|Mortality|3893990|Thyroid|2017
<1|~|~|~|~|Incidence|3893990|Thyroid|2017
<1|~|~|~|~|Mortality|3893990|Urinary Bladder|2017
<1|~|~|~|~|Incidence|3893990|Urinary Bladder|2017
1-4|1.8|2.3|2.0|326|Mortality|15947619|All Cancer Sites Combined|2018
1-4|20.7|22.2|21.4|3387|Incidence|15797519|All Cancer Sites Combined|2018
1-4|0.3|0.5|0.4|69|Mortality|15947619|Brain and Other Nervous System|2018
1-4|3.8|4.4|4.1|642|Incidence|15797519|Brain and Other Nervous System|2018
1-4|~|~|~|~|Mortality|7793028|Cervix|2018
1-4|~|~|~|~|Incidence|7719766|Cervix|2018
1-4|~|~|~|~|Mortality|15947619|Colon and Rectum|2018
1-4|~|~|~|~|Incidence|15797519|Colon and Rectum|2018
1-4|~|~|~|~|Mortality|7793028|Corpus and Uterus, NOS|2018
1-4|~|~|~|~|Incidence|7719766|Corpus and Uterus, NOS|2018
1-4|~|~|~|~|Mortality|15947619|Esophagus|2018
1-4|~|~|~|~|Incidence|15797519|Esophagus|2018
1-4|~|~|~|~|Mortality|7793028|Female Breast|2018
1-4|~|~|~|~|Incidence|7719766|Female Breast|2018
1-4|~|~|~|~|Incidence|7719766|Female Breast, <i>in situ</i>|2018
1-4|~|~|~|~|Mortality|15947619|Hodgkin Lymphoma|2018
1-4|0.1|0.2|0.1|20|Incidence|15797519|Hodgkin Lymphoma|2018
1-4|.|.|.|.|Mortality|15947619|Kaposi Sarcoma|2018
1-4|~|~|~|~|Incidence|15797519|Kaposi Sarcoma|2018
1-4|~|~|~|~|Mortality|15947619|Kidney and Renal Pelvis|2018
1-4|1.6|2.0|1.8|283|Incidence|15797519|Kidney and Renal Pelvis|2018
1-4|~|~|~|~|Mortality|15947619|Larynx|2018
1-4|~|~|~|~|Incidence|15797519|Larynx|2018
1-4|0.5|0.8|0.7|106|Mortality|15947619|Leukemias|2018
1-4|8.6|9.5|9.0|1425|Incidence|15797519|Leukemias|2018
1-4|~|~|~|~|Mortality|15947619|Liver and Intrahepatic Bile Duct|2018
1-4|0.5|0.7|0.6|94|Incidence|15797519|Liver and Intrahepatic Bile Duct|2018
1-4|~|~|~|~|Mortality|15947619|Lung and Bronchus|2018
1-4|~|~|~|~|Incidence|15797519|Lung and Bronchus|2018
1-4|~|~|~|~|Mortality|7793028|Male and Female Breast|2018
1-4|~|~|~|~|Incidence|7719766|Male and Female Breast|2018
1-4|~|~|~|~|Incidence|7719766|Male and Female Breast, <i>in situ</i>|2018
1-4|~|~|~|~|Mortality|15947619|Melanomas of the Skin|2018
1-4|0.1|0.2|0.1|17|Incidence|15797519|Melanomas of the Skin|2018
1-4|~|~|~|~|Mortality|15947619|Mesothelioma|2018
1-4|~|~|~|~|Incidence|15797519|Mesothelioma|2018
1-4|~|~|~|~|Mortality|15947619|Myeloma|2018
1-4|~|~|~|~|Incidence|15797519|Myeloma|2018
1-4|~|~|~|~|Mortality|15947619|Non-Hodgkin Lymphoma|2018
1-4|0.5|0.7|0.6|94|Incidence|15797519|Non-Hodgkin Lymphoma|2018
1-4|~|~|~|~|Mortality|15947619|Oral Cavity and Pharynx|2018
1-4|~|~|~|~|Incidence|15797519|Oral Cavity and Pharynx|2018
1-4|~|~|~|~|Mortality|7793028|Ovary|2018
1-4|~|~|~|~|Incidence|7719766|Ovary|2018
1-4|~|~|~|~|Mortality|15947619|Pancreas|2018
1-4|~|~|~|~|Incidence|15797519|Pancreas|2018
1-4|~|~|~|~|Mortality|8154591|Prostate|2018
1-4|~|~|~|~|Incidence|8077753|Prostate|2018
1-4|~|~|~|~|Mortality|15947619|Stomach|2018
1-4|~|~|~|~|Incidence|15797519|Stomach|2018
1-4|~|~|~|~|Mortality|8154591|Testis|2018
1-4|0.1|0.3|0.2|16|Incidence|8077753|Testis|2018
1-4|~|~|~|~|Mortality|15947619|Thyroid|2018
1-4|~|~|~|~|Incidence|15797519|Thyroid|2018
1-4|~|~|~|~|Mortality|15947619|Urinary Bladder|2018
1-4|~|~|~|~|Incidence|15797519|Urinary Bladder|2018
10-14|2.0|2.4|2.2|450|Mortality|20868629|All Cancer Sites Combined|2018
10-14|15.2|16.3|15.7|3251|Incidence|20671678|All Cancer Sites Combined|2018
10-14|0.6|0.8|0.7|143|Mortality|20868629|Brain and Other Nervous System|2018
10-14|2.6|3.1|2.9|594|Incidence|20671678|Brain and Other Nervous System|2018
10-14|~|~|~|~|Mortality|10214465|Cervix|2018
10-14|~|~|~|~|Incidence|10117973|Cervix|2018
10-14|~|~|~|~|Mortality|20868629|Colon and Rectum|2018
10-14|0.6|0.8|0.7|137|Incidence|20671678|Colon and Rectum|2018
10-14|~|~|~|~|Mortality|10214465|Corpus and Uterus, NOS|2018
10-14|~|~|~|~|Incidence|10117973|Corpus and Uterus, NOS|2018
10-14|~|~|~|~|Mortality|20868629|Esophagus|2018
10-14|~|~|~|~|Incidence|20671678|Esophagus|2018
10-14|~|~|~|~|Mortality|10214465|Female Breast|2018
10-14|~|~|~|~|Incidence|10117973|Female Breast|2018
10-14|~|~|~|~|Incidence|10117973|Female Breast, <i>in situ</i>|2018
10-14|~|~|~|~|Mortality|20868629|Hodgkin Lymphoma|2018
10-14|1.1|1.4|1.3|262|Incidence|20671678|Hodgkin Lymphoma|2018
10-14|.|.|.|.|Mortality|20868629|Kaposi Sarcoma|2018
10-14|~|~|~|~|Incidence|20671678|Kaposi Sarcoma|2018
10-14|~|~|~|~|Mortality|20868629|Kidney and Renal Pelvis|2018
10-14|0.2|0.3|0.2|45|Incidence|20671678|Kidney and Renal Pelvis|2018
10-14|~|~|~|~|Mortality|20868629|Larynx|2018
10-14|~|~|~|~|Incidence|20671678|Larynx|2018
10-14|0.4|0.6|0.5|110|Mortality|20868629|Leukemias|2018
10-14|3.0|3.5|3.2|661|Incidence|20671678|Leukemias|2018
10-14|~|~|~|~|Mortality|20868629|Liver and Intrahepatic Bile Duct|2018
10-14|0.1|0.1|0.1|19|Incidence|20671678|Liver and Intrahepatic Bile Duct|2018
10-14|~|~|~|~|Mortality|20868629|Lung and Bronchus|2018
10-14|~|~|~|~|Incidence|20671678|Lung and Bronchus|2018
10-14|~|~|~|~|Mortality|10214465|Male and Female Breast|2018
10-14|~|~|~|~|Incidence|10117973|Male and Female Breast|2018
10-14|~|~|~|~|Incidence|10117973|Male and Female Breast, <i>in situ</i>|2018
10-14|~|~|~|~|Mortality|20868629|Melanomas of the Skin|2018
10-14|0.2|0.3|0.2|50|Incidence|20671678|Melanomas of the Skin|2018
10-14|~|~|~|~|Mortality|20868629|Mesothelioma|2018
10-14|~|~|~|~|Incidence|20671678|Mesothelioma|2018
10-14|~|~|~|~|Mortality|20868629|Myeloma|2018
10-14|~|~|~|~|Incidence|20671678|Myeloma|2018
10-14|~|~|~|~|Mortality|20868629|Non-Hodgkin Lymphoma|2018
10-14|1.3|1.6|1.5|304|Incidence|20671678|Non-Hodgkin Lymphoma|2018
10-14|~|~|~|~|Mortality|20868629|Oral Cavity and Pharynx|2018
10-14|0.2|0.3|0.2|43|Incidence|20671678|Oral Cavity and Pharynx|2018
10-14|~|~|~|~|Mortality|10214465|Ovary|2018
10-14|0.7|1.1|0.9|92|Incidence|10117973|Ovary|2018
10-14|~|~|~|~|Mortality|20868629|Pancreas|2018
10-14|~|~|~|~|Incidence|20671678|Pancreas|2018
10-14|~|~|~|~|Mortality|10654164|Prostate|2018
10-14|~|~|~|~|Incidence|10553705|Prostate|2018
10-14|~|~|~|~|Mortality|20868629|Stomach|2018
10-14|~|~|~|~|Incidence|20671678|Stomach|2018
10-14|~|~|~|~|Mortality|10654164|Testis|2018
10-14|0.2|0.4|0.3|30|Incidence|10553705|Testis|2018
10-14|~|~|~|~|Mortality|20868629|Thyroid|2018
10-14|0.9|1.2|1.0|213|Incidence|20671678|Thyroid|2018
10-14|~|~|~|~|Mortality|20868629|Urinary Bladder|2018
10-14|~|~|~|~|Incidence|20671678|Urinary Bladder|2018
15-19|2.7|3.2|2.9|621|Mortality|21064661|All Cancer Sites Combined|2018
15-19|23.2|24.5|23.9|4984|Incidence|20883816|All Cancer Sites Combined|2018
15-19|0.5|0.7|0.6|123|Mortality|21064661|Brain and Other Nervous System|2018
15-19|2.0|2.4|2.2|458|Incidence|20883816|Brain and Other Nervous System|2018
15-19|~|~|~|~|Mortality|10308698|Cervix|2018
15-19|~|~|~|~|Incidence|10221034|Cervix|2018
15-19|~|~|~|~|Mortality|21064661|Colon and Rectum|2018
15-19|1.2|1.6|1.4|289|Incidence|20883816|Colon and Rectum|2018
15-19|~|~|~|~|Mortality|10308698|Corpus and Uterus, NOS|2018
15-19|~|~|~|~|Incidence|10221034|Corpus and Uterus, NOS|2018
15-19|~|~|~|~|Mortality|21064661|Esophagus|2018
15-19|~|~|~|~|Incidence|20883816|Esophagus|2018
15-19|~|~|~|~|Mortality|10308698|Female Breast|2018
15-19|0.1|0.3|0.2|21|Incidence|10221034|Female Breast|2018
15-19|~|~|~|~|Incidence|10221034|Female Breast, <i>in situ</i>|2018
15-19|~|~|~|~|Mortality|21064661|Hodgkin Lymphoma|2018
15-19|2.9|3.4|3.1|652|Incidence|20883816|Hodgkin Lymphoma|2018
15-19|.|.|.|.|Mortality|21064661|Kaposi Sarcoma|2018
15-19|~|~|~|~|Incidence|20883816|Kaposi Sarcoma|2018
15-19|~|~|~|~|Mortality|21064661|Kidney and Renal Pelvis|2018
15-19|0.2|0.3|0.2|45|Incidence|20883816|Kidney and Renal Pelvis|2018
15-19|~|~|~|~|Mortality|21064661|Larynx|2018
15-19|~|~|~|~|Incidence|20883816|Larynx|2018
15-19|0.7|0.9|0.8|162|Mortality|21064661|Leukemias|2018
15-19|3.0|3.5|3.3|679|Incidence|20883816|Leukemias|2018
15-19|~|~|~|~|Mortality|21064661|Liver and Intrahepatic Bile Duct|2018
15-19|0.1|0.2|0.2|33|Incidence|20883816|Liver and Intrahepatic Bile Duct|2018
15-19|~|~|~|~|Mortality|21064661|Lung and Bronchus|2018
15-19|0.1|0.2|0.2|34|Incidence|20883816|Lung and Bronchus|2018
15-19|~|~|~|~|Mortality|10308698|Male and Female Breast|2018
15-19|0.1|0.3|0.2|21|Incidence|10221034|Male and Female Breast|2018
15-19|~|~|~|~|Incidence|10221034|Male and Female Breast, <i>in situ</i>|2018
15-19|~|~|~|~|Mortality|21064661|Melanomas of the Skin|2018
15-19|0.7|0.9|0.8|161|Incidence|20883816|Melanomas of the Skin|2018
15-19|~|~|~|~|Mortality|21064661|Mesothelioma|2018
15-19|~|~|~|~|Incidence|20883816|Mesothelioma|2018
15-19|~|~|~|~|Mortality|21064661|Myeloma|2018
15-19|~|~|~|~|Incidence|20883816|Myeloma|2018
15-19|0.1|0.2|0.1|26|Mortality|21064661|Non-Hodgkin Lymphoma|2018
15-19|1.6|2.0|1.8|372|Incidence|20883816|Non-Hodgkin Lymphoma|2018
15-19|~|~|~|~|Mortality|21064661|Oral Cavity and Pharynx|2018
15-19|0.3|0.5|0.4|90|Incidence|20883816|Oral Cavity and Pharynx|2018
15-19|~|~|~|~|Mortality|10308698|Ovary|2018
15-19|1.0|1.4|1.2|123|Incidence|10221034|Ovary|2018
15-19|~|~|~|~|Mortality|21064661|Pancreas|2018
15-19|0.2|0.3|0.2|44|Incidence|20883816|Pancreas|2018
15-19|~|~|~|~|Mortality|10755963|Prostate|2018
15-19|~|~|~|~|Incidence|10662782|Prostate|2018
15-19|~|~|~|~|Mortality|21064661|Stomach|2018
15-19|0.1|0.1|0.1|19|Incidence|20883816|Stomach|2018
15-19|~|~|~|~|Mortality|10755963|Testis|2018
15-19|2.8|3.4|3.1|328|Incidence|10662782|Testis|2018
15-19|~|~|~|~|Mortality|21064661|Thyroid|2018
15-19|3.4|3.9|3.6|762|Incidence|20883816|Thyroid|2018
15-19|~|~|~|~|Mortality|21064661|Urinary Bladder|2018
15-19|0.1|0.2|0.1|22|Incidence|20883816|Urinary Bladder|2018
5-9|1.8|2.1|1.9|393|Mortality|20188285|All Cancer Sites Combined|2018
5-9|12.4|13.4|12.9|2576|Incidence|19996754|All Cancer Sites Combined|2018
5-9|0.8|1.0|0.9|183|Mortality|20188285|Brain and Other Nervous System|2018
5-9|3.1|3.6|3.3|666|Incidence|19996754|Brain and Other Nervous System|2018
5-9|~|~|~|~|Mortality|9875661|Cervix|2018
5-9|~|~|~|~|Incidence|9782083|Cervix|2018
5-9|~|~|~|~|Mortality|20188285|Colon and Rectum|2018
5-9|0.1|0.2|0.1|24|Incidence|19996754|Colon and Rectum|2018
5-9|~|~|~|~|Mortality|9875661|Corpus and Uterus, NOS|2018
5-9|~|~|~|~|Incidence|9782083|Corpus and Uterus, NOS|2018
5-9|~|~|~|~|Mortality|20188285|Esophagus|2018
5-9|~|~|~|~|Incidence|19996754|Esophagus|2018
5-9|~|~|~|~|Mortality|9875661|Female Breast|2018
5-9|~|~|~|~|Incidence|9782083|Female Breast|2018
5-9|~|~|~|~|Incidence|9782083|Female Breast, <i>in situ</i>|2018
5-9|~|~|~|~|Mortality|20188285|Hodgkin Lymphoma|2018
5-9|0.3|0.5|0.4|79|Incidence|19996754|Hodgkin Lymphoma|2018
5-9|.|.|.|.|Mortality|20188285|Kaposi Sarcoma|2018
5-9|~|~|~|~|Incidence|19996754|Kaposi Sarcoma|2018
5-9|0.1|0.1|0.1|18|Mortality|20188285|Kidney and Renal Pelvis|2018
5-9|0.6|0.8|0.7|138|Incidence|19996754|Kidney and Renal Pelvis|2018
5-9|~|~|~|~|Mortality|20188285|Larynx|2018
5-9|~|~|~|~|Incidence|19996754|Larynx|2018
5-9|0.3|0.4|0.3|66|Mortality|20188285|Leukemias|2018
5-9|3.9|4.4|4.2|831|Incidence|19996754|Leukemias|2018
5-9|~|~|~|~|Mortality|20188285|Liver and Intrahepatic Bile Duct|2018
5-9|0.1|0.2|0.1|23|Incidence|19996754|Liver and Intrahepatic Bile Duct|2018
5-9|~|~|~|~|Mortality|20188285|Lung and Bronchus|2018
5-9|~|~|~|~|Incidence|19996754|Lung and Bronchus|2018
5-9|~|~|~|~|Mortality|9875661|Male and Female Breast|2018
5-9|~|~|~|~|Incidence|9782083|Male and Female Breast|2018
5-9|~|~|~|~|Incidence|9782083|Male and Female Breast, <i>in situ</i>|2018
5-9|~|~|~|~|Mortality|20188285|Melanomas of the Skin|2018
5-9|~|~|~|~|Incidence|19996754|Melanomas of the Skin|2018
5-9|~|~|~|~|Mortality|20188285|Mesothelioma|2018
5-9|~|~|~|~|Incidence|19996754|Mesothelioma|2018
5-9|~|~|~|~|Mortality|20188285|Myeloma|2018
5-9|~|~|~|~|Incidence|19996754|Myeloma|2018
5-9|~|~|~|~|Mortality|20188285|Non-Hodgkin Lymphoma|2018
5-9|0.9|1.2|1.1|211|Incidence|19996754|Non-Hodgkin Lymphoma|2018
5-9|~|~|~|~|Mortality|20188285|Oral Cavity and Pharynx|2018
5-9|0.1|0.1|0.1|18|Incidence|19996754|Oral Cavity and Pharynx|2018
5-9|~|~|~|~|Mortality|9875661|Ovary|2018
5-9|0.1|0.3|0.2|17|Incidence|9782083|Ovary|2018
5-9|~|~|~|~|Mortality|20188285|Pancreas|2018
5-9|~|~|~|~|Incidence|19996754|Pancreas|2018
5-9|~|~|~|~|Mortality|10312624|Prostate|2018
5-9|~|~|~|~|Incidence|10214671|Prostate|2018
5-9|~|~|~|~|Mortality|20188285|Stomach|2018
5-9|~|~|~|~|Incidence|19996754|Stomach|2018
5-9|~|~|~|~|Mortality|10312624|Testis|2018
5-9|~|~|~|~|Incidence|10214671|Testis|2018
5-9|~|~|~|~|Mortality|20188285|Thyroid|2018
5-9|0.1|0.2|0.2|31|Incidence|19996754|Thyroid|2018
5-9|~|~|~|~|Mortality|20188285|Urinary Bladder|2018
5-9|~|~|~|~|Incidence|19996754|Urinary Bladder|2018
<1|1.0|1.8|1.3|51|Mortality|3815343|All Cancer Sites Combined|2018
<1|24.3|27.6|25.9|980|Incidence|3779884|All Cancer Sites Combined|2018
<1|~|~|~|~|Mortality|3815343|Brain and Other Nervous System|2018
<1|2.3|3.4|2.9|108|Incidence|3779884|Brain and Other Nervous System|2018
<1|~|~|~|~|Mortality|1863680|Cervix|2018
<1|~|~|~|~|Incidence|1846309|Cervix|2018
<1|~|~|~|~|Mortality|3815343|Colon and Rectum|2018
<1|~|~|~|~|Incidence|3779884|Colon and Rectum|2018
<1|~|~|~|~|Mortality|1863680|Corpus and Uterus, NOS|2018
<1|~|~|~|~|Incidence|1846309|Corpus and Uterus, NOS|2018
<1|~|~|~|~|Mortality|3815343|Esophagus|2018
<1|~|~|~|~|Incidence|3779884|Esophagus|2018
<1|~|~|~|~|Mortality|1863680|Female Breast|2018
<1|~|~|~|~|Incidence|1846309|Female Breast|2018
<1|~|~|~|~|Incidence|1846309|Female Breast, <i>in situ</i>|2018
<1|~|~|~|~|Mortality|3815343|Hodgkin Lymphoma|2018
<1|~|~|~|~|Incidence|3779884|Hodgkin Lymphoma|2018
<1|.|.|.|.|Mortality|3815343|Kaposi Sarcoma|2018
<1|~|~|~|~|Incidence|3779884|Kaposi Sarcoma|2018
<1|~|~|~|~|Mortality|3815343|Kidney and Renal Pelvis|2018
<1|1.1|1.9|1.4|54|Incidence|3779884|Kidney and Renal Pelvis|2018
<1|~|~|~|~|Mortality|3815343|Larynx|2018
<1|~|~|~|~|Incidence|3779884|Larynx|2018
<1|~|~|~|~|Mortality|3815343|Leukemias|2018
<1|3.6|4.9|4.2|159|Incidence|3779884|Leukemias|2018
<1|~|~|~|~|Mortality|3815343|Liver and Intrahepatic Bile Duct|2018
<1|1.3|2.1|1.7|63|Incidence|3779884|Liver and Intrahepatic Bile Duct|2018
<1|~|~|~|~|Mortality|3815343|Lung and Bronchus|2018
<1|~|~|~|~|Incidence|3779884|Lung and Bronchus|2018
<1|~|~|~|~|Mortality|1863680|Male and Female Breast|2018
<1|~|~|~|~|Incidence|1846309|Male and Female Breast|2018
<1|~|~|~|~|Incidence|1846309|Male and Female Breast, <i>in situ</i>|2018
<1|~|~|~|~|Mortality|3815343|Melanomas of the Skin|2018
<1|0.2|0.7|0.4|16|Incidence|3779884|Melanomas of the Skin|2018
<1|~|~|~|~|Mortality|3815343|Mesothelioma|2018
<1|~|~|~|~|Incidence|3779884|Mesothelioma|2018
<1|~|~|~|~|Mortality|3815343|Myeloma|2018
<1|~|~|~|~|Incidence|3779884|Myeloma|2018
<1|~|~|~|~|Mortality|3815343|Non-Hodgkin Lymphoma|2018
<1|~|~|~|~|Incidence|3779884|Non-Hodgkin Lymphoma|2018
<1|~|~|~|~|Mortality|3815343|Oral Cavity and Pharynx|2018
<1|~|~|~|~|Incidence|3779884|Oral Cavity and Pharynx|2018
<1|~|~|~|~|Mortality|1863680|Ovary|2018
<1|~|~|~|~|Incidence|1846309|Ovary|2018
<1|~|~|~|~|Mortality|3815343|Pancreas|2018
<1|~|~|~|~|Incidence|3779884|Pancreas|2018
<1|~|~|~|~|Mortality|1951663|Prostate|2018
<1|~|~|~|~|Incidence|1933575|Prostate|2018
<1|~|~|~|~|Mortality|3815343|Stomach|2018
<1|~|~|~|~|Incidence|3779884|Stomach|2018
<1|~|~|~|~|Mortality|1951663|Testis|2018
<1|~|~|~|~|Incidence|1933575|Testis|2018
<1|~|~|~|~|Mortality|3815343|Thyroid|2018
<1|~|~|~|~|Incidence|3779884|Thyroid|2018
<1|~|~|~|~|Mortality|3815343|Urinary Bladder|2018
<1|~|~|~|~|Incidence|3779884|Urinary Bladder|2018
1-4|2.5|3.0|2.7|418|Mortality|15339782|All Cancer Sites Combined|1999
1-4|19.1|20.5|19.8|2963|Incidence|14991152|All Cancer Sites Combined|1999
1-4|0.6|0.9|0.7|113|Mortality|15339782|Brain and Other Nervous System|1999
1-4|3.6|4.3|3.9|591|Incidence|14991152|Brain and Other Nervous System|1999
1-4|~|~|~|~|Mortality|7493614|Cervix|1999
1-4|~|~|~|~|Incidence|7323088|Cervix|1999
1-4|~|~|~|~|Mortality|15339782|Colon and Rectum|1999
1-4|~|~|~|~|Incidence|14991152|Colon and Rectum|1999
1-4|~|~|~|~|Mortality|7493614|Corpus and Uterus, NOS|1999
1-4|~|~|~|~|Incidence|7323088|Corpus and Uterus, NOS|1999
1-4|~|~|~|~|Mortality|15339782|Esophagus|1999
1-4|~|~|~|~|Incidence|14991152|Esophagus|1999
1-4|~|~|~|~|Mortality|7493614|Female Breast|1999
1-4|~|~|~|~|Incidence|7323088|Female Breast|1999
1-4|~|~|~|~|Incidence|7323088|Female Breast, <i>in situ</i>|1999
1-4|~|~|~|~|Mortality|15339782|Hodgkin Lymphoma|1999
1-4|~|~|~|~|Incidence|14991152|Hodgkin Lymphoma|1999
1-4|.|.|.|.|Mortality|15339782|Kaposi Sarcoma|1999
1-4|~|~|~|~|Incidence|14991152|Kaposi Sarcoma|1999
1-4|0.1|0.2|0.1|19|Mortality|15339782|Kidney and Renal Pelvis|1999
1-4|1.7|2.1|1.9|287|Incidence|14991152|Kidney and Renal Pelvis|1999
1-4|~|~|~|~|Mortality|15339782|Larynx|1999
1-4|~|~|~|~|Incidence|14991152|Larynx|1999
1-4|0.6|0.9|0.8|119|Mortality|15339782|Leukemias|1999
1-4|7.5|8.4|8.0|1195|Incidence|14991152|Leukemias|1999
1-4|0.1|0.3|0.2|29|Mortality|15339782|Liver and Intrahepatic Bile Duct|1999
1-4|0.4|0.6|0.5|69|Incidence|14991152|Liver and Intrahepatic Bile Duct|1999
1-4|~|~|~|~|Mortality|15339782|Lung and Bronchus|1999
1-4|~|~|~|~|Incidence|14991152|Lung and Bronchus|1999
1-4|~|~|~|~|Mortality|7493614|Male and Female Breast|1999
1-4|~|~|~|~|Incidence|7323088|Male and Female Breast|1999
1-4|~|~|~|~|Incidence|7323088|Male and Female Breast, <i>in situ</i>|1999
1-4|~|~|~|~|Mortality|15339782|Melanomas of the Skin|1999
1-4|~|~|~|~|Incidence|14991152|Melanomas of the Skin|1999
1-4|~|~|~|~|Mortality|15339782|Mesothelioma|1999
1-4|~|~|~|~|Incidence|14991152|Mesothelioma|1999
1-4|~|~|~|~|Mortality|15339782|Myeloma|1999
1-4|~|~|~|~|Incidence|14991152|Myeloma|1999
1-4|0.1|0.2|0.1|16|Mortality|15339782|Non-Hodgkin Lymphoma|1999
1-4|0.6|0.8|0.7|105|Incidence|14991152|Non-Hodgkin Lymphoma|1999
1-4|~|~|~|~|Mortality|15339782|Oral Cavity and Pharynx|1999
1-4|~|~|~|~|Incidence|14991152|Oral Cavity and Pharynx|1999
1-4|~|~|~|~|Mortality|7493614|Ovary|1999
1-4|~|~|~|~|Incidence|7323088|Ovary|1999
1-4|~|~|~|~|Mortality|15339782|Pancreas|1999
1-4|~|~|~|~|Incidence|14991152|Pancreas|1999
1-4|~|~|~|~|Mortality|7846168|Prostate|1999
1-4|~|~|~|~|Incidence|7668064|Prostate|1999
1-4|~|~|~|~|Mortality|15339782|Stomach|1999
1-4|~|~|~|~|Incidence|14991152|Stomach|1999
1-4|~|~|~|~|Mortality|7846168|Testis|1999
1-4|0.2|0.5|0.4|27|Incidence|7668064|Testis|1999
1-4|~|~|~|~|Mortality|15339782|Thyroid|1999
1-4|~|~|~|~|Incidence|14991152|Thyroid|1999
1-4|~|~|~|~|Mortality|15339782|Urinary Bladder|1999
1-4|~|~|~|~|Incidence|14991152|Urinary Bladder|1999
10-14|2.3|2.7|2.5|503|Mortality|20213364|All Cancer Sites Combined|1999
10-14|11.9|12.9|12.4|2447|Incidence|19742631|All Cancer Sites Combined|1999
10-14|0.5|0.7|0.6|124|Mortality|20213364|Brain and Other Nervous System|1999
10-14|2.4|2.9|2.7|524|Incidence|19742631|Brain and Other Nervous System|1999
10-14|~|~|~|~|Mortality|9855664|Cervix|1999
10-14|~|~|~|~|Incidence|9626112|Cervix|1999
10-14|~|~|~|~|Mortality|20213364|Colon and Rectum|1999
10-14|~|~|~|~|Incidence|19742631|Colon and Rectum|1999
10-14|~|~|~|~|Mortality|9855664|Corpus and Uterus, NOS|1999
10-14|~|~|~|~|Incidence|9626112|Corpus and Uterus, NOS|1999
10-14|~|~|~|~|Mortality|20213364|Esophagus|1999
10-14|~|~|~|~|Incidence|19742631|Esophagus|1999
10-14|~|~|~|~|Mortality|9855664|Female Breast|1999
10-14|~|~|~|~|Incidence|9626112|Female Breast|1999
10-14|~|~|~|~|Incidence|9626112|Female Breast, <i>in situ</i>|1999
10-14|~|~|~|~|Mortality|20213364|Hodgkin Lymphoma|1999
10-14|1.0|1.3|1.2|228|Incidence|19742631|Hodgkin Lymphoma|1999
10-14|.|.|.|.|Mortality|20213364|Kaposi Sarcoma|1999
10-14|~|~|~|~|Incidence|19742631|Kaposi Sarcoma|1999
10-14|~|~|~|~|Mortality|20213364|Kidney and Renal Pelvis|1999
10-14|0.1|0.2|0.1|25|Incidence|19742631|Kidney and Renal Pelvis|1999
10-14|~|~|~|~|Mortality|20213364|Larynx|1999
10-14|~|~|~|~|Incidence|19742631|Larynx|1999
10-14|0.7|1.0|0.9|175|Mortality|20213364|Leukemias|1999
10-14|2.6|3.1|2.8|559|Incidence|19742631|Leukemias|1999
10-14|~|~|~|~|Mortality|20213364|Liver and Intrahepatic Bile Duct|1999
10-14|0.1|0.1|0.1|18|Incidence|19742631|Liver and Intrahepatic Bile Duct|1999
10-14|~|~|~|~|Mortality|20213364|Lung and Bronchus|1999
10-14|~|~|~|~|Incidence|19742631|Lung and Bronchus|1999
10-14|~|~|~|~|Mortality|9855664|Male and Female Breast|1999
10-14|~|~|~|~|Incidence|9626112|Male and Female Breast|1999
10-14|~|~|~|~|Incidence|9626112|Male and Female Breast, <i>in situ</i>|1999
10-14|~|~|~|~|Mortality|20213364|Melanomas of the Skin|1999
10-14|0.3|0.4|0.3|65|Incidence|19742631|Melanomas of the Skin|1999
10-14|~|~|~|~|Mortality|20213364|Mesothelioma|1999
10-14|~|~|~|~|Incidence|19742631|Mesothelioma|1999
10-14|~|~|~|~|Mortality|20213364|Myeloma|1999
10-14|~|~|~|~|Incidence|19742631|Myeloma|1999
10-14|0.1|0.2|0.1|25|Mortality|20213364|Non-Hodgkin Lymphoma|1999
10-14|1.0|1.3|1.2|232|Incidence|19742631|Non-Hodgkin Lymphoma|1999
10-14|~|~|~|~|Mortality|20213364|Oral Cavity and Pharynx|1999
10-14|0.2|0.4|0.3|53|Incidence|19742631|Oral Cavity and Pharynx|1999
10-14|~|~|~|~|Mortality|9855664|Ovary|1999
10-14|0.5|0.9|0.7|67|Incidence|9626112|Ovary|1999
10-14|~|~|~|~|Mortality|20213364|Pancreas|1999
10-14|~|~|~|~|Incidence|19742631|Pancreas|1999
10-14|~|~|~|~|Mortality|10357700|Prostate|1999
10-14|~|~|~|~|Incidence|10116519|Prostate|1999
10-14|~|~|~|~|Mortality|20213364|Stomach|1999
10-14|~|~|~|~|Incidence|19742631|Stomach|1999
10-14|~|~|~|~|Mortality|10357700|Testis|1999
10-14|~|~|~|~|Incidence|10116519|Testis|1999
10-14|~|~|~|~|Mortality|20213364|Thyroid|1999
10-14|0.3|0.5|0.4|73|Incidence|19742631|Thyroid|1999
10-14|~|~|~|~|Mortality|20213364|Urinary Bladder|1999
10-14|~|~|~|~|Incidence|19742631|Urinary Bladder|1999
15-19|3.4|4.0|3.7|745|Mortality|20084602|All Cancer Sites Combined|1999
15-19|19.2|20.4|19.8|3875|Incidence|19585857|All Cancer Sites Combined|1999
15-19|0.5|0.7|0.6|115|Mortality|20084602|Brain and Other Nervous System|1999
15-19|1.8|2.2|2.0|399|Incidence|19585857|Brain and Other Nervous System|1999
15-19|~|~|~|~|Mortality|9761569|Cervix|1999
15-19|0.2|0.4|0.3|27|Incidence|9518101|Cervix|1999
15-19|~|~|~|~|Mortality|20084602|Colon and Rectum|1999
15-19|0.2|0.3|0.3|50|Incidence|19585857|Colon and Rectum|1999
15-19|~|~|~|~|Mortality|9761569|Corpus and Uterus, NOS|1999
15-19|~|~|~|~|Incidence|9518101|Corpus and Uterus, NOS|1999
15-19|~|~|~|~|Mortality|20084602|Esophagus|1999
15-19|~|~|~|~|Incidence|19585857|Esophagus|1999
15-19|~|~|~|~|Mortality|9761569|Female Breast|1999
15-19|0.1|0.3|0.2|17|Incidence|9518101|Female Breast|1999
15-19|~|~|~|~|Incidence|9518101|Female Breast, <i>in situ</i>|1999
15-19|0.1|0.2|0.2|31|Mortality|20084602|Hodgkin Lymphoma|1999
15-19|2.8|3.3|3.1|604|Incidence|19585857|Hodgkin Lymphoma|1999
15-19|.|.|.|.|Mortality|20084602|Kaposi Sarcoma|1999
15-19|~|~|~|~|Incidence|19585857|Kaposi Sarcoma|1999
15-19|~|~|~|~|Mortality|20084602|Kidney and Renal Pelvis|1999
15-19|0.1|0.2|0.1|29|Incidence|19585857|Kidney and Renal Pelvis|1999
15-19|~|~|~|~|Mortality|20084602|Larynx|1999
15-19|~|~|~|~|Incidence|19585857|Larynx|1999
15-19|1.0|1.3|1.1|221|Mortality|20084602|Leukemias|1999
15-19|2.5|2.9|2.7|524|Incidence|19585857|Leukemias|1999
15-19|0.1|0.1|0.1|19|Mortality|20084602|Liver and Intrahepatic Bile Duct|1999
15-19|0.1|0.2|0.2|35|Incidence|19585857|Liver and Intrahepatic Bile Duct|1999
15-19|~|~|~|~|Mortality|20084602|Lung and Bronchus|1999
15-19|0.1|0.2|0.2|30|Incidence|19585857|Lung and Bronchus|1999
15-19|~|~|~|~|Mortality|9761569|Male and Female Breast|1999
15-19|0.1|0.3|0.2|17|Incidence|9518101|Male and Female Breast|1999
15-19|~|~|~|~|Incidence|9518101|Male and Female Breast, <i>in situ</i>|1999
15-19|~|~|~|~|Mortality|20084602|Melanomas of the Skin|1999
15-19|1.2|1.5|1.3|260|Incidence|19585857|Melanomas of the Skin|1999
15-19|~|~|~|~|Mortality|20084602|Mesothelioma|1999
15-19|~|~|~|~|Incidence|19585857|Mesothelioma|1999
15-19|~|~|~|~|Mortality|20084602|Myeloma|1999
15-19|~|~|~|~|Incidence|19585857|Myeloma|1999
15-19|0.2|0.3|0.3|51|Mortality|20084602|Non-Hodgkin Lymphoma|1999
15-19|1.4|1.7|1.6|306|Incidence|19585857|Non-Hodgkin Lymphoma|1999
15-19|~|~|~|~|Mortality|20084602|Oral Cavity and Pharynx|1999
15-19|0.3|0.5|0.4|70|Incidence|19585857|Oral Cavity and Pharynx|1999
15-19|~|~|~|~|Mortality|9761569|Ovary|1999
15-19|1.1|1.6|1.3|124|Incidence|9518101|Ovary|1999
15-19|~|~|~|~|Mortality|20084602|Pancreas|1999
15-19|~|~|~|~|Incidence|19585857|Pancreas|1999
15-19|~|~|~|~|Mortality|10323033|Prostate|1999
15-19|~|~|~|~|Incidence|10067756|Prostate|1999
15-19|~|~|~|~|Mortality|20084602|Stomach|1999
15-19|~|~|~|~|Incidence|19585857|Stomach|1999
15-19|~|~|~|~|Mortality|10323033|Testis|1999
15-19|3.0|3.7|3.3|332|Incidence|10067756|Testis|1999
15-19|~|~|~|~|Mortality|20084602|Thyroid|1999
15-19|1.6|2.0|1.8|348|Incidence|19585857|Thyroid|1999
15-19|~|~|~|~|Mortality|20084602|Urinary Bladder|1999
15-19|0.1|0.2|0.1|21|Incidence|19585857|Urinary Bladder|1999
5-9|2.3|2.7|2.5|509|Mortality|20606460|All Cancer Sites Combined|1999
5-9|10.6|11.5|11.0|2225|Incidence|20146188|All Cancer Sites Combined|1999
5-9|0.8|1.0|0.9|184|Mortality|20606460|Brain and Other Nervous System|1999
5-9|3.1|3.6|3.3|668|Incidence|20146188|Brain and Other Nervous System|1999
5-9|~|~|~|~|Mortality|10052618|Cervix|1999
5-9|~|~|~|~|Incidence|9827638|Cervix|1999
5-9|~|~|~|~|Mortality|20606460|Colon and Rectum|1999
5-9|~|~|~|~|Incidence|20146188|Colon and Rectum|1999
5-9|~|~|~|~|Mortality|10052618|Corpus and Uterus, NOS|1999
5-9|~|~|~|~|Incidence|9827638|Corpus and Uterus, NOS|1999
5-9|~|~|~|~|Mortality|20606460|Esophagus|1999
5-9|~|~|~|~|Incidence|20146188|Esophagus|1999
5-9|~|~|~|~|Mortality|10052618|Female Breast|1999
5-9|~|~|~|~|Incidence|9827638|Female Breast|1999
5-9|~|~|~|~|Incidence|9827638|Female Breast, <i>in situ</i>|1999
5-9|~|~|~|~|Mortality|20606460|Hodgkin Lymphoma|1999
5-9|0.3|0.5|0.4|79|Incidence|20146188|Hodgkin Lymphoma|1999
5-9|.|.|.|.|Mortality|20606460|Kaposi Sarcoma|1999
5-9|~|~|~|~|Incidence|20146188|Kaposi Sarcoma|1999
5-9|0.1|0.2|0.1|23|Mortality|20606460|Kidney and Renal Pelvis|1999
5-9|0.4|0.6|0.5|107|Incidence|20146188|Kidney and Renal Pelvis|1999
5-9|~|~|~|~|Mortality|20606460|Larynx|1999
5-9|~|~|~|~|Incidence|20146188|Larynx|1999
5-9|0.5|0.7|0.6|130|Mortality|20606460|Leukemias|1999
5-9|3.4|3.9|3.6|731|Incidence|20146188|Leukemias|1999
5-9|~|~|~|~|Mortality|20606460|Liver and Intrahepatic Bile Duct|1999
5-9|~|~|~|~|Incidence|20146188|Liver and Intrahepatic Bile Duct|1999
5-9|~|~|~|~|Mortality|20606460|Lung and Bronchus|1999
5-9|~|~|~|~|Incidence|20146188|Lung and Bronchus|1999
5-9|~|~|~|~|Mortality|10052618|Male and Female Breast|1999
5-9|~|~|~|~|Incidence|9827638|Male and Female Breast|1999
5-9|~|~|~|~|Incidence|9827638|Male and Female Breast, <i>in situ</i>|1999
5-9|~|~|~|~|Mortality|20606460|Melanomas of the Skin|1999
5-9|~|~|~|~|Incidence|20146188|Melanomas of the Skin|1999
5-9|~|~|~|~|Mortality|20606460|Mesothelioma|1999
5-9|~|~|~|~|Incidence|20146188|Mesothelioma|1999
5-9|~|~|~|~|Mortality|20606460|Myeloma|1999
5-9|~|~|~|~|Incidence|20146188|Myeloma|1999
5-9|~|~|~|~|Mortality|20606460|Non-Hodgkin Lymphoma|1999
5-9|0.8|1.0|0.9|177|Incidence|20146188|Non-Hodgkin Lymphoma|1999
5-9|~|~|~|~|Mortality|20606460|Oral Cavity and Pharynx|1999
5-9|0.1|0.1|0.1|18|Incidence|20146188|Oral Cavity and Pharynx|1999
5-9|~|~|~|~|Mortality|10052618|Ovary|1999
5-9|0.1|0.3|0.2|17|Incidence|9827638|Ovary|1999
5-9|~|~|~|~|Mortality|20606460|Pancreas|1999
5-9|~|~|~|~|Incidence|20146188|Pancreas|1999
5-9|~|~|~|~|Mortality|10553842|Prostate|1999
5-9|~|~|~|~|Incidence|10318550|Prostate|1999
5-9|~|~|~|~|Mortality|20606460|Stomach|1999
5-9|~|~|~|~|Incidence|20146188|Stomach|1999
5-9|~|~|~|~|Mortality|10553842|Testis|1999
5-9|~|~|~|~|Incidence|10318550|Testis|1999
5-9|~|~|~|~|Mortality|20606460|Thyroid|1999
5-9|0.1|0.2|0.2|32|Incidence|20146188|Thyroid|1999
5-9|~|~|~|~|Mortality|20606460|Urinary Bladder|1999
5-9|~|~|~|~|Incidence|20146188|Urinary Bladder|1999
<1|1.4|2.3|1.8|68|Mortality|3795762|All Cancer Sites Combined|1999
<1|21.8|25.0|23.4|867|Incidence|3708753|All Cancer Sites Combined|1999
<1|~|~|~|~|Mortality|3795762|Brain and Other Nervous System|1999
<1|3.0|4.2|3.5|131|Incidence|3708753|Brain and Other Nervous System|1999
<1|~|~|~|~|Mortality|1852123|Cervix|1999
<1|~|~|~|~|Incidence|1809670|Cervix|1999
<1|~|~|~|~|Mortality|3795762|Colon and Rectum|1999
<1|~|~|~|~|Incidence|3708753|Colon and Rectum|1999
<1|~|~|~|~|Mortality|1852123|Corpus and Uterus, NOS|1999
<1|~|~|~|~|Incidence|1809670|Corpus and Uterus, NOS|1999
<1|~|~|~|~|Mortality|3795762|Esophagus|1999
<1|~|~|~|~|Incidence|3708753|Esophagus|1999
<1|~|~|~|~|Mortality|1852123|Female Breast|1999
<1|~|~|~|~|Incidence|1809670|Female Breast|1999
<1|~|~|~|~|Incidence|1809670|Female Breast, <i>in situ</i>|1999
<1|~|~|~|~|Mortality|3795762|Hodgkin Lymphoma|1999
<1|~|~|~|~|Incidence|3708753|Hodgkin Lymphoma|1999
<1|.|.|.|.|Mortality|3795762|Kaposi Sarcoma|1999
<1|~|~|~|~|Incidence|3708753|Kaposi Sarcoma|1999
<1|~|~|~|~|Mortality|3795762|Kidney and Renal Pelvis|1999
<1|1.4|2.3|1.8|68|Incidence|3708753|Kidney and Renal Pelvis|1999
<1|~|~|~|~|Mortality|3795762|Larynx|1999
<1|~|~|~|~|Incidence|3708753|Larynx|1999
<1|0.5|1.0|0.7|27|Mortality|3795762|Leukemias|1999
<1|3.7|5.1|4.3|161|Incidence|3708753|Leukemias|1999
<1|~|~|~|~|Mortality|3795762|Liver and Intrahepatic Bile Duct|1999
<1|0.7|1.4|1.0|38|Incidence|3708753|Liver and Intrahepatic Bile Duct|1999
<1|~|~|~|~|Mortality|3795762|Lung and Bronchus|1999
<1|~|~|~|~|Incidence|3708753|Lung and Bronchus|1999
<1|~|~|~|~|Mortality|1852123|Male and Female Breast|1999
<1|~|~|~|~|Incidence|1809670|Male and Female Breast|1999
<1|~|~|~|~|Incidence|1809670|Male and Female Breast, <i>in situ</i>|1999
<1|~|~|~|~|Mortality|3795762|Melanomas of the Skin|1999
<1|~|~|~|~|Incidence|3708753|Melanomas of the Skin|1999
<1|~|~|~|~|Mortality|3795762|Mesothelioma|1999
<1|~|~|~|~|Incidence|3708753|Mesothelioma|1999
<1|~|~|~|~|Mortality|3795762|Myeloma|1999
<1|~|~|~|~|Incidence|3708753|Myeloma|1999
<1|~|~|~|~|Mortality|3795762|Non-Hodgkin Lymphoma|1999
<1|~|~|~|~|Incidence|3708753|Non-Hodgkin Lymphoma|1999
<1|~|~|~|~|Mortality|3795762|Oral Cavity and Pharynx|1999
<1|~|~|~|~|Incidence|3708753|Oral Cavity and Pharynx|1999
<1|~|~|~|~|Mortality|1852123|Ovary|1999
<1|~|~|~|~|Incidence|1809670|Ovary|1999
<1|~|~|~|~|Mortality|3795762|Pancreas|1999
<1|~|~|~|~|Incidence|3708753|Pancreas|1999
<1|~|~|~|~|Mortality|1943639|Prostate|1999
<1|~|~|~|~|Incidence|1899083|Prostate|1999
<1|~|~|~|~|Mortality|3795762|Stomach|1999
<1|~|~|~|~|Incidence|3708753|Stomach|1999
<1|~|~|~|~|Mortality|1943639|Testis|1999
<1|0.6|1.6|1.1|20|Incidence|1899083|Testis|1999
<1|~|~|~|~|Mortality|3795762|Thyroid|1999
<1|~|~|~|~|Incidence|3708753|Thyroid|1999
<1|~|~|~|~|Mortality|3795762|Urinary Bladder|1999
<1|~|~|~|~|Incidence|3708753|Urinary Bladder|1999
1-4|2.5|3.0|2.7|420|Mortality|15322337|All Cancer Sites Combined|2000
1-4|19.9|21.4|20.7|3095|Incidence|14974472|All Cancer Sites Combined|2000
1-4|0.6|0.8|0.7|104|Mortality|15322337|Brain and Other Nervous System|2000
1-4|3.9|4.5|4.2|625|Incidence|14974472|Brain and Other Nervous System|2000
1-4|~|~|~|~|Mortality|7485852|Cervix|2000
1-4|~|~|~|~|Incidence|7315589|Cervix|2000
1-4|~|~|~|~|Mortality|15322337|Colon and Rectum|2000
1-4|~|~|~|~|Incidence|14974472|Colon and Rectum|2000
1-4|~|~|~|~|Mortality|7485852|Corpus and Uterus, NOS|2000
1-4|~|~|~|~|Incidence|7315589|Corpus and Uterus, NOS|2000
1-4|~|~|~|~|Mortality|15322337|Esophagus|2000
1-4|~|~|~|~|Incidence|14974472|Esophagus|2000
1-4|~|~|~|~|Mortality|7485852|Female Breast|2000
1-4|~|~|~|~|Incidence|7315589|Female Breast|2000
1-4|~|~|~|~|Incidence|7315589|Female Breast, <i>in situ</i>|2000
1-4|~|~|~|~|Mortality|15322337|Hodgkin Lymphoma|2000
1-4|0.1|0.2|0.1|16|Incidence|14974472|Hodgkin Lymphoma|2000
1-4|.|.|.|.|Mortality|15322337|Kaposi Sarcoma|2000
1-4|~|~|~|~|Incidence|14974472|Kaposi Sarcoma|2000
1-4|~|~|~|~|Mortality|15322337|Kidney and Renal Pelvis|2000
1-4|1.9|2.4|2.1|321|Incidence|14974472|Kidney and Renal Pelvis|2000
1-4|~|~|~|~|Mortality|15322337|Larynx|2000
1-4|~|~|~|~|Incidence|14974472|Larynx|2000
1-4|0.8|1.1|0.9|137|Mortality|15322337|Leukemias|2000
1-4|8.0|8.9|8.4|1263|Incidence|14974472|Leukemias|2000
1-4|0.1|0.2|0.2|23|Mortality|15322337|Liver and Intrahepatic Bile Duct|2000
1-4|0.4|0.6|0.5|69|Incidence|14974472|Liver and Intrahepatic Bile Duct|2000
1-4|~|~|~|~|Mortality|15322337|Lung and Bronchus|2000
1-4|~|~|~|~|Incidence|14974472|Lung and Bronchus|2000
1-4|~|~|~|~|Mortality|7485852|Male and Female Breast|2000
1-4|~|~|~|~|Incidence|7315589|Male and Female Breast|2000
1-4|~|~|~|~|Incidence|7315589|Male and Female Breast, <i>in situ</i>|2000
1-4|~|~|~|~|Mortality|15322337|Melanomas of the Skin|2000
1-4|~|~|~|~|Incidence|14974472|Melanomas of the Skin|2000
1-4|~|~|~|~|Mortality|15322337|Mesothelioma|2000
1-4|~|~|~|~|Incidence|14974472|Mesothelioma|2000
1-4|~|~|~|~|Mortality|15322337|Myeloma|2000
1-4|~|~|~|~|Incidence|14974472|Myeloma|2000
1-4|~|~|~|~|Mortality|15322337|Non-Hodgkin Lymphoma|2000
1-4|0.5|0.8|0.6|93|Incidence|14974472|Non-Hodgkin Lymphoma|2000
1-4|~|~|~|~|Mortality|15322337|Oral Cavity and Pharynx|2000
1-4|~|~|~|~|Incidence|14974472|Oral Cavity and Pharynx|2000
1-4|~|~|~|~|Mortality|7485852|Ovary|2000
1-4|~|~|~|~|Incidence|7315589|Ovary|2000
1-4|~|~|~|~|Mortality|15322337|Pancreas|2000
1-4|~|~|~|~|Incidence|14974472|Pancreas|2000
1-4|~|~|~|~|Mortality|7836485|Prostate|2000
1-4|~|~|~|~|Incidence|7658883|Prostate|2000
1-4|~|~|~|~|Mortality|15322337|Stomach|2000
1-4|~|~|~|~|Incidence|14974472|Stomach|2000
1-4|~|~|~|~|Mortality|7836485|Testis|2000
1-4|0.1|0.4|0.2|19|Incidence|7658883|Testis|2000
1-4|~|~|~|~|Mortality|15322337|Thyroid|2000
1-4|~|~|~|~|Incidence|14974472|Thyroid|2000
1-4|~|~|~|~|Mortality|15322337|Urinary Bladder|2000
1-4|~|~|~|~|Incidence|14974472|Urinary Bladder|2000
10-14|2.3|2.8|2.5|525|Mortality|20637696|All Cancer Sites Combined|2000
10-14|12.0|13.0|12.5|2520|Incidence|20164744|All Cancer Sites Combined|2000
10-14|0.6|0.9|0.7|150|Mortality|20637696|Brain and Other Nervous System|2000
10-14|2.6|3.0|2.8|565|Incidence|20164744|Brain and Other Nervous System|2000
10-14|~|~|~|~|Mortality|10063054|Cervix|2000
10-14|~|~|~|~|Incidence|9832364|Cervix|2000
10-14|~|~|~|~|Mortality|20637696|Colon and Rectum|2000
10-14|~|~|~|~|Incidence|20164744|Colon and Rectum|2000
10-14|~|~|~|~|Mortality|10063054|Corpus and Uterus, NOS|2000
10-14|~|~|~|~|Incidence|9832364|Corpus and Uterus, NOS|2000
10-14|~|~|~|~|Mortality|20637696|Esophagus|2000
10-14|~|~|~|~|Incidence|20164744|Esophagus|2000
10-14|~|~|~|~|Mortality|10063054|Female Breast|2000
10-14|~|~|~|~|Incidence|9832364|Female Breast|2000
10-14|~|~|~|~|Incidence|9832364|Female Breast, <i>in situ</i>|2000
10-14|~|~|~|~|Mortality|20637696|Hodgkin Lymphoma|2000
10-14|1.1|1.4|1.3|255|Incidence|20164744|Hodgkin Lymphoma|2000
10-14|.|.|.|.|Mortality|20637696|Kaposi Sarcoma|2000
10-14|~|~|~|~|Incidence|20164744|Kaposi Sarcoma|2000
10-14|~|~|~|~|Mortality|20637696|Kidney and Renal Pelvis|2000
10-14|0.1|0.2|0.1|23|Incidence|20164744|Kidney and Renal Pelvis|2000
10-14|~|~|~|~|Mortality|20637696|Larynx|2000
10-14|~|~|~|~|Incidence|20164744|Larynx|2000
10-14|0.7|1.0|0.8|173|Mortality|20637696|Leukemias|2000
10-14|2.3|2.7|2.5|502|Incidence|20164744|Leukemias|2000
10-14|~|~|~|~|Mortality|20637696|Liver and Intrahepatic Bile Duct|2000
10-14|0.1|0.2|0.1|22|Incidence|20164744|Liver and Intrahepatic Bile Duct|2000
10-14|~|~|~|~|Mortality|20637696|Lung and Bronchus|2000
10-14|~|~|~|~|Incidence|20164744|Lung and Bronchus|2000
10-14|~|~|~|~|Mortality|10063054|Male and Female Breast|2000
10-14|~|~|~|~|Incidence|9832364|Male and Female Breast|2000
10-14|~|~|~|~|Incidence|9832364|Male and Female Breast, <i>in situ</i>|2000
10-14|~|~|~|~|Mortality|20637696|Melanomas of the Skin|2000
10-14|0.3|0.4|0.3|67|Incidence|20164744|Melanomas of the Skin|2000
10-14|~|~|~|~|Mortality|20637696|Mesothelioma|2000
10-14|~|~|~|~|Incidence|20164744|Mesothelioma|2000
10-14|~|~|~|~|Mortality|20637696|Myeloma|2000
10-14|~|~|~|~|Incidence|20164744|Myeloma|2000
10-14|0.1|0.2|0.1|24|Mortality|20637696|Non-Hodgkin Lymphoma|2000
10-14|1.0|1.3|1.2|233|Incidence|20164744|Non-Hodgkin Lymphoma|2000
10-14|~|~|~|~|Mortality|20637696|Oral Cavity and Pharynx|2000
10-14|0.2|0.3|0.2|48|Incidence|20164744|Oral Cavity and Pharynx|2000
10-14|~|~|~|~|Mortality|10063054|Ovary|2000
10-14|0.5|0.9|0.7|69|Incidence|9832364|Ovary|2000
10-14|~|~|~|~|Mortality|20637696|Pancreas|2000
10-14|~|~|~|~|Incidence|20164744|Pancreas|2000
10-14|~|~|~|~|Mortality|10574642|Prostate|2000
10-14|~|~|~|~|Incidence|10332380|Prostate|2000
10-14|~|~|~|~|Mortality|20637696|Stomach|2000
10-14|~|~|~|~|Incidence|20164744|Stomach|2000
10-14|~|~|~|~|Mortality|10574642|Testis|2000
10-14|0.1|0.3|0.2|20|Incidence|10332380|Testis|2000
10-14|~|~|~|~|Mortality|20637696|Thyroid|2000
10-14|0.4|0.6|0.5|93|Incidence|20164744|Thyroid|2000
10-14|~|~|~|~|Mortality|20637696|Urinary Bladder|2000
10-14|~|~|~|~|Incidence|20164744|Urinary Bladder|2000
15-19|3.4|3.9|3.7|745|Mortality|20294955|All Cancer Sites Combined|2000
15-19|19.9|21.2|20.6|4073|Incidence|19799255|All Cancer Sites Combined|2000
15-19|0.4|0.6|0.5|105|Mortality|20294955|Brain and Other Nervous System|2000
15-19|2.0|2.4|2.2|434|Incidence|19799255|Brain and Other Nervous System|2000
15-19|~|~|~|~|Mortality|9854932|Cervix|2000
15-19|0.2|0.4|0.2|23|Incidence|9613113|Cervix|2000
15-19|~|~|~|~|Mortality|20294955|Colon and Rectum|2000
15-19|0.2|0.4|0.3|53|Incidence|19799255|Colon and Rectum|2000
15-19|~|~|~|~|Mortality|9854932|Corpus and Uterus, NOS|2000
15-19|~|~|~|~|Incidence|9613113|Corpus and Uterus, NOS|2000
15-19|~|~|~|~|Mortality|20294955|Esophagus|2000
15-19|~|~|~|~|Incidence|19799255|Esophagus|2000
15-19|~|~|~|~|Mortality|9854932|Female Breast|2000
15-19|~|~|~|~|Incidence|9613113|Female Breast|2000
15-19|~|~|~|~|Incidence|9613113|Female Breast, <i>in situ</i>|2000
15-19|0.1|0.2|0.1|21|Mortality|20294955|Hodgkin Lymphoma|2000
15-19|2.9|3.4|3.2|625|Incidence|19799255|Hodgkin Lymphoma|2000
15-19|.|.|.|.|Mortality|20294955|Kaposi Sarcoma|2000
15-19|~|~|~|~|Incidence|19799255|Kaposi Sarcoma|2000
15-19|~|~|~|~|Mortality|20294955|Kidney and Renal Pelvis|2000
15-19|0.1|0.2|0.1|27|Incidence|19799255|Kidney and Renal Pelvis|2000
15-19|~|~|~|~|Mortality|20294955|Larynx|2000
15-19|~|~|~|~|Incidence|19799255|Larynx|2000
15-19|1.0|1.4|1.2|242|Mortality|20294955|Leukemias|2000
15-19|2.5|3.0|2.8|547|Incidence|19799255|Leukemias|2000
15-19|~|~|~|~|Mortality|20294955|Liver and Intrahepatic Bile Duct|2000
15-19|0.1|0.1|0.1|17|Incidence|19799255|Liver and Intrahepatic Bile Duct|2000
15-19|~|~|~|~|Mortality|20294955|Lung and Bronchus|2000
15-19|0.1|0.2|0.1|28|Incidence|19799255|Lung and Bronchus|2000
15-19|~|~|~|~|Mortality|9854932|Male and Female Breast|2000
15-19|~|~|~|~|Incidence|9613113|Male and Female Breast|2000
15-19|~|~|~|~|Incidence|9613113|Male and Female Breast, <i>in situ</i>|2000
15-19|~|~|~|~|Mortality|20294955|Melanomas of the Skin|2000
15-19|1.3|1.7|1.5|299|Incidence|19799255|Melanomas of the Skin|2000
15-19|~|~|~|~|Mortality|20294955|Mesothelioma|2000
15-19|~|~|~|~|Incidence|19799255|Mesothelioma|2000
15-19|~|~|~|~|Mortality|20294955|Myeloma|2000
15-19|~|~|~|~|Incidence|19799255|Myeloma|2000
15-19|0.2|0.4|0.3|60|Mortality|20294955|Non-Hodgkin Lymphoma|2000
15-19|1.6|2.0|1.8|348|Incidence|19799255|Non-Hodgkin Lymphoma|2000
15-19|~|~|~|~|Mortality|20294955|Oral Cavity and Pharynx|2000
15-19|0.3|0.5|0.4|81|Incidence|19799255|Oral Cavity and Pharynx|2000
15-19|~|~|~|~|Mortality|9854932|Ovary|2000
15-19|1.1|1.5|1.3|124|Incidence|9613113|Ovary|2000
15-19|~|~|~|~|Mortality|20294955|Pancreas|2000
15-19|~|~|~|~|Incidence|19799255|Pancreas|2000
15-19|~|~|~|~|Mortality|10440023|Prostate|2000
15-19|~|~|~|~|Incidence|10186142|Prostate|2000
15-19|~|~|~|~|Mortality|20294955|Stomach|2000
15-19|~|~|~|~|Incidence|19799255|Stomach|2000
15-19|~|~|~|~|Mortality|10440023|Testis|2000
15-19|3.2|3.9|3.5|357|Incidence|10186142|Testis|2000
15-19|~|~|~|~|Mortality|20294955|Thyroid|2000
15-19|1.5|1.9|1.7|334|Incidence|19799255|Thyroid|2000
15-19|~|~|~|~|Mortality|20294955|Urinary Bladder|2000
15-19|0.1|0.2|0.1|26|Incidence|19799255|Urinary Bladder|2000
5-9|2.2|2.6|2.4|489|Mortality|20463852|All Cancer Sites Combined|2000
5-9|11.0|12.0|11.5|2300|Incidence|20008051|All Cancer Sites Combined|2000
5-9|0.7|0.9|0.8|166|Mortality|20463852|Brain and Other Nervous System|2000
5-9|3.1|3.7|3.4|679|Incidence|20008051|Brain and Other Nervous System|2000
5-9|~|~|~|~|Mortality|9984495|Cervix|2000
5-9|~|~|~|~|Incidence|9761736|Cervix|2000
5-9|~|~|~|~|Mortality|20463852|Colon and Rectum|2000
5-9|~|~|~|~|Incidence|20008051|Colon and Rectum|2000
5-9|~|~|~|~|Mortality|9984495|Corpus and Uterus, NOS|2000
5-9|~|~|~|~|Incidence|9761736|Corpus and Uterus, NOS|2000
5-9|~|~|~|~|Mortality|20463852|Esophagus|2000
5-9|~|~|~|~|Incidence|20008051|Esophagus|2000
5-9|~|~|~|~|Mortality|9984495|Female Breast|2000
5-9|~|~|~|~|Incidence|9761736|Female Breast|2000
5-9|~|~|~|~|Incidence|9761736|Female Breast, <i>in situ</i>|2000
5-9|~|~|~|~|Mortality|20463852|Hodgkin Lymphoma|2000
5-9|0.3|0.5|0.4|72|Incidence|20008051|Hodgkin Lymphoma|2000
5-9|.|.|.|.|Mortality|20463852|Kaposi Sarcoma|2000
5-9|~|~|~|~|Incidence|20008051|Kaposi Sarcoma|2000
5-9|0.1|0.2|0.1|21|Mortality|20463852|Kidney and Renal Pelvis|2000
5-9|0.5|0.7|0.6|124|Incidence|20008051|Kidney and Renal Pelvis|2000
5-9|~|~|~|~|Mortality|20463852|Larynx|2000
5-9|~|~|~|~|Incidence|20008051|Larynx|2000
5-9|0.6|0.8|0.7|142|Mortality|20463852|Leukemias|2000
5-9|3.5|4.0|3.8|752|Incidence|20008051|Leukemias|2000
5-9|~|~|~|~|Mortality|20463852|Liver and Intrahepatic Bile Duct|2000
5-9|~|~|~|~|Incidence|20008051|Liver and Intrahepatic Bile Duct|2000
5-9|~|~|~|~|Mortality|20463852|Lung and Bronchus|2000
5-9|~|~|~|~|Incidence|20008051|Lung and Bronchus|2000
5-9|~|~|~|~|Mortality|9984495|Male and Female Breast|2000
5-9|~|~|~|~|Incidence|9761736|Male and Female Breast|2000
5-9|~|~|~|~|Incidence|9761736|Male and Female Breast, <i>in situ</i>|2000
5-9|~|~|~|~|Mortality|20463852|Melanomas of the Skin|2000
5-9|0.1|0.1|0.1|18|Incidence|20008051|Melanomas of the Skin|2000
5-9|~|~|~|~|Mortality|20463852|Mesothelioma|2000
5-9|~|~|~|~|Incidence|20008051|Mesothelioma|2000
5-9|~|~|~|~|Mortality|20463852|Myeloma|2000
5-9|~|~|~|~|Incidence|20008051|Myeloma|2000
5-9|0.1|0.2|0.1|23|Mortality|20463852|Non-Hodgkin Lymphoma|2000
5-9|1.0|1.3|1.1|220|Incidence|20008051|Non-Hodgkin Lymphoma|2000
5-9|~|~|~|~|Mortality|20463852|Oral Cavity and Pharynx|2000
5-9|0.1|0.1|0.1|19|Incidence|20008051|Oral Cavity and Pharynx|2000
5-9|~|~|~|~|Mortality|9984495|Ovary|2000
5-9|0.1|0.3|0.2|22|Incidence|9761736|Ovary|2000
5-9|~|~|~|~|Mortality|20463852|Pancreas|2000
5-9|~|~|~|~|Incidence|20008051|Pancreas|2000
5-9|~|~|~|~|Mortality|10479357|Prostate|2000
5-9|~|~|~|~|Incidence|10246315|Prostate|2000
5-9|~|~|~|~|Mortality|20463852|Stomach|2000
5-9|~|~|~|~|Incidence|20008051|Stomach|2000
5-9|~|~|~|~|Mortality|10479357|Testis|2000
5-9|~|~|~|~|Incidence|10246315|Testis|2000
5-9|~|~|~|~|Mortality|20463852|Thyroid|2000
5-9|0.1|0.2|0.1|20|Incidence|20008051|Thyroid|2000
5-9|~|~|~|~|Mortality|20463852|Urinary Bladder|2000
5-9|~|~|~|~|Incidence|20008051|Urinary Bladder|2000
<1|1.9|2.9|2.4|92|Mortality|3855956|All Cancer Sites Combined|2000
<1|22.3|25.5|23.9|899|Incidence|3767637|All Cancer Sites Combined|2000
<1|0.3|0.8|0.5|20|Mortality|3855956|Brain and Other Nervous System|2000
<1|3.5|4.8|4.1|156|Incidence|3767637|Brain and Other Nervous System|2000
<1|~|~|~|~|Mortality|1881822|Cervix|2000
<1|~|~|~|~|Incidence|1838747|Cervix|2000
<1|~|~|~|~|Mortality|3855956|Colon and Rectum|2000
<1|~|~|~|~|Incidence|3767637|Colon and Rectum|2000
<1|~|~|~|~|Mortality|1881822|Corpus and Uterus, NOS|2000
<1|~|~|~|~|Incidence|1838747|Corpus and Uterus, NOS|2000
<1|~|~|~|~|Mortality|3855956|Esophagus|2000
<1|~|~|~|~|Incidence|3767637|Esophagus|2000
<1|~|~|~|~|Mortality|1881822|Female Breast|2000
<1|~|~|~|~|Incidence|1838747|Female Breast|2000
<1|~|~|~|~|Incidence|1838747|Female Breast, <i>in situ</i>|2000
<1|~|~|~|~|Mortality|3855956|Hodgkin Lymphoma|2000
<1|~|~|~|~|Incidence|3767637|Hodgkin Lymphoma|2000
<1|.|.|.|.|Mortality|3855956|Kaposi Sarcoma|2000
<1|~|~|~|~|Incidence|3767637|Kaposi Sarcoma|2000
<1|~|~|~|~|Mortality|3855956|Kidney and Renal Pelvis|2000
<1|1.2|2.0|1.5|58|Incidence|3767637|Kidney and Renal Pelvis|2000
<1|~|~|~|~|Mortality|3855956|Larynx|2000
<1|~|~|~|~|Incidence|3767637|Larynx|2000
<1|0.7|1.4|1.0|38|Mortality|3855956|Leukemias|2000
<1|4.1|5.5|4.7|178|Incidence|3767637|Leukemias|2000
<1|~|~|~|~|Mortality|3855956|Liver and Intrahepatic Bile Duct|2000
<1|0.8|1.6|1.2|44|Incidence|3767637|Liver and Intrahepatic Bile Duct|2000
<1|~|~|~|~|Mortality|3855956|Lung and Bronchus|2000
<1|~|~|~|~|Incidence|3767637|Lung and Bronchus|2000
<1|~|~|~|~|Mortality|1881822|Male and Female Breast|2000
<1|~|~|~|~|Incidence|1838747|Male and Female Breast|2000
<1|~|~|~|~|Incidence|1838747|Male and Female Breast, <i>in situ</i>|2000
<1|~|~|~|~|Mortality|3855956|Melanomas of the Skin|2000
<1|~|~|~|~|Incidence|3767637|Melanomas of the Skin|2000
<1|~|~|~|~|Mortality|3855956|Mesothelioma|2000
<1|~|~|~|~|Incidence|3767637|Mesothelioma|2000
<1|~|~|~|~|Mortality|3855956|Myeloma|2000
<1|~|~|~|~|Incidence|3767637|Myeloma|2000
<1|~|~|~|~|Mortality|3855956|Non-Hodgkin Lymphoma|2000
<1|~|~|~|~|Incidence|3767637|Non-Hodgkin Lymphoma|2000
<1|~|~|~|~|Mortality|3855956|Oral Cavity and Pharynx|2000
<1|~|~|~|~|Incidence|3767637|Oral Cavity and Pharynx|2000
<1|~|~|~|~|Mortality|1881822|Ovary|2000
<1|~|~|~|~|Incidence|1838747|Ovary|2000
<1|~|~|~|~|Mortality|3855956|Pancreas|2000
<1|~|~|~|~|Incidence|3767637|Pancreas|2000
<1|~|~|~|~|Mortality|1974134|Prostate|2000
<1|~|~|~|~|Incidence|1928890|Prostate|2000
<1|~|~|~|~|Mortality|3855956|Stomach|2000
<1|~|~|~|~|Incidence|3767637|Stomach|2000
<1|~|~|~|~|Mortality|1974134|Testis|2000
<1|~|~|~|~|Incidence|1928890|Testis|2000
<1|~|~|~|~|Mortality|3855956|Thyroid|2000
<1|~|~|~|~|Incidence|3767637|Thyroid|2000
<1|~|~|~|~|Mortality|3855956|Urinary Bladder|2000
<1|~|~|~|~|Incidence|3767637|Urinary Bladder|2000
1-4|0.2|0.4|0.3|44|Mortality|15339782|Acute Lymphocytic|1999
1-4|6.2|7.0|6.6|993|Incidence|14991152|Acute Lymphocytic|1999
1-4|0.2|0.4|0.3|50|Mortality|15339782|Acute Myeloid|1999
1-4|0.8|1.1|1.0|146|Incidence|14991152|Acute Myeloid|1999
1-4|~|~|~|~|Mortality|15339782|Bones and Joints|1999
1-4|0.1|0.3|0.2|32|Incidence|14991152|Bones and Joints|1999
1-4|0.6|0.9|0.8|119|Mortality|15339782|Leukemia|1999
1-4|7.5|8.4|8.0|1195|Incidence|14991152|Leukemia|1999
1-4|0.7|1.0|0.8|129|Mortality|15339782|Other|1999
1-4|3.7|4.3|4.0|601|Incidence|14991152|Other|1999
1-4|0.1|0.2|0.1|18|Mortality|15339782|Soft Tissue|1999
1-4|0.8|1.1|0.9|140|Incidence|14991152|Soft Tissue|1999
10-14|0.3|0.5|0.4|75|Mortality|20213364|Acute Lymphocytic|1999
10-14|1.8|2.2|2.0|390|Incidence|19742631|Acute Lymphocytic|1999
10-14|0.2|0.3|0.3|54|Mortality|20213364|Acute Myeloid|1999
10-14|0.5|0.7|0.6|115|Incidence|19742631|Acute Myeloid|1999
10-14|0.2|0.4|0.3|55|Mortality|20213364|Bones and Joints|1999
10-14|1.3|1.6|1.4|281|Incidence|19742631|Bones and Joints|1999
10-14|0.7|1.0|0.9|175|Mortality|20213364|Leukemia|1999
10-14|2.6|3.1|2.8|559|Incidence|19742631|Leukemia|1999
10-14|0.3|0.4|0.3|68|Mortality|20213364|Other|1999
10-14|2.1|2.6|2.3|463|Incidence|19742631|Other|1999
10-14|0.1|0.3|0.2|37|Mortality|20213364|Soft Tissue|1999
10-14|0.6|0.8|0.7|135|Incidence|19742631|Soft Tissue|1999
15-19|0.4|0.6|0.5|91|Mortality|20084602|Acute Lymphocytic|1999
15-19|1.2|1.5|1.4|265|Incidence|19585857|Acute Lymphocytic|1999
15-19|0.3|0.4|0.3|66|Mortality|20084602|Acute Myeloid|1999
15-19|0.7|1.0|0.9|171|Incidence|19585857|Acute Myeloid|1999
15-19|0.5|0.8|0.6|127|Mortality|20084602|Bones and Joints|1999
15-19|1.2|1.6|1.4|275|Incidence|19585857|Bones and Joints|1999
15-19|1.0|1.3|1.1|221|Mortality|20084602|Leukemia|1999
15-19|2.5|2.9|2.7|524|Incidence|19585857|Leukemia|1999
15-19|0.5|0.8|0.6|127|Mortality|20084602|Other|1999
15-19|7.5|8.3|7.9|1541|Incidence|19585857|Other|1999
15-19|0.2|0.4|0.3|65|Mortality|20084602|Soft Tissue|1999
15-19|0.9|1.2|1.0|197|Incidence|19585857|Soft Tissue|1999
5-9|0.2|0.4|0.3|65|Mortality|20606460|Acute Lymphocytic|1999
5-9|2.7|3.2|3.0|599|Incidence|20146188|Acute Lymphocytic|1999
5-9|0.1|0.2|0.1|29|Mortality|20606460|Acute Myeloid|1999
5-9|0.4|0.6|0.5|93|Incidence|20146188|Acute Myeloid|1999
5-9|0.1|0.2|0.1|24|Mortality|20606460|Bones and Joints|1999
5-9|0.5|0.7|0.6|117|Incidence|20146188|Bones and Joints|1999
5-9|0.5|0.7|0.6|130|Mortality|20606460|Leukemia|1999
5-9|3.4|3.9|3.6|731|Incidence|20146188|Leukemia|1999
5-9|0.4|0.6|0.5|108|Mortality|20606460|Other|1999
5-9|1.0|1.3|1.2|234|Incidence|20146188|Other|1999
5-9|0.1|0.2|0.1|28|Mortality|20606460|Soft Tissue|1999
5-9|0.5|0.7|0.6|112|Incidence|20146188|Soft Tissue|1999
<1|~|~|~|~|Mortality|3795762|Acute Lymphocytic|1999
<1|1.7|2.7|2.1|79|Incidence|3708753|Acute Lymphocytic|1999
<1|~|~|~|~|Mortality|3795762|Acute Myeloid|1999
<1|0.9|1.6|1.2|44|Incidence|3708753|Acute Myeloid|1999
<1|~|~|~|~|Mortality|3795762|Bones and Joints|1999
<1|~|~|~|~|Incidence|3708753|Bones and Joints|1999
<1|0.5|1.0|0.7|27|Mortality|3795762|Leukemia|1999
<1|3.7|5.1|4.3|161|Incidence|3708753|Leukemia|1999
<1|0.4|0.9|0.6|23|Mortality|3795762|Other|1999
<1|9.6|11.8|10.7|395|Incidence|3708753|Other|1999
<1|~|~|~|~|Mortality|3795762|Soft Tissue|1999
<1|2.2|3.3|2.8|102|Incidence|3708753|Soft Tissue|1999
1-4|0.2|0.4|0.3|48|Mortality|15322337|Acute Lymphocytic|2000
1-4|6.8|7.7|7.2|1082|Incidence|14974472|Acute Lymphocytic|2000
1-4|0.3|0.5|0.4|56|Mortality|15322337|Acute Myeloid|2000
1-4|0.7|1.0|0.8|121|Incidence|14974472|Acute Myeloid|2000
1-4|~|~|~|~|Mortality|15322337|Bones and Joints|2000
1-4|0.1|0.2|0.2|23|Incidence|14974472|Bones and Joints|2000
1-4|0.8|1.1|0.9|137|Mortality|15322337|Leukemia|2000
1-4|8.0|8.9|8.4|1263|Incidence|14974472|Leukemia|2000
1-4|0.7|1.0|0.9|135|Mortality|15322337|Other|2000
1-4|3.7|4.3|4.0|596|Incidence|14974472|Other|2000
1-4|0.1|0.2|0.1|20|Mortality|15322337|Soft Tissue|2000
1-4|0.9|1.2|1.1|158|Incidence|14974472|Soft Tissue|2000
10-14|0.4|0.5|0.4|92|Mortality|20637696|Acute Lymphocytic|2000
10-14|1.6|1.9|1.7|349|Incidence|20164744|Acute Lymphocytic|2000
10-14|0.2|0.3|0.2|47|Mortality|20637696|Acute Myeloid|2000
10-14|0.4|0.6|0.5|97|Incidence|20164744|Acute Myeloid|2000
10-14|0.2|0.4|0.3|62|Mortality|20637696|Bones and Joints|2000
10-14|1.2|1.5|1.3|269|Incidence|20164744|Bones and Joints|2000
10-14|0.7|1.0|0.8|173|Mortality|20637696|Leukemia|2000
10-14|2.3|2.7|2.5|502|Incidence|20164744|Leukemia|2000
10-14|0.3|0.5|0.4|76|Mortality|20637696|Other|2000
10-14|2.3|2.7|2.5|498|Incidence|20164744|Other|2000
10-14|0.1|0.2|0.1|27|Mortality|20637696|Soft Tissue|2000
10-14|0.7|1.0|0.9|175|Incidence|20164744|Soft Tissue|2000
15-19|0.4|0.6|0.5|98|Mortality|20294955|Acute Lymphocytic|2000
15-19|1.4|1.8|1.6|319|Incidence|19799255|Acute Lymphocytic|2000
15-19|0.3|0.5|0.4|77|Mortality|20294955|Acute Myeloid|2000
15-19|0.7|1.0|0.8|167|Incidence|19799255|Acute Myeloid|2000
15-19|0.4|0.6|0.5|98|Mortality|20294955|Bones and Joints|2000
15-19|1.2|1.6|1.4|274|Incidence|19799255|Bones and Joints|2000
15-19|1.0|1.4|1.2|242|Mortality|20294955|Leukemia|2000
15-19|2.5|3.0|2.8|547|Incidence|19799255|Leukemia|2000
15-19|0.6|0.8|0.7|138|Mortality|20294955|Other|2000
15-19|7.6|8.3|7.9|1573|Incidence|19799255|Other|2000
15-19|0.3|0.5|0.4|73|Mortality|20294955|Soft Tissue|2000
15-19|1.1|1.4|1.2|245|Incidence|19799255|Soft Tissue|2000
5-9|0.3|0.5|0.4|78|Mortality|20463852|Acute Lymphocytic|2000
5-9|2.9|3.4|3.1|627|Incidence|20008051|Acute Lymphocytic|2000
5-9|0.1|0.2|0.2|33|Mortality|20463852|Acute Myeloid|2000
5-9|0.3|0.5|0.4|79|Incidence|20008051|Acute Myeloid|2000
5-9|0.1|0.1|0.1|19|Mortality|20463852|Bones and Joints|2000
5-9|0.4|0.6|0.5|104|Incidence|20008051|Bones and Joints|2000
5-9|0.6|0.8|0.7|142|Mortality|20463852|Leukemia|2000
5-9|3.5|4.0|3.8|752|Incidence|20008051|Leukemia|2000
5-9|0.4|0.6|0.5|98|Mortality|20463852|Other|2000
5-9|1.0|1.3|1.2|236|Incidence|20008051|Other|2000
5-9|0.0|0.1|0.1|17|Mortality|20463852|Soft Tissue|2000
5-9|0.5|0.7|0.6|113|Incidence|20008051|Soft Tissue|2000
<1|0.2|0.7|0.4|16|Mortality|3855956|Acute Lymphocytic|2000
<1|1.9|2.9|2.4|89|Incidence|3767637|Acute Lymphocytic|2000
<1|~|~|~|~|Mortality|3855956|Acute Myeloid|2000
<1|1.0|1.8|1.4|52|Incidence|3767637|Acute Myeloid|2000
<1|~|~|~|~|Mortality|3855956|Bones and Joints|2000
<1|~|~|~|~|Incidence|3767637|Bones and Joints|2000
<1|0.7|1.4|1.0|38|Mortality|3855956|Leukemia|2000
<1|4.1|5.5|4.7|178|Incidence|3767637|Leukemia|2000
<1|0.4|0.9|0.6|24|Mortality|3855956|Other|2000
<1|9.1|11.2|10.1|380|Incidence|3767637|Other|2000
<1|~|~|~|~|Mortality|3855956|Soft Tissue|2000
<1|2.5|3.7|3.1|115|Incidence|3767637|Soft Tissue|2000
1-4|0.2|0.4|0.3|41|Mortality|15285559|Acute Lymphocytic|2001
1-4|7.1|8.0|7.6|1145|Incidence|15123657|Acute Lymphocytic|2001
1-4|0.4|0.6|0.5|73|Mortality|15285559|Acute Myeloid|2001
1-4|0.7|1.0|0.8|126|Incidence|15123657|Acute Myeloid|2001
1-4|~|~|~|~|Mortality|15285559|Bones and Joints|2001
1-4|0.1|0.2|0.1|22|Incidence|15123657|Bones and Joints|2001
1-4|0.9|1.2|1.0|155|Mortality|15285559|Leukemia|2001
1-4|8.5|9.5|9.0|1357|Incidence|15123657|Leukemia|2001
1-4|0.7|1.0|0.8|122|Mortality|15285559|Other|2001
1-4|4.2|4.9|4.6|690|Incidence|15123657|Other|2001
1-4|0.1|0.2|0.1|18|Mortality|15285559|Soft Tissue|2001
1-4|1.0|1.4|1.2|180|Incidence|15123657|Soft Tissue|2001
10-14|0.3|0.5|0.4|78|Mortality|20978678|Acute Lymphocytic|2001
10-14|1.8|2.2|2.0|419|Incidence|20758808|Acute Lymphocytic|2001
10-14|0.2|0.3|0.2|46|Mortality|20978678|Acute Myeloid|2001
10-14|0.5|0.8|0.7|136|Incidence|20758808|Acute Myeloid|2001
10-14|0.3|0.4|0.3|72|Mortality|20978678|Bones and Joints|2001
10-14|1.2|1.6|1.4|291|Incidence|20758808|Bones and Joints|2001
10-14|0.7|0.9|0.8|170|Mortality|20978678|Leukemia|2001
10-14|2.7|3.2|3.0|618|Incidence|20758808|Leukemia|2001
10-14|0.3|0.4|0.3|70|Mortality|20978678|Other|2001
10-14|2.5|2.9|2.7|555|Incidence|20758808|Other|2001
10-14|0.1|0.2|0.2|36|Mortality|20978678|Soft Tissue|2001
10-14|0.7|1.0|0.9|177|Incidence|20758808|Soft Tissue|2001
15-19|0.4|0.6|0.5|105|Mortality|20456284|Acute Lymphocytic|2001
15-19|1.3|1.7|1.5|306|Incidence|20227701|Acute Lymphocytic|2001
15-19|0.3|0.4|0.3|70|Mortality|20456284|Acute Myeloid|2001
15-19|0.7|1.0|0.9|173|Incidence|20227701|Acute Myeloid|2001
15-19|0.4|0.6|0.5|101|Mortality|20456284|Bones and Joints|2001
15-19|1.5|1.9|1.7|347|Incidence|20227701|Bones and Joints|2001
15-19|1.0|1.3|1.1|225|Mortality|20456284|Leukemia|2001
15-19|2.6|3.1|2.9|577|Incidence|20227701|Leukemia|2001
15-19|0.6|0.8|0.7|147|Mortality|20456284|Other|2001
15-19|7.9|8.7|8.3|1685|Incidence|20227701|Other|2001
15-19|0.2|0.4|0.3|61|Mortality|20456284|Soft Tissue|2001
15-19|1.0|1.3|1.1|225|Incidence|20227701|Soft Tissue|2001
5-9|0.3|0.5|0.4|84|Mortality|20173362|Acute Lymphocytic|2001
5-9|2.9|3.3|3.1|617|Incidence|19962452|Acute Lymphocytic|2001
5-9|0.1|0.2|0.2|31|Mortality|20173362|Acute Myeloid|2001
5-9|0.3|0.5|0.4|84|Incidence|19962452|Acute Myeloid|2001
5-9|~|~|~|~|Mortality|20173362|Bones and Joints|2001
5-9|0.5|0.7|0.6|114|Incidence|19962452|Bones and Joints|2001
5-9|0.6|0.9|0.8|153|Mortality|20173362|Leukemia|2001
5-9|3.5|4.0|3.8|751|Incidence|19962452|Leukemia|2001
5-9|0.3|0.5|0.4|88|Mortality|20173362|Other|2001
5-9|1.3|1.7|1.5|299|Incidence|19962452|Other|2001
5-9|0.1|0.2|0.1|26|Mortality|20173362|Soft Tissue|2001
5-9|0.4|0.6|0.5|95|Incidence|19962452|Soft Tissue|2001
<1|~|~|~|~|Mortality|4012658|Acute Lymphocytic|2001
<1|1.5|2.4|1.9|75|Incidence|3970113|Acute Lymphocytic|2001
<1|~|~|~|~|Mortality|4012658|Acute Myeloid|2001
<1|1.0|1.7|1.3|52|Incidence|3970113|Acute Myeloid|2001
<1|~|~|~|~|Mortality|4012658|Bones and Joints|2001
<1|~|~|~|~|Incidence|3970113|Bones and Joints|2001
<1|0.4|0.9|0.6|25|Mortality|4012658|Leukemia|2001
<1|3.5|4.7|4.1|161|Incidence|3970113|Leukemia|2001
<1|0.2|0.7|0.4|17|Mortality|4012658|Other|2001
<1|10.5|12.6|11.5|457|Incidence|3970113|Other|2001
<1|~|~|~|~|Mortality|4012658|Soft Tissue|2001
<1|2.8|3.9|3.3|132|Incidence|3970113|Soft Tissue|2001
1-4|0.2|0.3|0.2|34|Mortality|15477731|Acute Lymphocytic|2002
1-4|6.8|7.6|7.2|1103|Incidence|15313864|Acute Lymphocytic|2002
1-4|0.2|0.4|0.3|46|Mortality|15477731|Acute Myeloid|2002
1-4|0.7|1.0|0.9|133|Incidence|15313864|Acute Myeloid|2002
1-4|~|~|~|~|Mortality|15477731|Bones and Joints|2002
1-4|0.1|0.2|0.2|26|Incidence|15313864|Bones and Joints|2002
1-4|0.5|0.8|0.7|104|Mortality|15477731|Leukemia|2002
1-4|8.2|9.1|8.6|1319|Incidence|15313864|Leukemia|2002
1-4|0.7|1.0|0.9|136|Mortality|15477731|Other|2002
1-4|3.8|4.4|4.1|630|Incidence|15313864|Other|2002
1-4|0.1|0.2|0.1|23|Mortality|15477731|Soft Tissue|2002
1-4|1.0|1.4|1.2|183|Incidence|15313864|Soft Tissue|2002
10-14|0.3|0.5|0.4|91|Mortality|21261421|Acute Lymphocytic|2002
10-14|1.6|2.0|1.8|382|Incidence|21040663|Acute Lymphocytic|2002
10-14|0.2|0.3|0.2|44|Mortality|21261421|Acute Myeloid|2002
10-14|0.6|0.8|0.7|139|Incidence|21040663|Acute Myeloid|2002
10-14|0.2|0.4|0.3|61|Mortality|21261421|Bones and Joints|2002
10-14|1.2|1.5|1.3|277|Incidence|21040663|Bones and Joints|2002
10-14|0.7|0.9|0.8|168|Mortality|21261421|Leukemia|2002
10-14|2.6|3.0|2.8|583|Incidence|21040663|Leukemia|2002
10-14|0.3|0.5|0.4|78|Mortality|21261421|Other|2002
10-14|2.5|2.9|2.7|563|Incidence|21040663|Other|2002
10-14|0.1|0.3|0.2|41|Mortality|21261421|Soft Tissue|2002
10-14|0.7|0.9|0.8|171|Incidence|21040663|Soft Tissue|2002
15-19|0.4|0.6|0.5|106|Mortality|20610370|Acute Lymphocytic|2002
15-19|1.4|1.8|1.6|328|Incidence|20386049|Acute Lymphocytic|2002
15-19|0.3|0.5|0.4|78|Mortality|20610370|Acute Myeloid|2002
15-19|0.7|1.0|0.8|168|Incidence|20386049|Acute Myeloid|2002
15-19|0.4|0.6|0.5|94|Mortality|20610370|Bones and Joints|2002
15-19|1.4|1.8|1.6|329|Incidence|20386049|Bones and Joints|2002
15-19|1.0|1.3|1.1|237|Mortality|20610370|Leukemia|2002
15-19|2.6|3.1|2.8|575|Incidence|20386049|Leukemia|2002
15-19|0.6|0.8|0.7|148|Mortality|20610370|Other|2002
15-19|8.4|9.2|8.8|1787|Incidence|20386049|Other|2002
15-19|0.2|0.4|0.3|58|Mortality|20610370|Soft Tissue|2002
15-19|0.9|1.2|1.1|220|Incidence|20386049|Soft Tissue|2002
5-9|0.3|0.5|0.4|82|Mortality|19872417|Acute Lymphocytic|2002
5-9|2.9|3.4|3.1|615|Incidence|19665950|Acute Lymphocytic|2002
5-9|0.1|0.2|0.2|34|Mortality|19872417|Acute Myeloid|2002
5-9|0.3|0.5|0.4|84|Incidence|19665950|Acute Myeloid|2002
5-9|0.1|0.2|0.1|21|Mortality|19872417|Bones and Joints|2002
5-9|0.5|0.7|0.6|122|Incidence|19665950|Bones and Joints|2002
5-9|0.6|0.9|0.7|148|Mortality|19872417|Leukemia|2002
5-9|3.6|4.2|3.9|763|Incidence|19665950|Leukemia|2002
5-9|0.4|0.6|0.5|97|Mortality|19872417|Other|2002
5-9|1.4|1.8|1.6|311|Incidence|19665950|Other|2002
5-9|0.1|0.2|0.1|28|Mortality|19872417|Soft Tissue|2002
5-9|0.5|0.8|0.6|125|Incidence|19665950|Soft Tissue|2002
<1|~|~|~|~|Mortality|3951461|Acute Lymphocytic|2002
<1|1.5|2.4|1.9|74|Incidence|3910837|Acute Lymphocytic|2002
<1|~|~|~|~|Mortality|3951461|Acute Myeloid|2002
<1|1.0|1.7|1.3|51|Incidence|3910837|Acute Myeloid|2002
<1|~|~|~|~|Mortality|3951461|Bones and Joints|2002
<1|~|~|~|~|Incidence|3910837|Bones and Joints|2002
<1|0.3|0.8|0.5|21|Mortality|3951461|Leukemia|2002
<1|3.6|5.0|4.3|167|Incidence|3910837|Leukemia|2002
<1|0.5|1.1|0.8|31|Mortality|3951461|Other|2002
<1|10.0|12.1|11.0|430|Incidence|3910837|Other|2002
<1|~|~|~|~|Mortality|3951461|Soft Tissue|2002
<1|2.7|3.8|3.2|125|Incidence|3910837|Soft Tissue|2002
1-4|0.3|0.5|0.4|61|Mortality|15616575|Acute Lymphocytic|2003
1-4|6.4|7.2|6.8|1064|Incidence|15616575|Acute Lymphocytic|2003
1-4|0.2|0.3|0.2|38|Mortality|15616575|Acute Myeloid|2003
1-4|0.7|1.0|0.9|134|Incidence|15616575|Acute Myeloid|2003
1-4|~|~|~|~|Mortality|15616575|Bones and Joints|2003
1-4|0.2|0.3|0.2|36|Incidence|15616575|Bones and Joints|2003
1-4|0.7|1.0|0.9|133|Mortality|15616575|Leukemia|2003
1-4|7.7|8.6|8.1|1267|Incidence|15616575|Leukemia|2003
1-4|0.6|0.9|0.8|118|Mortality|15616575|Other|2003
1-4|4.0|4.7|4.3|678|Incidence|15616575|Other|2003
1-4|~|~|~|~|Mortality|15616575|Soft Tissue|2003
1-4|0.9|1.2|1.1|165|Incidence|15616575|Soft Tissue|2003
10-14|0.3|0.5|0.4|87|Mortality|21415353|Acute Lymphocytic|2003
10-14|1.6|1.9|1.7|371|Incidence|21415353|Acute Lymphocytic|2003
10-14|0.2|0.3|0.3|55|Mortality|21415353|Acute Myeloid|2003
10-14|0.5|0.7|0.6|132|Incidence|21415353|Acute Myeloid|2003
10-14|0.2|0.4|0.3|64|Mortality|21415353|Bones and Joints|2003
10-14|1.2|1.5|1.3|285|Incidence|21415353|Bones and Joints|2003
10-14|0.7|1.0|0.9|186|Mortality|21415353|Leukemia|2003
10-14|2.4|2.8|2.6|549|Incidence|21415353|Leukemia|2003
10-14|0.3|0.4|0.3|69|Mortality|21415353|Other|2003
10-14|2.7|3.2|2.9|631|Incidence|21415353|Other|2003
10-14|0.1|0.2|0.2|36|Mortality|21415353|Soft Tissue|2003
10-14|0.7|1.0|0.9|186|Incidence|21415353|Soft Tissue|2003
15-19|0.3|0.5|0.4|82|Mortality|20797166|Acute Lymphocytic|2003
15-19|1.3|1.6|1.4|301|Incidence|20797166|Acute Lymphocytic|2003
15-19|0.2|0.4|0.3|65|Mortality|20797166|Acute Myeloid|2003
15-19|0.7|0.9|0.8|168|Incidence|20797166|Acute Myeloid|2003
15-19|0.4|0.6|0.5|104|Mortality|20797166|Bones and Joints|2003
15-19|1.3|1.7|1.5|312|Incidence|20797166|Bones and Joints|2003
15-19|0.8|1.0|0.9|183|Mortality|20797166|Leukemia|2003
15-19|2.5|3.0|2.7|568|Incidence|20797166|Leukemia|2003
15-19|0.5|0.8|0.7|136|Mortality|20797166|Other|2003
15-19|8.4|9.2|8.8|1822|Incidence|20797166|Other|2003
15-19|0.3|0.4|0.3|68|Mortality|20797166|Soft Tissue|2003
15-19|1.1|1.4|1.2|253|Incidence|20797166|Soft Tissue|2003
5-9|0.4|0.5|0.4|87|Mortality|19620851|Acute Lymphocytic|2003
5-9|3.0|3.5|3.3|639|Incidence|19620851|Acute Lymphocytic|2003
5-9|0.1|0.3|0.2|39|Mortality|19620851|Acute Myeloid|2003
5-9|0.3|0.5|0.4|76|Incidence|19620851|Acute Myeloid|2003
5-9|~|~|~|~|Mortality|19620851|Bones and Joints|2003
5-9|0.4|0.6|0.5|91|Incidence|19620851|Bones and Joints|2003
5-9|0.7|0.9|0.8|156|Mortality|19620851|Leukemia|2003
5-9|3.6|4.2|3.9|759|Incidence|19620851|Leukemia|2003
5-9|0.4|0.6|0.5|101|Mortality|19620851|Other|2003
5-9|1.2|1.5|1.3|259|Incidence|19620851|Other|2003
5-9|0.1|0.2|0.1|26|Mortality|19620851|Soft Tissue|2003
5-9|0.4|0.7|0.5|107|Incidence|19620851|Soft Tissue|2003
<1|~|~|~|~|Mortality|3975871|Acute Lymphocytic|2003
<1|1.5|2.4|1.9|77|Incidence|3975871|Acute Lymphocytic|2003
<1|~|~|~|~|Mortality|3975871|Acute Myeloid|2003
<1|1.0|1.8|1.4|55|Incidence|3975871|Acute Myeloid|2003
<1|~|~|~|~|Mortality|3975871|Bones and Joints|2003
<1|~|~|~|~|Incidence|3975871|Bones and Joints|2003
<1|0.5|1.1|0.8|30|Mortality|3975871|Leukemia|2003
<1|3.8|5.2|4.5|177|Incidence|3975871|Leukemia|2003
<1|0.4|0.9|0.6|23|Mortality|3975871|Other|2003
<1|10.6|12.7|11.6|462|Incidence|3975871|Other|2003
<1|~|~|~|~|Mortality|3975871|Soft Tissue|2003
<1|2.6|3.7|3.1|124|Incidence|3975871|Soft Tissue|2003
1-4|0.2|0.4|0.3|42|Mortality|15771627|Acute Lymphocytic|2004
1-4|7.3|8.2|7.7|1217|Incidence|15771627|Acute Lymphocytic|2004
1-4|0.3|0.5|0.3|55|Mortality|15771627|Acute Myeloid|2004
1-4|0.7|1.0|0.9|140|Incidence|15771627|Acute Myeloid|2004
1-4|~|~|~|~|Mortality|15771627|Bones and Joints|2004
1-4|0.1|0.3|0.2|30|Incidence|15771627|Bones and Joints|2004
1-4|0.6|0.9|0.8|120|Mortality|15771627|Leukemia|2004
1-4|8.7|9.7|9.2|1446|Incidence|15771627|Leukemia|2004
1-4|0.7|1.0|0.8|130|Mortality|15771627|Other|2004
1-4|4.1|4.8|4.5|703|Incidence|15771627|Other|2004
1-4|0.1|0.2|0.2|24|Mortality|15771627|Soft Tissue|2004
1-4|0.9|1.3|1.1|171|Incidence|15771627|Soft Tissue|2004
10-14|0.3|0.4|0.3|72|Mortality|21411680|Acute Lymphocytic|2004
10-14|1.7|2.1|1.9|401|Incidence|21411680|Acute Lymphocytic|2004
10-14|0.2|0.3|0.2|50|Mortality|21411680|Acute Myeloid|2004
10-14|0.5|0.7|0.6|135|Incidence|21411680|Acute Myeloid|2004
10-14|0.2|0.3|0.3|57|Mortality|21411680|Bones and Joints|2004
10-14|1.3|1.6|1.4|309|Incidence|21411680|Bones and Joints|2004
10-14|0.6|0.9|0.7|156|Mortality|21411680|Leukemia|2004
10-14|2.6|3.1|2.8|606|Incidence|21411680|Leukemia|2004
10-14|0.3|0.4|0.3|69|Mortality|21411680|Other|2004
10-14|2.6|3.1|2.8|609|Incidence|21411680|Other|2004
10-14|0.1|0.3|0.2|42|Mortality|21411680|Soft Tissue|2004
10-14|0.8|1.1|1.0|206|Incidence|21411680|Soft Tissue|2004
15-19|0.4|0.5|0.4|93|Mortality|21102552|Acute Lymphocytic|2004
15-19|1.5|1.8|1.6|343|Incidence|21102552|Acute Lymphocytic|2004
15-19|0.2|0.4|0.3|64|Mortality|21102552|Acute Myeloid|2004
15-19|0.7|1.0|0.8|174|Incidence|21102552|Acute Myeloid|2004
15-19|0.4|0.6|0.5|114|Mortality|21102552|Bones and Joints|2004
15-19|1.4|1.7|1.5|319|Incidence|21102552|Bones and Joints|2004
15-19|0.9|1.1|1.0|210|Mortality|21102552|Leukemia|2004
15-19|2.6|3.1|2.9|604|Incidence|21102552|Leukemia|2004
15-19|0.6|0.8|0.7|151|Mortality|21102552|Other|2004
15-19|8.4|9.2|8.8|1862|Incidence|21102552|Other|2004
15-19|0.2|0.4|0.3|66|Mortality|21102552|Soft Tissue|2004
15-19|1.0|1.3|1.2|250|Incidence|21102552|Soft Tissue|2004
5-9|0.3|0.5|0.4|83|Mortality|19454237|Acute Lymphocytic|2004
5-9|3.0|3.5|3.3|636|Incidence|19454237|Acute Lymphocytic|2004
5-9|0.1|0.3|0.2|35|Mortality|19454237|Acute Myeloid|2004
5-9|0.4|0.6|0.4|87|Incidence|19454237|Acute Myeloid|2004
5-9|~|~|~|~|Mortality|19454237|Bones and Joints|2004
5-9|0.5|0.7|0.6|109|Incidence|19454237|Bones and Joints|2004
5-9|0.7|0.9|0.8|156|Mortality|19454237|Leukemia|2004
5-9|3.7|4.2|4.0|770|Incidence|19454237|Leukemia|2004
5-9|0.4|0.6|0.5|98|Mortality|19454237|Other|2004
5-9|1.4|1.8|1.6|305|Incidence|19454237|Other|2004
5-9|0.1|0.2|0.1|28|Mortality|19454237|Soft Tissue|2004
5-9|0.4|0.6|0.5|100|Incidence|19454237|Soft Tissue|2004
<1|~|~|~|~|Mortality|4014258|Acute Lymphocytic|2004
<1|1.6|2.5|2.0|79|Incidence|4014258|Acute Lymphocytic|2004
<1|~|~|~|~|Mortality|4014258|Acute Myeloid|2004
<1|1.2|2.0|1.5|61|Incidence|4014258|Acute Myeloid|2004
<1|~|~|~|~|Mortality|4014258|Bones and Joints|2004
<1|~|~|~|~|Incidence|4014258|Bones and Joints|2004
<1|0.4|0.9|0.6|23|Mortality|4014258|Leukemia|2004
<1|3.8|5.1|4.4|178|Incidence|4014258|Leukemia|2004
<1|0.3|0.8|0.5|20|Mortality|4014258|Other|2004
<1|10.9|13.1|11.9|479|Incidence|4014258|Other|2004
<1|~|~|~|~|Mortality|4014258|Soft Tissue|2004
<1|2.7|3.8|3.2|130|Incidence|4014258|Soft Tissue|2004
1-4|0.2|0.3|0.3|41|Mortality|15913007|Acute Lymphocytic|2005
1-4|7.0|7.8|7.4|1174|Incidence|15913007|Acute Lymphocytic|2005
1-4|0.3|0.5|0.4|60|Mortality|15913007|Acute Myeloid|2005
1-4|0.7|1.0|0.9|137|Incidence|15913007|Acute Myeloid|2005
1-4|~|~|~|~|Mortality|15913007|Bones and Joints|2005
1-4|0.1|0.3|0.2|32|Incidence|15913007|Bones and Joints|2005
1-4|0.6|0.9|0.8|120|Mortality|15913007|Leukemia|2005
1-4|8.2|9.2|8.7|1383|Incidence|15913007|Leukemia|2005
1-4|0.7|0.9|0.8|127|Mortality|15913007|Other|2005
1-4|4.2|4.8|4.5|715|Incidence|15913007|Other|2005
1-4|0.1|0.2|0.1|21|Mortality|15913007|Soft Tissue|2005
1-4|0.9|1.2|1.0|167|Incidence|15913007|Soft Tissue|2005
10-14|0.3|0.5|0.4|79|Mortality|21212579|Acute Lymphocytic|2005
10-14|1.7|2.1|1.9|397|Incidence|21212579|Acute Lymphocytic|2005
10-14|0.2|0.3|0.2|44|Mortality|21212579|Acute Myeloid|2005
10-14|0.5|0.7|0.6|125|Incidence|21212579|Acute Myeloid|2005
10-14|0.2|0.4|0.3|67|Mortality|21212579|Bones and Joints|2005
10-14|1.1|1.4|1.3|270|Incidence|21212579|Bones and Joints|2005
10-14|0.6|0.8|0.7|150|Mortality|21212579|Leukemia|2005
10-14|2.6|3.1|2.8|602|Incidence|21212579|Leukemia|2005
10-14|0.3|0.5|0.4|82|Mortality|21212579|Other|2005
10-14|2.6|3.1|2.9|609|Incidence|21212579|Other|2005
10-14|0.1|0.2|0.2|35|Mortality|21212579|Soft Tissue|2005
10-14|0.7|0.9|0.8|165|Incidence|21212579|Soft Tissue|2005
15-19|0.3|0.5|0.4|79|Mortality|21486214|Acute Lymphocytic|2005
15-19|1.4|1.7|1.5|331|Incidence|21486214|Acute Lymphocytic|2005
15-19|0.3|0.4|0.3|75|Mortality|21486214|Acute Myeloid|2005
15-19|0.6|0.8|0.7|154|Incidence|21486214|Acute Myeloid|2005
15-19|0.5|0.7|0.6|124|Mortality|21486214|Bones and Joints|2005
15-19|1.4|1.7|1.5|329|Incidence|21486214|Bones and Joints|2005
15-19|0.9|1.2|1.0|223|Mortality|21486214|Leukemia|2005
15-19|2.6|3.0|2.8|597|Incidence|21486214|Leukemia|2005
15-19|0.5|0.7|0.6|120|Mortality|21486214|Other|2005
15-19|8.7|9.5|9.1|1947|Incidence|21486214|Other|2005
15-19|0.3|0.5|0.4|80|Mortality|21486214|Soft Tissue|2005
15-19|1.0|1.3|1.2|248|Incidence|21486214|Soft Tissue|2005
5-9|0.3|0.4|0.3|64|Mortality|19389067|Acute Lymphocytic|2005
5-9|2.9|3.4|3.2|612|Incidence|19389067|Acute Lymphocytic|2005
5-9|0.1|0.2|0.1|29|Mortality|19389067|Acute Myeloid|2005
5-9|0.3|0.5|0.4|75|Incidence|19389067|Acute Myeloid|2005
5-9|0.1|0.1|0.1|17|Mortality|19389067|Bones and Joints|2005
5-9|0.5|0.7|0.6|115|Incidence|19389067|Bones and Joints|2005
5-9|0.5|0.8|0.6|125|Mortality|19389067|Leukemia|2005
5-9|3.5|4.1|3.8|732|Incidence|19389067|Leukemia|2005
5-9|0.4|0.6|0.5|90|Mortality|19389067|Other|2005
5-9|1.4|1.8|1.6|311|Incidence|19389067|Other|2005
5-9|0.1|0.2|0.1|21|Mortality|19389067|Soft Tissue|2005
5-9|0.5|0.8|0.6|126|Incidence|19389067|Soft Tissue|2005
<1|~|~|~|~|Mortality|4004393|Acute Lymphocytic|2005
<1|1.5|2.4|1.9|78|Incidence|4004393|Acute Lymphocytic|2005
<1|~|~|~|~|Mortality|4004393|Acute Myeloid|2005
<1|1.0|1.7|1.3|53|Incidence|4004393|Acute Myeloid|2005
<1|~|~|~|~|Mortality|4004393|Bones and Joints|2005
<1|~|~|~|~|Incidence|4004393|Bones and Joints|2005
<1|0.3|0.8|0.5|22|Mortality|4004393|Leukemia|2005
<1|3.7|5.0|4.3|174|Incidence|4004393|Leukemia|2005
<1|0.3|0.7|0.5|19|Mortality|4004393|Other|2005
<1|10.0|12.1|11.0|440|Incidence|4004393|Other|2005
<1|~|~|~|~|Mortality|4004393|Soft Tissue|2005
<1|3.1|4.4|3.7|149|Incidence|4004393|Soft Tissue|2005
1-4|0.2|0.4|0.3|44|Mortality|15897145|Acute Lymphocytic|2006
1-4|6.9|7.8|7.4|1170|Incidence|15897145|Acute Lymphocytic|2006
1-4|0.3|0.4|0.3|54|Mortality|15897145|Acute Myeloid|2006
1-4|0.8|1.1|0.9|147|Incidence|15897145|Acute Myeloid|2006
1-4|~|~|~|~|Mortality|15897145|Bones and Joints|2006
1-4|0.1|0.2|0.2|25|Incidence|15897145|Bones and Joints|2006
1-4|0.6|0.9|0.8|124|Mortality|15897145|Leukemia|2006
1-4|8.3|9.2|8.7|1384|Incidence|15897145|Leukemia|2006
1-4|0.6|0.8|0.7|108|Mortality|15897145|Other|2006
1-4|3.7|4.3|4.0|635|Incidence|15897145|Other|2006
1-4|0.1|0.2|0.1|23|Mortality|15897145|Soft Tissue|2006
1-4|1.0|1.3|1.1|180|Incidence|15897145|Soft Tissue|2006
10-14|0.3|0.4|0.3|69|Mortality|21033138|Acute Lymphocytic|2006
10-14|2.0|2.4|2.2|464|Incidence|21033138|Acute Lymphocytic|2006
10-14|0.1|0.3|0.2|42|Mortality|21033138|Acute Myeloid|2006
10-14|0.6|0.8|0.7|142|Incidence|21033138|Acute Myeloid|2006
10-14|0.1|0.2|0.2|37|Mortality|21033138|Bones and Joints|2006
10-14|1.1|1.4|1.3|268|Incidence|21033138|Bones and Joints|2006
10-14|0.6|0.8|0.7|152|Mortality|21033138|Leukemia|2006
10-14|3.0|3.5|3.2|678|Incidence|21033138|Leukemia|2006
10-14|0.3|0.4|0.3|68|Mortality|21033138|Other|2006
10-14|2.6|3.1|2.8|598|Incidence|21033138|Other|2006
10-14|0.1|0.2|0.1|25|Mortality|21033138|Soft Tissue|2006
10-14|0.7|1.0|0.9|180|Incidence|21033138|Soft Tissue|2006
15-19|0.3|0.5|0.4|92|Mortality|21807709|Acute Lymphocytic|2006
15-19|1.5|1.8|1.6|359|Incidence|21807709|Acute Lymphocytic|2006
15-19|0.3|0.4|0.3|71|Mortality|21807709|Acute Myeloid|2006
15-19|0.7|0.9|0.8|177|Incidence|21807709|Acute Myeloid|2006
15-19|0.4|0.6|0.5|115|Mortality|21807709|Bones and Joints|2006
15-19|1.5|1.8|1.6|357|Incidence|21807709|Bones and Joints|2006
15-19|0.8|1.1|0.9|207|Mortality|21807709|Leukemia|2006
15-19|2.8|3.2|3.0|656|Incidence|21807709|Leukemia|2006
15-19|0.4|0.6|0.5|117|Mortality|21807709|Other|2006
15-19|8.0|8.8|8.4|1824|Incidence|21807709|Other|2006
15-19|0.2|0.4|0.3|60|Mortality|21807709|Soft Tissue|2006
15-19|0.9|1.2|1.1|230|Incidence|21807709|Soft Tissue|2006
5-9|0.2|0.3|0.3|52|Mortality|19544688|Acute Lymphocytic|2006
5-9|3.0|3.5|3.2|625|Incidence|19544688|Acute Lymphocytic|2006
5-9|0.1|0.1|0.1|17|Mortality|19544688|Acute Myeloid|2006
5-9|0.3|0.5|0.4|81|Incidence|19544688|Acute Myeloid|2006
5-9|0.1|0.1|0.1|18|Mortality|19544688|Bones and Joints|2006
5-9|0.6|0.8|0.7|137|Incidence|19544688|Bones and Joints|2006
5-9|0.4|0.6|0.5|104|Mortality|19544688|Leukemia|2006
5-9|3.6|4.1|3.9|755|Incidence|19544688|Leukemia|2006
5-9|0.4|0.6|0.5|96|Mortality|19544688|Other|2006
5-9|1.5|1.9|1.7|327|Incidence|19544688|Other|2006
5-9|0.1|0.2|0.2|31|Mortality|19544688|Soft Tissue|2006
5-9|0.5|0.7|0.6|116|Incidence|19544688|Soft Tissue|2006
<1|~|~|~|~|Mortality|4041738|Acute Lymphocytic|2006
<1|1.8|2.8|2.3|92|Incidence|4041738|Acute Lymphocytic|2006
<1|~|~|~|~|Mortality|4041738|Acute Myeloid|2006
<1|0.9|1.7|1.3|51|Incidence|4041738|Acute Myeloid|2006
<1|~|~|~|~|Mortality|4041738|Bones and Joints|2006
<1|~|~|~|~|Incidence|4041738|Bones and Joints|2006
<1|0.5|1.1|0.8|31|Mortality|4041738|Leukemia|2006
<1|4.1|5.5|4.8|194|Incidence|4041738|Leukemia|2006
<1|0.4|0.9|0.6|24|Mortality|4041738|Other|2006
<1|11.4|13.6|12.4|502|Incidence|4041738|Other|2006
<1|~|~|~|~|Mortality|4041738|Soft Tissue|2006
<1|2.5|3.6|3.0|120|Incidence|4041738|Soft Tissue|2006
1-4|0.2|0.3|0.2|38|Mortality|15977965|Acute Lymphocytic|2007
1-4|7.6|8.5|8.1|1289|Incidence|15977965|Acute Lymphocytic|2007
1-4|0.2|0.4|0.3|47|Mortality|15977965|Acute Myeloid|2007
1-4|0.7|1.0|0.8|131|Incidence|15977965|Acute Myeloid|2007
1-4|~|~|~|~|Mortality|15977965|Bones and Joints|2007
1-4|0.1|0.3|0.2|33|Incidence|15977965|Bones and Joints|2007
1-4|0.5|0.8|0.7|106|Mortality|15977965|Leukemia|2007
1-4|8.8|9.8|9.3|1485|Incidence|15977965|Leukemia|2007
1-4|0.6|0.9|0.7|115|Mortality|15977965|Other|2007
1-4|4.4|5.1|4.7|752|Incidence|15977965|Other|2007
1-4|0.1|0.2|0.1|17|Mortality|15977965|Soft Tissue|2007
1-4|1.0|1.4|1.2|188|Incidence|15977965|Soft Tissue|2007
10-14|0.3|0.5|0.4|80|Mortality|20841042|Acute Lymphocytic|2007
10-14|1.7|2.1|1.9|395|Incidence|20841042|Acute Lymphocytic|2007
10-14|0.2|0.3|0.2|52|Mortality|20841042|Acute Myeloid|2007
10-14|0.6|0.8|0.7|138|Incidence|20841042|Acute Myeloid|2007
10-14|0.2|0.3|0.2|48|Mortality|20841042|Bones and Joints|2007
10-14|1.2|1.5|1.3|274|Incidence|20841042|Bones and Joints|2007
10-14|0.7|1.0|0.8|175|Mortality|20841042|Leukemia|2007
10-14|2.7|3.1|2.9|605|Incidence|20841042|Leukemia|2007
10-14|0.2|0.4|0.3|62|Mortality|20841042|Other|2007
10-14|2.4|2.9|2.7|555|Incidence|20841042|Other|2007
10-14|0.1|0.2|0.2|35|Mortality|20841042|Soft Tissue|2007
10-14|0.7|1.0|0.8|171|Incidence|20841042|Soft Tissue|2007
15-19|0.3|0.5|0.4|82|Mortality|22067816|Acute Lymphocytic|2007
15-19|1.5|1.9|1.7|371|Incidence|22067816|Acute Lymphocytic|2007
15-19|0.2|0.4|0.3|66|Mortality|22067816|Acute Myeloid|2007
15-19|0.7|0.9|0.8|170|Incidence|22067816|Acute Myeloid|2007
15-19|0.4|0.6|0.5|111|Mortality|22067816|Bones and Joints|2007
15-19|1.3|1.6|1.5|326|Incidence|22067816|Bones and Joints|2007
15-19|0.8|1.1|0.9|202|Mortality|22067816|Leukemia|2007
15-19|2.7|3.2|3.0|652|Incidence|22067816|Leukemia|2007
15-19|0.5|0.7|0.6|133|Mortality|22067816|Other|2007
15-19|8.7|9.5|9.1|2004|Incidence|22067816|Other|2007
15-19|0.2|0.3|0.3|58|Mortality|22067816|Soft Tissue|2007
15-19|1.1|1.4|1.2|270|Incidence|22067816|Soft Tissue|2007
5-9|0.3|0.5|0.4|85|Mortality|19714611|Acute Lymphocytic|2007
5-9|3.1|3.7|3.4|668|Incidence|19714611|Acute Lymphocytic|2007
5-9|0.1|0.2|0.1|27|Mortality|19714611|Acute Myeloid|2007
5-9|0.3|0.5|0.4|86|Incidence|19714611|Acute Myeloid|2007
5-9|~|~|~|~|Mortality|19714611|Bones and Joints|2007
5-9|0.5|0.7|0.6|113|Incidence|19714611|Bones and Joints|2007
5-9|0.6|0.8|0.7|139|Mortality|19714611|Leukemia|2007
5-9|3.8|4.3|4.1|799|Incidence|19714611|Leukemia|2007
5-9|0.4|0.6|0.5|103|Mortality|19714611|Other|2007
5-9|1.3|1.6|1.5|289|Incidence|19714611|Other|2007
5-9|0.1|0.2|0.1|24|Mortality|19714611|Soft Tissue|2007
5-9|0.6|0.9|0.7|147|Incidence|19714611|Soft Tissue|2007
<1|~|~|~|~|Mortality|4147997|Acute Lymphocytic|2007
<1|1.5|2.3|1.9|77|Incidence|4147997|Acute Lymphocytic|2007
<1|~|~|~|~|Mortality|4147997|Acute Myeloid|2007
<1|1.1|1.9|1.4|60|Incidence|4147997|Acute Myeloid|2007
<1|~|~|~|~|Mortality|4147997|Bones and Joints|2007
<1|~|~|~|~|Incidence|4147997|Bones and Joints|2007
<1|0.3|0.8|0.5|21|Mortality|4147997|Leukemia|2007
<1|3.8|5.0|4.4|181|Incidence|4147997|Leukemia|2007
<1|0.4|0.9|0.6|26|Mortality|4147997|Other|2007
<1|10.9|13.0|11.9|494|Incidence|4147997|Other|2007
<1|~|~|~|~|Mortality|4147997|Soft Tissue|2007
<1|3.0|4.1|3.5|146|Incidence|4147997|Soft Tissue|2007
1-4|0.2|0.4|0.3|42|Mortality|16138392|Acute Lymphocytic|2008
1-4|7.4|8.3|7.9|1268|Incidence|16138392|Acute Lymphocytic|2008
1-4|0.3|0.4|0.3|54|Mortality|16138392|Acute Myeloid|2008
1-4|0.8|1.1|0.9|150|Incidence|16138392|Acute Myeloid|2008
1-4|~|~|~|~|Mortality|16138392|Bones and Joints|2008
1-4|0.1|0.2|0.2|25|Incidence|16138392|Bones and Joints|2008
1-4|0.6|0.9|0.8|123|Mortality|16138392|Leukemia|2008
1-4|8.8|9.7|9.2|1491|Incidence|16138392|Leukemia|2008
1-4|0.6|0.8|0.7|112|Mortality|16138392|Other|2008
1-4|4.0|4.6|4.3|690|Incidence|16138392|Other|2008
1-4|0.1|0.2|0.1|22|Mortality|16138392|Soft Tissue|2008
1-4|1.2|1.5|1.4|219|Incidence|16138392|Soft Tissue|2008
10-14|0.2|0.4|0.3|65|Mortality|20706655|Acute Lymphocytic|2008
10-14|2.0|2.4|2.2|449|Incidence|20706655|Acute Lymphocytic|2008
10-14|0.1|0.3|0.2|41|Mortality|20706655|Acute Myeloid|2008
10-14|0.5|0.8|0.7|135|Incidence|20706655|Acute Myeloid|2008
10-14|0.2|0.3|0.2|45|Mortality|20706655|Bones and Joints|2008
10-14|1.2|1.5|1.3|271|Incidence|20706655|Bones and Joints|2008
10-14|0.6|0.9|0.7|152|Mortality|20706655|Leukemia|2008
10-14|2.9|3.4|3.2|656|Incidence|20706655|Leukemia|2008
10-14|0.2|0.4|0.3|60|Mortality|20706655|Other|2008
10-14|2.5|3.0|2.8|571|Incidence|20706655|Other|2008
10-14|0.1|0.2|0.1|29|Mortality|20706655|Soft Tissue|2008
10-14|0.7|1.0|0.8|171|Incidence|20706655|Soft Tissue|2008
15-19|0.3|0.4|0.3|77|Mortality|22210880|Acute Lymphocytic|2008
15-19|1.5|1.9|1.7|376|Incidence|22210880|Acute Lymphocytic|2008
15-19|0.2|0.3|0.3|56|Mortality|22210880|Acute Myeloid|2008
15-19|0.8|1.0|0.9|193|Incidence|22210880|Acute Myeloid|2008
15-19|0.4|0.6|0.5|120|Mortality|22210880|Bones and Joints|2008
15-19|1.3|1.6|1.5|324|Incidence|22210880|Bones and Joints|2008
15-19|0.8|1.0|0.9|196|Mortality|22210880|Leukemia|2008
15-19|2.8|3.3|3.1|678|Incidence|22210880|Leukemia|2008
15-19|0.5|0.7|0.5|121|Mortality|22210880|Other|2008
15-19|8.6|9.4|9.0|1992|Incidence|22210880|Other|2008
15-19|0.2|0.4|0.3|71|Mortality|22210880|Soft Tissue|2008
15-19|1.0|1.3|1.1|246|Incidence|22210880|Soft Tissue|2008
5-9|0.2|0.4|0.3|57|Mortality|19929602|Acute Lymphocytic|2008
5-9|3.3|3.8|3.5|707|Incidence|19929602|Acute Lymphocytic|2008
5-9|0.1|0.2|0.1|26|Mortality|19929602|Acute Myeloid|2008
5-9|0.3|0.5|0.4|86|Incidence|19929602|Acute Myeloid|2008
5-9|~|~|~|~|Mortality|19929602|Bones and Joints|2008
5-9|0.5|0.7|0.6|122|Incidence|19929602|Bones and Joints|2008
5-9|0.4|0.6|0.5|100|Mortality|19929602|Leukemia|2008
5-9|3.9|4.5|4.2|832|Incidence|19929602|Leukemia|2008
5-9|0.4|0.5|0.4|89|Mortality|19929602|Other|2008
5-9|1.4|1.8|1.6|318|Incidence|19929602|Other|2008
5-9|0.1|0.2|0.2|35|Mortality|19929602|Soft Tissue|2008
5-9|0.6|0.8|0.7|143|Incidence|19929602|Soft Tissue|2008
<1|~|~|~|~|Mortality|4132735|Acute Lymphocytic|2008
<1|1.6|2.5|2.0|84|Incidence|4132735|Acute Lymphocytic|2008
<1|~|~|~|~|Mortality|4132735|Acute Myeloid|2008
<1|1.2|2.0|1.6|65|Incidence|4132735|Acute Myeloid|2008
<1|~|~|~|~|Mortality|4132735|Bones and Joints|2008
<1|~|~|~|~|Incidence|4132735|Bones and Joints|2008
<1|0.4|1.0|0.7|27|Mortality|4132735|Leukemia|2008
<1|4.0|5.3|4.6|190|Incidence|4132735|Leukemia|2008
<1|0.4|0.9|0.6|25|Mortality|4132735|Other|2008
<1|11.5|13.7|12.6|520|Incidence|4132735|Other|2008
<1|~|~|~|~|Mortality|4132735|Soft Tissue|2008
<1|2.8|3.9|3.3|137|Incidence|4132735|Soft Tissue|2008
1-4|0.1|0.3|0.2|34|Mortality|16240931|Acute Lymphocytic|2009
1-4|7.4|8.3|7.8|1274|Incidence|16240931|Acute Lymphocytic|2009
1-4|0.2|0.4|0.3|45|Mortality|16240931|Acute Myeloid|2009
1-4|0.8|1.1|0.9|151|Incidence|16240931|Acute Myeloid|2009
1-4|~|~|~|~|Mortality|16240931|Bones and Joints|2009
1-4|0.1|0.2|0.1|24|Incidence|16240931|Bones and Joints|2009
1-4|0.6|0.9|0.7|118|Mortality|16240931|Leukemia|2009
1-4|8.8|9.7|9.2|1498|Incidence|16240931|Leukemia|2009
1-4|0.5|0.8|0.6|104|Mortality|16240931|Other|2009
1-4|4.0|4.6|4.3|699|Incidence|16240931|Other|2009
1-4|0.1|0.2|0.1|22|Mortality|16240931|Soft Tissue|2009
1-4|1.0|1.4|1.2|192|Incidence|16240931|Soft Tissue|2009
10-14|0.3|0.4|0.3|69|Mortality|20660564|Acute Lymphocytic|2009
10-14|2.0|2.4|2.2|449|Incidence|20660564|Acute Lymphocytic|2009
10-14|0.1|0.2|0.2|33|Mortality|20660564|Acute Myeloid|2009
10-14|0.5|0.7|0.6|121|Incidence|20660564|Acute Myeloid|2009
10-14|0.2|0.3|0.3|55|Mortality|20660564|Bones and Joints|2009
10-14|1.2|1.6|1.4|290|Incidence|20660564|Bones and Joints|2009
10-14|0.5|0.7|0.6|127|Mortality|20660564|Leukemia|2009
10-14|2.8|3.3|3.1|633|Incidence|20660564|Leukemia|2009
10-14|0.2|0.3|0.2|50|Mortality|20660564|Other|2009
10-14|2.7|3.2|2.9|607|Incidence|20660564|Other|2009
10-14|0.1|0.3|0.2|40|Mortality|20660564|Soft Tissue|2009
10-14|0.8|1.0|0.9|183|Incidence|20660564|Soft Tissue|2009
15-19|0.2|0.4|0.3|66|Mortality|22192810|Acute Lymphocytic|2009
15-19|1.4|1.8|1.6|354|Incidence|22192810|Acute Lymphocytic|2009
15-19|0.2|0.4|0.3|63|Mortality|22192810|Acute Myeloid|2009
15-19|0.7|0.9|0.8|180|Incidence|22192810|Acute Myeloid|2009
15-19|0.4|0.6|0.5|102|Mortality|22192810|Bones and Joints|2009
15-19|1.3|1.7|1.5|334|Incidence|22192810|Bones and Joints|2009
15-19|0.7|0.9|0.8|172|Mortality|22192810|Leukemia|2009
15-19|2.6|3.1|2.8|632|Incidence|22192810|Leukemia|2009
15-19|0.5|0.7|0.6|125|Mortality|22192810|Other|2009
15-19|8.8|9.6|9.2|2048|Incidence|22192810|Other|2009
15-19|0.2|0.4|0.3|66|Mortality|22192810|Soft Tissue|2009
15-19|1.1|1.4|1.2|276|Incidence|22192810|Soft Tissue|2009
5-9|0.2|0.4|0.3|62|Mortality|20182499|Acute Lymphocytic|2009
5-9|3.3|3.8|3.6|719|Incidence|20182499|Acute Lymphocytic|2009
5-9|0.1|0.2|0.1|30|Mortality|20182499|Acute Myeloid|2009
5-9|0.3|0.5|0.4|80|Incidence|20182499|Acute Myeloid|2009
5-9|0.1|0.1|0.1|18|Mortality|20182499|Bones and Joints|2009
5-9|0.5|0.7|0.6|114|Incidence|20182499|Bones and Joints|2009
5-9|0.5|0.7|0.6|117|Mortality|20182499|Leukemia|2009
5-9|3.9|4.5|4.2|842|Incidence|20182499|Leukemia|2009
5-9|0.3|0.5|0.4|84|Mortality|20182499|Other|2009
5-9|1.4|1.8|1.6|318|Incidence|20182499|Other|2009
5-9|0.1|0.2|0.2|34|Mortality|20182499|Soft Tissue|2009
5-9|0.5|0.7|0.6|127|Incidence|20182499|Soft Tissue|2009
<1|~|~|~|~|Mortality|4003587|Acute Lymphocytic|2009
<1|1.6|2.5|2.0|79|Incidence|4003587|Acute Lymphocytic|2009
<1|~|~|~|~|Mortality|4003587|Acute Myeloid|2009
<1|0.9|1.6|1.2|48|Incidence|4003587|Acute Myeloid|2009
<1|~|~|~|~|Mortality|4003587|Bones and Joints|2009
<1|~|~|~|~|Incidence|4003587|Bones and Joints|2009
<1|0.4|1.0|0.7|27|Mortality|4003587|Leukemia|2009
<1|3.5|4.7|4.1|163|Incidence|4003587|Leukemia|2009
<1|0.6|1.2|0.8|33|Mortality|4003587|Other|2009
<1|11.0|13.2|12.1|483|Incidence|4003587|Other|2009
<1|~|~|~|~|Mortality|4003587|Soft Tissue|2009
<1|3.0|4.2|3.5|141|Incidence|4003587|Soft Tissue|2009
1-4|0.2|0.3|0.2|37|Mortality|16237385|Acute Lymphocytic|2010
1-4|7.2|8.1|7.6|1242|Incidence|16237385|Acute Lymphocytic|2010
1-4|0.2|0.4|0.3|46|Mortality|16237385|Acute Myeloid|2010
1-4|0.8|1.1|0.9|152|Incidence|16237385|Acute Myeloid|2010
1-4|~|~|~|~|Mortality|16237385|Bones and Joints|2010
1-4|0.1|0.3|0.2|29|Incidence|16237385|Bones and Joints|2010
1-4|0.6|0.8|0.7|112|Mortality|16237385|Leukemia|2010
1-4|8.5|9.5|9.0|1460|Incidence|16237385|Leukemia|2010
1-4|0.5|0.7|0.6|97|Mortality|16237385|Other|2010
1-4|5.1|5.8|5.4|879|Incidence|16237385|Other|2010
1-4|~|~|~|~|Mortality|16237385|Soft Tissue|2010
1-4|1.0|1.3|1.2|190|Incidence|16237385|Soft Tissue|2010
10-14|0.2|0.4|0.3|59|Mortality|20680606|Acute Lymphocytic|2010
10-14|2.0|2.4|2.2|459|Incidence|20680606|Acute Lymphocytic|2010
10-14|0.2|0.3|0.2|50|Mortality|20680606|Acute Myeloid|2010
10-14|0.6|0.8|0.7|138|Incidence|20680606|Acute Myeloid|2010
10-14|0.2|0.3|0.3|53|Mortality|20680606|Bones and Joints|2010
10-14|1.2|1.5|1.3|276|Incidence|20680606|Bones and Joints|2010
10-14|0.6|0.8|0.7|142|Mortality|20680606|Leukemia|2010
10-14|3.0|3.5|3.2|667|Incidence|20680606|Leukemia|2010
10-14|0.3|0.5|0.4|88|Mortality|20680606|Other|2010
10-14|3.1|3.6|3.3|687|Incidence|20680606|Other|2010
10-14|0.1|0.2|0.2|32|Mortality|20680606|Soft Tissue|2010
10-14|0.9|1.1|1.0|205|Incidence|20680606|Soft Tissue|2010
15-19|0.2|0.4|0.3|66|Mortality|21981099|Acute Lymphocytic|2010
15-19|1.4|1.7|1.5|334|Incidence|21981099|Acute Lymphocytic|2010
15-19|0.2|0.4|0.3|67|Mortality|21981099|Acute Myeloid|2010
15-19|0.8|1.0|0.9|201|Incidence|21981099|Acute Myeloid|2010
15-19|0.3|0.5|0.4|91|Mortality|21981099|Bones and Joints|2010
15-19|1.2|1.5|1.3|292|Incidence|21981099|Bones and Joints|2010
15-19|0.6|0.9|0.7|163|Mortality|21981099|Leukemia|2010
15-19|2.7|3.2|2.9|643|Incidence|21981099|Leukemia|2010
15-19|0.5|0.7|0.6|133|Mortality|21981099|Other|2010
15-19|8.8|9.6|9.1|2011|Incidence|21981099|Other|2010
15-19|0.2|0.4|0.3|67|Mortality|21981099|Soft Tissue|2010
15-19|1.0|1.3|1.1|249|Incidence|21981099|Soft Tissue|2010
5-9|0.2|0.4|0.3|61|Mortality|20331228|Acute Lymphocytic|2010
5-9|3.4|4.0|3.7|752|Incidence|20331228|Acute Lymphocytic|2010
5-9|0.1|0.2|0.1|29|Mortality|20331228|Acute Myeloid|2010
5-9|0.3|0.5|0.4|74|Incidence|20331228|Acute Myeloid|2010
5-9|0.1|0.2|0.1|20|Mortality|20331228|Bones and Joints|2010
5-9|0.4|0.7|0.5|111|Incidence|20331228|Bones and Joints|2010
5-9|0.4|0.7|0.5|111|Mortality|20331228|Leukemia|2010
5-9|4.0|4.6|4.3|867|Incidence|20331228|Leukemia|2010
5-9|0.3|0.5|0.4|83|Mortality|20331228|Other|2010
5-9|1.8|2.2|2.0|413|Incidence|20331228|Other|2010
5-9|0.1|0.2|0.1|28|Mortality|20331228|Soft Tissue|2010
5-9|0.6|0.8|0.7|134|Incidence|20331228|Soft Tissue|2010
<1|~|~|~|~|Mortality|3951430|Acute Lymphocytic|2010
<1|1.2|2.0|1.5|60|Incidence|3951430|Acute Lymphocytic|2010
<1|~|~|~|~|Mortality|3951430|Acute Myeloid|2010
<1|1.4|2.2|1.7|69|Incidence|3951430|Acute Myeloid|2010
<1|~|~|~|~|Mortality|3951430|Bones and Joints|2010
<1|~|~|~|~|Incidence|3951430|Bones and Joints|2010
<1|0.4|0.9|0.6|25|Mortality|3951430|Leukemia|2010
<1|3.7|5.0|4.3|169|Incidence|3951430|Leukemia|2010
<1|0.3|0.7|0.5|18|Mortality|3951430|Other|2010
<1|12.1|14.4|13.2|521|Incidence|3951430|Other|2010
<1|~|~|~|~|Mortality|3951430|Soft Tissue|2010
<1|2.8|4.0|3.4|133|Incidence|3951430|Soft Tissue|2010
1-4|0.1|0.3|0.2|31|Mortality|16160011|Acute Lymphocytic|2011
1-4|7.5|8.3|7.9|1275|Incidence|16160011|Acute Lymphocytic|2011
1-4|0.2|0.4|0.3|46|Mortality|16160011|Acute Myeloid|2011
1-4|0.8|1.1|1.0|156|Incidence|16160011|Acute Myeloid|2011
1-4|~|~|~|~|Mortality|16160011|Bones and Joints|2011
1-4|0.2|0.3|0.3|41|Incidence|16160011|Bones and Joints|2011
1-4|0.5|0.7|0.6|95|Mortality|16160011|Leukemia|2011
1-4|8.7|9.7|9.2|1483|Incidence|16160011|Leukemia|2011
1-4|0.6|0.8|0.7|110|Mortality|16160011|Other|2011
1-4|4.9|5.6|5.3|851|Incidence|16160011|Other|2011
1-4|0.1|0.2|0.1|23|Mortality|16160011|Soft Tissue|2011
1-4|1.0|1.4|1.2|190|Incidence|16160011|Soft Tissue|2011
10-14|0.3|0.5|0.4|76|Mortality|20712798|Acute Lymphocytic|2011
10-14|2.0|2.4|2.2|451|Incidence|20712798|Acute Lymphocytic|2011
10-14|0.1|0.2|0.2|32|Mortality|20712798|Acute Myeloid|2011
10-14|0.5|0.8|0.6|132|Incidence|20712798|Acute Myeloid|2011
10-14|0.2|0.3|0.2|51|Mortality|20712798|Bones and Joints|2011
10-14|1.3|1.6|1.4|297|Incidence|20712798|Bones and Joints|2011
10-14|0.5|0.7|0.6|127|Mortality|20712798|Leukemia|2011
10-14|2.9|3.4|3.1|647|Incidence|20712798|Leukemia|2011
10-14|0.2|0.4|0.3|62|Mortality|20712798|Other|2011
10-14|3.2|3.7|3.5|721|Incidence|20712798|Other|2011
10-14|0.1|0.3|0.2|38|Mortality|20712798|Soft Tissue|2011
10-14|0.7|0.9|0.8|165|Incidence|20712798|Soft Tissue|2011
15-19|0.3|0.4|0.3|70|Mortality|21658481|Acute Lymphocytic|2011
15-19|1.6|1.9|1.7|374|Incidence|21658481|Acute Lymphocytic|2011
15-19|0.2|0.3|0.3|57|Mortality|21658481|Acute Myeloid|2011
15-19|0.8|1.1|1.0|206|Incidence|21658481|Acute Myeloid|2011
15-19|0.4|0.6|0.5|101|Mortality|21658481|Bones and Joints|2011
15-19|1.2|1.5|1.4|295|Incidence|21658481|Bones and Joints|2011
15-19|0.7|0.9|0.8|177|Mortality|21658481|Leukemia|2011
15-19|2.9|3.4|3.1|681|Incidence|21658481|Leukemia|2011
15-19|0.5|0.7|0.6|132|Mortality|21658481|Other|2011
15-19|8.9|9.7|9.3|2014|Incidence|21658481|Other|2011
15-19|0.2|0.4|0.3|64|Mortality|21658481|Soft Tissue|2011
15-19|0.9|1.2|1.1|230|Incidence|21658481|Soft Tissue|2011
5-9|0.1|0.3|0.2|42|Mortality|20332498|Acute Lymphocytic|2011
5-9|3.5|4.0|3.8|766|Incidence|20332498|Acute Lymphocytic|2011
5-9|0.1|0.2|0.1|28|Mortality|20332498|Acute Myeloid|2011
5-9|0.3|0.5|0.4|86|Incidence|20332498|Acute Myeloid|2011
5-9|0.0|0.1|0.1|16|Mortality|20332498|Bones and Joints|2011
5-9|0.5|0.7|0.6|126|Incidence|20332498|Bones and Joints|2011
5-9|0.4|0.6|0.5|98|Mortality|20332498|Leukemia|2011
5-9|4.2|4.8|4.5|906|Incidence|20332498|Leukemia|2011
5-9|0.3|0.5|0.4|74|Mortality|20332498|Other|2011
5-9|1.9|2.3|2.1|420|Incidence|20332498|Other|2011
5-9|0.1|0.2|0.1|21|Mortality|20332498|Soft Tissue|2011
5-9|0.5|0.8|0.6|132|Incidence|20332498|Soft Tissue|2011
<1|~|~|~|~|Mortality|3963092|Acute Lymphocytic|2011
<1|1.5|2.4|1.9|77|Incidence|3963092|Acute Lymphocytic|2011
<1|~|~|~|~|Mortality|3963092|Acute Myeloid|2011
<1|1.0|1.8|1.4|54|Incidence|3963092|Acute Myeloid|2011
<1|~|~|~|~|Mortality|3963092|Bones and Joints|2011
<1|~|~|~|~|Incidence|3963092|Bones and Joints|2011
<1|0.3|0.8|0.6|22|Mortality|3963092|Leukemia|2011
<1|3.6|5.0|4.3|169|Incidence|3963092|Leukemia|2011
<1|0.4|1.0|0.7|27|Mortality|3963092|Other|2011
<1|11.2|13.5|12.3|488|Incidence|3963092|Other|2011
<1|~|~|~|~|Mortality|3963092|Soft Tissue|2011
<1|2.8|4.0|3.4|133|Incidence|3963092|Soft Tissue|2011
1-4|0.2|0.4|0.3|42|Mortality|16049495|Acute Lymphocytic|2012
1-4|7.3|8.2|7.7|1243|Incidence|16049495|Acute Lymphocytic|2012
1-4|0.3|0.6|0.4|71|Mortality|16049495|Acute Myeloid|2012
1-4|0.8|1.1|0.9|150|Incidence|16049495|Acute Myeloid|2012
1-4|~|~|~|~|Mortality|16049495|Bones and Joints|2012
1-4|0.1|0.3|0.2|28|Incidence|16049495|Bones and Joints|2012
1-4|0.7|1.0|0.8|136|Mortality|16049495|Leukemia|2012
1-4|8.6|9.6|9.1|1457|Incidence|16049495|Leukemia|2012
1-4|0.6|0.8|0.7|111|Mortality|16049495|Other|2012
1-4|5.2|5.9|5.5|890|Incidence|16049495|Other|2012
1-4|0.1|0.2|0.1|19|Mortality|16049495|Soft Tissue|2012
1-4|1.0|1.4|1.2|189|Incidence|16049495|Soft Tissue|2012
10-14|0.2|0.4|0.3|63|Mortality|20669745|Acute Lymphocytic|2012
10-14|1.9|2.3|2.1|439|Incidence|20669745|Acute Lymphocytic|2012
10-14|0.1|0.2|0.2|36|Mortality|20669745|Acute Myeloid|2012
10-14|0.5|0.7|0.6|115|Incidence|20669745|Acute Myeloid|2012
10-14|0.2|0.3|0.2|48|Mortality|20669745|Bones and Joints|2012
10-14|1.3|1.7|1.5|312|Incidence|20669745|Bones and Joints|2012
10-14|0.5|0.7|0.6|126|Mortality|20669745|Leukemia|2012
10-14|2.7|3.2|3.0|614|Incidence|20669745|Leukemia|2012
10-14|0.3|0.4|0.4|73|Mortality|20669745|Other|2012
10-14|3.1|3.6|3.3|689|Incidence|20669745|Other|2012
10-14|0.2|0.3|0.2|48|Mortality|20669745|Soft Tissue|2012
10-14|0.8|1.1|0.9|189|Incidence|20669745|Soft Tissue|2012
15-19|0.2|0.4|0.3|67|Mortality|21369214|Acute Lymphocytic|2012
15-19|1.4|1.7|1.5|329|Incidence|21369214|Acute Lymphocytic|2012
15-19|0.2|0.3|0.3|56|Mortality|21369214|Acute Myeloid|2012
15-19|0.8|1.1|0.9|198|Incidence|21369214|Acute Myeloid|2012
15-19|0.4|0.6|0.5|110|Mortality|21369214|Bones and Joints|2012
15-19|1.3|1.6|1.5|314|Incidence|21369214|Bones and Joints|2012
15-19|0.6|0.9|0.7|156|Mortality|21369214|Leukemia|2012
15-19|2.8|3.2|3.0|639|Incidence|21369214|Leukemia|2012
15-19|0.5|0.7|0.6|129|Mortality|21369214|Other|2012
15-19|9.5|10.4|10.0|2130|Incidence|21369214|Other|2012
15-19|0.3|0.4|0.4|76|Mortality|21369214|Soft Tissue|2012
15-19|0.8|1.1|1.0|209|Incidence|21369214|Soft Tissue|2012
5-9|0.2|0.3|0.2|43|Mortality|20467140|Acute Lymphocytic|2012
5-9|3.2|3.7|3.4|698|Incidence|20467140|Acute Lymphocytic|2012
5-9|0.1|0.2|0.1|27|Mortality|20467140|Acute Myeloid|2012
5-9|0.3|0.5|0.4|85|Incidence|20467140|Acute Myeloid|2012
5-9|0.0|0.1|0.1|17|Mortality|20467140|Bones and Joints|2012
5-9|0.5|0.7|0.6|113|Incidence|20467140|Bones and Joints|2012
5-9|0.4|0.6|0.5|97|Mortality|20467140|Leukemia|2012
5-9|3.7|4.3|4.0|822|Incidence|20467140|Leukemia|2012
5-9|0.3|0.5|0.4|89|Mortality|20467140|Other|2012
5-9|1.9|2.3|2.1|423|Incidence|20467140|Other|2012
5-9|0.1|0.2|0.1|26|Mortality|20467140|Soft Tissue|2012
5-9|0.5|0.7|0.6|126|Incidence|20467140|Soft Tissue|2012
<1|~|~|~|~|Mortality|3926570|Acute Lymphocytic|2012
<1|1.6|2.5|2.0|79|Incidence|3926570|Acute Lymphocytic|2012
<1|~|~|~|~|Mortality|3926570|Acute Myeloid|2012
<1|0.9|1.6|1.2|48|Incidence|3926570|Acute Myeloid|2012
<1|~|~|~|~|Mortality|3926570|Bones and Joints|2012
<1|~|~|~|~|Incidence|3926570|Bones and Joints|2012
<1|0.3|0.8|0.5|19|Mortality|3926570|Leukemia|2012
<1|3.5|4.8|4.1|162|Incidence|3926570|Leukemia|2012
<1|0.3|0.8|0.5|19|Mortality|3926570|Other|2012
<1|12.1|14.4|13.2|519|Incidence|3926570|Other|2012
<1|~|~|~|~|Mortality|3926570|Soft Tissue|2012
<1|3.0|4.2|3.5|139|Incidence|3926570|Soft Tissue|2012
1-4|0.1|0.3|0.2|33|Mortality|15917957|Acute Lymphocytic|2013
1-4|6.7|7.6|7.1|1135|Incidence|15917957|Acute Lymphocytic|2013
1-4|0.2|0.4|0.3|45|Mortality|15917957|Acute Myeloid|2013
1-4|0.8|1.1|0.9|144|Incidence|15917957|Acute Myeloid|2013
1-4|~|~|~|~|Mortality|15917957|Bones and Joints|2013
1-4|0.2|0.4|0.3|47|Incidence|15917957|Bones and Joints|2013
1-4|0.5|0.7|0.6|96|Mortality|15917957|Leukemia|2013
1-4|8.0|8.9|8.4|1345|Incidence|15917957|Leukemia|2013
1-4|0.4|0.7|0.6|89|Mortality|15917957|Other|2013
1-4|4.9|5.6|5.2|829|Incidence|15917957|Other|2013
1-4|0.1|0.2|0.2|24|Mortality|15917957|Soft Tissue|2013
1-4|1.1|1.5|1.3|210|Incidence|15917957|Soft Tissue|2013
10-14|0.2|0.4|0.3|63|Mortality|20650890|Acute Lymphocytic|2013
10-14|1.8|2.2|2.0|416|Incidence|20650890|Acute Lymphocytic|2013
10-14|0.2|0.3|0.2|43|Mortality|20650890|Acute Myeloid|2013
10-14|0.6|0.8|0.7|140|Incidence|20650890|Acute Myeloid|2013
10-14|0.2|0.3|0.2|51|Mortality|20650890|Bones and Joints|2013
10-14|1.2|1.5|1.4|283|Incidence|20650890|Bones and Joints|2013
10-14|0.6|0.8|0.7|139|Mortality|20650890|Leukemia|2013
10-14|2.8|3.3|3.0|627|Incidence|20650890|Leukemia|2013
10-14|0.2|0.4|0.3|62|Mortality|20650890|Other|2013
10-14|3.4|4.0|3.7|763|Incidence|20650890|Other|2013
10-14|0.1|0.3|0.2|41|Mortality|20650890|Soft Tissue|2013
10-14|0.8|1.0|0.9|185|Incidence|20650890|Soft Tissue|2013
15-19|0.2|0.3|0.3|56|Mortality|21177456|Acute Lymphocytic|2013
15-19|1.4|1.8|1.6|334|Incidence|21177456|Acute Lymphocytic|2013
15-19|0.2|0.4|0.3|59|Mortality|21177456|Acute Myeloid|2013
15-19|0.8|1.0|0.9|192|Incidence|21177456|Acute Myeloid|2013
15-19|0.4|0.6|0.5|108|Mortality|21177456|Bones and Joints|2013
15-19|1.3|1.7|1.5|313|Incidence|21177456|Bones and Joints|2013
15-19|0.6|0.9|0.8|159|Mortality|21177456|Leukemia|2013
15-19|2.8|3.3|3.0|642|Incidence|21177456|Leukemia|2013
15-19|0.4|0.6|0.5|113|Mortality|21177456|Other|2013
15-19|9.0|9.8|9.4|1991|Incidence|21177456|Other|2013
15-19|0.3|0.5|0.4|82|Mortality|21177456|Soft Tissue|2013
15-19|0.9|1.2|1.0|218|Incidence|21177456|Soft Tissue|2013
5-9|0.1|0.3|0.2|42|Mortality|20567323|Acute Lymphocytic|2013
5-9|3.1|3.6|3.4|694|Incidence|20567323|Acute Lymphocytic|2013
5-9|0.1|0.2|0.1|30|Mortality|20567323|Acute Myeloid|2013
5-9|0.4|0.6|0.5|95|Incidence|20567323|Acute Myeloid|2013
5-9|~|~|~|~|Mortality|20567323|Bones and Joints|2013
5-9|0.5|0.7|0.6|128|Incidence|20567323|Bones and Joints|2013
5-9|0.4|0.6|0.5|94|Mortality|20567323|Leukemia|2013
5-9|3.9|4.4|4.1|848|Incidence|20567323|Leukemia|2013
5-9|0.4|0.5|0.4|92|Mortality|20567323|Other|2013
5-9|2.0|2.4|2.2|447|Incidence|20567323|Other|2013
5-9|0.1|0.2|0.1|29|Mortality|20567323|Soft Tissue|2013
5-9|0.5|0.7|0.6|128|Incidence|20567323|Soft Tissue|2013
<1|~|~|~|~|Mortality|3931258|Acute Lymphocytic|2013
<1|1.2|2.1|1.6|63|Incidence|3931258|Acute Lymphocytic|2013
<1|~|~|~|~|Mortality|3931258|Acute Myeloid|2013
<1|1.1|1.9|1.5|59|Incidence|3931258|Acute Myeloid|2013
<1|~|~|~|~|Mortality|3931258|Bones and Joints|2013
<1|~|~|~|~|Incidence|3931258|Bones and Joints|2013
<1|0.3|0.8|0.5|21|Mortality|3931258|Leukemia|2013
<1|3.7|5.0|4.3|170|Incidence|3931258|Leukemia|2013
<1|~|~|~|~|Mortality|3931258|Other|2013
<1|13.3|15.7|14.5|569|Incidence|3931258|Other|2013
<1|~|~|~|~|Mortality|3931258|Soft Tissue|2013
<1|3.1|4.3|3.7|145|Incidence|3931258|Soft Tissue|2013
1-4|0.2|0.3|0.2|36|Mortality|15917562|Acute Lymphocytic|2014
1-4|6.9|7.8|7.3|1166|Incidence|15917562|Acute Lymphocytic|2014
1-4|0.2|0.4|0.3|43|Mortality|15917562|Acute Myeloid|2014
1-4|0.8|1.1|1.0|154|Incidence|15917562|Acute Myeloid|2014
1-4|~|~|~|~|Mortality|15917562|Bones and Joints|2014
1-4|0.1|0.3|0.2|34|Incidence|15917562|Bones and Joints|2014
1-4|0.5|0.8|0.6|101|Mortality|15917562|Leukemia|2014
1-4|8.3|9.3|8.8|1401|Incidence|15917562|Leukemia|2014
1-4|0.5|0.8|0.6|102|Mortality|15917562|Other|2014
1-4|4.8|5.5|5.1|812|Incidence|15917562|Other|2014
1-4|~|~|~|~|Mortality|15917562|Soft Tissue|2014
1-4|1.1|1.4|1.3|201|Incidence|15917562|Soft Tissue|2014
10-14|0.2|0.3|0.3|55|Mortality|20665650|Acute Lymphocytic|2014
10-14|1.9|2.3|2.1|435|Incidence|20665650|Acute Lymphocytic|2014
10-14|0.1|0.2|0.1|22|Mortality|20665650|Acute Myeloid|2014
10-14|0.5|0.8|0.6|133|Incidence|20665650|Acute Myeloid|2014
10-14|0.2|0.4|0.3|63|Mortality|20665650|Bones and Joints|2014
10-14|1.4|1.7|1.5|319|Incidence|20665650|Bones and Joints|2014
10-14|0.4|0.6|0.5|97|Mortality|20665650|Leukemia|2014
10-14|2.8|3.3|3.1|635|Incidence|20665650|Leukemia|2014
10-14|0.3|0.4|0.3|69|Mortality|20665650|Other|2014
10-14|3.5|4.1|3.8|783|Incidence|20665650|Other|2014
10-14|0.1|0.2|0.1|30|Mortality|20665650|Soft Tissue|2014
10-14|0.8|1.1|0.9|196|Incidence|20665650|Soft Tissue|2014
15-19|0.2|0.4|0.3|66|Mortality|21052826|Acute Lymphocytic|2014
15-19|1.5|1.9|1.7|354|Incidence|21052826|Acute Lymphocytic|2014
15-19|0.2|0.3|0.3|54|Mortality|21052826|Acute Myeloid|2014
15-19|0.9|1.1|1.0|211|Incidence|21052826|Acute Myeloid|2014
15-19|0.4|0.6|0.5|96|Mortality|21052826|Bones and Joints|2014
15-19|1.3|1.6|1.4|298|Incidence|21052826|Bones and Joints|2014
15-19|0.6|0.9|0.8|160|Mortality|21052826|Leukemia|2014
15-19|3.0|3.5|3.2|679|Incidence|21052826|Leukemia|2014
15-19|0.4|0.6|0.5|104|Mortality|21052826|Other|2014
15-19|9.4|10.3|9.9|2074|Incidence|21052826|Other|2014
15-19|0.2|0.4|0.3|67|Mortality|21052826|Soft Tissue|2014
15-19|1.0|1.3|1.1|239|Incidence|21052826|Soft Tissue|2014
5-9|0.2|0.3|0.2|50|Mortality|20515031|Acute Lymphocytic|2014
5-9|3.2|3.7|3.5|712|Incidence|20515031|Acute Lymphocytic|2014
5-9|0.1|0.2|0.1|21|Mortality|20515031|Acute Myeloid|2014
5-9|0.4|0.5|0.4|92|Incidence|20515031|Acute Myeloid|2014
5-9|0.1|0.2|0.1|20|Mortality|20515031|Bones and Joints|2014
5-9|0.6|0.8|0.7|138|Incidence|20515031|Bones and Joints|2014
5-9|0.3|0.5|0.4|87|Mortality|20515031|Leukemia|2014
5-9|3.9|4.5|4.2|859|Incidence|20515031|Leukemia|2014
5-9|0.4|0.6|0.5|94|Mortality|20515031|Other|2014
5-9|2.1|2.5|2.3|477|Incidence|20515031|Other|2014
5-9|0.1|0.2|0.1|25|Mortality|20515031|Soft Tissue|2014
5-9|0.6|0.8|0.7|141|Incidence|20515031|Soft Tissue|2014
<1|~|~|~|~|Mortality|3954787|Acute Lymphocytic|2014
<1|1.1|1.9|1.5|58|Incidence|3954787|Acute Lymphocytic|2014
<1|~|~|~|~|Mortality|3954787|Acute Myeloid|2014
<1|1.4|2.2|1.7|69|Incidence|3954787|Acute Myeloid|2014
<1|~|~|~|~|Mortality|3954787|Bones and Joints|2014
<1|~|~|~|~|Incidence|3954787|Bones and Joints|2014
<1|~|~|~|~|Mortality|3954787|Leukemia|2014
<1|3.3|4.6|3.9|156|Incidence|3954787|Leukemia|2014
<1|0.3|0.8|0.5|20|Mortality|3954787|Other|2014
<1|13.9|16.3|15.1|596|Incidence|3954787|Other|2014
<1|~|~|~|~|Mortality|3954787|Soft Tissue|2014
<1|2.5|3.6|3.0|118|Incidence|3954787|Soft Tissue|2014
1-4|0.2|0.3|0.2|180|Mortality|79763246|Acute Lymphocytic|2014-2018
1-4|7.4|7.7|7.6|5967|Incidence|79030316|Acute Lymphocytic|2014-2018
1-4|0.3|0.4|0.3|257|Mortality|79763246|Acute Myeloid|2014-2018
1-4|0.9|1.0|1.0|764|Incidence|79030316|Acute Myeloid|2014-2018
1-4|~|~|~|~|Mortality|79763246|Bones and Joints|2014-2018
1-4|0.2|0.2|0.2|163|Incidence|79030316|Bones and Joints|2014-2018
1-4|0.6|0.7|0.7|540|Mortality|79763246|Leukemia|2014-2018
1-4|8.7|9.1|8.9|7053|Incidence|79030316|Leukemia|2014-2018
1-4|0.6|0.7|0.6|509|Mortality|79763246|Other|2014-2018
1-4|4.9|5.3|5.1|4026|Incidence|79030316|Other|2014-2018
1-4|0.1|0.2|0.2|132|Mortality|79763246|Soft Tissue|2014-2018
1-4|1.1|1.3|1.2|944|Incidence|79030316|Soft Tissue|2014-2018
10-14|0.2|0.3|0.2|257|Mortality|103527771|Acute Lymphocytic|2014-2018
10-14|2.2|2.4|2.3|2322|Incidence|102580702|Acute Lymphocytic|2014-2018
10-14|0.2|0.2|0.2|184|Mortality|103527771|Acute Myeloid|2014-2018
10-14|0.6|0.7|0.7|693|Incidence|102580702|Acute Myeloid|2014-2018
10-14|0.3|0.3|0.3|305|Mortality|103527771|Bones and Joints|2014-2018
10-14|1.4|1.6|1.5|1561|Incidence|102580702|Bones and Joints|2014-2018
10-14|0.5|0.6|0.5|539|Mortality|103527771|Leukemia|2014-2018
10-14|3.2|3.4|3.3|3351|Incidence|102580702|Leukemia|2014-2018
10-14|0.3|0.3|0.3|300|Mortality|103527771|Other|2014-2018
10-14|3.9|4.2|4.1|4156|Incidence|102580702|Other|2014-2018
10-14|0.2|0.2|0.2|190|Mortality|103527771|Soft Tissue|2014-2018
10-14|0.8|1.0|0.9|919|Incidence|102580702|Soft Tissue|2014-2018
15-19|0.3|0.4|0.3|335|Mortality|105422374|Acute Lymphocytic|2014-2018
15-19|1.7|1.9|1.8|1869|Incidence|104535275|Acute Lymphocytic|2014-2018
15-19|0.2|0.3|0.3|266|Mortality|105422374|Acute Myeloid|2014-2018
15-19|0.8|0.9|0.9|928|Incidence|104535275|Acute Myeloid|2014-2018
15-19|0.5|0.5|0.5|529|Mortality|105422374|Bones and Joints|2014-2018
15-19|1.4|1.6|1.5|1544|Incidence|104535275|Bones and Joints|2014-2018
15-19|0.7|0.8|0.7|762|Mortality|105422374|Leukemia|2014-2018
15-19|3.1|3.3|3.2|3334|Incidence|104535275|Leukemia|2014-2018
15-19|0.5|0.6|0.5|558|Mortality|105422374|Other|2014-2018
15-19|10.3|10.7|10.5|11012|Incidence|104535275|Other|2014-2018
15-19|0.3|0.3|0.3|323|Mortality|105422374|Soft Tissue|2014-2018
15-19|1.1|1.3|1.2|1243|Incidence|104535275|Soft Tissue|2014-2018
5-9|0.2|0.2|0.2|216|Mortality|101923663|Acute Lymphocytic|2014-2018
5-9|3.4|3.6|3.5|3522|Incidence|100972303|Acute Lymphocytic|2014-2018
5-9|0.1|0.1|0.1|117|Mortality|101923663|Acute Myeloid|2014-2018
5-9|0.4|0.5|0.4|415|Incidence|100972303|Acute Myeloid|2014-2018
5-9|0.1|0.1|0.1|98|Mortality|101923663|Bones and Joints|2014-2018
5-9|0.6|0.7|0.6|656|Incidence|100972303|Bones and Joints|2014-2018
5-9|0.4|0.5|0.4|427|Mortality|101923663|Leukemia|2014-2018
5-9|4.0|4.3|4.1|4178|Incidence|100972303|Leukemia|2014-2018
5-9|0.3|0.4|0.4|380|Mortality|101923663|Other|2014-2018
5-9|2.1|2.3|2.2|2225|Incidence|100972303|Other|2014-2018
5-9|0.1|0.2|0.2|163|Mortality|101923663|Soft Tissue|2014-2018
5-9|0.6|0.7|0.7|666|Incidence|100972303|Soft Tissue|2014-2018
<1|0.1|0.2|0.1|20|Mortality|19602874|Acute Lymphocytic|2014-2018
<1|1.5|1.9|1.7|327|Incidence|19424309|Acute Lymphocytic|2014-2018
<1|0.2|0.3|0.2|43|Mortality|19602874|Acute Myeloid|2014-2018
<1|1.4|1.8|1.6|307|Incidence|19424309|Acute Myeloid|2014-2018
<1|~|~|~|~|Mortality|19602874|Bones and Joints|2014-2018
<1|0.2|0.3|0.2|42|Incidence|19424309|Bones and Joints|2014-2018
<1|0.4|0.6|0.5|96|Mortality|19602874|Leukemia|2014-2018
<1|3.9|4.5|4.2|816|Incidence|19424309|Leukemia|2014-2018
<1|0.4|0.6|0.5|91|Mortality|19602874|Other|2014-2018
<1|13.8|14.9|14.3|2784|Incidence|19424309|Other|2014-2018
<1|0.0|0.1|0.1|16|Mortality|19602874|Soft Tissue|2014-2018
<1|2.9|3.4|3.2|614|Incidence|19424309|Soft Tissue|2014-2018
1-4|0.2|0.4|0.3|44|Mortality|15934097|Acute Lymphocytic|2015
1-4|7.5|8.4|7.9|1263|Incidence|15934097|Acute Lymphocytic|2015
1-4|0.2|0.4|0.3|45|Mortality|15934097|Acute Myeloid|2015
1-4|0.8|1.2|1.0|158|Incidence|15934097|Acute Myeloid|2015
1-4|~|~|~|~|Mortality|15934097|Bones and Joints|2015
1-4|0.1|0.3|0.2|32|Incidence|15934097|Bones and Joints|2015
1-4|0.6|0.9|0.7|115|Mortality|15934097|Leukemia|2015
1-4|8.9|9.8|9.3|1488|Incidence|15934097|Leukemia|2015
1-4|0.5|0.8|0.6|101|Mortality|15934097|Other|2015
1-4|5.0|5.8|5.4|861|Incidence|15934097|Other|2015
1-4|0.1|0.3|0.2|29|Mortality|15934097|Soft Tissue|2015
1-4|1.1|1.5|1.3|205|Incidence|15934097|Soft Tissue|2015
10-14|0.2|0.3|0.3|52|Mortality|20604377|Acute Lymphocytic|2015
10-14|2.0|2.4|2.2|447|Incidence|20604377|Acute Lymphocytic|2015
10-14|0.2|0.3|0.2|44|Mortality|20604377|Acute Myeloid|2015
10-14|0.5|0.8|0.6|133|Incidence|20604377|Acute Myeloid|2015
10-14|0.2|0.4|0.3|65|Mortality|20604377|Bones and Joints|2015
10-14|1.3|1.6|1.5|300|Incidence|20604377|Bones and Joints|2015
10-14|0.5|0.7|0.6|115|Mortality|20604377|Leukemia|2015
10-14|2.9|3.4|3.1|645|Incidence|20604377|Leukemia|2015
10-14|0.2|0.3|0.2|46|Mortality|20604377|Other|2015
10-14|4.0|4.5|4.3|876|Incidence|20604377|Other|2015
10-14|0.1|0.3|0.2|38|Mortality|20604377|Soft Tissue|2015
10-14|0.8|1.1|0.9|191|Incidence|20604377|Soft Tissue|2015
15-19|0.2|0.4|0.3|60|Mortality|21081020|Acute Lymphocytic|2015
15-19|1.7|2.0|1.8|389|Incidence|21081020|Acute Lymphocytic|2015
15-19|0.2|0.3|0.3|56|Mortality|21081020|Acute Myeloid|2015
15-19|0.8|1.0|0.9|190|Incidence|21081020|Acute Myeloid|2015
15-19|0.4|0.6|0.5|113|Mortality|21081020|Bones and Joints|2015
15-19|1.3|1.6|1.4|305|Incidence|21081020|Bones and Joints|2015
15-19|0.6|0.8|0.7|147|Mortality|21081020|Leukemia|2015
15-19|3.1|3.6|3.3|699|Incidence|21081020|Leukemia|2015
15-19|0.5|0.7|0.5|115|Mortality|21081020|Other|2015
15-19|10.5|11.4|11.0|2309|Incidence|21081020|Other|2015
15-19|0.2|0.3|0.3|53|Mortality|21081020|Soft Tissue|2015
15-19|1.1|1.4|1.3|269|Incidence|21081020|Soft Tissue|2015
5-9|0.2|0.3|0.2|44|Mortality|20476769|Acute Lymphocytic|2015
5-9|3.3|3.9|3.6|735|Incidence|20476769|Acute Lymphocytic|2015
5-9|0.1|0.2|0.1|20|Mortality|20476769|Acute Myeloid|2015
5-9|0.3|0.5|0.4|88|Incidence|20476769|Acute Myeloid|2015
5-9|0.1|0.1|0.1|18|Mortality|20476769|Bones and Joints|2015
5-9|0.6|0.8|0.7|136|Incidence|20476769|Bones and Joints|2015
5-9|0.4|0.5|0.4|91|Mortality|20476769|Leukemia|2015
5-9|4.0|4.5|4.2|868|Incidence|20476769|Leukemia|2015
5-9|0.3|0.4|0.4|72|Mortality|20476769|Other|2015
5-9|2.1|2.5|2.3|462|Incidence|20476769|Other|2015
5-9|0.1|0.2|0.2|37|Mortality|20476769|Soft Tissue|2015
5-9|0.5|0.7|0.6|125|Incidence|20476769|Soft Tissue|2015
<1|~|~|~|~|Mortality|3983981|Acute Lymphocytic|2015
<1|1.3|2.1|1.7|67|Incidence|3983981|Acute Lymphocytic|2015
<1|~|~|~|~|Mortality|3983981|Acute Myeloid|2015
<1|1.3|2.1|1.7|67|Incidence|3983981|Acute Myeloid|2015
<1|~|~|~|~|Mortality|3983981|Bones and Joints|2015
<1|~|~|~|~|Incidence|3983981|Bones and Joints|2015
<1|0.3|0.8|0.6|22|Mortality|3983981|Leukemia|2015
<1|3.8|5.1|4.4|176|Incidence|3983981|Leukemia|2015
<1|0.2|0.7|0.4|16|Mortality|3983981|Other|2015
<1|13.9|16.3|15.1|601|Incidence|3983981|Other|2015
<1|~|~|~|~|Mortality|3983981|Soft Tissue|2015
<1|3.1|4.3|3.6|145|Incidence|3983981|Soft Tissue|2015
1-4|0.1|0.3|0.2|33|Mortality|15966986|Acute Lymphocytic|2016
1-4|7.0|7.9|7.5|1191|Incidence|15966986|Acute Lymphocytic|2016
1-4|0.3|0.5|0.4|59|Mortality|15966986|Acute Myeloid|2016
1-4|0.9|1.2|1.1|171|Incidence|15966986|Acute Myeloid|2016
1-4|~|~|~|~|Mortality|15966986|Bones and Joints|2016
1-4|0.1|0.3|0.2|32|Incidence|15966986|Bones and Joints|2016
1-4|0.6|0.8|0.7|108|Mortality|15966986|Leukemia|2016
1-4|8.4|9.4|8.9|1419|Incidence|15966986|Leukemia|2016
1-4|0.6|0.8|0.7|111|Mortality|15966986|Other|2016
1-4|4.7|5.5|5.1|813|Incidence|15966986|Other|2016
1-4|0.1|0.3|0.2|32|Mortality|15966986|Soft Tissue|2016
1-4|1.0|1.4|1.2|192|Incidence|15966986|Soft Tissue|2016
10-14|0.2|0.3|0.2|51|Mortality|20621321|Acute Lymphocytic|2016
10-14|2.3|2.7|2.5|519|Incidence|20621321|Acute Lymphocytic|2016
10-14|0.1|0.2|0.2|37|Mortality|20621321|Acute Myeloid|2016
10-14|0.7|0.9|0.8|159|Incidence|20621321|Acute Myeloid|2016
10-14|0.2|0.4|0.3|56|Mortality|20621321|Bones and Joints|2016
10-14|1.4|1.7|1.6|322|Incidence|20621321|Bones and Joints|2016
10-14|0.4|0.6|0.5|108|Mortality|20621321|Leukemia|2016
10-14|3.4|3.9|3.6|747|Incidence|20621321|Leukemia|2016
10-14|0.3|0.4|0.3|67|Mortality|20621321|Other|2016
10-14|3.8|4.3|4.1|837|Incidence|20621321|Other|2016
10-14|0.1|0.2|0.1|30|Mortality|20621321|Soft Tissue|2016
10-14|0.7|1.0|0.9|178|Incidence|20621321|Soft Tissue|2016
15-19|0.3|0.4|0.3|72|Mortality|21129270|Acute Lymphocytic|2016
15-19|1.6|2.0|1.8|384|Incidence|21129270|Acute Lymphocytic|2016
15-19|0.2|0.3|0.2|46|Mortality|21129270|Acute Myeloid|2016
15-19|0.8|1.1|0.9|194|Incidence|21129270|Acute Myeloid|2016
15-19|0.5|0.7|0.6|118|Mortality|21129270|Bones and Joints|2016
15-19|1.4|1.7|1.5|324|Incidence|21129270|Bones and Joints|2016
15-19|0.6|0.8|0.7|148|Mortality|21129270|Leukemia|2016
15-19|3.0|3.5|3.2|678|Incidence|21129270|Leukemia|2016
15-19|0.5|0.7|0.5|116|Mortality|21129270|Other|2016
15-19|10.6|11.5|11.0|2325|Incidence|21129270|Other|2016
15-19|0.2|0.4|0.3|60|Mortality|21129270|Soft Tissue|2016
15-19|1.1|1.4|1.2|257|Incidence|21129270|Soft Tissue|2016
5-9|0.2|0.4|0.3|55|Mortality|20434232|Acute Lymphocytic|2016
5-9|3.4|3.9|3.6|741|Incidence|20434232|Acute Lymphocytic|2016
5-9|0.1|0.2|0.1|29|Mortality|20434232|Acute Myeloid|2016
5-9|0.3|0.5|0.4|82|Incidence|20434232|Acute Myeloid|2016
5-9|0.1|0.2|0.1|22|Mortality|20434232|Bones and Joints|2016
5-9|0.6|0.8|0.7|144|Incidence|20434232|Bones and Joints|2016
5-9|0.4|0.6|0.5|106|Mortality|20434232|Leukemia|2016
5-9|4.0|4.6|4.3|880|Incidence|20434232|Leukemia|2016
5-9|0.3|0.4|0.3|71|Mortality|20434232|Other|2016
5-9|2.1|2.5|2.3|464|Incidence|20434232|Other|2016
5-9|0.1|0.3|0.2|41|Mortality|20434232|Soft Tissue|2016
5-9|0.6|0.8|0.7|138|Incidence|20434232|Soft Tissue|2016
<1|~|~|~|~|Mortality|3954773|Acute Lymphocytic|2016
<1|1.5|2.4|1.9|75|Incidence|3954773|Acute Lymphocytic|2016
<1|~|~|~|~|Mortality|3954773|Acute Myeloid|2016
<1|1.0|1.8|1.3|53|Incidence|3954773|Acute Myeloid|2016
<1|~|~|~|~|Mortality|3954773|Bones and Joints|2016
<1|~|~|~|~|Incidence|3954773|Bones and Joints|2016
<1|0.5|1.1|0.7|29|Mortality|3954773|Leukemia|2016
<1|3.7|5.0|4.3|172|Incidence|3954773|Leukemia|2016
<1|0.3|0.8|0.5|20|Mortality|3954773|Other|2016
<1|12.9|15.3|14.0|555|Incidence|3954773|Other|2016
<1|~|~|~|~|Mortality|3954773|Soft Tissue|2016
<1|2.8|4.0|3.4|134|Incidence|3954773|Soft Tissue|2016
1-4|0.2|0.3|0.2|37|Mortality|15996982|Acute Lymphocytic|2017
1-4|6.9|7.7|7.3|1165|Incidence|15996982|Acute Lymphocytic|2017
1-4|0.3|0.4|0.3|54|Mortality|15996982|Acute Myeloid|2017
1-4|0.8|1.1|1.0|154|Incidence|15996982|Acute Myeloid|2017
1-4|~|~|~|~|Mortality|15996982|Bones and Joints|2017
1-4|0.2|0.3|0.2|39|Incidence|15996982|Bones and Joints|2017
1-4|0.6|0.8|0.7|110|Mortality|15996982|Leukemia|2017
1-4|8.2|9.1|8.6|1382|Incidence|15996982|Leukemia|2017
1-4|0.5|0.7|0.6|90|Mortality|15996982|Other|2017
1-4|4.8|5.6|5.2|831|Incidence|15996982|Other|2017
1-4|0.1|0.3|0.2|28|Mortality|15996982|Soft Tissue|2017
1-4|1.1|1.4|1.2|196|Incidence|15996982|Soft Tissue|2017
10-14|0.1|0.3|0.2|43|Mortality|20767794|Acute Lymphocytic|2017
10-14|2.2|2.6|2.4|494|Incidence|20767794|Acute Lymphocytic|2017
10-14|0.2|0.3|0.2|45|Mortality|20767794|Acute Myeloid|2017
10-14|0.5|0.8|0.6|133|Incidence|20767794|Acute Myeloid|2017
10-14|0.2|0.3|0.2|50|Mortality|20767794|Bones and Joints|2017
10-14|1.3|1.7|1.5|311|Incidence|20767794|Bones and Joints|2017
10-14|0.4|0.6|0.5|109|Mortality|20767794|Leukemia|2017
10-14|3.1|3.6|3.3|687|Incidence|20767794|Leukemia|2017
10-14|0.3|0.4|0.3|69|Mortality|20767794|Other|2017
10-14|3.6|4.2|3.9|808|Incidence|20767794|Other|2017
10-14|0.1|0.3|0.2|41|Mortality|20767794|Soft Tissue|2017
10-14|0.7|1.0|0.8|173|Incidence|20767794|Soft Tissue|2017
15-19|0.2|0.4|0.3|59|Mortality|21094597|Acute Lymphocytic|2017
15-19|1.5|1.8|1.6|346|Incidence|21094597|Acute Lymphocytic|2017
15-19|0.2|0.4|0.3|59|Mortality|21094597|Acute Myeloid|2017
15-19|0.7|0.9|0.8|172|Incidence|21094597|Acute Myeloid|2017
15-19|0.4|0.6|0.5|104|Mortality|21094597|Bones and Joints|2017
15-19|1.4|1.7|1.5|319|Incidence|21094597|Bones and Joints|2017
15-19|0.6|0.8|0.7|145|Mortality|21094597|Leukemia|2017
15-19|2.8|3.2|3.0|629|Incidence|21094597|Leukemia|2017
15-19|0.4|0.6|0.5|110|Mortality|21094597|Other|2017
15-19|9.6|10.5|10.1|2124|Incidence|21094597|Other|2017
15-19|0.2|0.4|0.3|62|Mortality|21094597|Soft Tissue|2017
15-19|1.1|1.4|1.2|262|Incidence|21094597|Soft Tissue|2017
5-9|0.1|0.3|0.2|39|Mortality|20309346|Acute Lymphocytic|2017
5-9|3.0|3.5|3.2|654|Incidence|20309346|Acute Lymphocytic|2017
5-9|0.1|0.1|0.1|18|Mortality|20309346|Acute Myeloid|2017
5-9|0.3|0.5|0.4|80|Incidence|20309346|Acute Myeloid|2017
5-9|~|~|~|~|Mortality|20309346|Bones and Joints|2017
5-9|0.4|0.7|0.5|110|Incidence|20309346|Bones and Joints|2017
5-9|0.3|0.5|0.4|77|Mortality|20309346|Leukemia|2017
5-9|3.6|4.1|3.9|782|Incidence|20309346|Leukemia|2017
5-9|0.3|0.5|0.4|82|Mortality|20309346|Other|2017
5-9|2.0|2.4|2.2|437|Incidence|20309346|Other|2017
5-9|0.1|0.2|0.1|29|Mortality|20309346|Soft Tissue|2017
5-9|0.6|0.8|0.7|135|Incidence|20309346|Soft Tissue|2017
<1|~|~|~|~|Mortality|3893990|Acute Lymphocytic|2017
<1|1.3|2.1|1.7|65|Incidence|3893990|Acute Lymphocytic|2017
<1|~|~|~|~|Mortality|3893990|Acute Myeloid|2017
<1|1.2|2.0|1.5|60|Incidence|3893990|Acute Myeloid|2017
<1|~|~|~|~|Mortality|3893990|Bones and Joints|2017
<1|~|~|~|~|Incidence|3893990|Bones and Joints|2017
<1|0.3|0.8|0.5|19|Mortality|3893990|Leukemia|2017
<1|3.6|4.9|4.2|163|Incidence|3893990|Leukemia|2017
<1|0.3|0.7|0.4|17|Mortality|3893990|Other|2017
<1|12.1|14.4|13.2|515|Incidence|3893990|Other|2017
<1|~|~|~|~|Mortality|3893990|Soft Tissue|2017
<1|2.6|3.7|3.1|120|Incidence|3893990|Soft Tissue|2017
1-4|0.1|0.3|0.2|30|Mortality|15947619|Acute Lymphocytic|2018
1-4|7.4|8.2|7.8|1231|Incidence|15797519|Acute Lymphocytic|2018
1-4|0.3|0.5|0.4|56|Mortality|15947619|Acute Myeloid|2018
1-4|0.7|1.0|0.8|133|Incidence|15797519|Acute Myeloid|2018
1-4|~|~|~|~|Mortality|15947619|Bones and Joints|2018
1-4|0.1|0.3|0.2|29|Incidence|15797519|Bones and Joints|2018
1-4|0.5|0.8|0.7|106|Mortality|15947619|Leukemia|2018
1-4|8.6|9.5|9.0|1425|Incidence|15797519|Leukemia|2018
1-4|0.5|0.8|0.7|105|Mortality|15947619|Other|2018
1-4|4.3|5.0|4.7|735|Incidence|15797519|Other|2018
1-4|0.1|0.3|0.2|28|Mortality|15947619|Soft Tissue|2018
1-4|0.9|1.2|1.0|159|Incidence|15797519|Soft Tissue|2018
10-14|0.2|0.3|0.3|56|Mortality|20868629|Acute Lymphocytic|2018
10-14|2.0|2.4|2.2|445|Incidence|20671678|Acute Lymphocytic|2018
10-14|0.1|0.2|0.2|36|Mortality|20868629|Acute Myeloid|2018
10-14|0.6|0.8|0.7|139|Incidence|20671678|Acute Myeloid|2018
10-14|0.3|0.4|0.3|71|Mortality|20868629|Bones and Joints|2018
10-14|1.4|1.7|1.5|320|Incidence|20671678|Bones and Joints|2018
10-14|0.4|0.6|0.5|110|Mortality|20868629|Leukemia|2018
10-14|3.0|3.5|3.2|661|Incidence|20671678|Leukemia|2018
10-14|0.2|0.3|0.2|49|Mortality|20868629|Other|2018
10-14|4.0|4.5|4.2|878|Incidence|20671678|Other|2018
10-14|0.2|0.3|0.2|51|Mortality|20868629|Soft Tissue|2018
10-14|0.8|1.0|0.9|187|Incidence|20671678|Soft Tissue|2018
15-19|0.3|0.5|0.4|78|Mortality|21064661|Acute Lymphocytic|2018
15-19|1.8|2.2|2.0|415|Incidence|20883816|Acute Lymphocytic|2018
15-19|0.2|0.3|0.2|51|Mortality|21064661|Acute Myeloid|2018
15-19|0.7|0.9|0.8|164|Incidence|20883816|Acute Myeloid|2018
15-19|0.4|0.6|0.5|98|Mortality|21064661|Bones and Joints|2018
15-19|1.3|1.6|1.5|308|Incidence|20883816|Bones and Joints|2018
15-19|0.7|0.9|0.8|162|Mortality|21064661|Leukemia|2018
15-19|3.0|3.5|3.3|679|Incidence|20883816|Leukemia|2018
15-19|0.4|0.6|0.5|113|Mortality|21064661|Other|2018
15-19|10.3|11.2|10.8|2250|Incidence|20883816|Other|2018
15-19|0.3|0.5|0.4|81|Mortality|21064661|Soft Tissue|2018
15-19|0.9|1.2|1.1|220|Incidence|20883816|Soft Tissue|2018
5-9|0.1|0.2|0.1|28|Mortality|20188285|Acute Lymphocytic|2018
5-9|3.3|3.8|3.6|711|Incidence|19996754|Acute Lymphocytic|2018
5-9|0.1|0.2|0.1|29|Mortality|20188285|Acute Myeloid|2018
5-9|0.3|0.5|0.4|79|Incidence|19996754|Acute Myeloid|2018
5-9|0.1|0.2|0.1|25|Mortality|20188285|Bones and Joints|2018
5-9|0.5|0.8|0.7|131|Incidence|19996754|Bones and Joints|2018
5-9|0.3|0.4|0.3|66|Mortality|20188285|Leukemia|2018
5-9|3.9|4.4|4.2|831|Incidence|19996754|Leukemia|2018
5-9|0.2|0.4|0.3|61|Mortality|20188285|Other|2018
5-9|1.8|2.2|2.0|393|Incidence|19996754|Other|2018
5-9|0.1|0.2|0.2|31|Mortality|20188285|Soft Tissue|2018
5-9|0.5|0.8|0.6|127|Incidence|19996754|Soft Tissue|2018
<1|~|~|~|~|Mortality|3815343|Acute Lymphocytic|2018
<1|1.4|2.2|1.7|66|Incidence|3779884|Acute Lymphocytic|2018
<1|~|~|~|~|Mortality|3815343|Acute Myeloid|2018
<1|1.2|2.0|1.6|59|Incidence|3779884|Acute Myeloid|2018
<1|~|~|~|~|Mortality|3815343|Bones and Joints|2018
<1|~|~|~|~|Incidence|3779884|Bones and Joints|2018
<1|~|~|~|~|Mortality|3815343|Leukemia|2018
<1|3.6|4.9|4.2|159|Incidence|3779884|Leukemia|2018
<1|0.3|0.7|0.5|18|Mortality|3815343|Other|2018
<1|13.1|15.5|14.3|540|Incidence|3779884|Other|2018
<1|~|~|~|~|Mortality|3815343|Soft Tissue|2018
<1|2.2|3.2|2.7|101|Incidence|3779884|Soft Tissue|2018
